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Several cytochrome P-450 enzymes are thought to have evolved to metabolise lipophillic
xenobiotics allowing subsequent conjugatory and excretory steps to occur. The nature of the
metabolic activity of these enzymes and their ability to activate a series of carcinogens has
implicated them in carcinogenesis. The CYP2E subfamily activates a series of common
carcinogens including N-nitrosodimethylamine (NDMA); situations therefore in which
CYP2E levels are elevated may lead to increased carcinogenic risk. A mouse CYP2E cDNA
and the single copy CYP2E gene were cloned and characterised and the regulation of
CYP2E in this species was studied.
Mouse CYP2E protein levels were seen to be elevated by acetone in a variety of tissues; no
concomitant increase in CYP2E mRNA was seen. Previous studies in the rat suggested that
the CYP2E elevation resulted from substrate induced protein stabilisation. This stabilisation
was suggested to be mediated by the presence of the substrate leading to the blocking of a
phosphorylation event which may trigger CYP2E protein degradation. This was investigated
using mutant forms of the mouse CYP2E protein lacking the phosphorylation site; in
mammalian tissue culture systems both mutant and native CYP2E proteins behaved
identically suggesting that the protein stabilisational event may be mediated via a mechanism
other than the blocking of a phosphorylational change in the CYP2E protein.
The CYP2E mRNA and protein became elevated both in the spontaneously diabetic BB/E
rat, and the mouse following starvation. As a result of increased p-oxidation in these states
ketone body levels become elevated which may lead to stabilisation of the CYP2E protein.
Previous studies in chemically induced diabetic rats suggested that the message elevation
resulted from the stabilisation of pre-existing CYP2E transcripts; previously characterised
events of this kind were seen to be mediated by elements within the 3' untranslated region
(UTR) of a message. The fact that the mouse CYP2E 3' UTR is interrupted by insertion of a
p2 repetitive element and that that the control transcript used in the chemically induced
diabetic rat was elevated in the spontaneously diabetic BB/E rat suggested that transcript
stabilisation may not be responsible for the CYP2E mRNA elevations seen in these
situations. The similarity between the induction pattern of the CYP2E subfamily and several
gluconeogenic enzymes, and the previous suggestion that the CYP2E subfamily may
possess an endogenous gluconeogenic role, prompted the analysis of the effect of insulin on
the transcriptional activity of the mouse CYP2E 5' region. The mouse CYP2E promoter was
functional in a promoter-assay system but insulin had no effect on its transcriptional activity.
In the BB/E rat the diabetic state also elevated the levels of several other P-450 subfamilies
potentially giving an insight either into the vestigial controls operating on, or the true
endogenous functions of these enzymes normally studied solely with regard to their
xenobiotic metabolising role.
In order to assess the metabolic role of the CYP2E subfamily the mouse cDNA was
heterologously expressed in procaryotic and eucaryotic systems and portions of the mouse
gene were used in a gene-targeting experiment attempting to delete the subfamily from the
mouse genome. Although unsuccessful in their original objectives, results from these
studies give insights into the basis for further analysis of the role of the CYP2E subfamily.
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Section 1.1: The Cytochrome P-450 multigene family
The cytochrome P-450 (P-450) multigene family encodes a series of enzymes with
monomeric Mr of around 50,000 containing non-covalently bound haem. The name of
this superfamily derives from the characteristic peak at 450 nm generated from the
difference between the absorption spectra due to the presence of a protohaem group,
produced by the enzymes when reduced and bound by carbon monoxide (Omura &
Sato, 1962). Members of this multigene family are widely dispersed throughout most
of the procaryotic and eucaryotic kingdoms. Although many P-450 "isoforms" (that is
an individual P-450 enzyme produced by a particular P-450 gene) exist, it is thought
that they are unified by their ability to catalyse a common reaction. The P-450 enzymes
function as terminal electron acceptors, receiving reducing equivalents from NADPH or
NADH, and their actions lead to the reductive activation of molecular oxygen. The
result of the activation of oxygen leads to the insertion of one oxygen molecule into the
substrate present within the active site of the P-450 enzyme. Due to the nature of this
reaction, the cytochrome P-450 superfamily of enzymes have been collectively termed
"mono-oxygenases" (Figure 1.1):
Figure 1.1: The basic and unifying reaction catalysed by all P-450 isoforms. RH
represents the substrate acted upon by the P-450 isoform in question.
RH + 02 + NADPH + H+ > ROH + H20 + NADP+
The oxygenation of the substrate can then allow a wide variety of reactions to proceed,
including hydroxylation, epoxidation, per-oxygenation, deamination, desulphation,
demethylation and dehalogenation (Porter & Coon, 1991). P-450 enzymes have also
been demonstrated to catalyse the reductive metabolism of chemicals when the donated
electrons are passed to the substrate rather than the oxygen molecule generating, in the
terminology of Figure 1, RH(H)2 (deGroot & Sies, 1989). In this manner the enzymes
can act as oxidases, following the reduction of oxygen , generating hydrogen peroxide
or water. This reaction has implicated the P-450 enzymes in oxidative stress and lipid
peroxidation as a result of the radicals generated by these reactions (Gorsky et
al., 1984).
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Mammalian P-450 are found predominantly in the liver although they have also been
observed to be present at lower levels in all tissues examined with the exception of
striated muscle. Mammalian P-450 can be divided broadly into two classes. The first
class of P-450 are those present in the mitochondrion which receive reducing
equivalents from membrane bound adrenodoxin. These P-450 catalyse very specific
reactions in the processes of steroid and bile acid biogenesis and their expression is
localised to those tissues associated with these biosynthetic pathways. The second class
of mammalian P-450 are bound to the endoplasmic reticulum and receive reducing
equivalents from NADPH P-450 reductase (P-450 reductase) and in some instances
cytochrome b5. This group subdivides broadly into two types of P-450 with one
group, in a similar manner to the mitochondrial P-450, catalysing very specific
reactions concerned with steroid metabolism. The second group however contains P-
450 isoforms capable of catalysing a diverse range of reactions involving both
endogenous chemicals, drugs and xenobiotics (i.e. a foreign compound which
possesses none of the capacities of the first two groups, such as environmental
pollutants) as substrates. Members of this group of enzymes are often termed
"xenobiotic metabolising" P-450 and each individual isoform from this group, unlike
most other enzymes, has the ability to catalyse reactions involving a broad substrate
range. Collectively these xenobiotic metabolising P-450 represent the most versatile
biological catalysts known and the combination of all the P-450 isoforms present in an
organism generates the ability to metabolise a vast array of chemicals. P-450 have been
observed to be capable of catalysing the metabolism of substrates ranging in size from
ethylene (Mr 28) to cyclosporin (Mr 1,201) aptly demonstrating the wide substrate
range of the xenobiotic metabolising P-450 enzymes (Ryan & Levin, 1990).
The majority of substrates metabolised by P-450 are lipophillic and one proposed role
for the non-steroidigenic P-450 isoforms is in the activation of these compounds to
enable their excretion; in this capacity P-450 are regarded as "Phase I" enzymes. By
catalysing an oxygenation reaction on a lipophillic compound, P-450 allow the
compound to become conjugated with a variety of chemical groups, such as
glutathione, glucuronic acid and other sugars, methyl, acetyl and sulphate as a result of
the activities of the "Phase II" enzyme systems. Enzymes of the Phase II system
include the products of the glutathione S-transferase (GST), N-acetyl transferase and
UDP-glucuronyl transferase gene families. The combination of these two processes
allows the excretion of the resultant polar compound to occur. The Phase II conjugatory
steps are spatially separate from the Phase I activation steps and the nature of the
pathway(s) of conjugation which a P-450 activated, or "functionalised", compound can
undergo are viewed as stochastic. (Astrom & DePierre, 1986. Gibson & Skett, 1986)
(Figure 1.2).
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The activities of many of the xenobiotic metabolising P-450 are induced by the
compounds which they metabolise, and this induction pattern is thought to represent
part of an adaptive response which an organism can mount on exposure to xenobiotics
to accelerate their excretion (Wolf, 1986) (Figure 1.3).
Figure 1.3: A feedback-loop whereby a xenobiotic may induce P-450 isoforms
involved in its own metabolism thus accelerating its removal from the body:
vrMnnlATin P-450 METABOLISINGXENOBIOTIC XENOBIOTIC
A
"X"
\ /(—) METABOLISM/REMOVAL ( ~Tj
OF XENOBIOTIC "X"
The actions of the xenobiotic metabolising P-450 can lead to both harmful and helpful
consequences within an organism. A combination of the stochastic nature of Phase II
conjugation reactions and the ability of many xenobiotics to induce their own
metabolism can result in situations where the high energy intermediates generated by P-
450 catalysed reactions are not efficiently conjugated by Phase II processes. These
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reactive compounds can then react with cellular proteins, RNA and DNA and can lead
to cell death, mutagenesis or the initiation of carcinogenesis. It is this potentially
harmful feature of the xenobiotic-metabolising P-450 families activity which has
stimulated much research into these enzymes (Wolf, 1986; Guengerich, 1988;
Gonzalez, 1990; Juchau, 1990; Guengerich, 1991, Gonzalez, 1992).
Section 1.2: Cytochrome P-450 structure
A three-dimensional structure for the soluble procaryotic P-450 CYP101 (P450 cam)
has been obtained from Pseudomonas putida. The P-450 enzyme resembles a triangular
prism with an asymmetrical clustering of a-helices to one half of the molecule which
also contains the haem prosthetic group (Poulos etal., 1987). No direct structural data
has been obtained from any of the membrane bound eucaryotic P-450. However the
membrane attachment region of the eucaryotic protein is suggested to be a small
membrane anchor at the N-terminus of the protein, and various studies have suggested
that the rest of the protein may generate a structure equivalent to that seen in CYP101
(Nelson & Strobel, 1988; Zvelebil et al., 1991). Given that all the P-450 enzymes
catalyse a reacdon with a common theme the suggestion that they will retain a generally
similar structure to accommodate this reaction does not appear unreasonable. A
diagrammatic representation of the structure of membrane bound P-450 is illustrated in
Figure 1.4.
Figure 1.4: A diagramatic representation of the proposed structure and membrane
attachment mechanism of membrane bound cytochrome P-450. Taken from Nelson &
Strobel (1988).
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Section 1.3: Cytochrome P-450 nomenclature
To aid in the distinction of particular P-450 isoforms and allow isoforms from different
species to be logically related, a nomenclature system for the supergene family has been
devised. The predicted or determined amino acid sequence for a new P-450 isoform is
aligned with the amino acid sequences of previously determined P-450. If the new
P-450 sequence shares greater than 40% similarity with any other P-450 sequence or
group of P-450 sequences, it is placed in a common group with them. Collectively
P-450 within a common group of this nature are described as being in the same
"family" denoted by the root "CYP" and distinguished from other families by an arabic
numeral. If sequences within a family share greater than 59% similarity with other
members of that family, then they are placed in a subgroup of the family termed a
"subfamily"; separate subfamilies are denoted by capital letters following the family
numeral. Isoforms within a subfamily are assigned an additional arabic numeral
according to the chronological order of their discovery. P-450 isoforms from different
species, which clearly represent the species-specific version of same enzyme, are given
the chronological discovery numeral of the first isoform in the subfamily to be isolated,
regardless of species of origin or order of discovery, of subsequent enzymes (Figure
Figure 1.4: An example of the application of the P-450 nomenclature system for the
CYP2E1 isoform.
Common root Family 2 Subfamily E First member to be isolated
The mouse P-450 are distinguished from those of all other species through the use of
smaller letters in both the root and subfamily delineation, for example CYP2E
represents the CYP2E subfamily in all species apart from the mouse and Cyp2e
represents the homologous P-450 subfamily in the mouse.
The nomenclature also distinguishes between an isoform's gene and transcript by
italicising the nomenclature, for example CYP2E1 represents either the transcript or the
gene of the CYP2E1 subfamily, whereas the cDNA and protein form of the subfamily
remain non-italicised.
1.4).
CYP 2 E 1
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Although the application of this nomenclature system has enabled the unification of
much of the research on this superfamily, several drawbacks and anomalies are still
present. The chronological assignment of subfamily members, if clear cross species
homologues cannot be assigned, means that genes from different species are mixed
together. The use of small letters to denote P-450 in the mouse and the italicised or non-
italicised distinction of the nature of the P-450 in question can both be confusing.
This nomenclature system is used where possible throughout this work and the trivial
names assigned to particular P-450 isoforms by the original investigators cited are
replaced in this manner. The nature of the P-450 referred to (i.e. whether it is a gene,
mRNA, cDNA or protein) is however stated rather than presented in an italicised or
non-italicised form to avoid confusion. Although when a mouse P-450 is discussed in
isolation small letters are used, if a subfamily is being discussed in general capital
letters are employed, so for example the "CYP2E subfamily" refers to all members of
that subfamily in all species including the mouse.
Section 1.4: Evolution of the P-450 superfamily
P-450 genes are widely spread throughout the procaryotic and eucaryotic kingdoms and
may have originated from a single ancestral gene. Through the analysis of P-450 amino
acid sequences obtained from a variety of organisms, in conjunction with information
about predicted speciation times, an evolutionary mechanism leading to the generation
of the P-450 superfamily has been postulated (Nelson & Strobel, 1987; Borlakoglu &
John, 1989; Ronis et al., 1989; Gonzalez & Nebert, 1990). The enzyme encoded by the
ancestral P-450 gene may have been involved in steroid metabolism and the
maintainance of lipid membranes, and is thought to have undergone a duplication event
approximately 1.4 billion years ago giving rise to the two classes of mitochondrial and
endoplasmic reticulum attached P-450. Approximately 900 million years ago, it is
predicted that several gene duplication events in the endoplasmically attached isoform
gene formed the basis for the development of the steroid biosynthetic and xenobiotic
metabolising P-450 forms. This latter lineage underwent a great deal of further
duplication and expansion approximately 400 to 600 million years ago. This period of
marked expansion of the xenobiotic metabolising P-450 is thought to have occurred in
the Devonian period of the Paleozoic era and may therefore have coincided with the
emergence of vertebrates onto land. The driving force behind this period of xenobiotic
P-450 gene expansion was suggested to be the result of "animal-plant chemical
warfare" experienced by the newly emerged land vertebrates (Gonzalez & Nebert,
1990). The expansion of xenobiotic metabolising P-450 genes may therefore have
reflected the need of land vertebrates to metabolise and excrete plant xenobiotics, or
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"phytoallexins"; the plants had colonised the land several million years before the
emergence of the vertebrates. The expansion of the xenobiotic metabolising P-450 is
thought to have arisen by gene duplication and following speciation, species unique
gene duplication and gene conversion events generated species specific P-450 gene
profiles. The P-450 profile present in a particular species may reflect the effect of the
specific diet of that species, which then drives the expansion of P-450 families or
subfamilies with metabolic activities pertinent to the xenobiotics encountered (Gonzalez
& Nebert, 1990). Examples of species specific subfamily gene expansion have been
seen, in the rat CYP2D subfamilies, which is suggested to have arisen by several clear
duplication and conversion events leading to expansion of the CYP2D subfamily to
contain at least 5 genes (Matsunaga etal., 1990).
Section 1.5: Mammalian P-450 families
The nomenclature system applied to delineate the P-450 superfamily has resulted in the
establishment of 10 mammalian P-450 families. These families can be broadly divided
according to their function and both the specificity and nature of the reactions which
they catalyse. Mammalian P-450 families 1 to 3, with the possible inclusion of family
4, are involved in the metabolise of xenobiotics and individual enzymes from these
families are capable of metabolising a wide substrate range. The other 6 families
(families 7, 11, 17, 19, 21 and 27) are involved in the metabolism of steroids and bile
acids and catalyse very specific substrates and reactions (Table 1.1).
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Table 1.1: Mammalian cytochrome P-450 families and their general metabolic
activities: The numbers of subfamily members represent all those known in all
mammalian species for which clear species independent homologues cannot be
established. Pseudogenes and allelic gene variants are not included in this table (Table
modified from Gonzalez, 1992).
P450 family No. of No. of General reactions
subfamilies isoforms catalysed
CYP1 1 2 Xenobiotic metabolism
CYP2 8 57 Xenobiotic and steroid metabolism
CYP3 1 10 Xenobiotic and steroid metabolism
CYP4 2 10 Fatty acid co-and co-1 hydroxylation
CYP7 1 1 Cholesterol 7a-hydroxylase
CYP11 2 3 Steroid llp-hydroxylase
CYP17 1 1 Steroid 17a-hydroxylase
CYP19 1 1 Steroid to oestrogen aromatase
CYP21 1 1 Steroid 21-hydroxylase
CYP27 1 1 Cholesterol 27-hydroxylase
Section 1.5.1: Mammalian P-450 families associated with xenobiotic metabolism
The CYP1 family: The gene copy number of this family has remained evolutionarily
conserved, and two enzymes, CYP1A1 and CYP1A2, are seen in all mammalian
species studied. In the trout only one CYP1A gene is present, suggesting that a gene
duplication event occurred after the divergence of land and sea vertebrates (Heilmann et
al., 1988). Induction of the CYP1A1 gene by xenobiotics has been well characterised
and is seen to be mediated via a transcription factor, the Ah-receptor (Aromatic
hydrocarbon), which is believed to be a member of the steroid hormone receptor
superfamily (Fujisuma-Sehara et al., 1988; Hoffman et al., 1991).This receptor binds
chemicals such as 3-methylcholanthrene and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
(TCDD), and activates transcription from the CYP1A1 gene on binding xenobiotic
DNA response elements (XREs) in the promoter region of the gene. These XREs
sequences are related to the glucocorticoid response elements (GREs) (Hapgood et al.,
1989). The CYP1A1 protein metabolises a series of xenobiotics including polyaromatic
hydrocarbons such as benzo[a]pyrene. The CYP1A2 gene is also inducible by
xenobiotics but this event may be mediated post-transcriptionally. CYP1A2 has been
shown to metabolise several mutagens such as the arylamine 2-acetyl aminofluorene,
aflatoxin Bi and caffeine (Silver & Krauter, 1990).
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The CYP2 family: This family has undergone a great deal of expansion and is now
represented by 8 subfamilies. The members of this family are suggested to be
principally responsible for the detoxification of xenobiotics and their expansion is
suggested to reflect this role (Nelson & Strobel, 1987; Henderson & Wolf, 1992).
The CYP2A subfamily: The members of this family are associated with the
metabolism of steroids with, for example, rat CYP2A1 and CYP2A2 catalysing the 7a
and 15a hydroxylation of several steroids including testosterone and dihydroxy-
testosterone. These reactions may play a role in the action of these hormones ; it was
seen that the 7a-hydroxylated form of testosterone does not possess androgenic
activity and can inhibit other enzymes associated with steroid metabolism (Sonderfan &
Parkinson, 1988). The CYP2A subfamily also metabolises drugs, such as coumarin,
and xenobiotics, for example some nitrosoamines (Yun et al., 1992). To date three
CYP2A members have been identified in the rat whereas mouse and human only
possess two. Members of this family have been seen to be transcriptionally induced by
3-methylcholanthrene (Nagata et al., 1987).
The CYP2B subfamily: Although the members of the CYP2B subfamily are
generally regarded as being inducible by compounds such as phenobarbital, this
subfamily demonstrates how members of the same gene subfamily can respond
differently to inducing agents. In the rat CYP2B subfamily, the CYP2B 1, 2, and 8
genes are transcriptionally induced by phenobarbital whilst CYP2B3 is not (Giachelli et
al., 1989). The molecular mechanism behind the transcriptional induction of the
CYP2B subfamily by compounds such as phenobarbital is unclear, and a nuclear
receptor for the inducing agents, if one exists, appears to possess little affinity for the
inducing chemicals (Okey, 1990). P-450 genes in Bacillus megaterium were also seen
to be inducible by compounds such as phenobarbital. This observation suggests that the
presence of common control elements in the regulation of P-450 genes across a wide
variety of species has been evolutionarily conserved (He & Fulco, 1991). The CYP2B
members have been shown to catalyse a variety of reactions including the N-
demethylation of benzphetamine, the hydroxylation of hexobarbital and a series of
steroid hydroxylations (Giachelli et al., 1989).
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The CYP2C subfamily: This subfamily is the largest of the family 2 P-450 with at
least 9 genes present in the rat and 6 in the human. The activities of these proteins has
been associated with the metabolism of both steroids and drugs such as mephenytoin.
Although some members of the CYP2C subfamily have been shown to be inducible,
for example the rabbit CYP2C 4 gene is induced by phenobarbital, most members are
considered as being constitutively expressed (Hasset & Omiecinski, 1990). In the rat
several members of the CYP2C subfamily demonstrate sexual dependence and
dimorphism and the mechanisms for establishing these differences is been analysed
(Mode etal., 1988).
The CYP2D subfamily: This subfamily contains at least 5 genes in the rat although
only 1 functional genes is present in the human (Matsunaga et al., 1990). The
subfamily does not appear to be inducible on exposure to xenobiotics, and is associated
with the metabolism of steroids as well as several drugs such as debrisoquine and
sparteine in humans (Gonzalez etal., 1987; Gough et al., 1990; Smith et al., 1992).
The CYP2E subfamily: the CYP2E subfamily represents the most highly
conserved family 2 subfamily, with only a single gene being observed in all species
examined apart from the rabbit where the gene has recently duplicated (Khani et al.,
1988). The CYP2E proteins catalyse the metabolism of a series of small solvent
molecules including ethanol, isopropanol, and acetone, drugs such as acetominophen
and several carcinogenic nitrosamines such as A-nitrosodimethylamine (NDMA).
Members of this subfamily are seen to be induced following exposure to several solvent
molecules, starvation or in the diabetic state (Yang et al., 1990). This subfamily is
discussed in more detail below.
The CYP2F subfamily: A subfamily related to the CYP2A subfamily and only
characterised to date in humans which appear to contain at least 2 CYP2F genes.
CYP2F protein is seen to be expressed in the lung, where it has been shown to
metabolise the lung toxin skatole (3-methylindole) (Thornton-Mannering etal., 1991).
The CYP2G subfamily: A subfamily characterised to date only in the rat where
CYP2G protein has been seen to be expressed only in the nasal mucosa. This
observation has led to the suggestion that this subfamily may be involved in the
biotransformation and detection of odorants and olfactory sensing (Nef et al., 1990).
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The CYP2H subfamily: A subfamily characterised to date only in chickens where 2
members are present. The genes appear to be inducible by phenobarbital, but the
reactions which they catalyse have not been extensively characterised (Hansen & May,
1989).
The CYP3 family: Members of the CYP3A subfamily are inducible by
glucocorticoids and synthetic steroids such as dexamethasone and pregnenelone 16 a-
carbonitrile. The human possesses at least 4 CYP3 genes and the transcripts from this
family are the most abundant in the liver (Aoyama et al., 1989). The CYP3A subfamily
members are involved in the metabolism of steroids and it is still a matter of debate as to
whether the reactions which they catalyse are purely degradative, or generate products
with an intrinsic biological role. Members of the CYP3A subfamily have also been
shown to metabolise drugs such as nifenipine and ethylmorphine, and xenobiotics such
as aflatoxin Bi and Cyclosporin A (Grogan et al., 1990)-
The CYP4 family: The CYP4 family is predicted to be very ancient and possesses 2
subfamilies which have themselves undergone some expansion in gene copy numbers.
The CYP4A subfamily catalyses the co, and co-1 hydroxylation of short to medium
chain fatty-acids such as palmitate, laurate, and arachidonate; it is not clear if this
subfamily is involved in the metabolism of xenobiotics. Several members of the
CYP4A subfamily are induced on exposure to a variety of hypolipidaemic drugs such
as clofibrate (Hardwick et al., 1986). This induction is mediated via the peroxisome
proliferation activated receptor (PPAR), a member of the steroid hormone superfamily,
and may form part of a gene locus associated with elevated peroxisomal activity (Reddy
et al., 1992; Isseman & Green, 1990). In the rat the second CYP4 subfamily, CYP4B,
has been shown to metabolise xenobiotics such as aflatoxin Bi and 2-
acetylaminofluorene (Nhanburo et al., 1989).
Section 1.5.2: Mammalian P-450 families associated with steroid anabolism
The endoplasmically attached CYP7, 17, 19, 21 and 27 families and the mitochondrial
CYP11 family are involved in the synthesis of steroid, sex-steroid, mineralocorticoid
and glucocorticoid hormones. Unlike families 1 to 4 these families catalyse very
specific reactions on very specific substrates and are seen to be expressed only in
tissues involved in steroid anabolism. These P-450 are generally thought not to
participate in the metabolism of xenobiotics, but this view has been questioned
(Niranjan et al., 1988. Hollis, 1990). Unlike the xenobiotic metabolising P-450, the
gene copy numbers of these gene families have not undergone significant expansion
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(Al-Othman et al., 1988; Fevold et al., 1989). Genes from the CYP 11, 17 and 21
families have been shown to be transcriptionally induced by elevations in cAMP levels
on stimulation of cells with adrenocorticotrophin hormone (ACTH) (Waterman et al.,
1988). Several genes from these families have been sequenced, and although they were
not seen to possess canonical cAMP response elements (CREs), they have been
suggested to contain several novel CREs (Inou et al., 1988).
Section 1.6: The role for P-450 enzymes in chemical carcinogenesis
P-450 catalysed activation of lipophillic compounds can lead to damage of cellular
macromolecules and the potential initiation of carcinogenesis. Since the observation that
these enzyme systems were responsible for the biotransformation and activation of
carcinogenic azo-dyes (Meuller & Miller , 1948; Meuller & Miller, 1953), attempts to
understand the roles which both individual P-450 isoforms, and the P-450 superfamily
as a whole, play in the generation of genotoxic damage, has been a central theme to a
large amount of P-450 research. Understanding physiological and environmental
situations which may perturb P-450 activity levels, with the resultant modifications in
potential carcinogenic risks, is also therefore of central importance in understanding
their role in carcinogenesis. Research establishing roles for P-450 in the initiation of
carcinogenesis has exploited both whole animal and reductionist systems, and
employed both biochemical and genetic approaches.
The biochemical analysis of P-450 initially addresses the possibility that the
metabolism of a compound is catalysed by P-450 and allows the nature of the products
of such a reaction to be analysed. Biochemical assays have employed endoplasmic
reticulum enriched fractions ("microsomes") and the involvement of P-450 in the
metabolism of a chemical has been established through the use of general P-450
inhibitors, such as metyrapone and SKF525A. The potential contribution of an
individual P-450 isoform in the metabolism of a chemical can then be assessed either by
employing microsomes in which that particular isoform has been induced (Kaminsky et
al., 1983), by adding inhibitory antibodies to a specific isoform to the microsomal
mixture (Edwards et al., 1991), or by adding chemical inhibitors to a particular isoform
(Hall et al., 1987). This approach has the advantage that it does not pre-suppose which
P-450 isoform may be involved in the metabolism of a chemical, and has been used to
delineate the P-450 isoforms involved in the metabolism of a variety of xenobiotics for
example aflatoxin Bi (Shimada & Guengerich, 1989; Forrester et al., 1990).
Alternatively, the potential reactions catalysed by an individual P-450 isoform can be
studied in isolation from the rest of the P-450 population; theoretically if a panel of
P-450 were generated in this manner the potential metabolism of a chemical by each
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individual P-450 isoform present in the total organism could be assessed. The P-450
isoform can either be purified directly from the animal tissue in which it is
endogenously expressed (Wood et al., 1976; Levin et al., 1986), or generated
heterologously. This second heterologous expression approach has now been applied
in bacterial (Barnes et al., 1991; Larson et al., 1991), yeast (Guengerich etal., 1991b)
and Drosophila (Jowett et al., 1991), systems and both in insect (Asseffa et al., 1989;
Thornton-Mannering et al., 1991) and mammalian tissue culture (Zuber et al., 1986,
Simula et al., 1993). In using this approach to determine the metabolic roles of P-450
isoforms in the metabolism of a certain chemical, it must always be remembered that,
particularly in the generation of the P-450 isoform by heterologous expression, the
possible use of an allelic variant of a P-450 isoform may greatly influence the results
obtained.
Whole animal models have been employed in the establishment of roles for P-450
isoforms in carcinogenesis. Mouse strains were discovered which, due to presumed
genetic differences in the Ah receptor protein, showed either a high, "responsive", or
low, "non-responsive", induction level of CYP1A1 following exposure to a variety of
polyaromatic hydrocarbons such as 3-methylcholanthrene (Nebert & Negishi, 1984).
On exposure to carcinogenic polyaromatic hydrocarbons, such as benzo[a]pyrene,
which is both carcinogenic and an inducer of the CYP1A1 isoform, the effect of the
level of CYP1A1 induction on chemical carcinogenesis was studied. It was seen that
the responsive strains, with high CYP1A1 induction, were more susceptible to
fibrosarcomas and lung tumours following subcutaneous injection and tracheal
instillation of the carcinogen respectively, than the non-responsive strains with lower
CYP1A1 levels. Conversely it was seen that the non-responsive strains were more
susceptible than the responsive strains to lymphosarcomas and leukemias as a result of
subcutaneous administration of the carcinogen (Nebert & Negishi, 1984). These results
are suggested to reflect the nature of the carcinogen administration. In the responsive
strains, the clearance and detoxification of the carcinogen by CYP1A1 and the
conjugatory systems within the liver, the "first pass" clearance, is greater than in the
non-responsive strains and reduces the delivery of the carcinogen to remote sites of the
body, leading to a reduced incidence of lymphomas and leukemias. Tumour generation
at the site of administration in the responsive strains was higher however, due to the
induction of CYP1A1 and the generation of activated metabolites at these sites in
higher levels than generated at the site of administration in the non-responsive strains
(Okey etal., 1988).
It was observed that the the human CYP1A1 gene in primary cultured lymphocytes
demonstrated a trimodal distribution of induction response with "high", "low", and
"intermediate" induction levels being seen (Kellerman et al., 1973). Studies suggested a
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correlation between the inducibility of the CYP1A1 subfamily and the level of cancers
resulting from exposure to carcinogens, such as benzo[a]pyrene, present in cigarette
smoke. Smokers of high and intermediate inducible CYP1A1 phenotype displaying a
36 fold and 16 fold higher incidence of bronchial carcinoma than those with a low
inducibility phenotype (Kouri etal., 1982).
By studying genetic polymorphisms in P-450 genes which result in a changed
metabolic activity and establishing a correlation between the modified metabolic activity
and the incidence of cancer, links between P-450 isoforms and carcinogenesis can be
established. Such studies provide a powerful genetic and epidemiological approach to
establish links between particular P-450 isoforms and particular cancer incidence
(Wolf, 1990; Smith et al., 1992). An example of the use of this approach was used in
the analysis of the human CYP2D locus; mutations in this locus lead to the loss of
functional CYP2D protein which is reflected in an individuals reduced ability to
metabolise the drugs debrisoquine and sparteine. Genotype analysis of polymorphisms
within the CYP2D locus lead to establishment of a correlation between the loss of
functional CYP2D subfamily activity and reduced susceptibility to smoking-induced
cancers (Gough et al., 1990; Smith et al., 1992).
By a combination of biochemical and genetic studies, it is clear that P-450 are capable
of metabolising and activating a variety of carcinogens, and it is seen that variations in
the P-450 isoforms present in the total P-450 population of an organism can effect the
degree of carcinogenesis experienced on exposure to foreign compounds.
Section 1.7: The CYP2E subfamily
Unlike other CYP2 subfamilies the CYP2E subfamily is unique in that it is present as a
single gene in most species studied; the proteins encoded by the CYP2E genes of a
variety of species are highly conserved suggesting that they may play a highly
conserved role in a variety of organisms. The rabbit provides an exception to this
observation; in this species two genes are present which are predicted to be the result of
a gene duplication event which took place around 11 million years ago, well after the
predicted rabbit speciation point. The two rabbit genes however are still highly similar
with only 18 amino changes present throughout the length of the 493 amino acid
sequence (Khani etal., 1988).
Interest in the CYP2E subfamily has mainly centred around its role in the metabolism of
a series of common environmental nitrosamines which are carcinogenic, and an
understanding of the control of this subfamily provides an insight into situations which
may lead to an increased carcinogenic risk following exposure to these compounds.
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Section 1.7.1: The role of the CYP2E subfamily in the metabolism of nitrosamines
and other solvents
Several nitrosamines are metabolised by the CYP2E subfamily and this class of
compounds represents one of the most potent group of carcinogens known. The
carcinogenic properties of nitrosamines have been recognised for many years (Magee &
Barnes, 1956), and nitrosamines have been shown in animal studies to be capable of
generating every class of human cancer (Lijinsky, 1992). The chemical structures of
several carcinogenic nitrosamines are illustrated in Figure 1.6:
Figure 1.6: The chemical structure of several carcinogenic nitrosamines (Taken from
Lijinsky, 1992).
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The majority of nitrosamines are solvents and most unsubstituted forms are liquid at
room temperature whether symmetrical or unsymmetrical, cyclic or acyclic. Although
some examples exist of nitrosamines being present in a native from in the environment,
such as the methylnitrosourea derivative streptozotocin which is produced by the soil
fungus Streptomyces achromogenes, most nitrosamines are formed endogenously
within the body. Nitrosamines are generated following reactions between nitrites and
either secondary or tertiary amines. Nitrites are used to produce cured meat and fish,
and are present in beverages produced from heated malt such as beer and whisky.
Nitrites are also produced within the body following the reduction of nitrates present in
the environment and the diet. Amines are naturally present in foods, and are used as
food additives and in agricultural, industrial and medicinal chemicals. The acidic nature
of the stomach provides a perfect environment for the formation of nitrosamines from
ingested amines and nitrite. Nitrosamines are also present in cured tobacco and, when
either inhaled into the lungs as smoke, the nose as snuff or chewed, represent the most
significant carcinogens present in these products. Occupational exposure to
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nitrosamines arises in the leather tanning and rubber manufacturing industries, as well
as from the general use of amines as bases in industrial synthesis and their inclusion in
cutting and lubricating oils (Winn, 1984; Bartsch & Montesano; 1984. Lijinsky,
1992).
Nitrosamines need to be activated to produce their carcinogenic action through reactions
leading to the generation of a reactive alkyldiazonium species capable of alkylating
DNA. The nature of the alkyldiazonium species generated is dependent on the parent
molecule so, for example, the activation of A-nitrosodimethylamine (NDMA) generates
methylated purine and pyrimidine nucleotides upon activation, whereas N-
nitosodiethylamine (NDEA) generates ethylation products (Lijinski, 1992). Given the
widespread distribution of these compounds in the environment and the ease of their
endogenous formation, coupled with their potent carcinogenic actions, the enzymes
capable of catalysing these activation reactions are of extreme importance.
Studies on the activation of NDMA by demethylation implicated P-450 enzymes in
catalysing this reaction. It appeared that several enzymes were involved in the
demethylation of NDMA as multiple Km values for this reaction were obtained (Czygan
et al., 1973). The enzyme with the lowest Km in the demethylation of NDMA,
approximately 20 }lM, was purified from rat liver and was shown to be CYP2E1
(Patten et al., 1986). The other enzymes with higher Km values (0.3-0.5 mM) for the
demethylation of NDMA were later seen to be members of the CYP2A subfamily (Yun
et al., 1992).
The rat CYP2E1 enzyme was shown to be capable of activating a series of other
nitrosamines including NDEA and A-nitrosobutylmethylamine (NBMA) and it appears
that the steric constraint engendered by the alkyl groups determine the ability of the
nitrosamine to enter the CYP2E1 active site and undergo activation (Lee et al., 1989).
As well as several nitrosamines, the CYP2E subfamily metabolises a series of small
solvents, for example, alcohols (Morgan et al., 1982), isopropanol, acetone (Koop &
Cassaza, 1986), benzene (Johansson & Ingelman-Sundberg, 1988), p-nitrophenol
(Koop, 1989), aniline (Patten et al., 1986), carbon tetrachloride (Johansson &
Ingelman-Sundberg, 1985), chloroform and several ethers (Pantuck et al., 1988. Brady
et al., 1988). The CYP2E subfamily has also been shown to metabolise several
common drugs such as acetominophen (Koop et al., 1982).
The capacity of the CYP2E subfamily to activate several carcinogenic nitrosamines as
well as its role in the metabolism of hepatotoxic chemicals such as carbon tetrachloride
and acetominophen, means that the study of this subfamily, and the nature of its
regulation, is of potential importance in understanding the carcinogenic and other
injurious actions mediated by these common xenobiotics.
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Section 1.7.2: Induction of the CYP2E subfamily
In common with the observation that many xenobiotics induce the levels of the P-450
isoforms which lead to their metabolism, the CYP2E subfamily protein levels were
seen to be induced by solvents such as ethanol and acetone. In trivial terminology the
CYP2E subfamily was previously described as the "ethanol-inducible" P-450. Solvent
exposure has been shown to generate increased levels of CYP2E subfamily protein in
all species studied, including the rat (Miller & Yang, 1983), chicken (Sinclair et al.,
1985), rabbit (Koop et al., 1982), hamster (Kubota et al., 1988), timber wolf (Hogy &
Crankshaw, 1992), and human (Perrot et al., 1989). Induction by solvent exposure
was noted in a variety of tissues other than the liver, including the rabbit kidney (Ueng
et al., 1987) and bone-marrow (Schier et al., 1989). Protein from the CYP2E
subfamily has been immunohistochemically detected in the rat brain; the observed
localisation of the CYP2E protein to the basal ganglia, frontal cortex and hippocampus
is intriguing as it is these regions which display biochemical and morphological
changes following alcohol consumption in experimental conditions (Hansson et al.,
1990).
No concomitant increase in CYP2E mRNA levels are observed on exposure to CYP2E
protein-inducing solvents; it is thought that the induction seen relates to substrate-
induced stabilisation of pre-existing CYP2E protein (Song et al., 1989). It has been
suggested that the substrate may induce increased stability of the CYP2E protein by
blocking a phosphorylation event at a conserved Serine residue; phosphorylation at this
site is suggested to lead to degradation of the CYP2E protein by a rapid proteolytic
system (Ingelman-Sundberg et al., 1992). There is also evidence that solvent induction
may lead to an increased translation rate of the CYP2E subfamily mRNA and a fall in
mRNA levels following induction (Kim & Novak, 1990; Kim et al., 1990).
The CYP2E subfamily has been seen to be induced by starvation and in the diabetic
state in both the rat (Young & Yang, 1983; Song et al., 1987) and the human (Song et
al., 1990). In both these cases an elevation of both the CYP2E1 mRNA and protein
was observed. It has been suggested that ketone bodies generated as a result of
increased (3-oxidation in both these states leads to a stabilisation of the CYP2E1 protein
in a similar manner to that observed following exposure to solvents (Miller & Yang,
1986). The elevation of the mRNA in these states has been suggested to result from a
stabilisation of pre-existing CYP2E1 mRNA (Song et al., 1987) although this point is
far from clear and a transcriptional role for the elevation of CYP2E subfamily
transcripts cannot be firmly ruled out.
The CYP2E subfamily has been seen to be developmentally regulated in several species
including the human (Jones et al., 1992), rat (Umeno et al., 1987) and rabbit (Bonfils
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al., 1990) where it is seen that the gene becomes demethylated and transcriptionally
active immediately after birth.
Potentially species specific controls are also seen to operate on the CYP2E subfamily;
examples of this type of control are seen in the mouse kidney where a sexual
dimorphism exists with higher levels being present in the male than the female (Hong et
al., 1989) and in the rat where the gene appears to be repressed by growth hormone
(Yamazoe et al., 1989a), a control not observed in the mouse for example (Henderson
etal., 1990).
Section 1.7.3: A role for the CYP2E subfamily in intermediary metabolism?
The observed induction of the CYP2E subfamily by solvents, starvation and diabetes
led to the suggestion that the common effector generating stabilisation of the CYP2E
protein in all these situations was acetone. The CYP2E subfamily was seen to catalyse
the conversion of acetone to acetol and methylglyoxal, both of these products can
potentially act as gluconeogenic precursors. This observation suggested that the CYP2E
subfamily may participate in a gluconeogenic pathway leading ultimately to the
gluconeogenic conversion of acetone, generated as a result of elevated p-oxidation in
starvation and diabetes, to glucose (Koop & Cassaza, 1986). Therefore acetone and the
other solvents which were observed to induce the CYP2E subfamily may exert their
effect by mimicking the actions of endogenously produced ketone bodies.
This suggestion emphasises how an understanding of the potential endogenous roles of
xenobiotic metabolising P-450 enzymes can lead to a better appreciation of situations in
which their activities may become elevated. The observation that superficially unrelated
situations, such as solvent exposure and starvation, both produce an elevation in the
activity of the CYP2E subfamily can be rationalised once it is appreciated that induction
in both cases may be generated by control mechanisms relating to the potential
gluconeogenic role of this subfamily.
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Section 1.8: Aims and Objectives
The CYP2E subfamily clearly may play a role in the carcinogenicity resulting from
exposure of an organism to a variety of common environmental chemicals such as
nitrosamines. Therefore understanding both the mechanisms by which this subfamily
is controlled and the contribution which it makes to carcinogenesis are of clear
importance.
The regulation of the CYP2E subfamily would be assessed using the spontaneously
diabetic BB/E rat. The effect of the diabetic state on the CYP2E subfamily would be
examined and the proposed mechanism of induction of the CYP2E subfamily in this
situation reviewed. This study would be combined with the analysis of changes in other
P-450 families and enzyme systems associated with xenobiotic metabolism, allowing a
wider view of the effects which the metabolic status could produce on the xenobiotic
metabolising capacity of an organism.
The presence of the CYP2E subfamily in the mouse would be firmly established and
the cDNA and gene of the Cyp2e member in this species obtained. This analysis would
establish the potential level of conservation of the CYP2E subfamily in this species and
so the potential conservation of metabolic function. The regulation of the Cyp2e
subfamily in the mouse would be studied both following exposure to chemicals and on
starvation. The molecular basis for the regulation of the CYP2E subfamily would be
studied by analysis of the flanking region of the Cyp2e gene.The potential role of
phosphorylation in the control of the CYP2E subfamily protein would be assessed
using Cyp2el proteins with mutations at the proposed controlling phosphorylation site
and observing the effect which these changes produce on the accumulation of Cyp2e
protein in heterologous systems.
The role of the CYP2E subfamily in carcinogenesis and the metabolism of xenobiotics
would be analysed using two approaches. Firstly the metabolism of nitrosamines and
other compounds would be assessed through the use of heterologous expression
systems producing Cyp2el protein following expression of the Cyp2el cDNA.
Secondly, using the Cyp2e gene to generate a vector targeting homologous
recombination within the mouse genome, a mouse-line in which the Cyp2e gene has
been removed would be generated and so the role of the CYP2E subfamily gene in this
species in both intermediary metabolism and carcinogen activation could be analysed by
abstraction.
The combination of these objectives will lead to a clearer understanding of the level of
conservation of the CYP2E subfamily enzymes and their control between species. Such
an understanding will allow a better appreciation of the situations which will lead to
increased carcinogenic risk as a result of the metabolic activities catalysed by the
CYP2E subfamily.
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Chapter 2: Materials and Methods
Section 2.1: General comments
Chemicals and reagents were obtained from BDH and all non-commercial materials are
acknowledged; all manipulations were carried out at room temperature unless otherwise
stated. All media and chemicals were either purchased in a sterile condition or sterilised
prior to use in an autoclave (Laboratory equipment 225 EH autoclave) or after passage
through 0.2|im disposable filters (Millipore).
Section 2.2: Bacterial strains, growth media and antibiotics
Section 2.2.1: Bacterial strains used in this study
E.coli : JM109
HB101
rec A1 sup E44 end A1 hsd R17 gyr A96 rel A1 thi A
(lac -pro AB)
F'[traD36 proAB+lacI d lacZ AM15]
Used as a general host for recombinant manipulation
and as a host in heterologous expression.
sup E44 hsd S20(r b~ m B~) rec A13 ara -14 pro A2
IacY 1 gal K 2 rps L20 xyl- 5 mtl- 1
Used as a host strain for recombinant manipulations
involving the pCAT (Promega) plasmids.
BL21(DE3) hsd S gal (Xel ts 857 ind 1 Sam 7 nin 5 lac UV5-
T7 gene 1) pLysE
Used in heterologous expression studies.
TGI sup E 44 hsd A5 thi A (lac-proAB )
F' [traD36proAB + lacN lacZ AM 15]
Used in the preparation of single-stranded DNA
BW313 HfrKL 16 Po /45 thi -I dut -1 ung -1 supE 44
Used to generate dUTP insertion into single-stranded
DNA for site-directed mutagenesis.
XLl-Blue sup E 44 hsd R 17 recA 1 endA 1 gyrA 46 thi relA 1
lac"
F' \proAB+lacll lacZ AM 15 TnlO (tet 0]
Used to plate and propagate XZAPII bacteriophage.
Y1090 supF hsdR ara D139 A/on Alac Ul69rpsL
trpC 22::TnlO (tet r) pMC9
Used to plate and propagate A,gtl 1 bacteriophage.
Q359 supE hsdR O80r P2
TTcnH In nlatp -inrl nmnaoatp ^PX/TRT t hnntnrinnha
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S. typhimurium : TA1538 and LR5000 strains, as described in Ames et al. (1979),
were used as hosts for heterologous expression.
Section 2.2.2: Bacterial culture media
L-broth/litre: 10 g Bactotryptone (Difco), 5 g yeast extract (Difco), 5 g NaCl
L-agar/litre: As for L-broth with an additional 15 g/litre agar (Difco).
Minimal agar/litre: 200 ml 5 X M9 salts (64 g NaHP04.7H20, 15 g KH2P04, 2.5 g
NaCl, 5 g NFLtCl, 20 ml 20% glucose [w/v]), supplemented with
maltose to 0.2% (w/v) and MgS04 to 10 mM. This agar was used to
ensure retention of the F'episome in bacterial strains.
2 X TY/litre: 16 g Bactotryptone, 10 g yeast extract, 5 g NaCl
H-top agar/litre: 10 g Bactotryptone, 8 g NaCl, 6 g agarose (Sigma).
Section 2.2.3: Antibiotics
Ampicillin: Stock of 50 mg/ml in distilled water, used at a working
concentration of 50 (ig/ml in both plates and media.
Chloramphenicol: Stock of 34 mg/ml in ethanol, used at a working
concentration of 25 |ig/ml.
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Section 2.3: DNA isolation and analysis
Section 2.3.1: Plasmid vectors used in this study
Vector

























Section 2.3.2: Phagemid vectors used in this study
Vector
pTZ18 and 19 R (Pharmacia)
pBS SKII(-) (Stratagene)
Use
General cloning and generation of ssDNA
Generated by in vivo excision ofXZAPII;
generates ssDNA
Section 2.3.3: Filamentous bacteriophage vectors used in this study
Vector Use
M13mpl8 and 19 (BCL) Generates ssDNA
Section 2.3.4: Double-stranded DNA isolation from plasmid and phagemid sources
Section 2.3.4a: DNA isolation from small scale (up to 2 ml) bacterial cultures
DNA was isolated from small scale cultures using a modification of the method of
Birnboin and Doly (1979). Bacteria from an overnight culture were harvested by
centrifugation at 12,000 g for 5 minutes and resuspended in 100 pi of Solution 1 (25
mM Tris.HCl (pH 8.0), 10 mM EDTA (pH 8.0), 50 mM glucose). The cells were
lysed on ice by addition of 200 [il of Solution 2 (0.2 M NaOH, 1% SDS[w/v]) and
subsequently 150 (J.1 of 3 M potassium acetate (pH 4.8), and incubated for 5 minutes.
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The bacterial genomic DNA and debris were removed by centrifugation at 12,000 g for
5 minutes. The plasmid DNA was precipitated from the supernatant on addition of 2
volumes of ethanol and centrifugation at 12,000 g for 5 minutes. The DNA pellet was
resuspended in in 10 |il of water.
Section 2.3.4b: DNA isolation from medium (up to 150 ml) and large scale (above
150 ml) bacterial cultures
Qiagen DNA affinity columns (Qiagen inc.)were used in the isolation of plasmid DNA
from medium and large scale bacterial cultures. Steps in the procedure were scaled up
accordingly from the protocol described above up to the addition of 3 M potassium
acetate (pH 4.8) where the sample was immediately centrifuged for 30 minutes at
20,000 g. The supernatant containing the plasmid DNA was applied to an appropriately
sized Qiagen column which had been pre-equilibrated with buffer QBT (750 mM NaCl,
50 mM MOPS (pH 7.0), 15% (v/v) ethanol, 0.15% (v/v) Triton X-100), and allowed
to enter the resin under gravity. The column was washed with 3 column volumes of
buffer QC (1M NaCl, 50 mM MOPS (pH 7.0), 15% (v/v) ethanol) during which
period the plasmid DNA remains attached to the resin. The DNA was eluted from the
column with 1.5 column volumes of high pH buffer QF (1.25 M NaCl, 50 mM MOPS
(pH 8.2), 15 % (v/v) ethanol). The plasmid DNA was precipitated from the eluant on
addition of 0.7 volumes of isopropanol and collected by centrifugation at 20,000 g for
30 minutes. The DNA pellet was resuspended in 20 (il of water per 100 ml of initial
culture.
Section 2.3.5: Genomic DNA isolation from mammalian tissues
Liver tissue was weighed and 10 volumes of extraction buffer (10 mM Tris.HCl (pH
8.0), 0.1 M EDTA (pH 8.0), 20 (ig/ml pancreatic RNase, 0.5% (w/v) SDS) were
added and the sample mechanically homogenised using a Silverson Laboratory mixer
emulsifier. The sample was incubated at 37 °C for 1 hour following proteinase K
addition to a concentration of 100 |ig/ml. The sample was mixed with an equal volume
of phenol equilibrated with 0.5 M Tris.HCl (pH 8.0) by inversion for 10 minutes. The
aqueous and phenol phases were separated by centrifugation at 5,000 g for 15 minutes.
The upper aqueous layer was transferred to a separate tube using a wide-bore pipette to
avoid shearing the DNA present in this fraction and the phenol extraction procedure
was repeated two further times. 0.2 volumes of 10 M ammonium acetate and 2 volumes
of ethanol were added to the aqueous phase and mixed to precipitate the genomic DNA.
The DNA was spooled using a glass rod, washed with 70% ethanol and allowed to air
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dry before being resuspended in 10 mM TE (pH 8.0) (10 mM Tris.HCl (pH 8.0), 1
mM EDTA [pH 8.0]).
Section 2.3.6: DNA and RNA concentration estimation
Spectrophotometric readings of a known dilution of a DNA or RNA sample were taken
at 260 nm and 280 nm. An A26O reading of 1 corresponds approximately to 50 fig/ml
for double stranded DNA and RNA and 40 |ig/ml for single stranded DNA. An
estimate of sample purity is provided by the ratio of the absobance values at 260 nm
and 280 nm value, pure DNA and RNA having a value of 1.8 and 2.0 respectively.
Section 2.3.7: Restriction endonuclease analysis of DNA samples
Restriction endonucleases were obtained from Boehringer Mannheim (BCL), New
England Biolabs, Bethesda Research Laboratories (BRL) or Amersham International
(Amersham). Digestions were carried out using the manufacturer's recommended
buffer and conditions.
Section 2.3.8: Agarose gel electrophoresis of DNA
DNA samples were analysed using horizontal gel electrophoresis tanks (BRL). Agarose
gels were prepared from either normal grade or low-melting point (Ultra Pure) agarose
for diagnostic and preparative gels respectively. Agarose was used at a variable
concentration between 0.6 and 1.0% (w/v) in TAE buffer (0.04 M Tris-acetate, 0.001
M EDTA, [pH 8.0]). 0.1 volumes of gel-loading dye ( 0.25% (w/v) bromophenol
blue, 0.25% (w/v) xylene cyanol FF, 15% (w/v) ficoll, in water). Following
electrophoresis DNA samples were stained with ethidium bromide by addition of
ethidium Bromide to a concentration of 0.5 (ig/ml from a 10 mg/ml stock, and
visualised using a short wavelength trans-illuminator.
Section 2.3.9: Non-denaturing poly-acrylamide gel electrophoresis (PAGE) of DNA
9% (w/v) PAGE gels were prepared (8.7% acrylamide, 0.3% N, A'-methylene-bis-
acylamide) in TBE (0.09 M Tris.Borate, 0.002 M EDTA, pH 8.0). Ammonium
persulphate (1% [w/v]) and N, N, N', /V'-tetra-methyl ethylenediamine (TEMED) were
added to 0.05% (v/v). The gels were prepared in BioRad Protean 2 vertical
electrophoresis equipment.
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Section 2.3.10: DNA size markers
Sizes in base-pairs; * indicates the inverted doublet of the RF <bX174/ Hae III markers.
Section 2.3.11: Southern Blotting of DNA samples
DNA samples were separated on an agarose gel, stained with ethidium bromide and
photographed. Following this the gel was washed in several changes of water and was
soaked for 45 minutes in denaturing solution (1.5 M NaCl, 0.5 M NaOH), and
neutralising solution for 45 minutes (3 M NaCl, 0.5 M Tris. HC1, [pH 7.5]). Gels
containing mammalian genomic DNA were depurinated by an initial soaking in 0.1 M
HC1 for 10 minutes to increase the efficiency of transfer of higher molecular weight
DNA. DNA fragments were transferred to Hybond-N filters (Amersham) in 20 X SSC
(3 M NaCl, 0.3 M sodium citrate) by capillary transfer according to the method of
Southern (1975). The transferred DNA fragments were cross-linked to the nylon





































Section 2.4: Recombinant DNA techniques
Section 2.4.1: Bacteriophage X libraries used in this study










Section 2.4.2: cDNA library synthesis
Section 2.4.2a: Total RNA isolation
0.5g pieces of male BALB/c mouse liver were placed in 2.5 ml of Solution A
(6 M guanadinium hydrochloride, 5 mM sodium citrate (pH 7.0), 0.1 M
(3-mercaptoethanol, 0.5% Sarkosyl [v/v]) and homogenised in a Silverson Laboratory
homogeniser-emulsifier. Insoluble material was removed from the homogenate by
centrifugation at 5, 000 g for 5 minutes, lg of CsCl (BCL, Molecular Biological
Grade) was dissolved into each 2.5 ml aliquot of the homogenate and the sample was
layered onto a 5.7 M CsCl, 0.1 M EDTA (pH 7.5) cushion in polyallomer tubes. The
homogenate was centrifuged at 125,000 g at 20 °C for 21 hours in a swinging bucket
rotor. The bouyant density of RNA in CsCl is much greater than that of other cellular
macro-molecules and so RNA pellets during centrifugation; the genomic DNA collects
as a band in the lower portion of the CsCl gradient. Following centrifugation the
supernatant was aspirated and the bottom of the polyallomer tube, containing the RNA
pellet, was sliced away using a scalpel. The RNA pellet was resuspended in 1 ml of
TE (10 mM Tris.HCl (pH 7.4), 1 mM EDTA) by repeated pipetting. The RNA solution
was heated at 65 °C for 10 minutes and kept on ice.
Section 2.4.2b: Poly (A)+ RNA isolation
Oligo (dT)-cellulose spun columns (Pharmacia) were equilibrated with 1 ml of high salt
buffer (10 mM Tris.HCl (pH 7.4), 1 mM EDTA, 0.5 M NaCl) which was allowed to
pass into the resin under gravity. 0.2 ml of sample buffer (10 mM Tris.HCl (pH 7.4),
1 mM EDTA, 3 M NaCl) was added to each 1.0 ml of total RNA in TE. 0.25 ml of this
solution was added to the equilibrated column and allowed to enter the resin under
gravity. The column was centrifuged at 350 g for 2 minutes in a swinging bucket rotor
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and washed and centrifuged as above following sequential addition two 0.25 ml
aliquots of high salt buffer and two 0.25 ml additions of low salt buffer (10 mM
Tris.HCl (pH 7.4), 1 mM EDTA, 0.1 M NaCl); the eluant from these manipulations
was discarded. The poly (A)+ RNA bound to the oligo (dT)-Cellulose was eluted in
four sequential 0.25 ml additions and centrifugations of TE (10 mM Tris.HCl (pH
7.4), 1 mM EDTA) which had been pre-warmed at 65 °C. This entire procedure was
repeated using a fresh oligo (dT)-Cellulose column and the poly(A)+ RNA enriched
eluant from the first column. The RNA concentration was estimated
spectrophotometrically (Section 2.3.6).
Section 2.4.2c: cDNA synthesis
5 (ig of poly (A)+ RNA was mixed with water to produce a final volume of 20 (il,
heated at 65 °C for 10 minutes and cooled on ice. 13(il of First-strand mix, a pre-made
mixture of Maloney Murine Leukemia virus (MMLV) reverse transcriptase, BSA,
oligo d(T)i2-i8 primer, dithiothrietol and dNTPs (Pharmacia) was added to the poly
(A)+ RNA and incubated at 37 °C for 1 hour during which period the oligo d(T)i2-i8
primer anneals to the poly-(A) tail of most mRNAs and the cDNA first-strand is
synthesised by the MMLV reverse transcriptase. This sample was added to 77 |il of
pre-made second strand mix, containing E. coli RNase H, E. coli DNA polymerase I
and dNTPs (Pharmacia) at 12 °C for 1 hour and 22 °C for 1 hour after which 1 unit of
Klenow fragment was added and the incubation continued for 30 minutes at 37 °C.
During this period the RNA: DNA duplex is nicked by the RNase H creating RNA 3'
termini which are used by DNA polymerase I to catalyse second DNA strand synthesis.
The addition of the Klenow fragment assures that most of the resultant cDNA
molecules have non-recessed, "blunt", 3' and 5' termini required for subsequent
ligation steps. The sample was heated at 65 °C for 10 minutes and the protein extracted
by addition of 100 (0.1 phenol/chloroform (1: 1 [vol/vol] ). The phases were separated
by centrifugation at 12, 000 g for 5 minutes and the upper cDNA containing aqueous
phase removed.
Section 2.4.2d: Size selection of cDNA products
As well as full-length cDNA products cDNA synthesis produces a mass of smaller
partial cDNA products generated either from degraded mRNA templates or resulting
from a variety of technical problems in cDNA synthesis from full-length mRNA
templates. To remove these smaller partial fragments the products from the cDNA
synthesis were passed through a Sephacyl-S400 spun column (Pharmacia), the column
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was pre-equilibrated in ligation buffer (66 mM Tris.HCl (pH 7.6), 1 mM spermidine,
10 mM MgCl2, 15 mM dithiothrietol, 0.2 mg/ml BSA) and the cDNA solution allowed
to enter the resin under gravity. The larger cDNA products (above 400 base-pairs) were
eluted from the column by centrifugation at 400 g for 2 minutes. Elution in ligation
buffer means that the subsequent adaptor addition step can proceed directly without the
need to precipitate and resuspend the cDNA molecules.
Section 2.4.2e: Addition of Eco R 1/ Not I adaptors to the cDNA products
5 jig ofEco R 1/ Not I adaptors and 3 units of T4 DNA ligase were added to the 100 pi
eluant from the size selection Sephacyl-S400 spun column and ligated overnight at
12 °C. By ligating the cDNA molecules into an oligonucleotide pair which form an-
effectively pre-digested Eco RI restriction endonuclese site the cDNA molecule can be
ligated directly into the Eco R I site of a vector without the need for methylation
treatment and digestion of a conventional linker.
Eco R 1/ Not I adaptors:
A ATT CGC GGC CGC
GCG CCG GCGp
The ligation mixture was heated at 65 °C to denature the ligase and the 5 ' extended
terminal of the Eco R 1/ Not I adaptors was phosphorylated on addition of 10 units of
polynucleotide kinase and dATP to a final concentration of 1 pM; the sample was
incubated at 37 °C for 30 minutes. The cDNA sample was phenol/chloroform extracted
(Section 2.11.1) and added to a non-size selecting Sephacryl S-300 spun column
(Pharmacia) pre-equilibrated in STE (150 mM NaCl, 10 mM Tris.HCl (pH 7.5), 1 mM
EDTA).
Section 2.4.2f: Insertion of adaptor-ligated and phosphorylated cDNA molecules
into the bacteriophage vector AZAPII
2 pg aliquots of EcoK I digested and alkaline phosphatase treated (Section 2.11.4)
AZAP II bacteriophage arms (Statagene) were mixed with 30 pi, 15 pi, and 10 pi
aliquots of the final cDNA in STE buffer. The DNA in these titrations was precipitated
at -70 °C for 15 minutes following addition of 1 pi of 3 M Sodium acetate (pH 7.0) and
60 pi of ethanol. The DNA was collected by centrifugation at 12,000 g for 15 minutes
and resuspended in 10 pi of ligation buffer (200 mM Tris.HCl (pH 7.6), 50 mM
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MgCl2, 50 mM dithiothrietol), lunit of T4 DNA ligase was added and the sample
ligated overnight at 12 °C.
Titrations of the cDNA: vector ligations were employed as, although the absolute DNA
concentration in the cDNA mix was known, the efficiency of the adaptor addition and
phosphorylation steps were not.
Section 2.4.2g: In vitro packaging of the cDNA/XZAP II bacteriophage arm ligation
reactions
The cDNA/XZAP II bacteriophage arm ligation reaction was mixed with 15 |il aliquots
of packaging protein extracts (Stratagene). These extracts are prepared from bacteria
harbouring 2 bacteriophage X mutants which are incapable of generating packaging
XDNA in isolation but are complementary in combination. The samples were incubated
for 2 hours at 22 °C during which time coat proteins containing the recombinant cDNA
containing bacteriophage are generated.
Section 2.5: Screening and isolating recombinant bacteriophage X clones
Section 2.5.1: E. coli host preparation and titration of recombinant-bacteriophage X
libraries
The E. coli cells relevant to the recombinant-bacteriophage vector employed were
grown overnight in L-broth supplemented with 0.2% maltose and 10 mM MgSC>4. The
cells were collected by centrifugation at 5,000 g for 5 minutes and resuspended in 10
mM MgSC>4 to give a final OD600 of 2. Addition of maltose to the media induces the
maltose operon which includes the lam B gene encoding the X receptor on the surface
of the E. coli. 10 fold serial dilutions of the recombinant-bacteriophage X stock to be
titrated were made in SM (5.8 g NaCl, 2 g MgSC>4, 50 ml 1 M Tris.HCl (pH 7.5) /litre)
to a final volume of 100 jxl. These were mixed with 100 |il of plating cells and
incubated at 37 °C for 10 minutes to allow the recombinant-bacteriophage to adsorb to
the E. coli.. The mixture was mixed with 3 ml of molten H-top (47 °C) and poured
onto L-agar plates, allowed to set and the plates were inverted and incubated at 37 °C
overnight. The plaque forming unit (pfu/ml) concentrations of the recombinant-
bacteriophage stocks were determined from the number of plaques present on the
resultant E. coli. lawns.
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Section 2.5.2: Plating and screening recombinant-bacteriophage X libraries
Using the known pfu/ml value of the recombinant-bacteriophage stock known dilutions
of bacteriophage were mixed with host E. coli cells to generate a near confluent plaque
density on a 20 cm2 bacterial lawn and screened in a similar manner to that described by
Benton and Davis (1977). For the XEMBL3 genomic library, and the cDNA libraries,
20 cm2 plates were prepared respectively as detailed above (Section 2.5.1) with
proportionately larger volumes of components. The agar plates were dried at 42 °C for
several hours prior to plating of the H-top mixture; this prevented streaking of the lawn
by condensation and the lifting of the H-top layer during subsequent manipulations.
Nylon filters were lowered onto the plaque containing bacterial lawns and a needle was
passed through the filter into the agar and an asymmetrical pattern generated that would
allow subsequent realignment of the filter with the plate. After 30 seconds the filter was
removed and the process repeated with a second filter onto which also was duplicated
the asymmetrical pattern; this filter was removed from the surface of the plate after 60
seconds. The nylon membranes were placed, bound DNA side up, on Whatmann
3MM paper soaked in denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 1 minute,
neutralising solution for 2 minutes (1.5 mM NaCl, 0.5 M Tris.HCl [pH 7.4]) and
allowed to air dried. The DNA was cross-linked to the nylon membrane by ultra-violet
irradiation (254 nm) for 30 seconds using a Stratalinker 2400.
The membranes were probed with a radioactively labelled DNA fragment, washed
(Section 2.12.2), and exposed to X-ray film (Section 2.13). The area of the bacterial
lawn seen to contain a plaque hybridising to the radiolabeled probe on both membranes
was excised from the plate using a glass pipette and the agar plug placed into SM. The
resulting recombinant-bacteriophage stock was titrated and the whole procedure
repeated until single clonal bacteriophage, which hybridised with the radiolabeled
probe, had been isolated.
Section 2.5.3: Isolation of cloned recombinant-bacteriophage X DNA
This procedure was necessary for bacteriophage X clones in EMBL3 and gtl 1 vectors.
1 X 1010 cells (OD600 of 1 represents 8 X 108 cells/ml) from a fresh overnight culture
of the appropriate bacterial host were added to 5 X 107 pfu/ml of clonal recombinant-
bacteriophage in a final volume of 500 pi and allowed to adsorb for 20 minutes at
37 °C; 10 fold titrations of the bacteriophage stocks were also adsorbed to host cells in
this manner. The mixture was added to 50 ml of pre-warmed L-broth and grown
overnight at 37 °C in an orbital shaker. At the correct host: bacteriophage ratio a large
amount of bacterial debris occurs as the bacteriophage lyse the host cells. 500 ml
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cultures were established using the bacteriophage: host cell ratio generating the most
lysis. Following over night culturing the remaining intact host cells were lysed by
addition of 1 ml of chloroform and shaken for 10 minutes. Bacterial debris was
removed from the culture by centrifugation at 5,000 g for 5 minutes and the supernatant
decanted. The recombinant-bacteriophage were pelleted from the supernatant by
centrifugation at 100,000 g for 90 minutes and the pellet from each 500 ml culture was
resuspended in 1 ml of SM. 1 p.1 of DNase (10 mg/ml) and RNase A (10 mg/ml) were
added and the bacterial RNA and DNA digested at 37 °C for 1 hour; the bacteriophage
DNA is resistant to these enzymes as it is within the phage coat proteins. This reaction
was stopped by addition of 200 pi of TES (0.3 M Tris.HCl (pH 9.0), 0.15 M EDTA
and 1.5% SDS [w/v]) and heated at 70 °C for 15 minutes; 150 pi of 8 M potassium
acetate was added and the sample left on ice for 15 minutes. The protein was removed
from the DNA by phenol extraction and ethanol precipitation (Section 2.11.1) and the
DNA resuspended in 100 pi of water.
Section 2.5.4: Isolation of recombinant XZAP II DNA by in vivo excision
The recombinant cDNA fragment in XZAP II is flanked by the dissected filamentous
bacteriophage (fl) origin of replication (OR) present within the pBS SKII (-) phagemid
with the initiation and termination elements of the fl OR on either side of the these
sequences. Host XLl-Blue E.coli are grown to an OD500 of 1 and mixed with 1 X 105
pfu/ml XZAP II SM stock and 1 X 10^ pfu/ml of the R408 filamentous fl "helper
phage" (Stratagene) to a final volume of 500 pi and allowed to adsorb at 37 °C for
20 minutes. The mixture was added to 5 ml of L-broth and incubated at 37 °C for 3
hours in an orbital shaker. During this period the host cells become infected by both the
A.ZAP II bacteriophage and the f1 R408 filamentous bacteriophage. Proteins produced
by the f1 R408 helper phage recognise the fl OR initiation site in the XZAPII genome
and nick it at these sites leading to the production of a single-stranded (ss) copy of the
DNA downstream of these sites, which includes the cDNA insert and the pBS SK II (-)
sequence, until the termination signal in the f 1 OR is reached. The ssDNA molecules
are circularised by other fl encoded proteins leading to the re-formation of functional
ORs, the DNA is packaged in coat proteins and secreted from the cell. The cultures
were heated at 70 °C for 20 minutes to kill the host bacteria which were removed by
centrifugation at 12,000 g for 1 minute. 20 pi of the recombinant packaged form of the
pBS SK II (-) phagemid was used to re-infect 200pl ofXLl-Blue E.coli (ODgoo of 1)
as described above, and plated onto LB plates containing ampicillin; on re-infection a
double-stranded DNA phagemid molecule is generated in the ampicillin resistant
bacterial colonies formed.
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Section 2.6: Cloning in the filamentous bacteriophage M13 and isolation of single-
stranded DNA
In order to prepare single-stranded (ss) DNA for sequencing and site-directed
mutagenesis, recombinant filamentous bacteriophage M13 (Ml3) was employed.
Subcloning into this vector was as described for general ligation reactions (Section
2.11.2) using the double-stranded replicative form (RF) of M13.
M13 ligation mixes were transformed into competent host cells (JM109 and TGI,
Section 2.11.6) and plated in H-top (Section 2.5.2); M13 allows a-complementation
to be applied to determine recombinant plaques on addition of 40 pi of X-gal (20
mg/ml in dimethylformamide) and 4 pi of IPTG (200 mg/ml stock in water) to the
H-top (Section 2.11.7a).
Using the tip of a sterile toothpick, a single M13 plaque was picked and transferred to
1.5 ml of 2 X TY containing a 25 pi aliquot of fresh host cells at an OD600 of 1. The
cells and M13 plaque were incubated for 6 hours at 37 °C in an orbital shaker during
which period ssDNA bacteriophage particles are extruded from the host cells. The host
cells are removed by centrifugation at 12,000 g for 10 minutes and the ssDNA particle-
containing supernatant removed; the bacterial pellet was retained to allow preparation of
the double-stranded RF M13 (Section 2.3.4). 1 ml aliquots of the supernatant were
mixed with 200 pi of PEGS (20% (w/v) polyethylene glycol (PEG 800, Sigma) in
2.5 M NaCl) and placed on ice for 30 minutes; this leads to aggregation of the phage
particles which were recovered by centrifugation at 12,000 g for 30 minutes. The
PEGS was removed by aspiration and the pellet resuspended in 100 pi TE (pH 8.0).
DNA was extracted by phenol extraction and ethanol precipitation (Section 2.11.1),
resuspended in 10 pi of water and the DNA concentration estimated (Section 2.3.6).
Section 2.7: Isolation of single-stranded DNA from phagemid vectors
By super-infecting bacterial host cells harbouring the recombinant phagemid with the fl
helper R408 (Section 2.5.4) particles containing ssDNA were produced and DNA
siolated as described for M13 ssDNA isolation (Section 2.6).
32
Section 2.8: DNA Sequencing and computer analysis of DNA, RNA and predicted
amino acid sequences
Section 2.8.1: Sequencing single-stranded DNA templates
Single-stranded DNA templates were sequenced using a modified version of the chain-
termination method (Sanger etal., 1977) using the Sequenase enzyme (USB), a genetic
variant of the T7 DNA polymerase lacking 3' - 5' exonuclease activity.
2 pg of ssDNA was mixed with lpmole of primer to a final volume of 8 pi in water
and 2 pi of sequencing buffer was added (200 mM Tris.HCl (pH7.5), 100 mM MgCl2,
250 mM NaCl). The sample was heated at 65 °C for 2 minutes and allowed to cool to
room temperature over a 30 minute period during which time the primer annealed to its
complimentary sequence in the template. Labelled DNA was generated from the
annealed primer in the extending reaction for 5 minutes at room temperature:
Annealed template/ primer mix 10 pi
0.1 M dithiothrietol 1 pi
5 X Labelling mix diluted 1: 5 in water 2 pi
[a-35S] dATP sp. activity 1000 Ci/mmol lOmCi/ml 1 pi
Sequenase (USB)diluted 1: 8 in dilution buffer 2 pi
5 X labelling mix: 7.5 mM each dCTP, dGTP, dTTP
Sequenase dilution buffer: 10 mM Tris.HCl (pH 7.5), 5 mM dithiothrietol, 0.5 mg/ml
BSA
3.5 pi aliquots of the extension reaction were terminated following addition to 4
separate tubes containing 2.5 pi of 8 pM each ddNTP. The termination reaction was
incubated for 5 minutes at 37 °C and was stopped by addition of 4 pi of loading buffer
(95% formamide, 20 mM EDTA, 0.05% Bromophenol Blue, 0.05% Xylene Cyanol
FF). The samples were heated at 80 °C for 2 minutes and resolved on a 6% acrylamide,
7 M urea (Ultrapure), 1 X TBE gel. Following electrophoresis the gel was fixed in 10%
(v/v) acetic acid, 10% (v/v) methanol and dried under vacuum at 80 °C prior to
exposure to X-ray film (Section 2.13).
Section 2.8.2: Sequencing double-stranded DNA templates
Section 2.8.2a: Manual sequencing of double-stranded DNA templates
Double-stranded (ds) DNA templates were prepared using a Qiagen column (Section
2.3.4b). 10 |ig of dsDNA in a final volume of 18 |il of water were denatured following
addition of 2 |il of freshly prepared 2 M NaOH and incubation for 5 minutes. The
sample was neutralised by addition of 8 pi 5 M ammonium acetate (pH 7.5) and,
following addition of 100 pi of ethanol, the DNA was precipitated at -70 °C for 20
minutes. The dsDNA was collected by centrifugation at 12,000 g for 20 minutes and
resuspended in 7 pi of water. The dsDNA was sequenced exactly as described for
ssDNA templates following the addition of 1 pmole of primer (Section 2.8.1).
Section 2.8.2b: Automated sequencing of double-stranded DNA templates
Performed using an Applied Biosystems Model 373A automatic sequencer
according to the manufacturer's instructions in collaboration with Mr R. McDonald,
Jackson Foundation, Rockville, MD.
Section 2.8.3: Computer analysis of DNA, RNA and predicted amino acid sequence
data
Sequence data was analysed for the generation of contiguous DNA sequences, the
presence of restriction endonuclease sites, and levels of homology to other specific
DNA sequences using the Best, Map and Gap programs of the GCG package
respectively (Devereux etal., 1984).Transcription factor consensus binding sequences
were defined using the MacPattern package and manually using the GCG Best
programme. RNA folding was performed using the Fold and Stemloop (Zucker, 1989)
programmes of the GCG package. Protein sequence alignment and phosphorylation site
analysis was performed using the Gap and Best programmes of the GCG package.
Hydrophobicity and sequence alignment plots of amino acid sequences were generated
using the GeneJockey package (Biosoft).
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Section 2.9: Generation of eDNA mutants by site-directed mutagenesis
Filamentous bacteriophage M13 ssDNA was prepared from an E. coli BM313 duf,
ung- host as described (Section 2.6). The dut * mutation leads to a high intracellular
concentration of dUTP and several molecules are incorporated per ssDNA molecule; the
ung' mutation means that the uracil A-glycosylase which normally removes dUTP
from the ssDNA template is inactive. The mutagenic oligonucleotides were
phosphorylated using T7 polynucleotide kinase (Section 2.12.1b) and the efficiency
established by a concomitant radiolabelling phosphorylation reaction; the reaction was
stopped by phenol extraction and ethanol precipitation (Section 2.11.1). lOpmoles of
the phosphorylated mutagenic oligonucleotide, lOpmoles of non-phosphorylated
"universal" oligonucleotide primer (USB) were annealed to 1 pg of dUTP containing
ssDNA (Section ) following addition of 1 pi of 10 X PE1 buffer (200 mM Tris.HCl
(pH 7.5), 100 mM MgCl2, 500 mM NaCl, 10 mM dithiothrietol) in a final volume of
10 pi in water. Second DNA strand synthesis primed from the annealed
oligonucleotides was carried out overnight at 16 °C:
10 XPE2 buffer 1 pi
2 mM each dNTPs (Pharmacia) 1 pi
10 mM dATP 1 pi
Oligonucleotide annealed ssDNA template 10 pi
T4 DNA ligase 5 units
Klenow fragment 2 units
Water to 20 pi
10 X PE2 buffer: 200 mM Tris.HCl (pH 7.5), 100 mM MgCl2, 100 mM dithiothrietol
The sample was transformed into competent JM109 E. coli which has a functional
uracil A-glycosylase leading to destruction of the parental ssDNA strand and replication
of the mutated DNA (Kunkel, 1985). ssDNA was isolated and the presence of the
mutation confirmed by sequencing (Section 2.8.1).
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Section 2.10: The Polymerase Chain Reaction (PCR)
Section 2.10.1: PCR involving recombinant vector DNA template
For reactions involving purified phage, plasmid, or phagemid DNA as a template, the
following mixture was prepared:
Template DNA 1 (ig
dNTPs (2.5 mM each dNTP [Pharmacia]) 8 (if
Oligonucleotide primers (1 [tg/ftl) 1 [tl each
10 X reaction buffer 10 |il
Taq DNA dependent DNA polymerase ("polymerase") 4 units
Water to 100 |il
10 X reaction buffer: 10 mM Tris.HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2, 0.01%
(w/v) gelatin
The mixture was overlaid with 50 [tl of white mineral oil (Sigma) to prevent
evaporation and subjected to the following reactions in a Hybaid Omnigene:
Mixing, 92 °C 5 minutes (1 cycle)
Denaturing, 92 °C 30 seconds (30 cycles)
Annealing, 50 °C 45 seconds (30 cycles)
Extending, 72 °C (See below) (30 cycles)
Terminating, 72 °C 5 minutes (1 cycle)
The length of the extension step was varied according to the expected length of the
product with an extension time of 1 minute per lKbp (Innis & Gelfand, 1990).
Section 2.10.2: PCR involving Embyronic stem cell genomic DNA template
For reactions involving Embryonic stem (ES) cell genomic DNA (Section 2.23.8) the
titrations of reaction components revealed the optimal conditions for PCR reactions
were found to be as detailed above (Section 2.10.1) with some modifications. DMSO
was added to 5% (v/v) and the MgCl2 concentration in the reaction buffer was lowered
to 10 mM, the reaction mixture was subjected to 60 cycles, as detailed above, with an
extension time of 1.5 minutes. After 30 cycles an additional 4 units of Taq polymerase
was added before completion of the final 30 cycles.
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Section 2.11: DNA fragment subcloning and bacterial transformation
Section 2.11.1: DNA fragment isolation and preparation for subcloning
The DNA fragment ("insert" DNA) to be subcloned, whether derived from a plasmid,
phagemid, recombinant-bacteriophage or polymerase chain reaction (PCR), was
separated from other DNA material on a 1% low-melting point agarose gel. The gel was
stained with ethidium bromide and the portion of the gel containing the fragment was
dissected from the body of the gel using a scalpel. The insert DNA was isolated from
the agarose using either Geneclean (Bio 101 inc.) glass bead solution or GlassMax
(BRL) glass bead spun-columns according to the manufacturer's instructions. If the
insert DNA required further modification prior to subcloning, for example "end-filling"
(Section 2.11.3) or restriction endonuclease digestion (Section 2.3.7), these
manipulations were performed. Following these manipulations the enzymes were
removed from the insert DNA by mixing the reaction sample with an equal volume of
phenol (equilibrated with TE [pH8.0]) and centrifugation at 12,000 g for 5 minutes to
separate the aqueous and phenol layers. The upper DNA containing aqueous layer was
removed and mixed with an equal volume of chloroform/iso-amyl alcohol (24:1 [v/v])
to remove the last traces of phenol and the phases separated following centrifugation at
12,000 g for 5 minutes. The upper aqueous layer was removed and DNA precipitated
for 30 minutes at -20 °C on addition of 0.1 volumes of sodium acetate (pH 4.8) and
2.5 volumes of ethanol; the DNA was collected by centrifugation at 12,000 g for 20
minutes and resuspended in 10 |il of water. Collectively this procedure is subsequently
referred to as "phenol extraction and ethanol precipitation"; the DNA concentration was
then estimated (Section 2.3.6).
Section 2.11.2: Vector preparation for the receipt of DNA inserts
The vector (phagemid, plasmid or bacteriophage) into which the DNA insert was to be
subcloned was digested with the appropriate restriction endonucleases and subjected to
any further necessary modifications such as "end-filling" (Section 2.11.3) or
dephosphorylation (Section 2.11.4). Following these manipulations the vector was
phenol extracted, ethanol precipitated, resuspended in water and the DNA concentration
was estimated (Section 2.3.6).
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Section 2.11.3: "End-filling" recessed 3' terminals with the "Klenow" fragment
In order to generate DNA molecules with non-recessed 3' termini ("blunt"), from the
products of a restriction endonuclease reaction generating recessed 3' termini, the
recessed termini are filled by the action of the large fragment of E. coli DNA
polymerase I ("Klenow" fragment) (BCL). 10 |!g of DNA were mixed with 50 mM
Tris. HC1 (pH7.5), 10 mM MgCh, 0. 25 mM each dNTP (Pharmacia) and 1 unit of
Klenow fragment in a final volume of 25 |J,1 and incubated at 37 °C for 30 minutes.
The Klenow fragment was removed by phenol extraction and ethanol precipitation
(Section 2.11.1) and the DNA resuspended in 10 pi of water.
Section 2.11.4: Dephosphorylation of 5' terminal phosphates
Vectors linearised using a single restriction endonuclease may recircularise on ligation;
this possibility was reduced by removal of the 5' terminal phosphates using calf
intestinal phosphatase (CIP) (Promega). 10 pg of DNA was resuspended in 40 pi of 10
mM Tris. HC1 (pH 8.0) and 5 pi of 10 X CIP buffer (0.5 mM Tris. HC1 (pH 9.0), 10
mM MgCl2, 1 mM ZnCl2, 10 mM spermidine) and 0.5 units of CIP were added and
incubated at 37 °C for 30 minutes when a second 0.5 unit addition of CIP was made.
After an additional 30 minutes the sample was phenol extracted, ethanol precipitated
(Section 2.11.1) and resuspended in 10 pi of water.
Section 2.11.5: Ligation of the prepared insert and vector DNA
For the ligation of DNA fragments and vectors with cohesive terminals 100-200ng of
vector DNA and a 5 fold excess of insert were mixed to a final volume of 7.5 pi in
water. To this was added 1 pi of 10 X ligation buffer (200 mM Tris.HCl (pH 7.6), 50
mM MgCl2, 50 mM dithiothrietol), 1 pi of 5 mM ATP and 1 unit of T4 DNA ligase
(BCL). The reaction was allowed to proceed for no longer than 16 hours at 12 °C.
Ligation of DNA fragments and vectors with blunt-ended terminals was carried out as
above but without the addition of 5 mM ATP.
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Section 2.11.6: Transformation of bacterial cells with plasmid or phagemid DNA =
Section 2.11.6a: Generating transformation-competent bacteria using calcium
chloride
1 ml of an overnight E.coli culture was added to 40 ml of L-broth and was grown with
shaking until the cells reached an OD600 of 0.6. Cells were pelleted by centrifugation at
5,000 g, 4 °C for 5 minutes, resuspended in 20 ml of 100 mM calcium chloride, and
kept on ice for 30 minutes. The cells were pelleted again by an identical centrifugation
step and resuspended in 4 ml of 100 mM calcium chloride. Cells were stored at 4 °C
and used within 2 days of preparation.
DNA (0.01 (ig-0.10 |ig) was added to 200 |il of competent cells and left on ice for 1
hour. The cells were heat shocked at 42 °C for 90 seconds and added to 200 |il of pre-
warmed L-broth. The cells were incubated at 37 °C for 1 hour to allow expression of
resistance proteins. The cells were pelleted by centrifugation at 12,000 g for 15
seconds, resuspended in 100 ql of water and applied to L-broth plates containing the
appropriate antibiotic and detection chemicals, inverted, and incubated overnight at
37 °C.
Section 2.11.6b: Transformation of bacteria by electroporation
CaCl2 treatment does not generate a high level of transformation competent cells in
S. typhimurium strains. These bacteria were transformed by electroporation; 0.1 (ig of
DNA was mixed with 500 pi of cells with an ODgoo of 0.6. The cells were
electroporated at 40 pF, 0.2 kV using an IBI electroporator. The cells were treated as
detailed above (Section 2.11.6a) from the heat shock treatment at 42 °C.
Section 2.11.7: Screening of bacterial colonies transformed with recombinant
plasmid or phagemid constructs
Section 2.11.7a: a-Complementation screening of bacterial colonies
The pTZ18R and 19R and pUC18 and 19 vectors used in this study carry a short
segment ofDNA that contains the regulatory sequence and the first 146 amino acids of
the E. coli lac Z gene encoding the (3-galactosidase enzyme. On transformation of the
parent plasmid into certain host strains, which produce the C-terminus of the (3-
galactosidase enzyme encoded on the F' episome, the two fragments can interact and
produce an active protein (Ullman et al., 1967); this process is termed a-
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complementation. Bacteria transformed with recombinant vector form blue colonies in
the presence of X-gal (5-bromo-4-chloro-3-indolyl-P- D-galactoside) on derepression
of the lac Z gene fragments by IPTG (isopropylthio-P-D-galactoside) addition.
Insertion of the recombinant fragment into the cloning site of the vector however
disrupts the lac Z N-terminal fragment and colonies containing recombinant plasmids
are white.
Bacteria transformed with vectors allowing a-complementation to be performed were
plated onto L-agar, ampicillin plates onto which was spread 40 p.1 of X-gal, from a
stock of 20 mg/ml in dimethylformamide, and 4 |il of IPTG, from a 200 mg/ml stock in
water.
Section 2.11.7b: Screening of bacterial transformants by colony hybridisation
If a-complementation was not possible due to the nature of the construct transformed, a
modification of the method of Grunstein and Hogness (1975) was used to screen for
recombinant bacteria. Transformed colonies resulting were picked using sterile
toothpicks and duplicate colonies streaked onto Hybond-N gridded nylon membranes
(Amersham) placed on L-agar plates containing ampicillin. Plates were inverted and
incubated at 37 °C overnight. One plate was stored at 4 °C (the "master" filter); the
second filter was removed from the L-agar plate and placed colony side up on
Whatman 3MM paper soaked in 10% SDS (w/v) for 3 minutes, denatured for
5 minutes (0.5 M NaCl, 1.5 M NaOH) and neutralised for 5 minutes (0.5 M Tris-HCl
(pH.7.5), 1. 5 M NaCl). Filters were air dried at room temperature and baked at 80 °C
for 2 hours. The bacterial debris was removed from the filters by washing in 50 mM
Tris. HC1 (pH 8.0), 1.5 M NaCl, 1 mM EDTA, and 1% SDS (w/v) in a shaking water
bath at 42 °C for 1 hour. Filters were prehybridised and hybridised with radiolabeled
insert containing probes, washed and exposed to X-ray film (Sections 2.12.2 and
2.13). Recombinant colonies seen to hybridise with the probe were picked and grown
from the duplicate colony on the retained master filter.
40
Section 2.12: DNA and RNA hybridisation techniques
Section 2.12.1: Radiolabelling DNA probes
Section 2.12.1a: Random prime labelling of double-strand derived DNA probes
Double-stranded DNA was labelled by the random priming method of Feinberg and
Vogelstein (1983). The DNA insert was heat denatured in the presence of a molar
excess of random hexanucleotide primers and radioactive nucleotides were added into
the probe DNA following primer extension by the large fragment of E. coli DNA
polymerase I ("Klenow" fragment). 25 ng of the DNA to be labelled was denatured at
100 °C for 3 minutes and mixed with the following components; the labelling reaction
was allowed to proceed at 37 °C for at least 3 hours:
OLB 3 Hi
BSA (10 mg/ml, Sigma) 2 pi
OLB comprised of a mixture of the solutions A, B, and C in a ratio of 2: 5: 3:
DNA





water to 100 ul








100 mM dTTP, dCTP, dGTP, and dATP
in 3 mM Tris-HCl (pH 8.0) 0.2 mM EDTA
(Pharmacia)
5 pi of each
B: 2MHEPES (pH 6.6)
C: Hexadeoxyribonucleotides in 3 mM Tris. HC1 (pH8.0), 0.2 mM EDTA (pH
7.0) to a concentration of 9000 units/ml (Pharmacia).
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Section 2.12.1b: Radiolabelling oligonucleotide probes
Synthetic oligonucleotides are synthesised without a phosphate group at the 5' terminal
and can be labelled by the transfer of [y-32P] ATP to the 5' termini using the bacterial
T4 polynucleotide kinase (PNK) in the following reaction mixture; the labelling reaction
was allowed to proceed at 37 °C for at least 45 minutes:
10 X PNK buffer: 0.5 M Tris.HCl (pH 7.6), 0.1 M MgCl2, 50 mM dithiothrietol,
1 mM spermidine, ImM EDTA (pH 8.0)
Section 2.12.1c: Establishing the efficiency of radiolabel incorporation into both
oligonucleotide and double-strand DNA derived probes
1 pi of the labelled probe mixture was spotted onto Whatman DE-81 filter paper. The
filter is positively charged and binds oligonucleotide and double-stranded DNA to the
origin whereas unincorporated radiolabeled nucleotides are bound less strongly and
can be separated chromatographically using 0.3 M ammonium formate (pH 8.0). By
exposing the resultant filter to X-ray film an assessment of the relative levels of
incorporated to unincorporated radiolabeled nucleotides was obtained; an efficiency of
greater than 80% was routinely obtained.
Section 2.12.2: Hybridisation of radiolabeled double-strand DNA derived DNA
probes to membrane-bound DNA
Membrane-bound DNA samples were prehybridised for at least 3 hours at 65 °C either
in sealed plastic bags in a shaking water bath or in glass tubes in a rotisserie oven
(Techne).





10 X PNK buffer




Prehybridisation solution, prepared to a final concentration in water of:
5 X SSPE
0.1% Sodium pyrophosphate (w/v)
0.5% SDS (w/v)
100 |ig/ml heat denatured and needle sheared herring sperm DNA
2 X Denhardt's solution
20 X SSPE (pH 8.0) /litre: 175.3 g NaCl, 27.6 g NaH2P04, 7.4 g EDTA
50 X Denhardt's solution/litre: 10 g each of BSA (Sigma), polyvinylpyrollidine
(Sigma), Ficoll-400 (Sigma) to 1 litre with water.
Heat denatured and needle sheared herring sperm DNA (Sigma) was diluted from a 10
mg/ml stock.
Hybridisation solution: As for prehybridisation solution but without the inclusion of
herring sperm DNA
The radiolabeled insert DNA probe was denatured at 100 °C for 3 minutes, added to
the filter and hybridised at 65 °C overnight.
Washing conditions: All washes were carried out at 65 °C with solutions heated to
65 °C prior to addition. Each wash was carried out for 20 minutes in a progressively
lower salt solution as indicated below. After the 1 x SSC wash the level of background
radioactivity attached to the filter was assessed using a hand-held monitor and the
lengths of the subsequent lower salt washes varied accordingly.
2 X SSC, 0.1% SDS (w/v), 0.1% sodium pyrophosphate (w/v)
1 X SSC, 0.1% SDS (w/v), 0.1% sodium pyrophosphate (w/v)
0.2 X SSC, 0.1% SDS (w/v), 0.1% sodium pyrophosphate (w/v)
0.1 X SSC, 0.1% SDS (w/v), 0.1% sodium pyrophosphate (w/v)
20 X SSC (pH 7.0): 175.3 g NaCl, 88.2 g sodium citrate.
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Section 2.12.3: Hydridisation of radiolabeled oligonucleotide probes to membrane-
bound DNA
Filters were prehybridised for at least 3 hours at 42 °C in glass tubes in a rotisserie
oven (Techne):
Prehybridisation solution to a final concentration in water of:
6 X SSPE
5 X Denhardt's solution
0.5% SDS (w/v)
0.1% sodium pyrophosphate (w/v)
100 pg/ml heat denatured and needle sheared herring sperm DNA
Hybridisation solution: As for prehybridisation solution without the inclusion of
herring sperm DNA.
Washing conditions: Filters were washed in pre-warmed 6 X SSC, 0.1% Sodium
pyrophosphate (w/v) at 48 °C for 30 minutes. Filters were examined with a hand-held
monitor and if they exhibited high levels of background radioactivity they were washed
in the same washing solution but with progressive 4 °C increases in temperature.
Section 2.12.4: Hybridisation of double-stranded DNA derived probes to
membrane-bound RNA
Membrane-bound RNA samples were prehybridised for at least 3 hours at 42 °C in
glass tubes in a rotisserie oven (Techne). The double-stranded DNA derived probe was
denatured at 100 °C for 3 minutes, added to the membrane and hybridised over night at
42 °C.
Pre-hybridisation/ hybridisation solution:
100% Formamide 10 ml
50 X Denhardt's solution (Section 2.12.2) 2 ml
10% (w/v) SDS 1 ml
20 X SSC (Section 2.12.2) 6 ml
50% (w/v) Dextran sulphate 3 ml
100 (ig/ml heat denatured and needle sheared herring sperm DNA 200 |il
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Washing conditions: All washes were carried out at 65 °C with solutions pre-warmed
to 65 °C as described in Section 2.12.2.
Section 2.13: Autoradiography
For analysis of filter-bound [y-32P] ATP, [a-32 P] dCTP and I125: After washing,
filters were wrapped in clear plastic film (Saran-wrap) and exposed to Kodak X-AR
film at -70°C in X-ray cassettes. Intensifying screens were incorporated in the cassettes
containing filters binding [y-32P] ATP and [a-32 P] dCTP.
For analysis of [a-35S]-dATP containing gels and 14C containing TLC plates: after
drying the radioactive materials were exposed directly to Kodak X-ARS film in X-ray
cassettes at room temperature ([a-35S]-dATP) and -70 °C (14C ).
Films were developed using a Geramatic 60 (Agfa-Gevaert) automatic developer.
Section 2.14: Heterologous expression of mammalian P-450 in bacteria
Section 2.14.1: IPTG (isopropylthio-|3-D-galactoside) derepression of bacterial
hosts harbouring pKK223-3(mod) and pET15b constructs
Host cells (E. coli and S. typhimurium) were grown to an ODgoo of 0.5 at 28 °C with
the relevant antibiotics (50 (ig/ml ampicillin in both cases and for pET15b additionally
25 (ig/ml chloramphenicol). IPTG was added to a final concentration of 1 mM and the
culture was grown for 6 to 8 hours at 28 °C. Prior to induction 8-amino laevulinic acid
(Sigma) was added to a final concentration of 6 X 10"6 M in some instances.
Section 2.14.2: Small scale isolation of protein from IPTG-derepressed bacteria
Derepressed host cells were collected by centrifugation at 5,000 g for 5 minutes and
resuspended in sucrose KCl-phosphate buffer (Section 2.19). The cells were disrupted
following two 15 second sonication steps at full power (Soniprep 150 sonicator, MSE);
during these manipulations the samples were kept on ice. The protein concentration in
the samples was estimated (Section 2.20).
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Section 2.14.3: Isolation of subcellular fractions of IPTG-derepressed bacteria
Based on the method of Yoshida and Aoyama (1984). Host cells were collected by
centrifugation at 5,000 g for 5 minutes and resuspended in sucrose KCl-phosphate
buffer (Section 2.19); the cells were disrupted by passage through a French press
(Enerpak) and the ice at a pressure of 200 lb/inch2; samples were kept on ice before
and after this procedure. Cell debris and unbroken cells were removed by centrifugation
at 5,000 g for 5 minutes and a membrane enriched fraction was isolated by
centrifugation of the supernatant for 2 X 80 minutes at 100,000 g. The membrane
enriched pellet was resuspended in sucrose KCl-phosphate buffer using a hand-held
teflon homogeniser between centrifugation steps. The cytosolic fraction from the first
ultracentrifugation step was retained and used as a source for reducing equivalents in p-
nitrophenol assays (Barnes et al., 1991. Section 2.14.5). Protein concentrations of the
fractions were estimated (Section 2.20).
Section 2.14.4: Measurement of P-450 haemoprotein by difference-spectra analysis
Performed according to the method of Omura and Sato (1964). A known concentration
of protein was added to cuvettes in a final volume of 1 ml in KCl-phosphate buffer
(Section 2.19) and an absorbance base line established between 400 and 500 nm on a
Shimadzu MPS-2000 scanning spectrophotometer. A few grains of sodium dithionite
were added to the cuvettes to reduce the P-450 and carbon monoxide was bubbled
through one cuvette. The difference spectra between the two samples was recorded
between 400 to 500 nm; the presence of detectable levels of haem within the P-450
generated an absorbance peak at 450 nm.
Section 2.14.5: p-Nitrophenol hydroxylation as a probe for CYP2E subfamily
activity
The hydroxylation of p-nitrophenol correlates with the observed level of CYP2E
subfamily protein in assays performed using perfused livers, purified CYP2E protein
and microsomal material and the activity is inhibited (>95%) following addition of
CYP2E subfamily inhibitory antibodies (Reinke & Moyer, 1985. Koop, 1989). p-
Nitrophenol hydroxylation generates a 4-nitrocatechol product which can be detected
by an increased absorption at 510 nm.
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Assays were performed in the following incubation mixtures with a known protein







NADPH regenerating system: 4 pinoles glucose 6-phosphate, 0.4 pmoles NADP, 0.4
units glucose 6-phosphate dehydrogenase, 2 pmoles
MgCl2.
In assays of bacterial fractions cytosolic protein (Section 2.14.3) was added in an
equal protein amount to the assayed protein concentration, to provide reducing
equivalents for the reaction. Studies have shown that this fraction contains components
of an electron transport system that are capable of donating electrons to mammalian
P-450 and so substituting for the P-450 reductase (Barnes et al., 1991). The
constituents were incubated at 37 °C in a shaking water bath and the reaction was
initiated following addition of the substrate. The reaction was allowed to proceed for 12
minutes and was stopped by addition of 0.25 ml of 0.6 M perchloric acid and
centrifuged for 5 minutes at 12,000 g. 1 ml of the supernatant was added to 0.1 ml of
10 M NaOH to ionise the 4-nitrocatechol and the absorbance at 510 nm was read
immediately in a Shimadzu MPS-2000 scanning spectrophotometer.
Section 2.15: Manipulation and culturing of Saccharomyces cerevisiae
Section 2.15.1: S. cerevisiae ("yeast") strains used in this study
KYI 18: a, his 3-200,lys 2-801am,a<ie 2-101oc,trpDl, ura 3-52
Used for expression studies as a host for the pMA56, pVTlOOU and
YepGAL vectors
W3031B: a, leu 2, his 3, trp 1, ura 3, ade 2-1, canR, cyr +
Used for expression studies as a host for the pYeDPl-10 vector
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Section 2.15.2: S. cerevisiae culture media
Yeast culture media/litre: 10 g yeast extract, 10 g peptone (Difco), 20 g glucose,
(YPD) 20 mg Adenine sulphate (Sigma)
YPD agar/litre: As above with an additional 20 g agar
Minimal media/litre : 6.7g yeast nitrogen base without amino acids (Difco), 20 g
(YMM) glucose, 20 mg each amino acid and vitamin supplement
required to give the requisite minimal media dependent on
the strain/selection employed
Supplemented YMM/litre: As above with an additional 10 g casamino acids
(SYMM)
SYMM agar/litre: As above with an additional 20 g agar
Section 2.15.3: The transformation of DNA constructs into S. cerevisiae using the
lithium acetate method
S. cerevisiae were made competent for DNA transformation by a modification of the
lithium acetate method of Itoh et al. (1983). A culture of the strain to be made
competent was grown at 28 °C in YPD until the OD600 reached 0.4. (early log. phase).
The cells were harvested by centrifugation at 5,000 g for 5 minutes and resuspended in
TE (pH 8.0). Lithium acetate (Sigma) was added to a final concentration of 0.1 M and
the cells were incubated with gentle shaking at 30 °C for 1 hour. DNA (10 |ig) was
added to 200 (il aliquots of the cells and the mixture incubated for 30 minutes.
Following this incubation PEG-4000 (Sigma) was added to a final concentration of
35% (w: v) and incubated for 1 hour at 30 °C. The cells were heat-shocked at 42 °C for
5 minutes, collected and washed by 2 periods of centrifugation for 2 minutes at 12,000
g followed by resuspension in water and plated onto minimal media plates lacking the
appropriate nutrient to allow selection of transformants. The plates were inverted and
incubated at 28 °C until transformed colonies appeared.
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Section 2.15.4: Small scale isolation of protein from S. cerevisiae
Glass beads (40mm mesh) were washed in concentrated HC1 and repeatedly rinsed in
water until the liquid surrounding the beads reached pH 7.0. At pH 7.0 the beads were
washed in KCl-phosphate buffer (Section 2.19) and excess liquid removed using a
pipette. Centrifugation harvested S. cerevisiae were resuspended in KCl-phosphate
buffer and the beads were added to just below the meniscus of the suspension. The
mixture was vortexed for 2 X 2 minutes and cooled on ice. The supernatant was
removed from the sample and the protein concentration estimated (Section 2.20).
Section 2.15.5: Isolation of S. cerevisiae subcellular fractions and the analysis of
P-450 difference spectra
As described for the preparation of bacterial subcellular fractions employing a French
Press (Section 2.14.3) using a modification of the method of Yoshida and Aoyama et
al. (1984); an initial centrifugation step at 11,000 g replaced the 5,000 g step however
in order to remove the mitochondrial fraction from the supernatant applied to the
subsequent ultracentrifugation steps.
Section 2.16: Animal maintenance and manipulation
Unless otherwise stated animals were kept at, and manipulations performed in, the
ICRF Clare Hall Laboratories, South Mimms, Hants. Animals were fed a standard
laboratory chow diet ad libitum and acclimatised for at least 4 days to a 12 hour
light/dark cycle prior to treatment.
Section 2.16.1: Mouse lines used in this study
BALB/c: used in cDNA library preparation
C57BL/6: used in regulation studies
DBA2/N: used in regulation studies
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Section 2.16.2: Experimental treatment of mice
Section 2.16.2a: Chemical treatment of mice
C57BL/6 and DBA2/N, male and female as stated, were subjected to a 3 day regime of
daily intraperitoneal injections (ip) or intragastric (ig) injections of:
TCPOBOP: 1,4-bis[2-(3,5-dichloropyridyloxy)benzene]
Animals were also given one dose of aflatoxin pi (50 mg/kg, ip).
All compounds were administered in corn oil apart from pyrazole and NDMA which
were administered in PBS (Section 2.16.5).
Acetone treated animals were administered 1% (v/v) acetone in their drinking water
over a 14 day period; animals allowed to recover from this treatment were returned to
normal drinking water for a 7 days.
Section 2.16.2b: Starvation of mice
Food and bedding material were withdrawn from animals for the stated periods.
Section 2.16.3: Rat lines used in this study
Wistar: Used for chemical induction studies



















Section 2.16.4: Experimental treatment of rats
Section 2.16.4a: Chemical treatment of Wistar rats
Acetone treatment of rats was identical to that described for acetone treatment of mice
(Section 2.16.2a).
Section 2.16.4b: Maintenance and monitoring of the BB/E spontaneously diabetic
rat
Animals from the diabetes prone (DP) subline, which show a 55-70% incidence of
diabetes, were weighed 3 times a week and the urine of those animals which did not
record a weight gain was analysed for the presence of glucose using m-multistix (Bayer
diagnostics). In those animals seen to have glucose present in their urine, daily blood
glucose analysis was undertaken on tail vein bleeds using BM-test strips (BCL).
Animals were classed as diabetic when their blood glucose levels rose above 18
mmoles/litre. One group of diabetic animals detected in this manner were left for 3 days
without insulin and sacrificed. A second group of diabetic animals was left without
insulin over the same period after which insulin was administered as a single
subcutaneous dose (Ultratard Bovine insulin, U-40 strength, ultralente, Novo,
Denmark) until the blood glucose level returned to the normal range of 2-4
mmoles/litre. Age- and sex-matched animals from the diabetes resistant (DR) subline,
with an incidence of diabetes of less than 1%, were taken for each of the DP animals
used in the study.
Animals were kept in isopositive pressure isolators and fed on SDS rat and mouse N^l
expanded feed (Special Diet Services, Witham, U.K.). Manipulations and maintenance
of the BB/E rats were performed in collaboration with Dr J. D. Baird, Dr R. M.
Lindsay and Mr W. Smith, at the Metabolic Unit, University of Edinburgh Department
ofMedicine, Western General Hospital, Edinburgh.
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Section 2.16.5: Animal sacrifice and tissue removal
Animals were killed by cervical dislocation, organs removed, rinsed in phosphate
buffered saline (PBS) and frozen in liquid nitrogen. Blood samples were removed and
placed in Lithium-heparin anticoagulent tubes. Samples for electron microscopy and
immunohistochemistry were placed in 2.5% (v/v) glutaraldehyde in KCl-phosphate
buffer (Section 2.19) and formal saline (14% (v/v) formaldehyde in PBS) respectively.
PBS/litre: 1.5 g Na2HP04 , 8 g NaCl, 0.1 g MgCl2.6H20, 1.5 g KH2P04, 0.2 g KC1,
0.132 g CaCl2.2H20
Section 2.17: Ultrastructural studies of fixed animal tissues
Section 2.17a: Transmission electron microscopy and peroxisome percentage
assessment
Liver samples from the BB/E DP and DR animals (Section 2.16.5) fixed in 2.5% (v/v)
glutaraldehyde in KCl-phosphate buffer (Section 2.19) were prepared for transmission
electron microscopy which was performed using a Jeol 100CX TEM in collaboration
with Dr J. Foster and Dr C. Bowling, Zeneca Central Toxicology laboratory, Cheshire.
Three representative areas of the liver sample were photographed at X 8,300
magnification and the micrographs were analysed for cytoplasmic peroxisomal content
using a 345 intercept square lattice allowing the percentage of the cytoplasm occupied
by peroxisomes to be assessed (Moody & Reddy, 1976).
Section 2.17b: Immunohistochemical analysis of animal tissue
Animal tissue fixed in formal saline (Section 2.16.5) were paraffin embedded,
sectioned and the structures assessed following staining with haematoxylin, which
stains nuclei black, and eosin, which stains cytoplasm and connective tissues red.
Fixed sections were immunohistochemical analysed following incubation with
antibodies to certain P-450. Tissue sections were blocked in pre-immune rabbit serum
(1:5 (v/v) dilution in PBS) for 10 minutes and incubated in the P-450 antibody of
interest (1:10 (v/v) dilution in TBS) at 4 °C overnight. The sections were blocked again
with pre-immune rabbit antisera as above and incubated with biotinylated swine anti-
rabbit serum for 30 minutes. The binding of the first and second antibody complex was
visualised following addition of the avadin-biotin horseraddish peroxidase complex and
its substrate (0.068% (w/v) imidazole, 2% (v/v) H202, 0.05% (w/v) 3, 3-
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diaminobenzidine) which binds to the immune complex and produces a brown staining.
The surrounding tissue structure was stained using haemotoxylin; tissue manipulation
and immunostaining was performed in collaboration with Dr D. J. Harrison and Mrs
H. Wolf, Department of Pathology, Edinburgh University.
Section 2.18: Biochemical analysis of animal sample material
The following analysis of components of the blood collected from the BB/E rats were
performed in collaboration with Dr R. M. Lindsay, The Metabolic Unit, University of
Edinburgh Department of Medicine, Western General Hospital, Edinburgh:
1) The percentage glycated haemoglobin content was determined using boronic acid
affinity chromatography (Pierce & Warriner).
2) The plasma insulin concentration was measured by radioimmune assay using rat
insulin standards (Novo, Denmark) and charcoal separation (Ashby and Speake,
1975).
3) Plasma concentrations of cholesterol and triglycerides were determined
colorimetrically on a Kodak 700XR C Series analyser (Kodak Clinical diagnostics).
4) Plasma non-esterified ("free") fatty acid concentration was assessed by an
enzymatic colorimetric assay (Wako Chemicals) using a centrifugal fast analyser.
5) Plasma hydroxy butyrate was determined spectrophotometrically using a Ranbut
enzymatic kit (Randox).
Glutathione S- Transferase activities in cytosolic fractions were assessed using a 1-
chloro-2,4-dinitrobenzene (CDMB) spectrophotometric assay in collaboration with Dr
L. I. McClellan, Department of Clinical Chemistry, Royal Infirmary, Edinburgh.
The level of cyanide insensitive (3-oxidation, a measure of peroxisomal activity, was
analysed in the "heavy pellet" spectrophotometrically in collaboration with Dr C.
Elcombe and Dr S. Tittensor, Zeneca Central Toxicology laboratory, Cheshire using
the method of Bronfman etal. (1979).
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Section 2.19: Isolation of subcellular fraction enriched protein samples from mouse
and rat tissue
The tissue was added to 3 volumes of KCl-phosphate buffer (10 mM potassium
phosphate (pH 7.4), 1.15% (w/v) KC1, 0.1 mM EDTA) and homogenised in a
Silverson Laboratory mixer homogeniser at 4 °C. The homogenate was centrifuged at
11,000 g for 20 minutes to remove cell debris and larger cellular organelles such as
mitochondria, nuclei and peroxisomes; this fraction constituted the "heavy pellet" and
was resuspended in KCl-phosphate sucrose buffer (0.25 M sucrose, 10 mM potassium
phosphate (pH 7.4) 1.15% (w/v) KC1, 0.1 mM EDTA). The supernatant was
centrifuged at 45,000 g for 80 minutes at 4 °C to pellet the endoplasmic reticulum-
enriched "microsomal" fraction. The supernatant from this centrifugation was retained
and constituted the cytosolic fraction in susequent analysis. The microsomal pellet was
resuspended in KCl-phosphate buffer using a Teflon-glass hand-homogeniser and
recentrifuged at 45,000 g for 60 minutes at 4 °C. The resulting pellet was resuspended
in sucrose buffer by hand-homogenisation; the protein concentration was estimated
(Section 2.20) and samples were maintained at -40 °C.
Section 2.20: Protein concentration estimation
The protein concentration of samples to be analysed was determined by the method of
Lowry et al. (1951) using a range of known bovine serum albumin (BSA) protein
concentrations as standards (0 to 200 |ig/ml). The sample to be analysed was mixed
1:40 (v/v) in 0.1 M NaOH. To this was added 5 volumes of freshly prepared alkaline
carbonate solution ( 490 ml 70 mM Na2C03: 40 mM NaOH, 5 ml 40 mM CUSO4, and
5 ml 71 mM potassium tatrate per 500 ml) and the solution was incubated for 10
minutes. 0.1 volumes of Folin Coicalteau reagent was added and the sample incubated
for 1 hour. The absorbance at 600 nm was determined using a Shimadzu U.V. 160
spectrophotometer.The standard protein concentration values were determined in
duplicate and the sample values in triplicate.
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Section 2.21: Analysis of isolated protein fractions
Section 2.21.1: Sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS
PAGE) of protein samples
Protein samples were prepared for SDS PAGE following dilution to a protein
concentration of 4 mg/ml in water, and addition of an equal volume of boiling mix
(0.05 M Tris.HCl (pH 6.8), 2% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, 10% (v/v)
glycerol, 0.05% (w/v) bromophenol blue dye); the sample was heated at 100 °C for
5 minutes.
For detection of P-450 proteins (Mr of approximately 50,000) samples were separated
on 9% (w/v) polyacrylamide (8.7% acrylamide, 0.3% N, A'-methylene-bis-
acrylamide) in 0.375 M Tris.HCl (pH 8.8), 0.15% (w/v) SDS. Ammonium
persulphate (AMPS, 1% [w/v]) and N, N, N N '-tetra-methyl ethylenediamine
(TEMED) were added to 0.05% (v/v). For detection of lower molecular weight
proteins, such as the approximately Mr 20,000 GSTs, samples were separated on 12%
(w/v) polyacrylamide gels. A stacking gel was prepared (4.5% (w/v) acrylamide, 0.125
M Tris.HCl (pH 6.8), 0.125% SDS, 0.05% each of TEMED and AMPS) and poured
over the the polymerised separating gel. The gels were prepared in BioRad Protean 2
vertical electrophoresis equipment and electrophoresed in electrode buffer (0.05 M
Tris.HCl (pH 8.3), 0.05 M glycine, 0.1% SDS). The protein sample was
electrophoresed through the stacking gel at 50mA and the separating gel at 30 mA per
gel at constant current.
Section 2.21.2: Protein molecular weight standards
Rainbow molecular weight markers (Amersham) were used to estimate the Mr of


















Section 2.21.3: Western blot analysis of SDS PAGE separated protein samples
Western blot analysis was performed by a modification of the method of Towbin etal.
(1979). SDS PAGE separated protein was transferred using a BioRad Protean II
transblot cell to 0.45 (im nitrocellulose filters (Schindler and Schuell) in transblot buffer
(20 mM disodium orthophosphate, 20% (v/v) methanol) for 12 hours at 250 mA. After
protein transfer the filter was washed in TBST (50 mM Tris.HCl (pH 7.9), 0.15 M
NaCl, 0.005% (v/v) Tween 20 [Sigma]) and blocked in 3% (w/v) low fat powdered
milk (Marvel, Cadbury's) in TBST for 1 hour. After blocking the filter was washed for
2 X 20 minute periods in TBST, and the first antibody, raised against the protein of
interest, was added at a 1:500 dilution in TBST and left for 1 hour. The first antibody
was removed and the filter washed by 4 X 20 minute periods in TBST and the second
antibody was added and incubated for 1 hour. The nature of the first antibody dictated
the second antibody added; if the first antibody was a mono- or poly- clonal then rabbit
anti-mouse or goat anti-rabbit antibodies were added respectively at a 1: 1000 dilution
in TBST. The immunoreactive protein-antibody complexes were iodinated in
0.19 MBq of 12^I-conjugated protein A in 50 ml of TBST for 45 minutes followed by
repeated washing in TBST to remove non-specifically bound radioactivity. The filters
were exposed to X-ray film (Section 2.13). Alternatively the immunoreactive protein-
antibody complexes were visualised using the Enhanced £hemiluminescence (ECL)
method (Amersham). The second antibodies are labelled with horse-raddish peroxidase
(HRP) which catalyses the oxidation of luminol in the presence of H2O2 generating
light and producing a response on X-ray film (Roswell & White, 1978); the reaction
was performed according to the manufacturer's instructions.
Section 2.21.4: Antisera used in the detection of proteins in this study
Polyclonal antisera to purified rat P-450 isoforms, other than CYP2E, have been
previously characterised for their specificity towards the stated epitopes (Wolf &
Oesch, 1983. Wolf et al., 1984). The CYP2E polyclonal antibody was raised against
purified rat protein and was the kind gift of Professor C. S. Yang, Rutgers University,
NJ. The specificity of the polyclonal antibodies raised to the rat CYP2E1 protein in the
detection of mouse Cyp2el has been previously demonstrated (Hong et al., 1989.).
Monoclonal antisera raised to purified rat CYP4A1 protein was produced by Ciba-
Geigy, Basel, Switzerland and its specificity has been previously demonstrated (Savoy
et al., 1990).
Polyclonal antisera to several cytosolic GST subunits and purified glyoxylase I were
the kind gift of Dr L. I. McClennan (Department of Clinical Chemistry, Royal
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Infirmary, Edinburgh) and their specificity has been previously demonstrated (Hayes &
Mantle, 1986). Polyclonal antisera raised against purified rat microsomal GST was the
kind gift of Dr M. B. Crichton (ICRF MPG, Edinburgh).
Section 2.22: Isolation and analysis of total RNA from mouse and rat tissues
Section 2.22.1: Isolation of total RNA
Total RNA was isolated from tissue samples for Northern blot analysis using the
method of Chomczynski and Sacchi (1987). 0.5 g of tissue was added to 5 ml of
solution D (Stock: 250 g guanidinium thiocyanate (Sigma), 293 ml water, 17.6 ml
Sodium citrate (pH 7.0), 26.4 ml 10% (v/v) sarcosyl; 0.36 ml of 2-mercaptoethanol
was finally added per 50 ml of stock to produce solution D). The tissue was
homogenised in solution D using a Silverson Laboratory mixer homogeniser. The
homogenate was centrifuged at 9,000 g for 5 minutes to remove insoluble tissue debris
and sequentially 0.5 ml of 2 M sodium acetate (pH 4.0), 5 ml of water saturated
phenol, and 1 ml of chloroform/isoamyl alcohol (49:1 [v/v]) were added to the
supernatant. The sample placed on ice for 20 minutes. Samples were centrifuged at
10,000 g for 20 minutes at 4 °C, RNA was present in the upper aqueous phase which
was removed and RNA precipitated at -20 °C for 20 minutes following addition of 5 ml
of isopropanol. RNA is collected by centrifugation at 10,000 g for 20 minutes at 4 °C
and the pellet resuspended in 1.5 ml of solution D; RNA is reprecipitated from this
solution at -20 °C for 1 hour following the addition of an equal volume of isopropanol.
The RNA is collected by centrifugation at 12,000 g for 20 minutes, resuspended in
1 ml of water, and heated at 65 °C for 10 minutes. RNA concentrations were then
estimated (Section 2.3.6) and the samples stored at -70 °C.
Section 2.22.2: Northern blotting of isolated total RNA
RNA was size fractionated on horizontal denaturing agarose gels; 1% (w/v) agarose
was melted in water and allowed to cool to 60 °C before addition of 5 X GRB (0.1 M
MOPS (3-[/V-morpholino]propanesulfonicacid) (pH 7.0), 40 mM Sodium acetate,
5 mM EDTA [pH 8.0]) and 12.3 M formaldehyde to give a final concentration of 1 X
and 2.2 M respectively.
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RNA samples were prepared following the addition of:
RNA (known concentration in water) 4.5 (il
5 X GRB 2.0 nl
Formaldehyde 3.5 |il
Formamide 10.0 (il
The sample was heated at 55 °C for 15 minutes and 2.0 |il of loading dye (0.4% (w/v)
each bromophenol blue and xylene cyanol FF, 50% glycerol, 1 mM EDTA [pH 8.0])
was added prior to loading. 3 (ig of RNA size markers (BRL) were treated in the same
manner as the RNA sample and loaded onto the gel.The gel was electrophoresed in 1 X
GRB and stained with ethidium bromide (Section 2.3.8) to establish the equal loading
of the samples by the relative amounts of 28 S (6,333 nucleotides) and 18 S (2,366
nucleotides) rRNA species present in the different tracks. The gel was washed in 10 X
SSC (Section 2.12.2) and transferred to hybond-N nylon membranes (Amersham) by
capillary transfer in 10 X SSC. The portion of the membrane corresponding to the track
on the gel containing the RNA markers was cut off and stained in methlyene blue
(0.04% methylene blue (w/v), 0.5 M NaOH) for 20 minutes and washed in several
changes of water to reveal the blue stained RNA size standards. The rest of the
membrane was treated as described for Southern blotting following capillary transfer of
the DNA sample to the nylon membrane (Section 2.3.11).
RNA size markers (Kb): 9.5, 7.5, 4.4, 2.4, 1.4, 0.3
Section 2.23: Mammalian tissue culture manipulations
Section 2.23.1: Cell lines used in this study
COS 7: Monkey kidney derived (Anderson et al., 1989)
HepG2: Human hepatocarcinoma derived (Knowles et al., 1980)
C3H/IOTI/2: Mouse embryo derived (Reznikoff et al., 1973)
Hepa 1: Mouse liver derived (Bernhard et al., 1973)
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Section 2.23.2: Tissue culture media and conditions
DMEM, with sodium pyruvate : HepG2 (5,10 or 15% FCS), COS 7 (10% FCS)
and glucose (Gibco) Hepa 1, (10% FCS)
aMEM (Gibco): C3H/10Tl/2 (10% FCS)
Glutamine (0.2 mM), foetal calf serum (FCS, at the amount stated above [v/v]),
penicillin (15 U/ml) and streptomycin (5 mg/ml) were added to all media. In some cases
insulin (Bovine, Sigma) was added to the medium to a final concentration of
1 X 10-7 M.
All cell culture was carried out at 37 °C in CO2 incubators and manipulations performed
in Class 2 Biological safety cabinets; all solutions were pre-warmed at 37 °C prior to
addition to the cells unless otherwise stated. Cells were only grown in the medium
shown above and so the term "medium" refers to the medium specific to a particular cell
line. All cell lines used in this study grow as monolayers in culture.
Section 2.23.3: Freezing and retrieving cell lines
On reaching confluency the cells were detached from the culture flask by addition of
0.1% trypsin, 0.001% EDTA; the solution was incubated until the cell monolayer was
seen to detach using light microscopy. The trypsin was diluted following addition of
medium and the cells harvested at 3,000 g for 5 minutes. The cell pellet was
resuspended at a density of 5-10 million cells/ml in 90% new-born calf serum, 10%
DMSO and frozen overnight at -70 °C before transfer to liquid nitrogen for long-term
storage. To retrieve cell aliquots from liquid nitrogen the 1 ml sample was quickly
thawed at 37 °C and resuspended in medium; the cells were collected following
centrifugation at 3,000 g for 5 minutes to ensure removal of most of the DMSO,
resuspended in medium and seeded into 25 cm2 flasks. The cells were allowed to
adhere overnight and were re-fed the following morning, by replacement of the
medium, to remove any dead cells.
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Section 2.23.4: Feeding and sub-culturing of cells
Cells were fed every second day to maintain correct growth conditions. On reaching
confluency the cells were washed twice in PBS (Section 2.12.5) and detached from the
culture dish and collected as described above (Section 2.23.3). The cell density was
estimated using a Neubayer haemocytometer manually under light microscopy. Cells
were re-seeded onto fresh plates at a dilution of 1: 10. The viability of cells was
estimated by the proportion of cells seen to exclude Nigrosin (Sigma); Nigrosin was
prepared as a stock at 0.5% (w/v) in water and added 1: 1 (v/v) to the cell suspension
and the level of viable cells was estimated immediately using light microscopy and a
Neubayer haemocytometer (Kaltenbach et al., 1958).
Section 2.23.5: Transfection of cell lines with plasmid DNA
For both heterologous protein accumulation studies and promoter assays DNA was
transfected into cell lines using the calcium phosphate method similar to that of Graham
and van der Eb (1974); the following description is for transfections of 1 X 106 cells
and larger transfection experiments were scaled up accordingly. Cells were harvested
by trypsinisation (Section 2.23.3) and 1 X 106 cells were replated in 25 cm2 flasks and
allowed to re-adhere to the flask in 5 ml of medium for 24 hours. 20 |ig of the DNA
sample to be transfected was mixed with TE/10 (0.1 mM EDTA, 1.0 mM Tris.HCl [pH
8.0]) to a final volume of 225 (il, to this mixture was added 25 fil of 2.5 M
CaCl2-6H20. The DNA/TE/10 and CaCl2 mixture was added slowly, with swirling, to
250 |il of 2 X HBS (0.28 M NaCl, 50 mM HEPES (A-2-hydroxyethylpiperazine-A'-2-
ethane sulphonic acid), 1.5 mM Na2HP04.2H20, [pH 7.1]) and left for 30 minutes
during which time a fine white precipitate forms. The mixture containing the precipitate
was added to the medium bathing the cells and incubated overnight; the following day
the DNA containing medium was removed, the cells re-fed fresh medium and the
culture allowed to grow for the required time.
Section 2.23.6: Isolation of protein from COS 7 cells
COS 7 cells, transfected with the pCMV4 expression vector (Section 2.23.5), were left
for the stated period until harvesting by trypsinisation (Section 2.23.3). The cell density
was estimated haemocytometrically (Section 2.23.4) and the cell pellet was
resuspended in 125 |il of ice cold buffer H (10 mM Na2HP04, 2 mM MgCl2, 2 mM
dithiothrietol, 1 mM EDTA, [pH 7.4]) per 25 cm2 flask. The cells were sonicated at
low power (Soniprep 150 sonicator, MSE) for 2 X 5 seconds and stored on ice between
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and after sonication periods. Cellular disruption was confirmed morphologically using
light microscopy and the protein concentration of the sample estimated (Section 2.20).
Section 2.23.7: Chloramphenicol acetyl-transferase (CAT) promoter activity assays
Chloramphenicol acetyl-transferase (CAT) promoter activity assays were carried out
using a modification of Gorman et al. (1982). Cells were plated on 90 mm circular
dishes, transfected with the DNA construct and 48 hours after DNA transfection the
cells were washed in Mg2+ and Ca2+ free PBS (per litre: 8 g NaCl, 0.2 g KC1, 1.44 g
Na2HPC>4, 0.24 g KH2PO4, [pH 7.4]), detached from the dish using a cell scraper and
collected in 1 ml of Mg2+ and Ca2+ free PBS. Cells were washed by two consecutive
15 seconds periods of centrifugation at 12,000 g and resuspension in Mg2+ and Ca2+
free PBS. Following this the Mg2+ and Ca2+ free PBS was aspirated and the cells
resuspended in 100 pi of Tris.HCl (pH 7.8). The cells were disrupted by three cycles
of freezing in a dry-ice ethanol bath and thawing at 37 °C; the disrupted cellular debris
was collected by centrifugation at 12,000 g for 5 minutes and the supernatant
containing the CAT was decanted. The level of de-acetylase activity in the supernatant
was reduced by heating the samples at 65 °C for 10 minutes. The protein concentration
in the supernatant was estimated (Section 2.20) and 50 pi aliquots of equal protein
concentration (dependent on the amount of protein present in the lowest protein
concentration sample) of all the samples to be assayed were added to 80 pi of CAT
reaction mix (50pl 1 M Tris.HCl (pH 7.8), 10 pi of 14C-labelled chloramphenicol
diluted to 0.1 mCi/ml, 20 pi of freshly prepared acetyl CoA [3.5 mg/ml in water]). The
samples were mixed and incubated for 2 hours at 37 °C. Following the incubation 1 ml
of ethylacetate was added to each sample and mixed by vortexing, the phases were
separated by centrifugation at 12,000 g for 5 minutes; the acetylated forms of
chloramphenicol partition into the upper organic phase and 900 pi of this phase was
removed. Ethylacetate was removed from the sample by centrifugation under vacuum
for 30 minutes (SpeedVac, Sorvall). The CAT reaction products were resuspended in
25 pi of ethylacetate and 15 pi of this was added to the origin of a thin layer
chromatography (TLC) plate in 5 pi aliquots; the site of addition was dried using a hair¬
drier between applications. The acetylation products were separated in
chloroform/methanol (95: 5 [v/v]) in a chromatography chamber; the plate was air dried
and sprayed with Enhance (DuPont) to decrease the absorption of the 14C signal by the
TLC plate during exposure to X-ray film (Section 2.13).
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Section 2.23.8: Transfection of Embryonic Stem (ES) cells by electroporation,
positive -negative selection and isolation of genomic DNA
Embryonic Stem (ES) cells were grown in DMEM/Hams F12 media (1:1) on 1%
gelatin treated culture flasks in the presence of 100 U/ml leukemia inhibitory factor
(LIF). LIF is a glycoprotein which reversibly inhibits the differentiation of the cells
(Smith et al., 1988). The cells were detached by trypsinisation (Section 2.23.3), 1 X
107 cells were mixed with 100 fig of linearised vector in a final volume of 1 ml PBS
(Section 2.16.5) and transfected by electroporation using 0.3 (iF capacitance, 0.8 kV in
a BRL electroporator. Following electroporation the cells were plated onto 10 X 25
cm2 plates in 5 ml of media per flask. The following day positive G418 (Geneticin, 200
(ig/ml) selection was applied and when resistant clones became visible gancyclovir
negative selection was applied (200 |ig/ml) for five days. Clones surviving both these
selections were picked and grown in 2 X 2 ml culture wells. The cells from one well
were frozen (Section 2.23.3) and genomic DNA was prepared from the cells in the
second well. Cells were washed in PBS and trypsinised (Section 2.23.3) and disrupted
in lysis buffer (500 (il PBS, 5 |ll 1% (w/v) SDS, 25 }ll proteinase K, from a 10 mg/ml
stock) and genomic DNA precipitated following addition of 0.1 volumes of 10 M
ammonium acetate and 2.5 volumes of isopropanol. Genomic DNA was spooled from
the sample using sealed glass pipettes, eluted into TE (pH 8.0) and DNA concentrations
estimated (Section 2.3.6). Maintainance and manipulation of ES cells was performed in
collaboration with Dr J. Dorin, MRC Human Genetics Unit, Western General Hospital,
Edinburgh.
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Chapter 3: The regulation of the CYP2E subfamily, and other xenobiotic metabolising
enzymes, by the diabetic state
Section 3,1 Introduction and aims: Physiological and Pathological control of the
xenobiotic metabolising and conjugating system
Although it is clear that many chemicals have the capacity to induce xenobiotic metabolism
by increasing the levels of certain cytochrome P-450 and other components of the
xenobiotic metabolising system the physiological situations in which such changes might
occur are less clear. It could be argued that certain components of the cytochrome P-450
superfamily have either evolved solely to function as xenobiotic metabolisers capable of
being induced in an organism by an adaptive response to chemical insult, or they have an
overlapping endogenous role which is coincidentally perturbed by exogenous chemical
challenge. Both physiological and pathological conditions have been seen to modify the
activity of "xenobiotic metabolising" enzymes. Conditions such as starvation (Johansson et
al., 1988) and diabetes ( Dixon et al., 1961) alter the rate of drug metabolism via
endogenously mediated modification in these enzyme systems. Arguably in order to truly
understand how a system is regulated, and the rationale behind the mechanism and form
which this regulation takes, the real function of the system must be established. Insight
gained from such an understanding will allow a logical assessment of overlapping changes
in the system introduced by non-physiological stimuli mimicking, in some fashion, the
endogenous control mechanism. To examine this argument a study of the effect of the
diabetic state on some of the components of the P-450 xenobiotic metabolising system and
some other components of the body's conjugatory systems was undertaken in the
spontaneously diabetic BB/E rat.
Section 3.1.1: Changes in xenobiotic metabolism in Diabetes
The fact that diabetes produces profound effects on drug metabolising systems has been
recognised for many years. Initial experiments on the nature of these changes focussed on
the effect of the diabetic state on chemical metabolism, later studies attributed the changes
seen to modifications in P-450 protein profiles and finally some of the proteins seen to be
involved in the changes were purified.
Early work showed that diabetes altered the length of hexobarbital sleeping time in rats
treated with the diabetogenic compound alloxan, suggesting changes in clearance rates of
drugs in the diabetic state ( Dixon et al., 1961). Increased metabolic activity was noted
towards a variety of compounds, including an increase in the hydroxylation of aniline
(Kato & Gillette, 1965), aryl-hydrocarbon compounds, and androsterone (Reinke et al.,
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1978). Changes in the activity of sex-dependent P-450 activities were seen to be depressed
in male rats ( Warren et al., 1983) and it was also noted that the changes in the drug
metabolising systems in diabetes generated changes in the susceptibility of the animal to
certain hepatotoxins such as carbon tetrachloride (Hanasono etal., 1975 a and b).
The changes in the profiles of the P-450 protein fraction were studied in chemically
induced diabetic animals. An increase in a Mr 52,000 band, the characteritic size of P-450
proteins, was seen on two dimensional gels in alloxan induced diabetic animals. This band
was not induced by chemicals, such as 3-methlycholanthrene or phenobarbital, which had
previously been seen to induce other P-450 isoforms. The characteristics of this diabetes-
associated protein band were seen to correlate with, and it was suggested to be the same as,
a band previously seen to be induced by alcohol dehydrogenase inhibitors such as pyrazole
(Past & Cook, 1982).
The use of antibodies prepared against purified P-450 proteins were used to follow the
changes in particular protein levels in diabetes. The protein levels of the rat male specific
testosterone 16 a-hydroxylase, now termed CYP2C11, were shown to be decreased in
streptozotocin-induced diabetic rats (Favreau et al., 1987a.). The same treatment induced
several other P-450 bands which were purified and analysed. The Mr 52,000 protein,
previously noted to be induced in diabetes, was purified and antibodies raised to it
confirmed the suggestion that it was the same P-450 as induced by pyrazole. The diabetes
induced protein was seen to be responsible for some of the marked increase in aniline
hydroxylation noted in diabetes and it was also seen to metabolise acetol (Favreau et al.,
1987a). the N-terminal sequence, although unique at the time, now places this protein in
the CYP2E subfamily. In a similar manner a predominantly male P-450, now placed in the
CYP2C7 subfamily, was purified following diabetes-induced elevation. Studies of two-
dimensional gels however revealed that these three P-450s were not the only proteins
within the P-450 Mr band which were modulated by the diabetic state (Favreau et al.,
1987b.) In a similar study, based on the purification of P-450 enzymes seen to be induced
by diabetes, CYP2E and another previously uncharacterised enzyme were purified, the
substrate profiles analysed and N-terminal sequenced (Imoaka et al., 1988). The second
enzyme displayed catayltic activity towards the metabloism of lauric acid, hydroxylating it
at the co an to-1 positions, activities suggested by its N-terminal sequence similarity to a
P-450 previously purified from rat kidney (Imoaka & Funae, 1986). By comparison of the
N-terminal sequence of theis enzyme with genomically derived sequences this protein can
now placed in the CYP4A, specifically CYP4A2, subfamily.
In summary initial biochemical studies, followed by purification and immunologically
based investigations, revealed that the levels of several forms of P-450 were both elevated
and depressed in diabetes. Several lines of investigation began to converge as it was seen
that chemicals, such as alcohol dehydrogenase inhibitors, could produce changes in certain
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P-450 isoforms similar to those seen in diabetes suggesting an overlap in the physiological
and xenobiotic control mechanisms operating on this enzyme system.
Section 3.2. Diabetes mellitus
Diabetes mellitus is a common pathological state affecting 2-4% of the population in
industrialised countries. The two commonest forms of the disorder are "Type I, insulin-
dependent diabetes mellitus" (IDDM), and "Type 2, non-insulin dependent". Type 2
diabetes generally occurs in older, often overweight, people and has a progressive onset
often associated with dysfunction of insulin secreting cells and peripheral resistance to
insulin; Type 2 diabetes will not be discussed further. Type I diabetes is caused by the
destruction of the insulin secreting (3-cells within the pancreatic Islets of Langerhans. The
disorder is insidious in onset with a slow destruction of the p-cells by auto-immune
processes, leading to "insulitis" (infiltration of the pancreas by mononucleur cells) over a
period of several years (Tarn et al., 1987). A genetic link between the incidence of the
disorder and the major histocompatibility complex gene locus has been established (Todd et
al., 1987) and it is clear that environmental factors also play a large part in the development
of the disorder. The only available treatment for the disorder is insulin replacement therapy
which, inspite of now having been available for more than sixty years, still does not
remove some of its debilitating effects. As a consequence diabetic subjects have a
significant reduction in life-expectancy, around 30%, generally attributable to the effects of
inadequate metabolic control afforded by insulin replacement therapy (Green & Hougard,
1984). Excess mortality is largely accounted for by vascular disease and hypertension,
although other complications, akin to an acceleration of aging, are also seen (Krowleski et
al., 1988). The lack ofmetabolic control in diabetic subjects leads to higher fluctuations in
blood sugar levels than in non-diabetic sujects. Blood sugar can react with proteins by a
condensation reaction between the sugar aldehyde group and the protein amino group in a
series of events termed the "Maillard" or "browning" reaction. This reaction generates a
stable ketoamine, or "Amadori" product on proteins with both a long, for example collagen
and myelin, and short half-life, for example haemoglobin, in the body. The generation of
these products leads to the detectable presence of glycated haemoglobin, termed HbAl, in
the circulation of diabetic subjects which is often used as a means of ascertaining an
individuals level of metabolic control as it correlates with the ambiant blood glucose levels
(Cerami, 1988). In long half-life proteins Amadori products can further react with each
other, via dehydration reactions possibly involving radical initiated reactions, generating
cross-linking bridges within or between molecules, termed "advanced glycosylation end"
(AGE) products. These processes occur in all individuals, for example the concentration of
Amadori and AGE products in the skin collagen is correlated with age, but, due to the
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higher fluctuations a diabetic subjects blood glucose level, these processes are accelerated
in diabetes (Dominiczak et al., 1990). The acceleration of these processes is thought to
account for many of the complications of diabetes including hypertension, via arterial and
cardiac stiffening, nephropathy associated with the thickening of the glomerular basement
membrane, collagen cross linking leading to joint stiffening, myelin glycation and
neuropathy, and cataract development (Dominiczak, 1991).
Section 3.2.1: Animal models of Type I diabetes mellitus
a) Chemically induced diabetes
Most studies into the effects of diabetes on the enzymes of the drug metabolising systems
have used chemically induced animal models. The two diabetogenic chemicals most
commonly used in these studies are detailed below with the possible problems associated
with such an interventionist approach for the generation of the disorder are discussed; the
structures for these chemicals is given in Figure 3.1.
Alloxan: As is common for the whole group of diabetogenic chemicals alloxan is thought
to act as a diabetogenic agent through an exploitation of the very high susceptibility of the
p-cells to damage generated by free-radicals. Within the p-cell alloxan has been seen to
react with sulphydryl-protein residues and alters the membrane permeability. Free-radicals
produced during oxidation and reduction cycling of alloxan produce protein and DNA
damage and increase the rate ofDNA repair (Yamamoto etal., 1981).
Streptozotocin: As with alloxan the diabetogenic property of streptozotocin appears to
relate to its ability to generate free-radicals within the P-cells.This is emphasised by the
observation that diabetogenic action of streptozotocin can be prevented by induction of
free-radical scavenging systems such as super-oxide dismutase. Insulitis is seen following
treatment with streptozotocin suggesting that the damage produced by the chemical may
cause antigen release from the P-cell leading to an auto-immune response accelerating the
destruction of the p-cells initiated by radical damage (Robbins et al., 1980; Yamamoto et
al., 1981).
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Figure 3.1: The structures of the two chemicals most commonly used to generate
diabetes in experimental animals.
Chemically induced animal models of diabetes: drawbacks in terms of their utility in the
investigation of xenobiotic metabolising systems
Despite the use of such diabetogenic chemicals to produce a diabetes-like state for the study
of changes in xenobiotic metabolising enzymes, several problems prevail in such systems.
The destructive effects of the diabetogenic chemicals are not directed solely at the (3-cells
and so extra-pancreatic toxicity of the chemical, and associated shock, cannot be ruled out
in the interpretation of results obtained by these methods. It was noted for example that in
using streptozotocin to generate diabetes in mice profound changes in the ultrastructure of
the hepatocytes were also produced. Degranulation of the endoplasmic-reticulum,
mitochondrial swelling, and dilation of the smooth endoplasmic-reticulum, were all seen in
the hepatocyte as a result of the administration of streptozotocin. These effects were noted
in the hepatocytes after a single injection of streptozotocin whether the animal displayed
diabetic symptoms or not (Languenset al., 1980). Studies employing chemically induced
diabetes have an added layer of complexity in that a direct effect of the chemical, which
generates the diabetic state, may also be producing other diffuse pathological changes
perturbing the levels of xenobiotic metabolising enzymes directly. A clear example of this
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was seen in the different effects on the activity of A-acetylases produced by diabetes in
spontaneously, and chemically-induced diabetes in rats. In streptozotocin-induced diabetic
animals the rate of acetylation of drugs such as sulphamethazine was seen to be markedly
decreased in the diabetic animals (Lindsay & Baty, 1989). By contrast, in the
spontaneously diabetic BB rats the rate of acetylation was increased with onset of diabetes
(Lindsay & Baird, 1990).
b) A spontaneously diabetic animal model for diabetes mellitus: the BB rat
The BB rat was first identified in a commercial breeding colony, Bio-Breeding Laboratories
hence "BB", in 1974 (Chapell & Chapcll, 1983). The animal presents an excellent model
for type I diabetes displaying many of the metabolic, physiological and functional changes
associated with the human disorder (Baird, 1989). Once diabetic animals undergo structural
changes in the retina, glomerular basement membrane, and nerves and display clinical
characteristics, such as weight loss despite hyperphagia, polyuria, and ketoacidosis,
leading to death if insulin is withheld. Diabetes in the animal also generates metabolic
changes such as hypoinsulinaemia, post-prandial hyperglycaemia, hyperketoneamia,
hyperlipidaemia, and proteinuraemia reflecting muscle protein catabolism (Tannenbaum et
al., 1981a; Marliss et al., 1983). The metabolic disorder in the BB rat, as in the human,
appears to be auto-immune in nature, with the presence of circulating antibodies against
insulin and islet cell-surface antigens (Dean et al., 1987). A peak in the incidence of
diabetes occurs when the rats reach sexual maturity, between 60 to 120 days after birth. As
has been observed with the human MHC locus, an association with the disorder and the
nature of the rat MHC equivalent, the RT1 locus, has been seen (Butler et al., 1983). The
destruction of the P-cells, associated with the insulitis following the onset of diabetes in the
rats, is highly specific and the glucagon and other hormone secreting cells within the
pancreas are left intact, and insulitis disappears after the p-cells are destroyed (In't Veld &
Pipeleers, 1988). The mechanism of P-cell destruction is unclear but the fact that P-cells
are highly susceptible to free-radical damage, as noted in the proposed mechanism of action
of diabetogenic chemicals, suggests that it may be mediated by radicals. Addition of
antioxidants in the diet, such as vitamin E, protect the p-cells from destruction suggesting
further that free radical damage is responsible for their removal (Malaisse, 1982; Assayam
et al., 1986. Nomikos et al., 1986).
As seen in human IDDM studies, where around 50% ofmonozygotic twins are discordant
for the development of IDDM (Leslie & Pyke, 1980), only around 50-80% of animals in a
single litter produced by a diabetes-prone (DP) BB rat develop the disorder. This suggests
a clear environmental role involving fators such as diet, stress or infection, in the
development of diabetes. Theuse of the seemingly non-diabetic, but diabetes-prone
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animals, as controls against which the changes observed in the diabetic litter-mates can be
compared is innapropriate. The seemingly non-diabetic animals can still display mild
metabolic disturbances without having lost enough of their (3-cells to need insulin
administration to survive. The use of the diabetes-prone animals not developing diabetes to
establish, by long term breeding, a diabetes-resistant subline (DR), which displays an
incidence of diabetes of less than 1%, however circumvents this problem and these animals
serve as an effective control without the introduction of any strain related differences.
Section 3.3: Hormonal and metabolic changes produced by the diabetic state
It is possible that the modifications seen in cytochrome P-450 levels at the onset of diabetes
relate to the hormonal and metabolic changes ensuing from the disorder. The major changes
in hormonal levels and their metabolic effects in the diabetic state are outlined below. The
changes in some, or all of these parameters may represent components of the endogenous
signaling systems controlling the xenobiotic metabolising enzymes of the P-450 system.
Understanding the role of these changes in the modulation of these systems may allow an
appreciation of the mechanisms whereby some components of the P-450 drug metabolising
system are physiologically controlled.
Section 3.3.1: Metabolic changes in diabetes
The loss of insulin, resulting from of the destruction of the P—cells in diabetes, prevents
most cells taking up, storing, and using glucose as a metabolic fuel source. As a result of
insulin loss post-prandial circulating levels of glucose are high, the renal glucose threshold
is passed and glucose is excreted in the urine. The body attempts to compensate for the
seeming lack of glucose by increased release of glucagon, simplistically the antagonist to
insulin, and the actions of this hormone lead to increased levels of gluconeogenesis,
glycogenolysis, lipolysis and a switching to the use of fatty acids as the main metabolic fuel
supply. With the prolonged use of free-fatty acids as a fuel source circulating levels of
ketone bodies rise. The processes of attempted glucose homeostasis in diabetic subjects are
essentially exaggerated and ineffectual versions of those employed in the body of the non-
diabetic subject during moderate fasting, for example overnight, or more prolonged
starvation. The main control of the fuel source used by the body is thought to be dictated by
the fuel used by the muscles. In a fasted, starved or diabetic state the insulin:glucagon ratio
falls and the circulating levels of blood lipid, either through increased lipolysis or decreased
re-esterification of free-fatty acids, rise. The increase in blood free-fatty acid levels leads to
69
a decrease in use of glucose in the muscle as citrate, produced by p-oxidation, inhibits
glycolysis by reducing the activity of phosphofructokinase, and the uptake of glucose.
The switch from the use of glucose to the use of free-fatty acids by the muscles means that
other tissues more dependent on glucose, such as the intestine, brain and kidneys, can use
the remaining glucose as the ambient levels fall. Increased levels of gluconeogenesis are
induced by changes in the insulin iglucagon ratio producing phosphorylation changes within
cells (Section 4.14.1). Glycerol, lactate and eventually, with prolonged starvation, certain
amino-acids produced by the breakdown of muscles, are used to fuel gluconeogenic
processes. Following feeding, in the presence of active p-cells, glucose levels rise causing
an increase in the insulin: glucagon ratio and the metabolic processes are reversed. The liver
takes up and uses glucose, replenishes glycogen stores and the rate of free-fatty acid release
is inhibited. As the muscles stop using free-fatty acids as a fuel source, citrate levels fall
and the rate of glycolysis rises. In a diabetic state the P-cells are not present to an effective
level and so, even in a fed-state, the insulin:glucagon ratio remains low and a pseudo-
starved metabolic state is maintained (Johnston et al., 1984; Pilkis etal., 1988).
Section 3.3.2: Ketone body metabolism and ketosis in diabetes
P-oxidation of free-fatty acids generates acetyl-coenzyme A (acetyl CoA) which in a non-
starved state feeds into the Krebs cycle generating citrate from oxaloacetate. The flux
through the Krebs cycle is fairly constant whereas, with increased levels of circulating free-
fatty acids in the fasted, starved or diabetic states, the activity of the mitochondrial P-
oxidation pathway varies. When the insulin:glucagon ratio falls, and increased lipolysis
occurs, a rise in the level of fatty-acyl coenzyme A entering the mitochondria occurs as the
activity of palmitoyl coenzyme-A transferase I, generating the substrate for the
mitochondrial carnitine shuttle, increases. As levels of acetyl-CoA produced by the
increased P-oxidation build up, and the levels of oxaloacetate fall, acetoacetate is produced
from two molecules of acetyl-CoA. Acetoacetate is enzymatically reduced to p-hydroxy
butyrate which can be used as a fuel source by peripheral tissues folowing its re-oxidation
to acetoacetate and the regeneration of two acetyl-CoA molecules. In the staved or diabetic
state, however, the uncontrolled increase in acetoacetate production cannot all be used by
peripheral tissues as glycolysis fails. This leads to high levels of circulating acetoacetate
and P-hydroxybutyrate as well as, due to decarboxylation of acetoacetate, the generation of
acetone. Collectively these processes produce ketosis in diabetes and the effect which this
generates on the pH of the blood is of critical importance in the acute damage induced in
diabetes (Johnston et al., 1982; Johnston et al., 1982).
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Section 3.3.3: Modifications in hormonal status in diabetes
Essentially it is difficult to dissect the metabolic and hormonal changes experienced in the
diabetic state. A change in the metabolic status elicits a change in hormonal status leading to
the generation of a feed-back loop which, in a non-diabetic subject, generates the most
efficient use of the metabolites available. As a result most changes in hormonal status
produce a negative feed-back loop controlling the level of hormonal secretion either directly
or indirectly; the antagonistic nature of insulin and glucagon reaffirms this hormonal and
metabolic interrelationship.
In the diabetic state glucagon levels rise leading to the stimulation of gluconeogenesis,
lipolysis, and glycogenolysis, and the levels of glycolysis and glycogen synthesis are
repressed; in a non-diabetic individual the secretion of insulin is also elevated. Insulin
antagonises the actions of glucagon and also stimulates glucagon secretion. In the diabetic
state insulin levels fall as the P-cells are destroyed. As well as the effect of diabetes on
these two hormones other circulating hormonal levels become modified and these too play a
part in the metabolic changes occuring. The level of somatostatin (somatotrophin-release
inhibiting factor, or SRIF) rise; SRIF is a hormone which has an inhibitory effect on the
actions of both glucagon and insulin and a variety of gut hormones and growth hormone
(Mortimer, et al. , 1974). Diabetes also produces profound effects on the circulating levels
of growth hormone in some species; studies of the ultradian secretion of growth hormone
in male BB rats showed that, with the onset of diabetes, the levels of growth hormone fell.
This fall in circulating growth hormone levels was reflected in a decrease in both the peak
height and the amplitude of the growth hormone release pulse (Tannenbaum etal., 1981b)
and this was also observed in streptozotocin treated rats (Tannenbaum, 1981b). The
decrease in growth hormone levels may relate to the effect of the diabetic state on the levels
of SRIF, as mentioned the rise in SRIF decreases the level of growth hormone release.
Insulin also has been shown to generate transcriptional activation of the growth hormone
promoter and loss of this activation in the diabetic state may also account for the drop in the
level of growth hormone (Isaacs et al., 1987). Starvation produces a similar drop in the
level of circulating growth hormone in the rat, presumably acting through similar
mechanisms as those which operate in diabetes (Tannenbaum, 1979). In human diabetic
subjects the levels of growth hormone, by contrast, are reported to be elevated (Asplin et
al., 1989); similarly growth hormone levels become elevated in starved human subjects
potentially complicating the cross-species interpretation of changes which may be caused
by modifications of growth hormone levels (Hansen & Johansen, 1970; Ho et al., 1988).
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Section 3.3.4: Global changes in the translation and degradation rates of proteins in
starvation and diabetes
As well as changes in intermediary metabolism the hormonal changes in diabetes, and
starvation, produce a series of changes in the translational and degradational systems within
the body. In general these changes generate a non-specific effect, but it is clear that their
roles have ramifications in understanding the molecular basis for any modifications in
enzyme systems in the starved or diabetic state.
Phosphorylation and dephosphorylation changes, as a result of hormonal actions, generate
modified activity in numerous components of the translational machinery leading to
changes in the translation rates of transcripts in general. There appears to be no general
theme of, for example, increased phosphorylation or dephosphorylation alone generating a
decrease or increase in the translation rate, rather a complex combination of both
phosphorylation and dephosphorylation of various components affects the ribosomal
translational efficiency. The actions of insulin increases the level of phosphorylation on the
initiation factors eIF-4B (a helicase), eIF-4F (a cap recognition protein), the ribosomal
associated eIF-3 as well as the ribosomal S6 protein in a co-ordinate manner leading to an
increase in the rate of translation. Serum starvation leads to loss of phosphorylation at these
sites and decreases translational rates (Marino et al., 1989). Thus the overall level of
translation in the diabetic state, with loss of phosphorylation of these ribosomal
components due to the loss of insulin, would be expected to be depressed.
Starvation leads to an increase in the level of degradation of a variety of proteins by the
induction of the level of macro- and microautophagy of proteins and organelles by
lysosomes. These pathways appear to be non-selective in the proteins or organelles which
they degrade. The elevations in activity of the lysosomal degradative pathways occur
predominantly in tissues which atrophy in starvation such as muscle, liver and kidney and
these processe may contribute to the provision of gluconeogenic amino-acid substrates
(Dice, 1987; Mortimore et al., 1988). In the rat the general activation of autophagasomal
pathways are supplemented, following two days of fasting, by the specific increase in a
selective lysosomal degradative pathway. The activation of the selective lysosomal pathway
leads to an increase in the turnover of a class of proteins, such as aspartate amino
transferase and pyruvate kinase, with a common lys. phe. glu. arg. gin motif which
presumably indicates to the degradative machinery that these proteins are dispensible to the
cell and can be selectively used as gluconeogenic precusors in starvation (Dice et al.,
1986).
Thus in the starved and diabetic states a general decrease in the overall levels of message
translation, due to a depression in the activity of ribosomes, and an increase in the level of
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both non-specific and specific pathways for protein degradation form the background to
any changes in the drug metabolising enzyme system components.
Section 3.4: Changes in the drug metabolising enzyme systems of the BB/E (Edinburgh)
rat with onset of type I diabetes
Using the spontaneously diabetic BB/E rat changes in cytochrome P-450 enzymes and
components of the phase 2 conjugating systems were investigated at a molecular level.
Using several antibodies and cDNA probes the changes induced by the diabetic state, and
the possibility of their reversibility by insulin, were studied. Both male and female rats
were used in this study.
Diabetes-prone (DP) animals were weighed three times a week, and the urine of animals
seen not to gain weight was analysed for the presence of glucose. If glucose was seen to be
present in the urine then blood glucose analysis was performed. From these results those
animals which displayed a blood glucose level of, or higher than, 18 mmoles per litre were
classed as diabetic. One group of diabetic DP animals detected in this manner was left for
three days without administration of insulin and then sacrificed; in subsequent references
to this group, these animals are termed DM (Diabetic male), or DF (diabetic female). A
second group of diabetic DP animals were left for the same period after detection of
diabetes but then were treated with insulin and their blood glucose levels were returned to
normal, around 2-4 mmoles per litre, prior to sacrifice; in subsequent references to this
group, these animals are termed IM (insulin treated male), or IF (insulin treated female).
Age and sex matched diabetes-resistant animals were taken to act as controls to the possible
changes induced by diabetes, and their potential reversal by insulin treatment; these animals
are referred to as SM (subline male) and SF (subline female) in subsequent analysis.
Biochemical analysis of blood samples taken from the animals was performed to establish
possible links between the metabolic changes seen and modifications in the xenobiotic
metabolising systems (Table 3.1). To analyse the potential role played by the elevated
levels of ketone bodies in the diabetic state in the production of changes in the P-450
system a separate study was undertaken where blood ketone levels were experimentally
elevated. In this study both male and female Wistar rats, the progenitor strain for the BB
rat, were given 1% acetone in their drinking water over a two week period. In addition to
these animals a third group of animals were studied which underwent the two week acetone
treatment, but were then placed back on standard drinking water to study the longevity of
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Figure 3.2: Western blot analysis of the effect of diabetes on the protein levels of the
CYP2E subfamily in the BB/E rat. Microsomal protein (lOpg of liver and 20pg of
kidney) isolated from subline male and female (SM and SF respectively), diabetes-
detected, diabetes-prone male and female (DM and DF respectively), and insulin-
treated, diabetes-detected, diabetes-prone male and female (IM and IF respectively)
animals were separated by SDS/PAGE on 9% gels.The proteins were transferred to
nitrocellulose filters and probed using polyclonal antibodies raised to purified rat
CYP2E1 protein. No bands other than those shown were detected. The CYP2E protein
ran with a Mr of approximately 52,000. The long (LONG) and short (SHORT)
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Figure 3.3: Western blot analysis of the effect of diabetes on the protein levels of the
CYP4A subfamily in the BB/E rat. Microsomal protein (lOpg of liver and 20pg of
kidney) isolated from subline male and female (SM and SF respectively), diabetes-
detected, diabetes-prone male and female (DM and DF respectively), and insulin-
treated, diabetes-detected, diabetes-prone male and female (IM and IF respectively)
animals were separated by SDS/PAGE on 9% gels. The proteins were transferred to
nitrocellulose filters and probed using polyclonal antibodies (POLY) raised to purified
rat CYP4A subfamily proteins and a monoclonal antibody (MONO) raised to purified
rat CYP4A1 protein. No bands other than those shown were detected and the P-450
subfamily proteins ran with a Mr of approximately 52,000. The CYP4A1 standard
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Figure 3.4: Western blot analysis of the effect of diabetes on the protein levels of the
CYP1A, CYP2B and CYP3A subfamilies in the BB/E rat. Microsomal protein (lOpg
of liver and 20pg of kidney) isolated from subline male and female (SM and SF
respectively), diabetes-detected, diabetes-prone male and female (DM and DF
respectively), and insulin-treated, diabetes-detected, diabetes-prone male and female
(IM and IF respectively) animals were separated by SDS/PAGE on 9% gels. The
proteins were transferred to nitrocellulose filters and probed with polyclonal antibodies
raised to purified rat P-450 subfamily proteins as indicated; no bands other than those
shown were detected. The P-450 protein bands all ran with a Mr of approximately
52,000. The CYP2B1 standard marks the upper cross-reacting band as CYP2B1 and
was isolated from rat liver.
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Figure 3.5: The effect of diabetes and acetone treatment on the CYP2E1 mRNA level
in the BB/E rat and Wistar rat. Total RNA was isolated from subline male and female
(SM and SF respectively), diabetes-detected, diabetes-prone male and female (DM and
DF respectively), and insulin-treated, diabetes-detected, diabetes-prone male and
female (IM and IF respectively) animals and from Wistar control male and female
(CM and CF), male and female acetone treated by 1% acetone addition to drinking
water (AM and AF) and animals allowed to recover from this treatment subsequently
by one week with standard drinking water (RM and RF). lOpg of each RNA sample
was subjected to horizontal gel-electrophoreses and transferred to nylon filters by
capillary action. The filters were hybridised with a radioactively labelled probe
generated from an 800bp mouse partial Cyp2el cDNA. No bands other than those
shown were detected and the CYP2E mRNA ran with a size of approximately 1,800
bases. „0
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Figure 3.6: The effect of diabetes and acetone treatment on the CYP4A1 mRNA level
in the BB/E rat and Wistar rat. Total RNA was isolated from subline male and female
(SM and SF respectively), diabetes-detected, diabetes-prone male and female (DM and
DF respectively), and insulin-treated, diabetes-detected, diabetes-prone male and
female (IM and IF respectively) animals and from Wistar control male and female
(CM and CF), male and female acetone treated by 1% acetone addition to drinking
water (AM and AF) and animals allowed to recover from this treatment subsequently
by one week with standard drinking water (RM and RF). lOpg of each RNA sample
was subjected to horizontal gel-electrophoreses and transferred to nylon filters by
capillary action. The filters were hybridised with a radioactively labelled probe
generated from a rat CYP4A1 cDNA. No bands other than those shown were detected
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Figure 3.7: Western blot analysis of the effect of acetone treatment on the protein
levels of the CYP2E subfamily in the Wistar rat. Microsomal protein (lOpg of liver and
20pg of kidney) isolated from control male and female (CM and CF), male and female
acetone treated by 1% acetone addition to drinking water (AM and AF) and animals
allowed to recover from this treatment subsequently by one week with standard
drinking water (RM and RF) were separated by SDS/PAGE on 9% gels. The proteins
were transferred to nitrocellulose fdters and probed using polyclonal antibodies raised
to purified rat CY2E1 protein. No bands other than those shown were detected and the
CYP2E protein ran with a Mr of approximately 52,000. The CYP2E1 standard (STD)
was prepared from the membranes of E. coli heterologously expressing the mouse
Cyp2el protein. The long (LONG) and short (SHORT) exposures of the blot allow a
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Figure 3.8: Western blot analysis of the effect of acetone treatment on the protein
levels of the CYP4A subfamily in the Wistar rat. Microsomal protein (lOpg of liver and
20pg of kidney) isolated from control male and female (CM and CF), male and female
acetone treated by 1% acetone addition to drinking water (AM and AF) and animals
allowed to recover from this treatment subsequently by one week with standard
drinking water (RM and RF) were separated by SDS/PAGE on 9% gels. The proteins
were transferred to nitrocellulose filters and probed using polyclonal antibodies
(POLY) raised against purified rat CYP4A subfamily proteins and a monoclonal
antibody (MONO) raised against purified rat CYP4A1 protein. No bands other than
those shown were detected. The PA50 proteins ran with a Mr of approximately 52,000.
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Section 3.4.1: The effect of the diabetic state on the protein level of a variety of
xenobiotic metabolising P-450
The diabetic state leads to a marked induction of the protein levels of all the subfamilies
studied. The protein levels of the CYP2E subfamily (Figure 3.2) , CYP4A subfamily, in
which the polyclonal antibody employed has previously been seen to recognise epitopes of
both CYP4A1 and CYP4A2, and the monoclonal specifically recognising CYP4A1
(Figure 3.3), CYP1A, both CYP1A1 and CYP1A2, CYP2B1 and CYP3A (Figure 3.4)
subfamilies were seen to be elevated in both sexes in the diabetic state. In both sexes
treatment of diabetic animals with insulin reversed these elevations; the CYP4A subfamily
protein levels however were seen not to completely return to the levels seen prior to the
onset of diabetes (Figure 3.3). These antibodies used in this study were raised against P-
450 proteins purified from the rat and have been previously characterised and their
specificity to the stated epitopes confirmed (CYP1A1, CYP1A2, CYP2B1 and CYP3A:
Wolf & Oesch, 1983; Wolf et al., 1984; CYP2E1: Hong et al., 1989. CYP4A 1 and 2:
Forrester et al., 1990. CYP4A1 monoclonal: Savoy etal., 1990).
The effect of the diabetic state on the mRNA levels of CYP2E1 (Section 5.2) and CYP4A1
(Earnshaw et al., 1988) subfamilies was investigated. Diabetes was seen to generate a
marked increase in the levels of both the CYP2E1 and messages in both sexes in the liver.
CYP2E1 mRNA levels are also elevated in the kidney in both sexes but elevation of
CYP4A1 mRNA is only seen in the male kidney. The elevation of mRNA of both
subfamilies was reversed by insulin treatment (Figure 3. 5, Figure 3.6).
Section 3. 5: The effect of acetone treatment on the protein and mRNA levels of the
CYP2E1 and CYP4A1 enzymes
The use of acetone treated animals allowed the potential role of ketone bodies in the
elevation in the levels of the CYP2E1 and CYP4A1 enzymes to be assessed. Acetone
treatment produced a marked elevation in the level of the CYP2E subfamily protein in both
the liver and the kidney in both male and female animals; this induction is reversed when
the animals are allowed to recover from acetone treatment (Figure 3.7). These increases in
CYP2E protein were not accompanied by increases in CYP2E mRNA levels in either the
liver or the kidney (Figure 3.5). A decrease in the level of CYP2E1 mRNA was seen in the
male kidney on treatment with acetone (Figure 3.5); several chemical inducers of the
CYP2E subfamily have been reported to decrease the levels of CYP2E transcripts and a
possible explanation for these observations is discussed in Section 3.7.5. By contrast the
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protein and mRNA levels of CYP4A subfamily were unchanged by acetone treatment
(Figure 3.6, Figure 3.8).
Section 3. 6: Control protein and mRNA markers for the diabetic and acetone treated
animals, and the strain differences noted in the sexual dimorphism of several proteins
between the BB and Wistar rats
Both the P-450 reductase and the microsomal glutathione S-transferase (jiGST) were
employed as microsomal protein markers and were seen to be unchanged by either the
diabetic state or following exposure to acetone (Figure 3.9, Figure 3.10, Figure 3.11). The
(iGST mRNA was also seen to be unaffected by diabetes or acetone treatment (Figure 3.9,
Figure 3.10). The (iGST provides an invariant control protein and mRNA for studies of
changes in xenobiotic metabolising P-450. Previous studies on the regulation of the (iGST
had shown that its levels were unchanged by compounds, such as 3-methylcholanthrene,
which generate induction of several P-450 isoforms. Studies have suggested that factors
regulating the level of jiGST activity appear to do so via post-translational modification of
pre-existing protein (Morgenstern & DePierre, 1988).
It is of note that a clear strain difference is present between the BB rats and the progenitor
Wistar strain. A sexual dimorphism in the kidney of the pGST, present at both the mRNA
and protein level in theWistar animals with higher levels in the male than the female, is lost
in the BB strain (Figure 3.9, Figure 3.10). Similarly a sexual dimorphism present in both
the kidney and liver for the CYP4A subfamily, with again higher levels being seen in the
male, is absent in the BB rats (Figure 3.3, Figure 3.6, Figure 3.7). A sexual dimorphism
in the level of the CYP3A subfamily protein is however retained in the BB animals (Figure
3.4). A similar observation for strain-, and sex-related differences in xenobiotic
metabolising enzymes has been noted previously. It was seen that the level of activity of
TV-acetylation was higher in the male BB/E rats than the female (Lindsay & Baird, 1990); in
other strains the reversed relative levels of A-acetylase activity had previously been
reported (Zidek & Janku, 1979). The basis for such differences in this instance is unclear
but the observation that different rat strains, and other rodents, possess differences in
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Figure 3.9: Western and Northern blot analysis of the effect of diabetes on the levels
of the microsomal GST (pGST) protein and mRNA in the BB/E rat. Western blot
(Upper): Microsomal protein (20pg of liver and 40pg of kidney) isolated from subline
male and female (SM and SF respectively), diabetes-detected, diabetes-prone male and
female (DM and DF respectively), and insulin-treated, diabetes-detected, diabetes-
prone male and female (IM and IF respectively) animals were separated by
SDS/PAGE on 12% gels. The proteins were transferred to nitrocellulose filters and
probed using polyclonal antibodies raised to purified rat pGST protein. No bands other
than those shown were detected and the pGST protein ran with a Mr of approximately
17,000. The pGST standard (STD) was prepared from the membranes of E. coli
heterologously expressing the rat pGST protein. Northern blots (Lower 2): Total RNA
was isolated from the tissues of animals treated as detailed above and lOpg of each
RNA sample was subjected to horizontal gel-electrophoreses and transferred to a nylon
filter by capillary action. The filters were hybridised with a radioactively labelled probe
generated from a rat pGST cDNA; no bands other than those shown were detected and
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Figure 3.10: Western and Northern blot analysis of the effect of acetone treatment on
the levels of the microsomal GST (pGST) protein and mRNA levels in the Wistar rat.
Western blot (Upper): Microsomal protein (20pg of liver and 40pg of kidney) isolated
from Wistar control male and female (CM and CF), male and female acetone treated by
'1% acetone addition to drinking water (AM and AF) and animals allowed to recover
from this treatment subsequently by one week with standard drinking water (RM and
RF) were separated by SDS/PAGE in 12% gels.The proteins were transferred to
nitrocellulose filters and probed using polyclonal antibodies raised to purified rat pGST
protein. No bands other than those shown were detected.The pGST protein ran with a
Mr of approximately 17,000. The pGST standard (STD) was prepared from the
membranes of E. coli heterologously expressing the rat pGST protein. Northern blots
(Lower 2): Total RNA was prepared from the tissues of animals treated as detailed
above and lOpg of each RNA sample was subjected to horizontal gel-electrophoreses
and transferred to nylon filters by capillary action. The filters were hybridised with a
radioactively labelled probe generated from a rat pGST cDNA; no bands other than
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Figure 3.11: Western blot analysis of the effect of diabetes and acetone treatment on
the protein levels of P-450 reductase in the BB/E rat and in the acetone-treated Wistar
rat. Microsomal protein (lOjxg of liver and 20pg of kidney) isolated from subline male
and female (SM and SF respectively), diabetes-detected, diabetes-prone male and
female (DM and DF respectively), and insulin-treated, diabetes-detected, diabetes-
prone male and female (IM and IF respectively) animals and the same quantity of
microsomal protein isolated from Wistar control male and female (CM and CF), male
and female acetone treated by 1% acetone addition to drinking water (AM and AF) and
animals allowed to recover from this treatment by one week with standard drinking
water (RM and RF), were separated by SDS/PAGE on 9% gels. The proteins were
transferred to nitrocellulose filters and probed using polclyonal antibodies raised to
purified rat P-450 reductase. The P-450 reductase protein has a Mr of approximately
100,000 and no bands other than those shown were detected. The P-450 reductase
standard (Std.) was isolated from rat liver.
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Section 3.7: What factors present in the diabetic state could account for the changes seen
in P-450 enzyme levels
Although the levels of all the P-450 studied were seen to be modified by the diabetic state,
the CYP2E and CYP4A subfamilies were more extensively studied and their potential
endogenous inducers were analysed more fully. From this work, allied with previously
noted changes in the diabetic state and the actions of chemical modulators of P-450 levels,
the endogenous signals which may precipitate the changes seen in diabetes may be
assessed.
Section 3.7.1: The diabetic modulation of the CYP2E subfamily mRNA and protein
levels; a role for ketoacidosis
CYP2E has previously been shown to be induced by a variety of small solvent molecules;
the endogenous signal for the induction in the diabetic state could therefore be the increased
levels of ketones present in the blood as a result of increased fatty acid metabolism and
decreased in glycolysis. Levels of P-hydroxy-butyrate were seen to rise approximately 22-
fold and 15-fold in the blood of the diabetic female and male animals respectively (Table
3.1). The role of acetone in the induction of the CYP2E1 protein was demonstrated by the
effects seen in the acetone-induced Wistar rats (Figure 3.7); this treatment however did not
elevate the level of CYP2E mRNA (Figure 3.5) which was seen to be increased in the
diabetic animals (Figure 3.5). Thus acetone may represent one of the endogenous signals
modulating the levels of CYP2E in the diabetic state. Previous studies have indicated that
acetone, and other small solvents metabolised by the CYP2E subfamily, have the capacity
to induce the protein in this manner. This protein elevation has been suggested to be
mediated by a process of substrate stabilisation of pre-existing CYP2E subfamily protein
(Song et al., 1989). The possibility also exists that acetone may accelerate the rate of
CYP2E mRNA translation and degradation leading to lower CYP2E mRNA levels in
chemically treated animals (Kim et al., 1990; Kim & Novak, 1990). This possibility is
discussed further in connection with the possible structural elements present within the
CYP2E subfamily mRNA 5' untranslated regions (UTRs) (Section 3.7.5).
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Section 3.7.2: The mechanism for the increase in CYP2E mRNA levels
The increase in the level of CYP2E mRNA could be the result of increased transcription,
stabilisation of existing mRNA, or a combination of both these possibilities. Situations
have been reported previously where both message stabilisation and increased transcription
are seen. For example, in the control of phosphoenolpyruvate carboxykinase (PEPCK), a
key enzyme in the control of gluconeogenesis, glucagon stimulated changes in intracellular
cAMP levels and their associated phosphorylational changes, generate both an increase in
the level of PEPCK transcription and an increase in message stability; these changes in the
PEPCK transcript levels s are reversed by the action of insulin (Hod and Hanson, 1986;
Petrsen et al., 1989). In the only report attempting to address the molecular level at which
the CYP2E transcript elevation occurs, nuclear run-on experiments were carried out from
the CYP2E1 gene in hepatic tissue isolated from streptozotocin-treated rats. The data
obtained from these experiments indicated that the CYP2E mRNA level increase seen was
due to a stabilisation of pre-existing mRNA; no increase in CYP2E1 transcription was seen
by comparison to the run-on results obtained from the P-actin gene (Song et al., 1987). If
this analysis is correct, then the mechanism for the elevation of the CYP2E subfamily
transcript level in diabetes would generate a pleasing parallel to the proposed stabilisation
of the protein also occurring in this state. However, results obtained in the present study of
the control of the CYP2E subfamily in the diabetic state suggest that a transcript
stabilisational does not occur, or, if it does it, may not account entirely for the increased
levels of CYP2E mRNA seen.
Section 3.7.3: The use of P-actin as a probe for an invarient transcription rate in the
diabetic state; the effect of the diabetic state on p-actin transcript levels in the BB/E rats
In suggesting that the CYP2E mRNA becomes stabilised in the diabetic state Song et al.
(1987) based their findings on the assumption that the P-actin gene transcription levels
would be unchanged either by the metabolic and hormonal changes experienced in the
diabetic state, or resulting directly from the effects of streptozotocin treatment.
The effect of the diabetic state on P-actin transcript levels in twelve BB/E rat livers was
studied; in this study the metabolic status of the animal was not revealed until after the
analysis had been completed (i.e. a blind study). It is clear from this analysis that the level
of P-actin is not unaffected but elevated by the diabetic state (Figure 3.12).
88





Figure 3.12: The effect of diabetes in the BB/E rat on the levels of (3-actin transcripts
compared to the effects observed in the microsomal GST (pGST) and CYP2E
subfamily transcript levels. Total RNA was isolated from the livers of twelve BB/E
animals, lOpg of total RNA was loaded per track, separated by horizontal gel
electrophoresis and transferred to a nylon filter by capillary action. The filter was
sequentially hybridised, and then stripped, with radioactively labelled probes generated
from rat (3-actin, rat pGST and mouse partial Cyp2el cDNAs. The nature of the source
of the sample was then decoded to reveal the source of the tissue as indicated: C:
Control subline. D: Diabetes-detected, diabetes-prone. T: Diabetes-detected, insulin
treated, diabetes-prone. The mRNA sizes ran with marker sizes of 1,000, 1,800 and
950 bases for (3-actin, CYP2E and pGST respectively.
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The nature of the rise in P-actin transcripts could be due either to transcriptional elevation or
mRNA stabilisation and, if a similar change in the P-actin mRNA levels occurs in the
streptozotocin treated animals, nuclear run-on experiments using p-actin as a presumed
invariant control in isolation cannot distinguish between these two events. This observation
means that the P-actin gene transcription rate cannot be used to gauge relative changes in
the transcription levels of other messages in isolation.
Although P-actin is often regarded as a housekeeping gene has often been seen to be
transcriptionally regulated. P-actin, and other cytoskeletal components such as a-actin and
the tubulin gene family, have been shown to be transcriptionally regulated in a variety of
situations including the actions of protein synthesis inhibitors (Greenberg et al., 1986),
serum stimulation (Ryseck et al., 1989.), lectins (McCairns et al., 1984), growth factors
(Leof etal., 1986) and insulin (Messina, 1992); transcriptional activation of p-actin is also
seen to be correlated with cellular damage in certain cell types (Hoock et al., 1991) where
its trancriptional activity was decreased potentially by the actions of the nucleur phospho-
protein p53.
Stabilisation of the CYP2E mRNA in the diabetic state cannot however be excluded as a
result of this observation; analysis of features possessed by messages known to be
regulated by stabilisation and the comparison of the nature of these features to those
possessed by the CYP2 subfamily mRNA may reveal the possibility of mRNA stabilisation
in the diabetic state.
Section 3.7.4: Regulating the stability of mRNA
If the CYP2E mRNA becomes stabilised in diabetes it is possible that structural
comparisons can be drawn between it and other messages known to have regulated
stability. mRNA is degraded from the 3' to the 5' end; the presence of a poly-(A) tail, and
the subsequent protective action of the poly-(A) binding protein (PAbp), reduces the speed
at which this occurs (Baer & Kornberg, 1983). Situations have been reported where the
length of poly-(A) tails are modulated, for example growth hormone mRNA elongates in
response to glucocorticoids (Paek & Axel, 1987). This type of response has been seen to be
mediated by the actions of secondary messenger systems, for example, factors which
modulate protein-kinase C activity, leading to a change in the length of poly-(A) tail
present on the corticotrophin releasing hormone mRNA (Adler et al., 1992). Specific
elements within the 3' untranslated (UTR) region of a message can also determine the rate
of degradation, potentially by generating a competing binding site for pABP. Examples of
messages with a stability of several days, for example haemoglobin, and several minutes,
90
for example c-fos, have been reported (Shaw & Kamen, 1986; Brawerman, 1989; Section
4.5.2).
These observations highlight the fact that a message is not a naked piece of RNA but a
complex interaction between RNA and a variety of different proteins. An mRNA
population is therefore divisible into two subpopulations; the first is being actively
translated within ribosomes, the second is held within an inactive protein-bound messenger
ribonuclear protein (mRNP) complex. The inactive mRNP component of a message
population can account for up to 30% of the messages present within a muscle cell for
example (Bag & Sarkar, 1985). The distribution between these two pools can be changed
in response to a stimuli, for example, in the pancreatic islet cells at low glucose
concentrations insulin messages are found mainly in the mRNP form however when
stimulated by elevated glucose levels the mRNP becomes mobilised to the polysomes and
translated (Welsh et al., 1986). Most of the proteins present in these complexes, except
PAbp, have not been well characterised and it appears that different proteins can either bind
all mRNA molecules non-specifically or specifically bind only to a certain mRNA or group
of mRNAs (Dreyfuss, 1986). The nature of the nucleases involved in the degradation of
the messages is also not clear and whether a specific nuclease targets a certain mRNA or
mRNA family, and is controllable in abstraction from the activity of other nucleases is
uncertain. The existance of specific nucleases has been suggested, for example in the
degradation of histone messages, although again this nuclease may just recognise messages
lacking a poly-(A) tail (Ross et al., 1987).
Many messages have been reported to become stabilised by the inhibition of protein
synthesis; this observation suggests either that the nucleases responsible for degradation are
rapidly turned over, or that to be degraded the message has to be translated and nucleases
may be associated with the polysomes. It is clear therefore that there is an overlap between
a messages stability and its translation rate; in many instances increased translation leads to
accelerated degradation of a message and a block of translation leads to an increase in the
stability of a message (Wisdom & Lee, 1991; Hua & Yaachov, 1992). The stability of a
message is therefore the result of a complex series of interactions between structural
features of the message, RNA binding and degrading proteins, and the translational
machinery.
Section 3.7.5: Increased translation of the CYP2E subfamily mRNA after chemical
induction
The translation of CYP2E mRNA has been reported to rise rapidly after treatment of
animals with chemical inducers of the protein such as acetone (Kim & Novak, 1990, Kim
et al., 1990). Using sucrose density gradients it was shown that the CYP2E mRNA
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population shifted to a higher density polysomal band after treatment with chemical
inducers. This indicated that the number of ribosomes bound to each message increases on
chemical treatment. In general it appears that translation may be limited by the initiation
step, if the rate of initiation is increased, that is the translatability of the message increases,
theoretically ribosomes can become stacked onto the message at a frequency of
approximately one per thirty nucleotides. The stacking up of ribosomes on a message in
this fashion leads to the shifting of the message to a higher density polysomal fraction
(Wolin & Walter, 1988). In a separate study on the induction of CYP2E1 in the hamster it
was suggested that ethanol treatment led to an increase in the level of CYP2E mRNA; the
basis for this statement was the observation that ethanol treatment led to an increase in the
ammount of CYP2E1 protein produced by a specific quantity of total RNA used to
programme a reticulocyte-lysate translation system (Kubota et al., 1988). It is however also
possible to interpret these observations by suggesting that the level of translatability of the
CYP2E1 messages present, as opposed the total amount, has become elevated by the
chemical treatment as no direct quantification of the CYP2E1 mRNA was carried out.
The level of translatability of a message is dependent on a complex interaction of structural
features of the message itself and other protein components. Factors affecting the level of
translation of a message, or its "specific activity" or "strength", include the type and context
of the initiation codon as well as the effect of proteins binding recognition sites, possibly
contained within RNA folding structures, both within and outside the coding region of the
message (Galili etal., 1988).
Section 3.7.6: An example of regulatable mRNA stability and translatability: ferritin and
transferrin receptor mRNA in iron homeostasis
The potentially damaging effect of free radicals generated by iron stored within cells mean
that a precise control of cellular iron levels must be maintained. Iron is stored in association
with the protein ferritin and is taken up into cells, in association with its transport protein
transferrin, by the transferrin receptor. In situations of high iron concentration levels of
ferritin synthesis rise to increase iron storage via a ten to forty fold increase in the
translatability of pre-existing ferritin mRNA, actually the product of two highly related
genes. Conversely the level of iron uptake falls due to a twenty fold decrease in the stability
of the transferrin-receptor mRNA stability. The reverse situation occurs in the presence of
low iron or following addition of iron chelators such as desferrioxamine (Rao etal. , 1986,
Bridges & Cudkowski, 1989).
Deletion analysis of the transferrin-receptor mRNA revealed that the portion of the message
responsible for the regulatable stability was present within the 3' untranslated region (UTR)
and consisted of sixty nucleotides which generated, when sub-optimally folded in a
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computer analysis, 5 firm stem-loop structures. The transferrin-receptor mRNA is
stabilised by the regulatable binding of a protein which recognises sequence motifs within
structural features at the 3' end of the message (Owen & Kuhn, 1987). Deletion analysis of
the ferritin messages revealed a role for sequences within the 5' UTR necessary for the
generation of regulatable translatability of the messages. The 28 nucleotide region of the 5'
UTR which varied the message translatability was capable of forming a similar predicted
stem-loop secondary structure to those seen at the 3' UTR in the transferrin-receptor
mRNA. This feature of the 5' UTR was seen to be conserved in the ferritin messages of all
the species studied (Hentz et al., 1987; Roualt et al., 1989). Translational initiation of the
ferritin message is blocked in the presence of iron by the binding of the regulatory protein
to the 5' UTR motif; in the absence of iron the 5' UTR/protein interaction is lost and the
mRNA shifts from mRNP to the polysomes where it is translated (Brown et al., 1989;
Haile etal, 1989).
Thus, in a reciprocal manner, a regulatable RNA-binding protein can bind structural
features contained within the untranslated regions of a message and modify either the rate
of translation or degradation operating on the message. In this instance the presence of the
protein binding 3' UTR of the transferrin-receptor mRNA generates increased stability of a
message, or, as is seen in the ferritin messages, binding at the 3' UTR blocks the
translation of the message. In a similar manner computer prdicted stem-loop structures have
been defined within the 3' UTR of histone messages, again widely conserved throughout
evolution, which lead to the generation of regulatable stability of these messages in S-phase
(Levin et al., 1987). A similar observation has been made in connection with the regulated
stability of the phosphoenolpyruvate carboxykinase mRNA where it was seen that motifs
within the 3' UTR conferred increased stability to the message in the presence of
glucocorticoids (Petersen, et al., 1989).
It is not always the case however that features controlling message stability or translatability
are contained within the UTR regions. Tubulin mRNA stability is regulatedby a feedback
mechanism dependent on the levels of ambient tubulin heterodimers within a cell. These
heterodimers interact with the first four amino-acids at the N-terminal of the protein as it
becomes translated and, potentially either by causing the translation process to slow and so
giving more opportunity for degradation, or by activation of a nuclease associated with the
ribosome, increase the degradation rate of the tubulin message. In this instance however,
where the controlling features for a message's stability are contained within the coding
region, the fact that the proteins involved naturally oligermerise may indicate that such
control mechanisms are unique to proteins capable of self-recognition via oligermerisation
(Patcher et al., 1988; Yen etal., 1988). More generally portions of a message contributing
to regulation are contained within the UTRs and, being free from amino-acid coding
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restraints, can be used to generate specific secondary structures and contain recognition
motifs to allow binding of regulatory proteins.
Section 3.7.7: Does the CYP2E subfamily mRNA possess features which may allow
the modulation of degradation or translation
Molecular evidence suggesting the possibility of regulatable translation or degradation of
the CYP2E subfamily mRNA
One factor governing the rate of translational initiation of a message is determined by the
nucleotide context of its first AUG codon. The presence, or absence, of certain nucleotides
in proximity to the initiation codon plays an important role in determining the level of
translational initiation from a message. The presence features within the 5' UTR, with the
possibility of formation of structures and content of sequence motifs interacting with
regulatable protein components, as seen with ferritin mRNA, also may allow the control of
initiation.
The initiation AUG codons of the CYP2E subfamily messages are all in near perfect
consensus contexts ( Kozak, 1987) suggesting that the CYP2E messages are potentially
readily translated (Table 3.2).
Table 3.2: The context of the initiation methionine codons of the CYP2E subfamily
messages known to date compared with the derived mammalian consensus (Con.) AUG
context.
Rabbit A A G C A C c A U G G C
Human C G G C A C c A u G U C
Rat U G G C A c c A u G G C
Mouse c G G C A c c A u G G C
Con. c G G C A c c A u G G C
The 5' UTR of the human (Umeno et al., 1988a), rat (Umeno et al., 1988b) and rabbit
(Khani et al., 1988) CYP2E messages were determined by SI mapping and primer
extension assays showing the messages to have a leader UTR of around fifty nucleotides.
Alignment of the 5' UTR, and by homology the mouse Cyp2el UTR, and computer
generated folding of these sequences to their lowest energy state form allowed the
determination of folding structures which may be adopted by the messages (Section 5.4.4,
Figure 5.7a). The generation of these folding patterns indicated that a highly conserved
secondary structure could be generated by the 5' UTR of the CYP2E subfamily messages;
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sequence analysis of this portion of the CYP2E subfamily message suggested the presence
of a highly conserved NFxp recognition site which could potentially recognised by the
series of DNA binding proteins (Section 4.13; Section 4.13.1; Figure 5.7b). Some of the
proteins which have been shown to bind NFk(3 recognition sites contain zinc-finger motifs
potentially capable of binding both RNA and DNA (Baldwin et al., 1990; Dressier &
Gruss, 1988). The presence within the 5' UTR of the CYP2E subfamily messages of these
highly conserved structural elements, and possible protein recognition motifs, suggests that
a mechanism for the regulation of translation could be mediated by factors binding to this
portion of the message in a similar manner as discussed in connection with ferritin mRNA
translation control (Section 3.7.6).
The level of conservation in the 3' UTR of the CYP2E subfamily messages is low (Section
5.4). This observation suggests that the 3' UTR of the CYP2E subfamily messages may
not contain ragulatable degradation conferring motifs as seen in the transferrin receptor
mRNA 3' UTR (Section 3.7.6). This suggestion is stressed by the observation that the
mouse Cyp2e message was seen to have lost its original 3' UTR sequence following the
insertion of a $2 repeat element. The removal of the original Cyp2e mRNA 3' UTR by the
P2 repeat element does not however block the induction of the message by starvation in the
mouse (Section 4.5). That Cyp2el mRNA induction is still seen in the starved mouse
suggests that the 3' UTR plays no function in regulation of the Cyp2e mRNA and so
potentially the other CYP2E messages. If stabilisation of the CYP2E subfamily messages
were to occur in diabetes then these observations collectively suggest that it would have to
involve regions outside the 3' UTR; with the exception of the autoregulation of oligermeric
self-recognising proteins (Yen et al., 1988) no evidence for stabilisation of a message by a
region other than the 3' UTR has been reported.
The combined observations that [Uactin transcript levels are elevated in the diabetic state
and so cannot form a reliable invariant control transcript and that there is apparently no role
for a conventional mechanism involving the 3' UTR in the starved mouse, suggests that a
role for stabilisation of the CYP2E subfamily in the diabetic state is questionable. Such a
control mechanism and may not account for the changes in the levels of CYP2E transcripts
seen. It is possible however that there may be a role for a increase in translatabilty of the
CYP2E subfamily message in the diabetic state potentially mediated by features within the
conserved 5' UTR.
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Section 3.7.8: Factors previously seen to modify CYP2E mRNA levels in the rat and
their potential role in the diabetic induction of this subfamily; The role of growth hormone
in the regulation of the CYP2E sufamily in the rat
Growth hormone has previously been shown to modulate the levels of rat CYP2E1 mRNA;
it is perhaps important to note therefore that growth hormone levels fall in the diabetic rat
(Tannenbaum et al., 1981. Tannenbaum, 1981). Hypophysectomy, leading to a loss of
growth hormone, has been demonstrated to affect the levels of several P-450s in the rat.
The levels of CYP1A, the CYP2B subfamily and CYP2E1 were seen to be elevated in the
hypophysectomised rat; CYP2E levels were seen to be elevated by both biochemical and
immunological assay following hypophysectomy and the removal of growth hormone
(Williams & Simonet, 1988; Yamazoe et al., 1989a). The hepatic content of CYP2E1
mRNA was seen to increase between two and five-fold and the levels were returned to
normal after administration of growth hormone to the hypophysectomised rat (Yamazoe
et al., 1989a). As previously noted in earlier biochemical studies of P-450 changes in
diabetic rats the levels of certain sex dependent P-450 change (Warren et al., 1983), for
example the level of CYP2C11 was seen to fall with the onset of diabetes in the male rat
(Favreau et al., 1987a).
The effects of growth hormone and its mechanism of action on the P-450 genes which it
regulates have been extensively studied in the rat CYP2C gene family. Some members of
the rat CYP2C subfamily are sexually dimorphic and some are sex-dependent. CYP2C11
(associated with testosterone 16 a-hydroxylase activity) and CYP2C13 (associated with
testosterone 6 ^-hydroxylase activity) are male specific, whereas CYP2C12 (steroid
sulphate 15 P-hydroxylating) is female specific. CYP2C7 (retinoic acid and vitamin A
metabolising) is a constitutive but sexually dimorphic enzyme with around a three-fold
higher activity in the female. Hypophysectomy suppresses the expression of CYP2C11 in
males, CYP2C12 in females and CYP2C7 in both sexes. The level of expression of
CYP2C11 and CYP2C13 however become elevated in the female to ten and fifty percent of
those present in the male (Mode et al., 1988; McClellan et al., 1989; Westin et al.,
1990;Zaphiropoulos et al., 1990). The nature of CYP2C gene elevations were studied by
nuclear run-on assays using both P-actin and tyrosine amino-transferase gene transcription
as controls, and were shown to be mediated transcriptionally (Legraverend et al., 1992).
A fall in the level of CYP2C11 occurred in both hypophysectomised and diabetic male rats;
it is possible that in both these situations the signalling pathways modulated to produce the
changes in transcript level are the same and therefore in both cases the changes may be
mediated transcriptionally. Growth hormone treatment of the diabetic male animal however
did not reverse the decrease in CYP2C11 mRNA whereas insulin treatment did (Yamazoe
et al., 1989b). In a separate study it was reported that diabetes leads to resistance to the
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actions of growth hormone and the levels of the growth hormone receptor are reduced in
the diabetic state in rats suggesting that insulin allows a growth hormone signalling
pathway to operate (Baxter etal., 1980).
A synergistic action between insulin and growth hormone may therefore produce
transcriptional changes in the level of certain P-450 in the rat in diabetes. Problems with
this suggestion however arise when the both the effect of diabetes on the level of growth
hormone, and the effect of growth hormone on P-450s, in other species are examined. In
the human it was seen that the levels of growth hormone were elevated in starvation and the
diabetic state (Ho et al., 1988; Asplin et al., 1989) yet the level of CYP2E1 protein was
observed to be elevated in the lymphocytes of diabetic patients (Song et al., 1990). Studies
in the mouse, using both hypophysectomised and genetic models to remove circulating
growth hormone, have shown that the lack of growth hormone does not produce any
change in the levels of a variety of P-450s in this species (Henderson et al., 1990; Hong
et al., 1990. Section 4.6) yet starvation was seen to elevate the Cyp2e subfamily protein
(Section 4.5.2). These observations suggest either that in diabetes rat P-450 genes are
controlled by changes in growth hormone levels and that elevations seen in the human
CYP2E subfamily in diabetes, and the mouse in starvation, are coincidental and arrived at
by another mechanism, or that common controls, not involving growth hormone mediate
the P-450 elevations seen in diabetes. Differences in the potential transcriptional control
elements inthe rat and CYP2E subfamily gene and the mouse have been identified which
may allow regulation by growth hormone to occur in one species alone (Section 4.12).
However, n the light of the observed cross species conservation in the induction of the
CYP2E subfamily in diabetes and starvation, it would seem logical to suggest that changes
in growth hormone levels, which are not conserved between species in these states, may
not be the sole effectors of the changes in CYP2E subfamily transcript levels in these
states.
Section 3.8: The factors contributing to the modulation of the CYP4A subfamily in
diabetes
The CYP4A subfamily was seen to be elevated in the diabetic state at both the mRNA and
protein level (Figutre 3.3, Figure 3.6). Changes in the diabetic state, either hormonal or
metabolic, must therefore be responsible for these changes and produce them as a result of
the actions of endogenous signalling pathways.
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Section 3.8.1: The role for diabetic ketosis in the induction of CYP4A
Treatment ofWistar rats with 1% acetone in their drinking water had no effect on the level
of CYP4A protein or mRNA (Figure 3.8, Figure 3.6). Thus the CYP2E protein induction
seen on acetone treatment appears likely to operate via a substrate linked stabilisation
mechanism rather than a process which, via an acetone associated or activated pathway,
P-450s in general become stabilised. This suggests that other components of the metabolic
and hormonal changes occuring in diabetes may be responsible for the endogenous signals
leading to CYP4A subfamily induction.
Section 3.8.2: Factors previously seen to induce the CYP4A subfamily: peroxisome
proliferators
Xenobiotics capable of inducing members of the CYP4A subfamily have been seen to
include a group of hypolipidaemic drugs such as clofibric acid and its structural analogues
nafenopin, methlyclofenapate and WY-14,643, as well as industrial plasticizers such as
phthalate esters, for example di-(2-ethyhexyl)-phthalate, and certain herbicides, for
example 2,4,5 trichloropheno-oxyacetic acid. Collectively all these chemicals have the
capacity to generate peroxisomal proliferation and are therefore termed "peroxisome
proliferators". Treatment with clofibrate, and other peroxisomal proliferators, induces the
diagnostic activities associated with a series of enzymes responsible for the cyanide-
insensitive P-oxidation pathway within the peroxisomes (Reddy et al., 1986). The
hypolipidaemic drugs mediate their action by generating a proliferation of peroxisomes and
so accelerating fatty acid metabolism leading to hypolipidaemia. Broadly therefore, in
physiological terms, the actions of peroxisome proliferators could be likened to the effects
of a fall in the insulin:glucagon levels leading to an acceleration of the use of free-fatty acid
as a fuel (Section 3.3). These compounds have become paradigms for non-genotoxic
xenobiotics, i.e. they generate cellular damage indirectly potentially through the elevation of
oxidative stresses within the cell as the level of peroxisomal activity becomes induced
(Reddy et al., 1992).
Increased levels of both CYP4A protein, to and CO-1 hydroxylation of lauric acid (the
diagnostic activies of the CYP4A subfamily), and mRNA were observed in the livers of
clofibrate-treated rats (Hardwick et al., 1987). Nuclear run-on assays, using CYP3A and
CYP2B subfamily members previously shown to be unaffected by clofibrate treatment as
invariant controls, showed that the induction was mediated transcriptionally (Hardwick
et al., 1987). The actions of hypolipidaemic drugs appear to be localised predominantly to
the liver. Studies on the level of renal induction of the CYP4A subfamily revealed that,
although CYP4A is present as a high percentage of the total P-450 content in the kidney
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(around 30% in the kidney, but only around 5% in the liver), the kidney is less responsive
to the inducing effects of peroxisomal proliferators (Sharma etal., 1989).
Section 3.8.3: The mechanism of action of peroxisome proliferating xenobiotics
The broad effect of peroxisomal proliferators could be likened to the induction of the use
of free-fatty acids as a fuel supply in the fasted, starved or diabetic states as the insulin:
glucagon ratio falls. It is therefore possible that peroxisomal proliferators are utilising an
inductive signalling pathway normally stimulated by physiological agents. The processes
by which the peroxisome proliferators operate may therefore, in potentially mimicking the
actions of endogenous stimulators, give an insight into the processes that lead to CYP4A
induction in the diabetic state.
DNA binding proteins capable of acting as effectors for the actions of peroxisomal
proliferators have been isolated. The first was found through the probing of a mouse cDNA
library with oligonucleotides generated to the conserved binding regions of the steroid
hormone superfamily of receptors. The compounds capable of activating the steroid
hormone receptor proteins encoded by the clones obtained were analysed through the
fusion of the ligand binding domain of the novel receptors to the DNA binding domain of
receptors, glucocorticoid and oestrogen, with known DNA target sequences. Using this
assay, in conjunction with the target DNA sequences upstream of a chloramphenicol acetyl-
transferase (CAT) transcript in mammalian tissue culture, the chemicals capable of
activating the chimeric receptors were analysed. One such receptor, with a Mr of around
52,400, was activated by peroxisomal proliferators and was termed the mouse peroxisomal
proliferator activated receptor (mPPAR). A good correlation between the ability of a
compound to generate peroxisome proliferation in vivo and the strength of the CAT
response was noted. The peroxisome proliferators did not however bind the receptor itself
directly strongly suggesting that they mediated their actions indirectly via another signalling
pathway (Isseman & Green, 1990).
A similar study leading to the cloning of a rat analogue, the rPPAR which has 97%
similarity to the mPPAR, studied more inducing chemicals in an attempt to isolate the
physiologically relevant activator. These studies concentrated on free-fatty acids such as
arachidonate, laurate, and linolate and their metabolic intermediates as potential endogenous
ligands for the PPAR. These potential ligands again, as seen for the peroxisome
proliferators, did not bind the PPAR with the degree of specificity that might be expected
from analysis of other members of the steroid hormone receptor superfamily. The presence
of an easily generated, but poorly metabolised, acidic group in the compounds was the only
common structural feature identified in the potential ligands (Gottlicher et al., 1992). What
seems to be a likely candidate for the position of the PPAR ligand is a compound generated
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in response to common intermediates in the metabolism of fatty acids. The ligand may be
generated by lipid associated signalling pathways, such as those generated by arachidonic
acid, and the biologically active intermediate may act either as the PPAR ligand itself or lead
to the generation of post-translational modification of the PPAR allowing it to bind the true
ligand (Gottlicher et al., 1992). The direct action of free-fatty acids as low avidity ligands
however cannot be ruled out totally and it has been observed that poorly metabolised free
fatty acids as well as increased levels of free-fatty acids per se act as peroxisome
proliferators in vivo (Berge et al., 1989; Aarsland et al., 1989).
More members of the PPAR subfamily have been identified. A PPAR cDNA has been
cloned from human (Schmidt et al., 1992) and three PPAR cDNAs cloned from Xenopus
(Dreyer et al., 1992). The three receptors cloned from Xenopus are developmental^
regulated and are capable of inducing CAT activity in a non-chimeric form from the 5'
flanking region of acyl-CoA oxidase gene, a component of the peroxisomal P-oxidation
pathway seen to become transcriptionally activatedm vivo by peroxisomal proliferators
(Dreyer et al., 1992). In a similar manner regions of the 5' of the rat peroxisomal enoyl-
CoA hydratase/3-hydroxy acyl CoA dehydrogenase gene involved in the response to
peroxisome proliferators has been identified (Zang et al., 1992).
Many other members of the steroid-hormone receptor superfamily have been isolated in a
manner similar to that for the PPAR but very few ligands have been identified suggesting
perhaps that these "orphan" receptors may participate in intracellular signal responses and
that their ligands are generated intracellularly as a result (OMalley, 1990).
A peroxisomal proliferator binding protein (PPbp) was purified from the cytoplasm of rat
livers using affinity columns containing immobilised peroxisomal proliferators. The PPbp
had a Mr of around 70,000, far greater than that of the PPAR and is thought to exist as a
dimer in the cytoplasm (Lalwani et al., 1987). The relationship between the PPAR and the
PPbp is not clear, the PPAR was activated by the hypolipidaemic WY 14,643 whereas the
PPbp did not bind this compound for example; these results suggest that potentially more
than one signalling pathway may be employed by the peroxisomal proliferators or the PPbp
may be the binding protein per se for the xenobiotics and endogenous signals are then
generated which go on to generate the PPAR ligand.
It is also not clear if the peroxisome proliferators generate the actual peroxisome
proliferation seen. The transcriptional induction of components of the cyanide-insensitive
peroxisomal P-oxidation pathway and the induction of actual peroxisomes has been seen to
be temporally separated. Benzafibrate induces the level of p-oxidation enzymes but not the
actual quantity of peroxisomes in the rat (Lazarow et al., 1982) and similarly, although
inducing the P-oxidation components, clofibrate did not induce peroxisomes in Xenopus
(Ciolek & Dauca, 1991). Peroxisome proliferators have now been shown to
transcriptionally activate the 5' regions of the CYP4A sufamily in association with the
100
PPAR. In luciferase reporter experiments in mammalian tissue culture the rabbit CYP4A6
gene 5' region was activated by clofibrate in the presence of a co-transfected PPAR; the
DNA elements found to be necessary for this induction were found to be highly similar to
those of the previously characterised fatty-acyl CoA oxidase gene (Muerkoff etal., 1992).
This suggests that the processes involved in the action of peroxisome proliferators, and so
potentially the endogenous activators, in the induction of the CYP4A subfamily operate.
One striking feature of their action is the co-ordinate induction of a series of genes which
contribute to the acceleration of peroxisomal P-oxidation.
Section 3.8.4: Changes in peroxisomal activity in the diabetic BB/E rat
If similar pathways for induction of the CYP4A subfamily are used by both the peroxisome
proliferators and the diabetic state then potentially the co-ordinate activation of cyanide-
insensitive P-oxidation and peroxisomal proliferation may also occur. Both the levels of
cyanide-insensitive P-oxidation and the ultra-structure of the BB/E diabetic rat livers were
investigated to see if such a co-ordinate fatty acid metabolism response is associated with
the CYP4A induction seen in diabetes. An increase in the level of cyanide-insensitive
P-oxidation was seen in the diabetic animals suggesting that the components of the
peroxisomal P-oxidation pathway, seen to be activated in a co-ordinate manner by
peroxisomal proliferators, also become activated in diabetes (Table 3.3). An increase in the
percentage of the cytoplasm occupied by peroxisomes in the liver cells, as an indication of
peroxisomal proliferation (Table 3.3, Figure 3.13), was however only markedly seen in
one diabetic animal suggesting that a separation in the activation of P-oxidation and
peroxisomal proliferation may occur in diabetes. A similar observation had been made in
chemically treated rats where, although an increase in peroxisomal activity was seen, no
actual peroxisomal proliferation occurred (Lazaro et ai, 1981; Ciolek & Dauca, 1991).
Potentially more marked peroxisomal proliferation may be produced if it were possible to
extend the period which the animal remains diabetic; this however is not possible as,
without insulin administration, the animals die soon after the sampling times of the animals
used in this study (Figure 3.13).
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Figure 3.13: Transmission electron microscopic (TEM) analysis of the level of
peroxisomes present in the hepatocytes of the BB/E rats. Liver samples taken from the
BB/E animals were fixed and analysed by TEM to a magnification of X 8,300. A:
Analysis of the level of peroxisomes present in the hepatocyte cytoplasm of a diabetes-
resistant, subline, BB/E male rat. B: Analysis of the hepatocyte cytoplasm of the one
male BB/E diabetes-detected, diabetes-prone male rat in which an increase in
peroxisomal volume in the cytoplasm was noted. Peroxisomes are seen as dark staining
microbodies as indicated by the arrow in B. This analysis was carried out in
collaboration with Dr J. Foster and Dr C. Bowling, Zeneca Central Toxicology
Laboratories, Cheshire.
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Table 3.3: The changes in the rates of cyanide insensive P-oxidation and cytosolic
peroxisomal content in the BB/E rat study .The rate of NAD reduced (nmoles/min/mg of
liver sample) in the presence of cyanide is an assay for the activity of palmitoyl CoA
dependent reduction of NAD+ and so reflects the level of peroxisomal P-oxidation
(Bronfman et al., 1979); assays were performed in collaboration with Dr C. Elcombe and
Dr S. Tittensor, Zeneca Central Toxicology, Cheshire. The percentage peroxisomal content
in the centrilobular hepatocytes was estimated on X 8,300 transmission electron
micrographs using a 345 intercept square lattice (Moody & Reddy, 1976); analysis was
performed in coaboration with Dr J. Foster and Dr C. Bowling, Zeneca Central
Toxicology, Cheshire.
nmol reduced peroxisome
NAD per min, in the
per mg protein. cytoplasm
SUBLINE MALE 2.33 1.55
2.77 2.13
1.85
DIABETIC MALE 3.61 2.50
4.25 6.66
INSULIN TREATED MALE 1.84 3.07
Section 3.8.5: The endogenous signals potentially inducing the CYP4A subfamily in
diabetes
In the diabetic state the activation of lipolysis and the switch to the use of free-fatty acids as
the insulin:glucagon levels fall leads to the elevation of free-fatty acid levels in the blood.
From the studies into the potential effectors of peroxisomal proliferator action it is possible
that an increase in free-fatty acid, or triglyceride levels, contributes either directly or
indirectly to the activation of the PPAR and PPbp. As a result of these stimuli the activated
PPAR may transcriptionally activate the CYP4A genes (Muerhoff et al., 1992) and it has
been shown to transcriptionally activate the acetyl-CoA oxidase (Dreyer et al., 1992) and
enoyl-CoA hydratase/3-hydroxy acyl-CoA dehydrogenase (Zang et al., 1992) components
of the peroxisomal P-oxidation pathway. The putative endogenous signal for the elevation
of CYP4A may therefore be either the elevated levels of triglycerides, seen to be increased
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approximately 3-fold and two-fold in the male and female animal respectively, or free-fatty
acids, seen to be elevated approximately 3-fold or 2-fold in the male and female animal
respectively (Table 3.1), or metabolites with biological activity arising from these
elevations.
The fact that little change was seen in the levels of CYP4A in the diabetic kidney suggests
that the same pathway leading to the induction of the CYP4A subfamily by the the
peroxisome proliferators, which produce little CYP4A response in the kidney, (Sharma
etal., 1989) may be operating in diabetes. The seeming refractory nature of extra-hepatic
tissues to the effects of peroxisomal proliferators appears as a common feature shared by
other peroxisomal-associated genes activated by their action in the liver. It was seen that
components of the peroxisomal (3-oxidation pathway were unaffected by clofibrate
treatment in the rat kidney despite being highly induced in the liver (Nemali,et al., 1988).
This may reflect potentially a lower concentration of signalling components of the activating
pathway machinery within the kidney and this observation is in marked contrast to the
increased levels of CYP2E mRNA and protein in the diabetic kidney. This observation
suggests that potentially two distinct endogenous mechanisms are responsible for the
elevation of the CYP2E and CYP4A subfamilies.
Section 3.9: The endogenous signals responsible for the changes in the levels of the
other P-450 seen to be modulated in the BB/E rat
Protein level increases were seen to occur in the diabetic livers of the CYP1A, CYP2B and
CYP3A subfamilies. As has been suggested for the CYP2E and CYP4A subfamilies a
combination of metabolic and hormonal changes may be responsible for the generation of
the changes seen suggesting the presence of endogenous control mechanisms for these
components of the drug metabolising system. Proteins in the CYP1A subfamily have
previously been noted to become elevated in rats by treatment with high levels of tri-acyl
glycerol, leading to elevated ketone body levels (Barnet et al., 1990); this suggests a role
for acetone in the CYP1A protein induction seen in diabetes. Similarly increased levels of
acetone have been shown previously to generate increases in the levels ofmembers of the
CYP2B subfamily (Johansson etal., 1988). A comparison of the regulation of the CYP2E,
CYP2B and CYP1A subfamilies in the diabetic state, in terms of the potential role of
acetone as an endogenous controller, can be drawn. Hypophysectomy generated an
elevation in the level of the CYP2B subfamily suggesting that growth hormone has a
negative effect on its level of expression in the rat (Yamazoe et al., 1987).
Hypophysectomy however produced no changes in the levels of the CYP1A subfamily
suggesting therefore that a growth hormone level decrease in the diabetic state would leave
the CYP1A unaffected (Yamazoe,et al., 1987). Hypophysectomy has also been shown to
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increase the level of the CYP3A subfamily in both rats and mice (Meehan et al., 1988;
Lemoine et al., 1988). The possible species differences associated with these responses has
been discussed in connection with the CYP2E subfamily (Section 3.7.8).
Section 3.10: Potential roles for the P-450 levels modulated by endogenous signals in
the diabetic state
If the changes seen in the P-450 profiles are induced through the actions of endogenous
signalling pathways then such changes may be generated for a reason and may not just be
the inadvertent results of metabolic and hormonal perturbations in the diabetic state.
Potential roles, unrelated to the metabolism of exogenous xenobiotics, for some of the
xenobiotic metabolising P-450 enzymes may therefore be present and these may provide a
rationale behind the induction of these enzymes in diabetes and so potentially fasting and
starvation.
Section 3.10.1: A role for the CYP2E subfamily in acetone metabolism in diabetes and
starvation
Acetone, produced as a result of incomplete use of the products of fatty acid oxidation, is
now thought to be further metabolised and not, as previously believed, just accumulate
prior to passive excretion in the breath, urine and sweat. Although some tissues, such as
the brain, can adapt to use ketone bodies as an energy source, the potential conversion of
ketone bodies to glucose could generate a significant gluconeogenic resource in the starved
and diabetic states where fatty acid metabolism becomes elevated. Whilst the glyoxylate
pathway, allowing the conversion of fatty acids to glucose tby by-passing the two CO2
liberating steps of the Kreb's cycle, has long been recognised to exist in many plant and
micro-organism species (Kornberg & Krebs, 1957) the presence of a gluconeogenic bridge
between fatty acids and glucose has only more recently been established in mammalian
systems.
Studies using l^C acetone in humans showed that less than 30% of the labelled acetone
was excreted in that form and the label appeared in glucose, carbon dioxide and
amino-acids suggesting metabolism of acetone within the body (Reichard et al., 1979).
[2-l^C] labelled acetone was seen to be incorporated into blood glucose in diabetic ketotic
humans (Owen et al, 1982). Similar studies in the post-mitochondrial fractions of rat livers
showed that the labelled carbon atom, added into the system in acetone, was incorporated
into lactate and if the liver fractions were prepared from starved animals the level of this
encorporation was elevated (Coleman, 1980). Possible metabolic intermediates for the
pathway converting acetone to glucose were suggested by the analysis ofmetabolites in the
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blood of the people and animals used in these studies, principal amongst these was seen to
be 1, 2-propandiol (Reichard et al., 1979). Studies in rats began to dissect the possible
gluconeogenic pathways for acetone. The initial oxidation of acetone to acetol was shown
to be mediated by the microsomal fractions of rat livers and required the presence of
oxygen and an NADPH regenerating system. The enzyme catalysing this step was termed
the "acetone mono-oxygenase". Rats pre-treated with 1% acetone in their drinking water
showed a ten-fold increase in their ability to catalyse this reaction. By addition of a
glyoxylase trapping system, glutathione and glyoxylase I, to this reaction mixture D-lactate
was seen to be produced. Similarly, pre-treatment of the rats with 1% acetone led to a four¬
fold increase in the ability of the microsomes to catalyse this reaction. Studies using
mixtures of labelled and unlabelled putative intermediates in the conversion of acetone to
lactate and glucose validated the proposed pathways; it was seen however that the pathway
between methyl-glyoxal and D-lactate was not the principal route as addition of unlabelled
D-lactate did not greatly reduce the level of labelled glucose produced after the addition of
labelled acetone. 1, 2-propandiol, one of the intermediates of the acetone to glucose
conversion identified in the blood, was mixed with the microsomal reaction leading to the
generation of L-lactate. This reaction was blocked by methyl-pyrazole, an alcohol
dehydrogenase inhibitor, and cyanamide, an aldehyde dehydrogenase inhibitor suggesting
a role for these enzymes in the conversion of acetone to glucose. Perfusion studies
suggested that the liver was not capable of generating all the 1, 2-propandiol present in the
blood, suggesting the presence of an extrahepatic generating system metabolising acetol
and returning it to the liver as the 1, 2-propandiol precursor for gluconeogenesis (Cassaza
et al., 1984). On the basis of this work two pathways for the gluconeogenic conversion of
acetone were proposed to account for the conversion of acetone to pyruvate and so glucose.
Firstly, the "methyl-glyoxal" pathway utilising acetol produced within the liver in
conjunction with the acetone and acetol mono-oxygenase and glyoxylase enzymes. The
second "propandiol" pathway used extrahepatically derived 1, 2-propandiol as its substrate
(Cassaza et al., 1984).
The nature of the acetone and acetol mono-oxygenase components of these systems, with
their obvious similarities to P-450 in terms of the reactions catalysed and their
requirements, were further investigated. The experiments in the rat were repeated in acetone
treated and control rabbits. Attention was focussed on CYP2E as this enzyme had
previously been shown to be induced by and metabolise, amongst many other small solvent
molecules, acetone. The levels of activity and the levels by which acetone pre-treatment
enhanced these activities were comparable to the results obtained in the rat. Antibodies to
purified rabbit P-450 3a (CYP2E) blocked 90% of the acetone mono-oxygenase activity
and 70% of the acetol mono-oxygenase components of the gluconeogenic pathway in
acetone treated animals. In untreated animals, although the acetone mono-oxygenase
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component was still blocked by 90%, the antibody to CYP2E only blocked 30% of the
acetol mono-oxygenase activity suggesting that in the control state other P-450 may
contribute to its metabolism. In reconstituted membrane assay systems using purified
P-450 components CYP2B1, CYP2C3, and CYP1A2 were also shown to be capable of
converting acetol to methyl-glyoxal suggesting potential roles for these P-450 as acetol
mono-oxygenase. The relative activities of these isoforms in the catalysis of this reaction
(nmol acetol hydroxylation/min/nmol P-450) were CYP2B1 2.48, CYP2E 12.00, CYP2C3
1.51, CYP1A2 0.55. CYP1A1 and CYP3A1 in the same reconstitution experiments were
unable to catalyse the metabolism of acetol (Koop and Cassaza, 1986).
These results are summarised with additional enzymes which may potentially contribute to
the pathways added in Figure 3.14. The fact that similar intermediates seen in the rabbit and
rat proposed propandiol and methyl-glyoxal pathways are present in human suggest that
these pathways may play a role in the metabolism of diabetes, starvation and fasting in this
species also. It was noted in fasted humans that the rate of acetone metabolism was
accelerated allowing up to 59% of the acetone produced to be metabolised. If this
metabolised actone could potentially enter gluconeogenic pathways it would potentially
contribute 11% of gluconeogenically produced glucose in 21 day fasted human subjects
(Reichard et al., 1979; Reichard et al., 1986.). Other pathways for the metabolism of
acetone, not passing through D- or L-lactate, have also been suggested based on the
distribution of labelled carbon atoms obtained in glucose when animals are given specific
carbon number labelled acetone (Kosugi et al., 1986).
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Figure 3.14: The proposed pathways for the gluconeogenic conversion of acetone to
glucose involving the CYP2E subfamily. Acetone (top left), produced as a result of
increased (3-oxidation of fatty acids in diabetes and starvation, passes through the
acetone-, and acetol-monoxygenase enzyme now known to be the CYP2E subfamily
protein (CYP2E). The products of these reactions then pass through either the methyl
gloxal pathway (bottom left), or the propandiol (top right) gluconeogenic pathways to
ultimately generate glucose. Figure compiled from information contained in Cassaza et
al. (1984), Argiles (1986), and Koop and Cassaza (1986).
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Section 3.10.2: An endogenous metabolic role for CYP2E as a rationale for the
induction of this subfamily in diabetes and starvation
It is possible that CYP2E, with its capacity to act as acetol mono-oxygenase and as the
major acetone mono-oxygenase, has a crucial role to play in intermediary metabolism acting
to catalyse the gluconeogenic conversion of fatty acids to glucose via the bridging acetone
molecule. As suggested by radiolabelling studies, these acetone conversion pathways may
provide a sizeable quantity of gluconeogenically derived glucose in the starved or diabetic
states (Reichard et al., 1979). The induction of CYP2E, as proposed via the substrate
stabilisation mediated action of acetone and an increase in the level of CYP2E mRNA, may
thus represent a component of the body's adaptive response to starvation and diabetes. As a
result of the CYP2E induction, acetone metabolism would be increased providing
substrates for gluconeogenic pathways and the flux through the 1, 2-propandiol and
methly-glyoxal gluconeogenic pathways would rise. In this manner the high levels of
acetone produced, due to a switch to fatty acid metabolism in starvation and diabetes, could
be converted into glucose. These pathways may also aid in the restoration of the pH
balance of the blood in diabetes. The fact that the CYP2E response was seen at both the
protein and mRNA levels in the kidney and that acetone has been seen to induce the mouse
Cyp2el protein in a variety of extra-hepatic tissues (Section 4.4.2) suggests that it may
provide acetol to extrahepatic 1,2-propandiol generating systems throughout the body.
Section 3.10.3: A role for the CYP4A subfamily in fatty acid metabolism in diabetes
Peroxisomal proliferators induce the CYP4A subfamily transcriptionally and the
physiological signalling pathways involved in this action, potentially activated by increases
in circulating free-fatty acids, may be the same as those inducing CYP4A in diabetes. Other
genes activated by peroxisome proliferators, seemingly in a co-ordinate manner, are
associated with the generation of an increase in the level of cyanide-insensitive P-oxidation
within the peroxisomes. These genes include most of the components of the peroxisome
associated P-oxidation pathway, the peroxisomal fatty acyl-CoA oxidase, the enoyl-CoA
hydratase/3-Hydroxyacyl-CoA dehydrogenase and both the carnitine and palmitoyl
transferases; other components of the peroxisome, such as catalase, remain unaffected
suggesting a specific and co-ordinate induction only of those components associated with
fatty acid metabolism (Reddy et al., 1986). Results gained from this and other studies
(Hoire etal., 1981) suggest that diabetes leads to an activation of peroxisomal P-oxidation,
potentially progressing to peroxisomal proliferation in extreme cases. It is possible
therefore that the induction of the CYP4A subfamily by both peroxisomal proliferators and
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diabetes also reflects the shift from the use of glucose to the use of free-fatty acids as the
fuel source in these states.
The CYP4A subfamily members have been shown to metabolise medium chain fatty acids
by CO and co-1 hydroxylation; the co-hydroxylation reaction is however the reaction
predominantly catalysed by the CYP4A subfamily (CaJacob et al., 1988). The primary
alcohols produced by these reactions can then be converted to dicarboxylic acids within the
body by aldehyde and alcohol dehydrogenases. The presence of such medium chain
dicarboxylic acids has been noted in the urine of rats and humans and it was seen that the
levels of these compounds were dramatically elevated in fasted, high fat content fed and
diabetic animals; by using [1-l^C] labelled medium chain fatty acids the rate of
co-hydroxylation was seen to increase in these states (Mortensen & Grcgersen, 1981). As
[l-l^C] labelled medium chain fatty acids were used then direct P-oxidation would lead to
a loss of the label in the first acyl-CoA generated as the thiol esterification reaction with
CoA would occur only with the labelled carboxylic acid group. Labelled dicarboxylic acids
however were recovered suggesting that co-hydroxylation, and so generation of a carboxy
group at both ends of the molecule, occurred prior to P-oxidation (Mortensen & Gregersen,
1981). By inducing peroxisomes in rats by treatment with clofibric acid and then blocking
mitochondrial p-oxidation with cyanide it was seen that these dicarboxylic acid molecules
were actively consumed by peroxisomal P-oxidation (Mortensen et al., 1982).
These observations suggest that in the diabetic state the body increases the release of free-
fatty acids and accelerates P-oxidation, the levels of CYP4A are also increased and this
induction manifests itself on intermediary metabolism through an increase in the level of
production of dicarboxylic fatty acids. These dicarboxylic acids can, as well as the more
normal mono-carboxylic fatty acids, enter into peroxisomal P-oxidation. It is of interest in
the proposed co-ordinate nature of CYP4A and peroxisomal P-oxidation that genetic
defects in mitochondrial P-oxidation, for example in the mitochondrial acyl-CoA
dehydrogenase, or in valproate treatment which inhibits the mitochondrial acyl-CoA
dehydrogenase that the levels of urinary dicarboxylic acids also become elevated
(Gregersen et al., 1976). In these instances it is possible that, as mitochondrial P-oxidation
fails, situations in which lipolysis occurs lead to a more rapid rise in circulating free-fatty
acids and the induction of peroxisomal P-oxidation and CYP4A as suggested by the
presence of the dicarboxylic acids. The fact that a possible co-ordinate activation of CYP4A
and the components of the peroxisomal p-oxidation components occurs suggests that an
endogenous role for the CYP4A subfamily may lie in their capacity to co-hydroxylate
medium chain free-fatty acids.
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A role for the CYP4A subfamily induction in diabetes in the acceleration of
co-hydroxylation of fatty acids
In the past the process of co-hydroxylation of fatty acids, and the presence of dicarboxylic
acids and their oxidation by both the mitochondrial and peroxisomal (3-oxidation
pathways, even though it was seen to be prevalent particularly in the starved state, has
been viewed essentially as a biochemical quirk. Early investigations into the amount of
free-fatty acids that become co-hydroxylated suggested that a high proportion, around 20%
of laurate and 10% of palmitate, underwent co-hydroxylation in starved animals, in the
control animals the levels were very low (Kam et al., 1978). Potentially what this process
allows however is very pertinent to the needs of the body in a starved and diabetic state,
those states in which co-hydroxylation and di-carboxylic acid production have previously
been noted to become elevated.
co-Hydroxylation of an even carbon numbered free-fatty acid, followed by complete
oxidation of the even-carbon dicarboxylic fatty acid produced, generates succinyl-CoA, a
precursor of succinate. Succinate, on entering the Kreb's cycle, could then lead to the
generation of pyruvate and so, by reverse glycolysis, glucose. Free-fatty acid labelling
studies have shown that this process occurs in vitro in both hepatic and extrahepatic tissues
(Kolvaa & Gregersen, 1986; Vameq & Draye, 1989). CYP4A may therefore represent a
component within a gluconeogenic pathway allowing a link between the accelerated level of
fatty acid metabolism in the starved and diabetic states and gluconeogenesis.
Section 3.10.4: Possible endogenous roles for the other P-450 seen to be induced in
diabetes
The proposed gluconeogenic endogenous roles for the CYP2E subfamily, via acetone
metabolism, and the CYP4A subfamily, via dicarboxylic acid generation, may also be the
rationale behind the induction of the other P-450 seen in the diabetic state. The CYP1A and
CYP2B subfamily were seen to be capable of acting as acetol-monooxygenase components
in reconstitution investigations into the methyl-glyoxal pathway for acetone
gluconeogenesis although with a much lower level of activity than CYP2E; CYP3A
however was not seen to be capable of catalysing this reaction (Koop and Cassaza, 1986).
It is possible that the increase in CYP3A levels, and those members of the CYP2C
subfamily involved in steroid biotransformation seen to be elevated (Yamazoe etal., 1989;
Favreau et al., 1987a), may relate to a possible role in increased, possibly degradative,
metabolism of the elevated levels of steroids and cholesterol present in the circulation in
diabetes. It is possible that the products generated from the steroids metabolised by these
P-450 may themselves have a biological function; this has been seen to be the case in some
1 1 1
of the metabolites of testosterone generated by the catalytic activities of CYP2C subfamily
for example (Sonderfan & Parkinson, 1988).
Section 3.11: Changes in other components of the xenobiotic metabolising system in
diabetes
As well as changes in the levels of certain P-450 the effect of the diabetic state on some
components of phase II, associated with the removal of reactive metabolites and
xenobiotics, was investigated. The possible effect which diabetes produces on glyoxylase
I, in connection with its proposed role in the methly-glyoxal gluconeogenic pathway
(Section 3.10.1), was investigated. The effect of the diabetic state on the levels of certain
glutathione S-transferases (GSTs), as well as its general effect on the glutathione
conjugation activity were investigated in order to gauge the potential ability to conjugate
activated xenobiotic potentially generated as a result of the inductions of the P-450 seen. In
this context examples of increases in the activties of A-acetylases, an enzyme activity
associated with phase II metabolism of xenobiotics, with the onset of diabetes in the BB/E
rat has previously been reported (Lindsay & Baird, 1990).
Section 3.11.1: Glyoxylase I and the diabetic state
The glyoxylase system has been proposed to play a role in the methyl-glyoxal pathway of
acetone gluconeogenesis (Cassaza et al., 1984). The effect of type I diabetes on the activity
of the glyoxylate cycle in humans was studied in red blood cells and an increase in the
activity of gloxylase I was noted (Thornalley, 1990). The use of anuclear red blood cells
however may not allow the assessment of changes in glyoxylase enzyme activities possibly
resulting from transcriptional changes. To investigate this possibility the effect of diabetes
on the level of glyoxalase I was studied in the cytoplasm of male rats using a polyclonal
antibody to purified mouse glyoxylase I (kind gift, Dr L. McClellen, Department of Clinical
Biochemistry, The Royal Infirmary, Edinburgh.). Diabetes however was seen not to
change the protein level of glyoxylase I (Figure 3. 15). The increased glyoxylase I activity
previously seen (Thornalley, 1990) may potentially relate to a post-translational change
in the pre-existing enzyme. It has been seen that both glycerol and
12-0-tetradecanoylphorbol-13-acetate (TPA) activate glyoxylase I in leukocytes; TPA may
mediate the changes in glyoxylase activity via phosphorylational changes in the enzyme
(Gillespie., 1981). It is interesting that glycerol has the ability to activate glyoxylase I; this
feature could allow an increase in the flux through the methyl-glyoxal pathway
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Figure 3.15: The effect of diabetes on the protein level of glyoxylase I in the male
BB/E rat. Total cytosolic protein (10p,g of liver and 20pg of kidney) isolated from
BB/E subline male (SM), diabetes-detected, diabetes-prone male (DM), and diabetes-
detected, insulin-treated, diabetes-prone male (IM) were separated by SDS/PAGE on
12% gels. The proteins were transferred to nitrocellulose filters and probed using
polyclonal antibodies raised to purified mouse gloxylase I protein. No bands other than
those shown were detected. The standard (Std.) was prepared from glyoxylase I
purified from mouse liver cytosols and the glyoxylase I protein ran with a Mr of
approximately 22,000.
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Section 3.11.2: Modifications in GST levels and activities in diabetes
In viewing P-450 classes 1 to 3 as xenobiotic metabolising enzymes the effects of the
potentially injurious reactive products which they can generate can be diminished by their
conjugation with cofactors, such as glutathione, allowing subsequent excretion (Section
1.1). Situations are encountered where xenobiotics, such as phenobarbital and
3-methylcholanthrene generate a concomitant increase in both the levels of P-450 and GST
thus potentially allowing the P-450 generated activation and GST mediated conjugation
steps to potentially co-ordinately accelerate the removal of xenobiotics (Pickett et al.,
1984). In view of the increases in the levels of P-450 in diabetes the effect which this state,
and so in xenobiotic metabolising terms the level of protection available against reactive
metabolites, on GST levels of was investigated. As shown by this study diabetes produced
no change in the level, either protein or mRNA, of the microsomal GST; the microsomal
GST however is genetically and evolutionarily distinct from the cytosolic classes of GST
(Ketterer et al., 1988).
Previous activity based assessments on the effect of diabetes in chemically induced rats and
mice on the level of GST activity, using the conjugation of glutathione to l-chloro-2,4-
dinitrobenzene (CDNB) as a marker for total GST activity, have produced conflicting
results. One study using alloxan and streptozotocin-treated rats demonstrated a short-term
increase in the level of CDNB conjugation with diabetes. The increase in CDNB activity
returned to control levels after one week and below control levels after two weeks. Insulin
treatment of the diabetic animals with depressed GST activity generated an increase in
CDNB activity above the activity of the control animals (Carnovale et al., 1990). In a study
of streptozotocin-treated mice an increase in the level of GST activity was reported to occur
for several weeks during diabetes (Agius & Gidani, 1985). Long-term decrease in the
levels of activity of GSTs was noted in other studies however (Watkins et al., 1988; Grant
& Duthie, 1987; Aniya et al., 1989). The variability in the results obtained suggests that
they may reflect the degree of severity of the disorder produced as the times which the
animals were left in a diabetic state without insulin therapy were very long.
Western blot analysis of three classes of rat GST in male liver cytosols of the BB/E rats
used in this study revealed that the diabetic state did not produce any profound effects,
either inductive or repressive, on the protein levels of any of the GSTs examined (Figure
3.16). CDNB assays of the cytosols however suggest that the level of GST activity is
increased in the diabetic state and treatment of the animals with insulin generates a further
rise in the general GST conjugation ability of the cytosols (Table 3.4).
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Figure 3.16: Western blot analysis of the effect of diabetes on the protein level of
certain GST enzymes in the male BB/E rat. Total cytosolic protein (10pg of liver and
20pg of kidney) isolated from BB/E subline male (SM), diabetes-detected, diabetes-
prone male (DM), and diabetes-detected, insulin-treated, diabetes-prone male (IM)
were separated by SDS/PAGE on 12% gels.The proteins were transferred to
nitrocellulose filters and probed using polyclonal antibodies raised to various purified
rat GST enzymes as indicated. No bands other than those shown were detected. The
standards (STD) were prepared from rat liver cytosols and the GST proteins all ran
with a Mr of approximately 23,000.
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This increased CDNB activity, without a rise in the level of the GST proteins analysed,
may be accounted for by the possibility that other classes of GST not recognised by the
polyclonal antibodies employed may become elevated as there are at least ten subunits
capable of this activity in the rat (Ketterer et al., 1988) It is also possible that the kinetic
parameters of the pre-existing enzymes may be modified in a similar manner to that
proposed for the glyoxylase I enzyme (Gillespie, 1981) and reports have suggested the
possible role of both phosphorylational and methylational modifications in mediating such
events (Siegel, et al. , 1990). The total CDNB assay results however suggest that diabetes
may produce a rise in the ability to generate glutathione conjugates and this rise may reflect
an increased xenobiotic metabolising ability due to the elevated P-450 levels.
Table 3.4: The effect which the diabetic state produced on the ability of rat liver cytosols
to catalyse the conjugation of l-chloro-2,4-dinitrobenzene (CDNB) was investigated. All
assays were performed in triplicate; the assays were performed in collaboration with Dr. L.
I. McClellan, Department of Clinical Biochemistry, The Royal Infirmary, Edinburgh.
Glutathione conjugation of CDNB, nmol per min
per mg cytosol protein
X an -1
SUBLINE MALE 698.02 (20.21)
SUBLINE FEMALE 626.03 (6.28)
DIABETIC MALE 776.23 (11.44)
DIABETIC FEMALE 910.89 (20.39)
859.75 (14.11)
INSULIN TREATED MALE 1841.33 (18.77)
INSULIN TREATED FEMALE 1219.39 (10.64)
Section 3.12: Xenobiotic metabolism and chemical carcinogenesis in diabetes; the
implications of increased P-450 levels
Studies on the effect of diabetes on the metabolism and activation of a variety of
compounds indicate that these processes are accelerated in chemically-induced diabetic
animals. The hepatotoxicity of carbon-tetrachloride (Hanasono et al., 1975a and b),
chloroform (Aniya et al., 1989), thioacetamide (El-Hawari & Plaa, 1983), and certain
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nitrosamines (Lorr et al., 1984) were all seen to be elevated in the diabetic state for
example. As suggested in this study endogenous induction of P-450, to perform potential
gluconeogenic roles, manifest themselves in an increased level of xenobiotic metabolism
and resultant toxicity; in a similar manner the non-genotoxic effects associated with damage
produced in situations of accelerated peroxisomal activity may also be expected to increase
(Reddy et al., 1992). In diabetic humans, if similar endogenous roles are performed by
certain P-450, in periods of poor metabolic control where levels of insulin fall and acute
periods of hypoglycaemia and lipidaemia are experienced, the endogenous induction of
certain P-450 would be predicted to occur. This has been seen to be the case for the CYP2E
subfamily which is seen to be elevated in the lymphocytes of diabetic subjects (Song et al.,
1990). The induction of these P-450 would result potentially in an increase in the capacity
to metabolise and activate xenobiotics. Similar situations would also be predicted to arise as
the result of periods of fasting and starvation where again metabolic changes would
generate signals leading to the increase in certain P-450 levels.
Could such periods of heightened xenobiotic sensitivity lead to, as has been seen in animal
models, increases in the levels of their toxicity and even carcinogenicity? In this context it is
of note that the diabetic BB rat has a marked increase in the incidence of certain cancers far
above the levels in the diabetes-resistant subline. The long-term insulin maintained diabetic
animals show around a 15% incidence of lymphomas as opposed a 1% incidence in the
non-diabetic diabetes resistant subline for example (Kalant & Seemayer, 1979; Seemayer
et al., 1982; Seemayer et al., 1983). Could the higher incidence of hyperlipidaemia and
thus potential periods of higher vulnerability to xenobiotics result in higher cancer incidence
in human diabetic subjects ?
A major survey looking at cancer mortality in human diabetic subjects was undertaken over
a twenty-six year period looking at a cohort of 21,447 people. The numbers of specific
cancers and the overall level of cancers leading to mortality was compared against the
expected mortality rates in the non-diabetic population. This report indicated that there
appeared to be no change in the overall level of cancer mortality amongst female diabetic
subjects and that the level of cancer mortality in male diabetic subjects actually is reduced
by around 15%. The reduction in male cancer mortality rate is however offset by the affects
of diabetes-associated complications such as hypertension and coronary heart disease
(Kessler, 1970). In general diabetic subjects have, due to the complications associated with
the disorder, an approximately 30% reduced life-expectancy as compared non-diabetics
(Green & Hougard, 1984). In the context of the potential effect of periods of P-450
induction on xenobiotic activation therefore the effect of the diabetic state on the incidence
of specific cancers, rather than the mortality generated by them, would be more
illuminating.
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Section 3.13: Roles for the changes in P-450 in the aetiology of diabetes
The causes of type I insulin-dependent diabetes are not known. In human, rat and mouse,
diabetes appears to be an autoimmune disease in which the P-cells, comprising less than
2% of the total pancreatic mass are destroyed. Circulating antibodies to several P-cell
surface antigens and insulin are seen to be present in the blood; immunisation with insulin
itself, however, does not lead to insulitis and (3-cell destruction (Dean et al., 1987; Zeigler
et al, 1989). The initial events leading to autoimmunity are however obscure and, although
genes associated with the functioning of the immune system have been linked to the
susceptibility of developing the disorder, the development is clearly multi-factorial (Todd
et al., 1987). Clearly environmental factors play a large role in the initiation of the disorder
as illustrated by monozygotic twin studies on human diabetics showing a 50% discordance
in the development of the disorder (Leslie & Pyke, 1980). Whether the autoimmune aspect
of the disorder correlates with differences in the immune system allowing the P-cell
destruction, or whether other events lead initially to a release of antigens previously unseen
from the P-cell triggering this auto-immune response is unclear. The P-cells are highly
susceptible to oxidative damage as demonstrated by their rapid destruction by alloxan and
streptozotocin and subsequent generation of insulitis (Section 3.2.1). These observations
make an initial environmental input into P-cell destruction, leading to antigen release, in
association potentially with a predisposition in the immune system to generate auto-immune
responses, a possibility in the initiation of the disorder (Malaisse et al., 1982; Assayama
et al., 1986; Nomikos et al., 1986). If such a scenario could be envisaged then, in
association with genetic predisposition to generate an auto-immune response, the triggering
event may be environmental. No single environmental factor alone need be solely
responsible and multifactorial events would present the same phenotype due to the fragility
of the P-cells.
Several environmental factors have been suggested to be capable of triggering this initiation
event. Viral infection has been associated with P-cell destruction; Epstein-Barr, Coxsackie
B4 and congenital rubella infection have all been associated with P-cell destruction
however it is not clear if the p-cell infection by these agents has preceded their destruction
or followed it. In the case of Rubella infection it is of note that a predisposition to other
auto-immune diseases, such as thyroiditis, is seen potentially taking the place of the genetic
predisposition associated with the immune-system (Helmke et al., 1986. Tuverno et al.,
1988). Other factors leading to a triggering of the disorder may relate to xenobiotics both
in the environment and in the diet illustrated by the use of alloxan and streptozotocin in the
establishment of animal models of the disorder.
Some studies have indicated potential environmental chemicals which may participate in the
initiation of the destrucyion of the p-cells. The rodenticide "Vacor", with an V-3-pyridyl
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methyl-A-p-nitrophenylurea active component, produced similar effects in the (3-cells of
humans accidentally exposed to it illustrating the common theme of P-cell fragility in the
development of the disorder in humans also (Lee et al., 1977). The potential triggering of
P~cell destruction by xenobiotics in foodstuffs has been noted. A relationship between
parental consumption of smoked cured mutton, seasonally consumed in Denmark during
December, and the appearance of a high incidence of diabetes of children born in October
was seen (Berne et al., 1974). This observation was further investigated using mice fed
similar nitrosamine rich foods at various stages prior to and during pregnancy. Diabetes
resulted in 16% of male and 5% of female offspring as a result of these treatments against a
very low control incidence suggesting that environmental nitrosamines may be triggering
p-cell damage in utero (Helgason et al., 1982). It is of note in the context of the potential
role of nitrosamines in the triggering of P~cell destruction that streptozotocin, a strongly
diabetogenic compound produced by the soil fungus Streptomyces achromogenes, is one
of the few naturally occuring nitrosamines (Herr et al., 1967).
Although certain xenobiotics seem to be capable of triggering P-cell destruction on their
own in a more general sense it seems probable that a wide variety of factors both genetic
and environment, contribute to the potential development of the disorder. It is particularly
interesting, in the light of the observation that metabolic changes in diabetes induce P-450
levels, that some of the xenobiotics implicated in the triggering of P-cell destruction can
potentially be metabolised and activated by P-450.
Another interesting observation is the suggested involvement of radicals in the further
reactions of glycated proteins to generate advanced glycosylation, or AGE products (Hunt
et al., 1988; Wolff et al., 1989). These products are associated with the complications of
the metabolic disorder, leading to cataracts, kidney failure, neuropathy, joint stiffening,
hypertension and cardiac failure (Section 3.2). P-450 enzymes have been seen to generate
free radicals and have been implicated in the past in the generation of lipid peroxidation as a
result of this action (Gorsky et al., 1984). It is an intriguing possibility that the elevation of
P-450 enzymes in diabetes, and so an elevation in their radical generating activities, may
contribute to the generation of increased AGE products and so the long-term side effects
associated with diabetes.
Section 3.14; P-450 expression and induction in the pancreas; implications for the
destruction of the P—cell in diabetes and possible roles in these cells
The presence of Cyp2el in the pancreas of mice and its induction by acetone was noted in
Western blot analysis (Section 4.4.2, Figure 4.3). The CYP4A subfamily was seen to be
expressed in the BB/E rat pancreas by imunohistochemical analysis and more specifically in
the insulin producing (3-cells (Figure 3.17).
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igure 3.17: Immunohistochemical localisation of the CYP4A subfamily to the f$-
;lls of the pancreatic islet of the BB/E rat. The structure of the pancreas was
;termined by haematoxylin and eosin (H/E) staining seen in the upper half of the
gures.Thc presence of the CYP4A subfamily proteins in the p-cells of the pancreatic
let was determined using polyclonal antisera raised to purified rat CYP4A subfamily
"oteins. The antibodies recognising the CYP4A protein were complexed with
otinylated swine anti-rabbit antisera and the immune-complex detected using an
/adin-biotin peroxidase detection system with its substrate, 3, 3-diaminobenzidine,
ving the brown staining seen in the lower half of the figures. A: The pancreas of a
abetes-resistant, subline male BB/E rat showing normal pancreatic islets on staining
ith H/E and weak staining with the CYP4A antisera. B: The pancreas of a diabetes-
:tected, diabetes-prone male BB/E rat showing insulitis in the pancreatic islets marked
/ infiltration with mononuclear imflammatory cells on H/E staining. The p-cells show
ear expression of the CYP4A subfamily proteins on staining with the CYP4A
itisera. This analysis was performed in collaboration with Dr D. J. Harrison and Mrs
. Wolf, Department of Pathology, Edinburgh University.
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Figure 3.17 (Continued).
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Although only weakly detectable in the P-cells in the control BB/E animals the level of
CYP4A protein in the P-cells was seen to rise markedly with the onset of diabetes (Figure
3.17). The presence of P-450 in the pancreas suggests that they may play a role in the
activation of xenobiotics within that organ; the potential generation of reactive metabolites
by P-450 in the pancreas could contribute to p-cell DNA and membrane permeability
damage either directly, through increased levels of lipid peroxidation, or indirectly through
the generation of free-radicals. If endogenous controls led to an induction of P-450 in the
pancreas, as they appear to do for Cyp2e on acetone treatment (Section 4.4.2) and the
CYP4A subfamily (Figure 3.17), an initial P~cell damaging event, be it viral, genetic or
environmental, leading to a fall in the levels of insulin would, by switching metabolism to
the use of fatty acids as a fuel and so inducing P450, accelerate the damaging effect of
P450 action in the pancreas. If a diabetogenic xenobiotic was principally activated by P-450
then the actual triggering event of P-cell destruction could potentially be mediated by the
presence of the P-450 within the (3—cell.
Given the potential damaging effect which activated compounds and radicals can produce
on the P-cell what potential role could P-450 be playing in their presence in this cell type?
The mechanisms controlling the release of insulin within P-cells is poorly understood and
is highly complex involving cross-talk between other endocrine and paracrine signalling
pathways and metabolite levels. Together these signals must allow careful monitoring of
the blood and tissue levels of various fuels and respond to changes in these fuels by
generating signals leading to the co-ordinating of the various enzymes involved in cellular
energy metabolism. The mechanism by which the body can monitor the levels of such
metabolites is poorly understood.
The P-cells are sensitive to the levels of glucose and controlling signalling proteins such as
glucagon-like protein-1 (GLP-1) for example. GLP-1 in the presence of glucose generates
elevations in intracellular cAMP and calcium levels and controls the permeability of
potassium channels in the P-cell membrane. Via these signalling pathways the ambient
levels of glucose determine the rate of pro-insulin production and insulin secretion (Holtz
et al., 1993).
Another signalling system that has been reported to allow secretory responses within the
pancreas is through the generation of the biologically active metabolites of arachidonic acid,
certain of these components such as the cis-epoxyeicosatrienoic acids (EETs) have been
shown to generate insulin release from isolated P-cells for example (Falck et al., 1983).
Arachidonic acid is metabolised by three main pathways to generate the products which are
active secondary messengers within cells. Arachidonic acid is metabolised by cyclo-
oxygenase and lipo-oxygenase pathways to generate biologically active eicosanoids and a
mono-oxygenase pathway generating the cis-epoxyeicosatrienoic acids (EETs), hydroxy-
eicosatrienoic acids (HETEs), and co- and ci>-l biologically active forms of arachidonic acid
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(Needleman et al., 1986). The mono-oxygenase component of arachidonic acid metabolism
is performed by cytochrome P-450 (Fitzpatrick & Murphy, 1989). The EET and HETE
signalling molecules have been demonstrated to generate stimulus coupling in endocrine,
renal, ocular and secretory cells and as mentioned specifically in this context generate
insulin release from the P-cells. These signalling compounds appear to mediate their actions
via modulations in intracellular calcium possibly in a similar manner to the better
understood action of the phosphatidyl-inositol signalling pathway (Kutsey et al., 1983).
Hormones such as vasopressin have been shown to elevate the levels of EETs and HETEs
within a cell leading to release of intracellular calcium stores and these effects are abolished
by the addition of P-450 inhibitors such as SKF-525A and ketoconazole (Holm et al.,
1989). The specific P-450 involved in the generation of the biologically active arachidonic
acid are unclear although inhibitory antibody studies suggest a role for the CYP1A family
(Holm et al., 1989) and the presence of CO and co-1 hydroxylation reactions suggests a
possible role for CYP4A in these processes.
Given the presence of Cyp2e and CYP4A in the pancreas and more specifically of CYP4A
in the (3-cell itself and the ability of EETs to elicit a secretory response from P-cells (Falk
et al., 1983.) the possibility that certain P-450 in the P-cell may act as sensors to the
prevailing fatty acid levels and respond to these through a signalling mechanism employing
HETEs and EETs is intriguing. These P-450, seen to be induced in diabetes, could respond
to ambiant fatty acid levels through endogenous induction pathways and, through the
changes in their metabolic activities, generate signals reflecting the ambient levels of fatty
acids. Possible roles of P-450 in signalling processes within the cell are a matter of
speculation but are clearly highly intriguing (Nebert, 1990). These signalling molecules
could well represent the ligands controlling the large numbers of "orphan" steroid hormone
receptor superfamily proteins suggested to be involved in intracrine cellular signalling
(O' Malley, 1990). The observed low affinity of peroxisome proliferators for the PPAR
(Isseman & Green, 1990; Gottlicher et al., 1992), and also the low afinity of other
xenobiotics, such as phenobarbital, for other P450 associated transcription factors (Okey,
1990), could be reconciled if the actions of the xenobiotic were mediated indirectly through
paracrine signalling systems. It is interesting in the context of a role for these signalling
systems in diabetes that vasopressin, in stimulating the elevation of HETEs and EETs
leading to the modulation of intracellular calcium levels, generates the activation of
phosphorylase-a and so the activation of glycogenolysis in hepatocytes suggesting that
these signalling systems may be involved in the regulation of intracellular energy
metabolism (Yoshida etal., 1990).
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Section 3.15: Summary: P-450 Subfamilies 1 to 4; enzymes with endogenous roles
marked by xenobiotic metabolism
It appears that certain members of the P-450 1 to 4 families possess endogenous roles in
the diabetic state and are controlled by endogenous signalling systems. By analogy,
physiological states such as fasting, where similar but less exaggerated metabolic and
hormonal perturbations occur, will generate similar signals producing similar P-450
elevations. Such elevations have been seen to occur as would be expected from this
postulate in starvation in the CYP2B and CYP2E subfamilies in the rat (Johansson et al.,
1988), and in the Cyp2el subfamily in the mouse (Section 4.5). The increases in P-450
levels manifest themelves in diabetes through an increased capacity to metabolise
xenobiotics (Hanasono etal., 1975 a and b; Aniya et al., 1989; El-Hawri et al. , 1983; Lon¬
er al., 1984).
Some of these enzymes, for example the CYP2E and CYP4A subfamilies, possess
potential roles in the acceleration of gluconeogenic return of the byproducts of increased
fatty acid metabolism; P-450 increases, through their contribution to the mono-oxidase
metabolism of arachidonic acid, may also potentially act as sensors for ambient fatty acid
levels in the body.
One interpretation of these observations is that there is an endogenous role for these P-450
families in intermediary metabolism; this role however has been overlooked as a result of
the ability of these enzymes to activate xenobiotics and so contribute to carcinogenesis. An
alternative interpretation, however, might be that the potential roles of these enzymes in
gluconeogenesis and intracellular signalling are now replaced by their roles as catalysts of
xenobiotic metabolism. The roles in intermediary metabolism, it would be argued, have
now essentially become vestigial, with the endogenous inductive fatty acid related controls
however remaining. Regardless of the "true" roles of these enzymes, the fact that the
enzymes themselves clearly do retain the capacity to be endogenously controlled by
perturbations in fatty acid metabolism and associated hormonal changes, is very significant.
This observation allows a better understanding, and predictive appreciation, of both the
actions of certain xenobiotics, for example the peroxisome proliferators, as well as
physiological situations in which xenobiotic metabolism, and so carcinogenesis, will
change.
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Chapter 4: The regulation of the mouse Cyp2el subfamily
Section 4.1: Introduction and Aims
In order to better understand the regulation of the CYP2E subfamily the regulation of
the Cyp2e 1 subfamily was studied in the mouse. The effect of chemicals previously
seen to modify the levels of other P-450 was studied to ascertain any similarity in the
mechanisms regulating the CYP2E subfamily and other xenobiotic metabolising P-450
families. The effect of acetone on Cyp2el was studied to establish the level of cross
species conservation of this chemical as an inducer of the CYP2E subfamily. The levels
of Cyp2el mRNA and protein were studied in the mouse following starvation; the
changes observed were compared to the changes seen in the diabetic state in the rat.
Given the suggestion that the CYP2E subfamily mRNA may become stabilised in the
diabetic state (Song et al., 1987), and that in other transcripts such an event has been
seen to be mediated by motifs in the 3' untranslated region (UTR), the fact that the
3' UTR of the Cyp2el transcript has been disrupted by insertion of a (32 element is of
particular significance.
As well as studies on the control of the Cyp2el subfamily in the whole animal the
molecular basis for the regulation patterns observed was studied. The suggestion has
been made that acetone stabilisation of the CYP2E subfamily protein is mediated by a
substrate induced inhibition of a phosphorylation event which normally channels the
CYP2E protein for rapid degradation (Ingelman-Sundberg et al., 1992). This
suggestion was investigated through the generation and expression of Cyp2el protein
with mutations at the proposed controlling phosphorylation. The mutant Cyp2el
proteins were expressed in mammalian tissue culture and the effect of these changes on
the accumulation of Cyp2el protein in this system was studied.
The similarity between the pattern of regulation of the CYP2E subfamily and
gluconeogenic enzymes, such as phosphoenolpyruvate carboxykinase, coupled with
the suggestion that the CYP2E subfamily may play an endogenous gluconeogenic role
(Koop & Cassaza, 1986) prompted an analysis of the possible control regions present
in the 5 ' region of the Cyp2el gene. The 5' region of the gene was analysed for
putative control elements and the possible effect of insulin on the transcriptional activity
of the Cyp2el gene was investigated.
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Section 4.2: The use of the mouse Cyp2el as a model system to predict the
behaviour of the human CYP2E1 homologue
The products of the CYP2E1 genes from species other than mouse have been shown to
be responsible for the activation of a variety of carcinogens, for example several
nitrosamine (e.g. iV-nitrosodimethylamine (NDMA) A-nitroso-A-methylmethylamide
(NMMA), A-nitroso-A-butylbutylamine (NBBA), iV-nitroso-TV-methylbenzylamine
(NMBA) and A-nitroso-dimethylethlyamine (NDEA) amongst others (Young & Yang,
1983), as well as a variety of hepatotoxins such as carbon tetrachloride (Johansson &
Ingelman-Sundberg, 1985), benzene (Johansson & Ingelmann-Sundberg, 1988) and
acetominophen (Koop et al., 1982). CYP2E enzymes have also benn seen to
metabolise of a variety of small solvent molecules such as alcohol (Morgan et al.,
1982), acetone and isopropanol (Koop & Cassaza, 1986), as well as a variety of
solvent based anaesthetic molecules such as ethers, chloroform, enflurane and diethyl-
ether (Pantuck et al., 1988; Brady et al., 1988.).
As a result of the observed metabolic roles and substrate profile of the CYP2E
subfamily, it is clear that these enzymes play an important role in the potential
development of chemical carcinogenesis particularly as a result of the activation of
several environmentally common nitrosamines. An understanding of the regulation of
the CYP2E subfamily is important to allow the prediction of situations in which
changes in these metabolic activities may arise as a result the activities of enzymes in
this subfamily are modified. Due to the high levels of sequence homology between the
three cloned CYP2E subfamily gene sequences, both in the coding and non-coding
regions, and the mouse Cyp2el gene, it is possible that mechanisms of control which
operate on both the Cyp2el gene, transcript and protein can be extrapolated to the
behaviour of the cognate CYP2E1 behaviour in a similar set of circumstances in other
species. Thus an understanding of both chemically induced and both the physiological
and pathological situations in which Cyp2el activities are modified in the mouse may
allow an insight into situations in which similar perturbations of the human CYP2E1
activities may arise. These situations would therefore be expected to result in changes in
the metabolism of a range of biologically relevant compounds which form the
substrates for the CYP2E subfamily.
Initially the effect of chemicals and starvation on Cyp2el levels in the mouse were
assessed in whole animal studies; secondly the potential molecular basis for these
controls, both at the level of the Cyp2el protein and the gene, were studied.
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Jection 4.3: Chemical inducers of the CYP2E subfamily
t has long been known that ethanol produces a profound effect not only on the rate of
ts own metabolism, but also the levels of P-450 enzymes in the liver (Lieber &
DeCarli, 1968). Ethanol exposure was noted to lead to proliferation of the smooth
endoplasmic reticulum and an increase in the levels of certain metabolic activities such
is aniline hydroxylation, an enzymatic activity now associated with the CYP2E
;ubfamily (Rubin et al., 1968). It is now known that small solvent molecules such as
ethanol, acetone and isopropanol increase the enzymatic activity of the CYP2E
;ubfamily and protein levels in the liver in a variety of species including the rat (Miller
fc Yang, 1984), chicken (Sinclair et al., 1985), rabbit (Koop et al., 1982), hamster
Kubota et al., 1986), timber wolf (Hogy & Crankshaw, 1992) and human (Perot
't al., 1989). The range of species in which solvents can induce members of the
!!YP2E subfamily suggests that this function may be universally applicable to a
3YP2E homologue in any species. Solvent induction may therefore represent a
:ommon theme for the regulation of the CYP2E sufamily members metabolic activities.
DYP2E protein induction by solvents was also seen to occur in the rabbit kidney (Ueng
■t al., 1987) and bone-marrow cells (Schnier etal., 1989). As discussed in connection
vith the diabetic induction of the CYP2E subfamily it is possible that acetone represents
in endogenous substrate and inducing agent for this subfamily and that other small
olvent molecules may possess their inducing capabilities by mimicking acetone both as
l substrate and an inducer (Koop & Cassaza, 1986, Section 3.10.1).
n vitro studies on the induction of CYP2E1 protein in the rat suggested that acetone,
ind other inducing chemicals, operated through the stabilisation of pre-existing
)YP2E1 protein. As a result of gene extinction, primary rat hepatocyte cell cultures are
een to lose detectable levels of CYP2E1 mRNA and protein around three days after the
ulture has been established. If however CYP2E1 substrates are added to the culture
nedium, although the CYP2E1 gene still becomes extinct and CYP2E1 mRNA is no
onger detectable, the CYP2E1 protein levels are maintained at 75% of the original
evel, whilst control cells grown in the absence of CYP2E1 substrates lose 85% of the
iriginal CYP2E1 protein level. A correlation was seen between the level of activity of
)YP2E1 to the various substrates and the level of CYP2E1 protein retention which they
;enerated; the more tightly a substrate bound the CYP2E1 protein, as measured
pectrophotometrically, the better its ability to maintain the CYP2E1 protein levels in
he primary culture system. These results suggest that the substrates generate CYP2E1
nduction by binding to the CYP2E1 protein and potentially render it resistant to a
lormal degradative process (Eliasson etal., 1988).
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rhese in vitro results matched those obtained in in vivo studies. In the rat it was seen
that the induction of the CYP2E1 protein and its associated metabolic activities was
issociated with an elevation in CYP2E1 protein levels without an increase in CYP2E1
mRNA level (Song et al., 1986). The increase in the level of the CYP2E1 protein and
issociated biochemical activities in the rat liver were seen to be quickly reversed
following removal of the inducing chemical, for example the ethanol-induced increase
in /7-nitrophenol hydroxylase activity, an activity associated with the CYP2E
subfamily, was seen to be lost one day after ethanol withdrawal (Hetu & Joly, 1985).
rhese studies suggest that the CYP2E1 protein is stabilised in the whole animal in a
similar manner to that observed in tissue culture systems and that the protein is rapidly
aimed over in the hepatocyte.
By labelling newly synthesised proteins with a pulse of radioactive amino-acid
precursors and then immuno-precipitating the CYP2E1 protein, it was possible to
observe the effect produced by solvent molecules on the turn over of the CYP2E1
protein in the rat liver. It was seen that in control animals CYP2E1 protein was
legraded in a biphasic manner consisting of a rapid and slower turnover pathway,
generating a CYP2E1 protein half-life of around 7 hours and 37 hours respectively. In
:he acetone-treated animals it was seen that the rapid CYP2E1 turnover pathway was
jxhibiting a reduced level of degradative activity and that the majority of the CYP2E1
protein was lost via the slower degradative system. As a result of this change in
iegradation pathways a longer half-life for the CYP2E1 protein was observed (Song
Hal., 1989).
tt is possible thatthe induction of CYP2E1 protein could result from either stabilisation
pf the pre-existing protein or increased translation of the message. By monitoring the
ncorporation of a radioactive pulse into CYP2E1 protein in control and acetone treated
mimals it was seen that the specific radioactivity was higher per unit of CYP2E1
protein in the control animals than in the treated animals. This suggests that the
chemical induction was not due to an increase in translation as in the acetone-induced
inimals the non-radioactive labelled pre-existing CYP2E1 proteins which become
chemically stabilised effectively dilute the newly synthesised CYP2E1 proteins (Song
Hal., 1989).
rhese studies suggest that the CYP2E subfamily of many species contains a common
•egulatory theme of induction by substrate molecules. This induction appears to be the
esult of substrate-induced protein stabilisation and may operate through the blocking of
i rapid degradative system acting upon the CYP2E subfamily proteins in the control
itate. This mechanism of control may also extend to physiological and pathological
iituations in which the levels of CYP2E subfamily member activities are seen to be
egulated.
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Section 4.4: Induction of Cyp2el by chemicals in the mouse
Section 4.4.1: The effect of chemicals known to induce other P-450 families on the
level ofCyp2el protein in the liver
The effect of chemicals seen previously to produce dramatic effects on the protein levels
of other P-450 families and other proteins associated with drug metabolism on the level
of Cyp2el protein in the mouse liver was investigated. Mice were treated with
P-naphthoflavone, 3-methylcholanthrene (CYP1 family inducers), dexamethasone,
phenobarbital and 1, 4-bis[2-(3,5-dichloropyridyloxy) benzene] (TCPOBOP),
2-acetylaminofluorene, pyrazole and aflatoxin B1 (CYP2 and 3 family inducers), and
A-nitrosodimethylamine (NDMA), as detailed in Section 2.16.2a. Protein was
prepared from the livers and the effects of these inducers on Cyp2el protein levels was
assessed using a polyclonal antibody raised to purified rat CYP2E1 protein; polyclonal
antibodies raised to rat CYP2B1 were also used to demonstrate the effects of some of
the chemicals on another CYP2 subfamily.
It was seen that no chemical treatment produced any profound effect on the level of
Cyp2el protein (Figure 4.1); the nature of the lower molecular weight band seen below
the Cyp2el protein is discussed below. By comparison the levels of protein in the
Cyp2b subfamily can be seen to have become elevated by phenobarbital,
dexamethasone, 3-methylcholanthrene, phenobarbital, 1 , 4-bis [ 2 - ( 3, 5 - dichloro-
pyridyloxy) benzene] (TCPOBOP), and 2-acetylaminofluorene. NDMA, a substrate of
the CYP2E subfamily, generated a drop in the level of Cyp2el protein but also caused a
marked degeneration of the liver; in this respect it is interesting however that the levels
of Cyp2b can be seen to be elevated. In conclusion Cyp2el levels appear to be
unaffected by chemicals which markedly induce the levels of a variety of other P-450
subfamily members (Figure 4.1).
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Figure 4.1: The effect of known inducers of P-450 protein on the level of Cyp2el
protein in the mouse liver. Hepatic microsomal protein was isolated from C57BL/6 (C)
and DBA/2N (D) male mice treated with the following compounds: DEX.:
Dexamethasone, 3MC: 3-methylcholanthrene, PYR: Pyrazole, DEN: N-
nitrosodiethylnitrosamine, BNF: fdnapthoflavone, PB: Phenobarbital, 2AAF: 2-
acetylaminofluorene, TCPOBOP: 1, 4- bis [ 2 - ( 3, 5 -dichloropyridyloxy) benzene),
AFB1: Aflatoxin Bl. Actual tretment regimes are detailed (Section 2.16.2).15pg of
microsomal protein was separated by SDS/PAGE on 12% gels, transferred to
nitrocellulose filters and probed with polyclonal antibodies raised to purified rat
CYP2B1 and CYP2E1 protein; the CYP2B1 standard (STD.) was purified from rat
liver. The P-450 proteins migrated with a Mr of approximately 52,000 and no bands
were detected other than those shown.
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Section 4.4.2: Induction of Cyp2el by acetone
It would be predicted that, in view of the very high levels of amino-acid sequence
conservation between the mouse Cyp2el and CYP2E1 proteins of other species that
acetone would lead to an induction of the level of Cyp2el protein in the mouse. To test
this postulate male and female DBA/2N mice were fed 1% (v/v) acetone in their
drinking water for 14 days. Protein was prepared from a variety of organs from both
control and acetone treated animals and the effect of the chemical treatment
investigated.Acetone treatment could be seen to generate an increase in the level of
Cyp2el protein in the liver, kidney, lung, spleen, oesophagus, testes and pancreas;
essentially anywhere that the Cyp2el protein could be immunologically detected it was
seen to become elevated (Figure 4.3). Cyp2el could not be detected using this
technique in the brain, heart, intestine, stomach or striated muscle. From these results it
is apparent that acetone potentially can penetrate throughout the body and lead to an
increase in the level of Cyp2el protein in any tissue which expresses it (Figure 4.3).
The observation that the CYP2E subfamily is present, and acetone-induced, in the
oesophagus is of particular note given the established link between alcohol
consumption and oesophageal cancers in humans (Lieber & Garro, 1990). The
incidence of oesophageal cancer is particularly high in certain geographical regions
noted for the local production of drinks with a high nitrosamine content, an example of
this being Calvados, the apple-based brandy from the Calvados Department of
Normandy (Tuyns et al., 1987). Immunohistochemical studies of the female
oesophagus, in which the cross-reacting band is absent, clearly demonstrate the extent
of the Cyp2el protein induction by acetone in this tissue (Figure 4.4).
These studies illustrate a sexual dimorphism in the level of expression of Cyp2el
protein in both the lungs and kidneys, with much lower levels being seen in the male
and female organs respectively (Figure 4.2); the significance and possible reasons for
this observation are discussed below.
The polyclonal antibody employed in these studies also recognises a slightly lower
molecular weight protein running just below the Cyp2el protein on the acrylamide gels
in preparations from some tissues. The cross-reacting band is however not present in
other tissues for example the kidney, pancreas and spleen, and is clearly sexually
dimorphic, if not dependent, in the oesophagus (Figure 4.3). It is likely that this band
represents a P-450 protein distinct from Cyp2el but sharing a common epitope(s). The
cross-reacting band has been noted in other studies employing this rat polyclonal
antibody on certain mouse protein preparations (Hong etal., 1989); in this study it was
suggested to represent a degradation product of the Cyp2el protein (Hong et al.,
1989). From the pattern produced by this second band in the study of the effect of a
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range of chemical inducers it can be seen that the lower band demonstrates some of the
inductive behaviour of the CYP2B subfamily to certain compounds (Figure 4.1). The
lower band is decreased by acetone treatment in the liver and lung (Figure 4.3); in a
study on the effect of ethanol treatment on the levels of a variety of P-450 in the rat liver
it was seen that an increase in the level of benzephetamine A-demethylase, a
biochemical activity associated with the CYP2B subfamily, was observed after
withdrawal of ethanol suggesting that a members of this subfamily may be repressed by
acetone treatment (Hetu & Joly, 1985). If this band represented a degradation product
of the Cyp2el protein it may be expected to be seen in all tissues expressing Cyp2el;
collectively these observations suggest that the lower cross-reacting band represents a
P-450 protein distinct from Cyp2el, potentially a member of the Cyp2b subfamily,
which shares a common epitope(s) with Cyp2el.
Acetone treatment did not lead to a concomitant increase in the level ofCyp2el mRNA,
suggesting that the Cyp2el protein induction does not result from increased
transcriptional activity of the Cyp2el gene. The level of Cyp2el mRNA was seen to
decrease in the female kidney upon acetone treatment (Figure 4.5). Decreased CYP2E
mRNA levels have been observed in the rabbit (Porter et al., 1989), and rat hetatic
tissues following chemical induction, and a similar observation was made in the BB/E
diabetic male rat kidney (Section 3.4); in the rat liver the message level was seen to
drop by 50% following chemical induction (Kim & Novak, 1990. Kim et al., 1990).
Reductions in the level of the CYP2E subfamily mRNA may be as a result of a potential
increase in the translation initiation from the message leading increased mRNA (Section
3.7.5).
The Cyp2el protein behaves as would be predicted on treatment with acetone and
consistent with the idea that the presence of a substrate stabilises pre-existing Cyp2el
protein. No increase in the level of Cyp2el mRNA is seen on chemical induction with
acetone. A fall in the level of Cyp2el mRNA is seen in the female kidney suggesting
that a modification in the translatability of the Cyp2el mRNA may be occurring.
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Figure 4.2: The effect of acetone treatment on the level of Cyp2el protein in the
mouse liver and kidney. Microsomal protein was isolated from control (C) and acetone-
treated (A), male (M) and female (F) DBA2/N mice tissues as indicated. 15p,g of
protein were separated by SDS/PAGE on 12% gels, transferred to a nitrocellulose filter
and probed polyclonal antibodies raised to purified rat CYP2E1 protein. No bands were
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Figure 4.3: The effect of acetone treatment on the level of Cyp2el protein in a variety
of mouse tissues. A: Microsomal protein was isolated from control (C) and acetone-
treated (T), male and female (as indicated) DBA2/N mouse kidney (KID.), spleen
(SPL.), oesophagus (OES.), and pancreas (PAN.). 15pg of kidney and lOOpg of
other tissue proteins were loaded per track. B: Microsomal protein was isolated from
control (C) and acetone-treated (T), male and female (as indicated) DBA2/N mouse
lung (left hand 4 tracks) and female kidney (right hand 2 tracks). 15pg of each sample
was loaded per track. The arrow indicates the Cyp2el protein and the lower cross-
reacting band is discussed in the text. C: Microsomal protein was isolated from control
(C.) and acetone-treated (T.) DBA2/N mouse testes, female (F.) spleen and
oesophagus (OES.) and lOOpg was loaded per track together with lOpg of female
acetone-treated kidney (F. T. KID.). In each instance the samples were separated by
SDS/PAGE on 12% gels and the protein transferred to nitrocellulose filters. The filters
were probed using polyclonal antibodies raised to purified rat CYP2E1 protein. The
Cyp2el protein migrated with a Mr of approximately 52,000 and no bands were
detected other than those shown. 135
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Figure 4.4: Immunohistochemical localisation of the Cyp2el in the female DBA2/N
mouse oesophagus. The presence, and acetone-induction, of the Cyp2el protein in the
oesophagus was determined using polyclonal antisera raised to purified rat CYP2E1
protein. The antibodies recognising the Cyp2el protein were complexed with
biotinylated swine anti-rabbit antisera and the immune-complex detected using an
avadin-biotin peroxidase detection system; the reaction of this system with its substrate,
3, 3-diaminobenzidine, gives the dark staining seen indicating the localisation of the
Cyp2el protein. A: Control animal. B: Acetone treated animal. This analysis was
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Figure 4.5: The effect of acetone treatment on the levels of Cyp2el mRNA in the
liver and kidney. Total RNA was isolated, using the tissue indicated, from control (C)
male (M) and female (F) DBA2/N mice, animals treated with acetone (A), and animals
treated with acetone and then returned to normal conditions (R) (Section 2.16.2a).
10pg of total RNA was separated on an agarose gel and transferred to a nylon
membrane by capillary action. The filter was hybridised with radioactive probes
generated from a mouse partial Cyp2el and (3-actin cDNA respectively. The Cyp2el
transcript and fTactin transcript migrated with a size of approximately 1,800 and 1,000
bases respectively and no bands other than those shown were present.
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Section 4.5: Induction of Cyp2el by starvation
The possible endogenous substrate and inducing agent of the CYP2E subfamily
enzymes may be acetone. Acetone is produced as a result of elevated fatty-acid
P-oxidation in response to modifications in the ambient fuel sources available. Such
elevations occur in diabetes and starvation; in this respect diabetes could be looked
upon as being an extreme form of starvation. The CYP2E subfamily is suggested to
have an endogenous gluconeogenic role in these situations allowing the conversion of
acetone indirectly to glucose (Koop & Cassaza, 1986), and the observed pattern of its
induction in these and the chemically induced situations can be rationalised in
connection with this role.
In both the diabetic state and as a result of starvation, an elevation of both CYP2E1
mRNA and protein has been observed in the rat (Young & Yang, 1982; Miller & Yang,
1984; Section 3.4.1). These observations are reflected biochemically by the increased
activation of carcinogens known to be metabolised by CYP2E1 in the starved animal,
with levels of NDMA demethylation, for example, being enhanced by between 50 and
100% following starvation in rats (Venkatensan et al., 1970).
Section 4.5.1: The mechanism for induction of CYP2E1 in the starved and diabetic
states; the role of acetone and the determination ofmessage stability
The induction of the CYP2E subfamily in the starved and diabetic states may relate in
part to the elevation of ketone bodies leading to the stabilisation of the enzyme by its
substrate. This observation cannot account for the elevation in CYP2E1 mRNA as such
an event was not seen in chemical induction alone. In the rat it was calculated that the
acetone level increase alone could not proportionately account for the levels of CYP2E1
protein increase seen, and that the induced message levels were not therefore a passive
feature of the starved state (Miller & Yang, 1984). The increase in CYP2E1 mRNA
has previously been suggested to be the result of stabilisation of existing messages
(Song et al., 1987); however, possible problems concerning this suggestion have bee
discussed (Section 3.7.3).
To date most mRNAs which have been seen to be controlled by regulatable stability
have been shown to possess structural features within the untranslated regions (UTRs)
of the message, principally the 3' UTRs as these portions of the message are free from
the restraints present in the coding portions of the message. The 3' UTR can therefore
potentially generate structural motifs and contain recognition sequences bound by
regulatable protein components, leading in turn to differential degradation of the
message. Examples of this mechanism of control are seen in the transferrin-receptor
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(Owen et al., 1987), phosphoenolpyruvate carboxykinase (Petersen et al., 1989) and
certain histone (Levin et al., 1987) mRNAs.
In general terms, as well as in the specific cases of mRNA possessing regulated
degradation, the stability of a message has been seen to be determined by the nature of
its 3'UTR. Messages can have a half-life of several days, as seen for example in the
globin genes, to only a few minutes, as seen in the case ofmany messages involved in
the control of cellular division. UAAAU motif sequence elements in rapidly degraded
messages, for example c-fos, dictate this rapid turnover; in this instance components
present in c-fos which lead to its rapid turnover are seen to be absent in the oncogenic
equivalent v-fos and the resulting mRNA is therefore much more stable. However,
by fusing the 3' UTR of c-fos onto v-fos the rapid degradation of the message returns
(Miller et al., 1984). Similar transfers of message stability on transfer of heterologous
3' UTR sequences have been seen in several experiments. For example the exchange
of a human short half-life lymphokine mRNA's 3' UTR with the long half-life globin
mRNA's 3' UTR leads also to a reciprocal exchange of message stabilities (Shaw &
Kamen, 1986). The main conclusion of these and other related experiments is that one
of the major determinants for the half-life of a mRNA resides in the 3' UTR and its
associated poly-(A) tail (See also Section 3.7.4).
It would be expected that Cyp2el protein would behave in a similar manner to that
observed in other species in starvation if the suggestion that acetone plays a role in its
induction in this situation is correct. What is not clear however is how the Cyp2el
mRNA would behave in starvation given the suggestion that the induction observed in
the diabetic rat is the result of CYP2E1 mRNA stabilisation. The endogenous Cyp2el
3' UTR has been ablated following the insertion of a [32 short interspersed repetitive
element (SINE, Section 5.4.1). If the control of the CYP2E subfamily message
stability is executed by previously recognised mechanisms involving the 3' UTR, this
control may be lost in the mouse Cyp2el mRNA. In this respect the mouse offers an
excellent in vivo genetic model to investigate the potential nature of the CYP2E
subfamily message regulation. If the [32 SINE insertion event had not happened
naturally to generate a model system of this kind producing a Cyp2el message without
a 3' UTR by conventional transgenic techniques would take a long time both to
engineer and assay. The effect of starvation in the mouse on the Cyp2el protein and
mRNA levels was investigated to address these possibilities.
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Section 4.5.2: The effect of starvation on the Cyp2el protein and mRNA
The effect of starvation on the hepatic level of Cyp2el mRNA and protein was studied
in male and female mice over a period of starvation extending for both 12 and 24 hours.
Protein was isolated from the control and starved animal groups and the level of
Cyp2el protein assessed by Western blott analysis; the level of Cyp2el protein is seen
to become elevated upon starvation (Figure 4.6).
Total RNA was isolated from control and the two starved animal groups, was separated
on denaturing agarose gels and transferred to nylon membranes; the resultant
memebrane was hybridised with the 800 base-pair partial mouse Cyp2el cDNA probe
(Section 5.2). Starvation leads to an elevation in the level of hepatic Cyp2el mRNA in
both male and female mice; it is also apparent that longer term starvation (24 hour) leads
to a higher elevation than that seen by shorter term (12 hour) starvation. The cDNA for
the rat microsomal glutathione S-transferase (GST) was used as a control probe to
demonstrate equal loading of the total RNA; as discussed (Section 3.6) the microsomal
GST potentially represents a good control probe for this purpose as it was seen to be
unaffected by the diabetic state in the rat and so may be expected to be unaffected by
starvation in the mouse (Figure 4.6).
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Figure 4.6: The effect of starvation on the level of Cyp2el mRNA and protein in the
mouse. A: 10 pg of hepatic microsomal protein isolated from male (M) and female (F)
control (C), 12 hour starved (12) and 24 hour starved (24) DBA2/N mice were
saparated by SDS/PAGE on a 12% and 9% gel. The proteins were transferred to
nitrocellulose filters and the proteins separated on the 12% and 9% gels were probed
with polyclonal antisera raised to purified rat CYP2E1 and microsomal GST (pGST)
proteins respectively. The pGST standard (Std.) was prepared from purified pGST
protein hetrologously expressed in E. coli. The Cyp2el protein and pGST protein
migrated with a Mr of approximately 53,000 and 17,000 respectively and no bands
other than those shown were detected. B: Total RNA was isolated from the livers of
DBA2/N mice, identified as detailed above, separated on an agarose gel and transferred
to a nylon membrane by capillary action. The filter was hybridised with radioactive
probes generated from a mouse partial Cyp2el and a rat cDNA respectively. The
Cyp2el transcript and pGST transcript migrated with a size of approximately 1,800
and 950 bases respectively.
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Section 4.5.3: The implication of the elevation of the Cyp2el mRNA in the starved
state
The Cyp2el mRNA was seen to be elevated in starvation; previous observations of
CYP2E1 mRNA elevations in chemically-induced diabetic rats have been attributed to a
stabilisation effect of the diabetic state on pre-existing CYP2E messages and so it was
suggested that similar mechanism operated in starvation (Song et al., 1987). Possible
problems relating to this conclusion have been discussed (Section 3.7.3), and the
observation that the mouse Cyp2el mRNA levels are elevated in starvation adds further
doubt to a role for a stabilisation event in the control of CYP2E mesage levels in
general.
The Cyp2el does not possess its endogenous 3' UTR, but an inserted (32
retrotransposon and its accompanying poly-(A) addition signal; if a regulatable stability
of the CYP2E subfamily messages is to be executed by conventional mechanisms then
a role for the 3' UTR in this process would be expected and the observed Cyp2el
mRNA elevation in starvation would not be predicted. Unless a stabilisational event is
mediated as a result of elements contained within the residual endogenous Cyp2el
3' UTR or other areas of the CYP2E subfamily transcripts, or via a previously
unknown stabilisation mechanism, this observation provides a strong genetic argument
for the induction of the CYP2E messages to occur via other means.
The fact that prolonged starvation produced a further elevation of both the Cyp2el
mRNA and protein levels may reflect the severity of the starved state at the two time
points; a larger proportion of cells in the liver may be affected by starvation in the 24
hour than in the 12 hour starved samples resulting in a proportionate increase in the
Cyp2el mRNA and protein levels in each instance.
A report on the effect of starvation on the induction of NDMA-demethylase activity
associated with CYP2E1 subfamily, in the rat liver showed that no elevation was seen
in the presence of the RNA synthesis inhibitor actinomycin D. This observation would
suggest a possible role for transcriptional activation of the CYP2E1 gene in the
generation of CYP2E1 mRNA elevation as the result of starvation (Young and Yang,
1982). Transcriptional activation of the CYP2E subfamily would agree with one
interpretation of the results obtained in connection with the elevated CYP2E1 mRNA
levels in the diabetic state in the rat (Section 3.7.8).
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Section 4.6: Other controls of the Cyp2el subfamily: Sex hormones and the Pituitary
Cyp2el is clearly sexually dimorphic in the mouse kidney, with higher levels being
expressed in the male than in the female (Figure 4.3). The sexual dimorphism in
Cyp2el levels may be reflected in the observed sexually dimorphic effects of several
carcinogenic nitrosamines on the mouse kidney with neoplasms predominating in the
male kidney in every instance (Noronha, 1977. Hong et al., 1980; Mohla, 1981;
Hawke & Welch, 1985; Ampy & Williams, 1988; Hong et al., 1989). It was noted that
chloroform is relatively much more toxic to the male than the female kidney in the
mouse (Pohl et al., 1984) which also could potentially relate to the sexual dimorphism
in Cyp2el levels in this tissue.
Sexually dimorphic and sexually dependent P-450 levels are observed in the rat and
these differences are thought to be attributable to differences in the patterns of growth
hormone secretion between the two sexes (Section 3.7.8). In mice a sexually dimorphic
pattern of growth hormone is seen with male animals having, in a manner similar to the
rat, a more stable continuous level of growth hormone (MacLoed et al., 1991). It is
possible to modify the levels of growth hormone present in mice both by the use of
hypophysectomised animals and genetic model strains (MacLeod & Shapiro, 1989.
Norstedt & Palmiter, 1984). In this laboratory the "little" mouse strain, a C57BL/6
derived strain deficient in the pituitary receptor for growth hormone releasing factor and
consequently displaying a 90 to 95% decrease in growth hormone levels, the effect of
the fall in growth hormone on the renal Cyp2el protein level was analysed. As well as
sexual dimorphism occurring in Cyp2el protein levels, it was also noted for members
of the Cyp4a, Cyp2b, Cyp3a, and Cyp2c subfamilies. The little mice studies however,
suggested that growth hormone played no part in the generation of the Cyp2el sexual
dimorphism, or that of any other P-450 subfamily, as the levels of this and the other
P-450 proteins were unchanged in the growth hormone deficient little-mouse strain
relative to its control (Henderson et al., 1990). Growth hormone has been suggested to
regulate the levels of Cyp2a4 protein in a separate study however (Noshiro & Negishi,
1986).
The "dwarf rat has similarly low levels of circulating growth hormone and so can be
compared to the little-mouse strain as a model for the effect of growth hormone. Using
the dwarf-rat strain no changes in the sexually dependent P-450 patterns in the CYP2C
subfamily are observed, leading to a similar suggestion that growth hormone played no
role in the establishment of sex differences in this subfamily in the rat liver (Bullock
et al., 1991). In a different interpretation of the same dwarf rat model it was seen that,
although the absolute levels of growth hormone were reduced, the sexually dimorphic
secretory pattern of the enzyme was retained and so the CYP2C enzyme profiles were
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unaffected (Shapiro et al., 1989). In a similar manner the secretory pattern of growth
hormone in the little mouse strain may be maintained and so a role for growth hormone
can not be ruled out based on this model system alone.
In a separate study employing hypophysectomised mice it was seen that the complete
removal of growth hormone by this technique had no effect on the regulation of the
Cyp2el protein in the mouse liver although it did not address the dimorphism in the
kidney (Hong et al., 1990). This observation is significant as a similar treatment in the
rat leads to an elevation of both the CYP2E1 mRNA and protein levels (Yamazoe et al.,
1989a ). Hypophysectomy also effects the levels of several other P-450 in the rat;
levels of CYP1A, CYP2B as well as CYP2E were seen to be elevated in the
hypophysectomised rat (Williams and Simonet, 1988. Yamazoe et al., 1989a). As
discussed (Section 3.7.8) the levels of circulating growth hormone, both in terms of
peak height and amplitude, are decreased in starvation in the rat and similarly in
diabetes (Tannenbaum, 1979. Tannenbaum etal., 1981.). It was suggested that the fall
in growth hormone levels in diabetes and starvation may be responsible for the elevated
CYP2E1 mRNA levels seen in these situations (Yamazoe et al., 1989a). If growth
hormone does not generate the same effect on levels of Cyp2el mRNA or protein in
the mouse as it is seen to do in the rat, either a different control mechanism is operating
in this species or the changes in growth hormone level in the rat are coincidental to
other common, and unknown, modifications occuring in starvation in both species. In
humans, growth hormone levels are elevated by both starvation (Hansen etal., 1970;
Ho et al., 1988) and diabetes (Asplin et al., 1989) but CYP2E1 levels were seen to be
elevated (Song et al., 1990) which would not be expected if an analogy to the apparent
effect of growth hormone on rat CYP2E1 levels applied. Alternatively, differences exist
in the promoter regions between the rat, human and mouse genes and these may
account for differences in transcriptional control mechanisms between species (Section
4.12); if this is the case it may be that the control of Cyp2el in the mouse may more
closely resemble that of the human CYP2E1.
Clear results were obtained regarding the role of the sex hormones in the sexual
dimorphism of Cyp2el in the mouse kidney. Castration of male mice led to the
generation of a female renal Cyp2el level and this effect was reversed by administration
of testosterone; similarly the female renal Cyp2el protein levels were seen to be
elevated by testosterone administration (Henderson et al., 1990). Using the
"testicularly-feminised" (Tfm) mouse strain, which have defective androgen receptors,
it was seen that a female-like renal Cyp2el protein level was present in the males. This
lower Cyp2el protein level could not be reversed directly by testosterone suggesting
that the androgen receptor pathway plays a role in the establishment of the Cyp2el
dimorphism (Henderson & Wolf, 1991). Elevations in renal Cyp2el levels in female
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mice took around eight days to occur following testosterone administration, suggesting
that testosterone mediates its effect indirectly through changes in the expression of other
genes rather than exerting a direct effect on the Cyp2el gene itself (Henderson & Wolf,
1991). The testosterone-mediated induction ofCyp2el in the female kidney was shown
to be transcriptional, however, testosterone produced no changes on the levels of
Cyp2el protein ormRNA in the female liver (Hong et al., 1989).
The generation of the observed Cyp2el sexual dimorphism demonstrates that elements
controlling the transcription of the Cyp2el gene can be regulated. The observed lack of
effect of growth hormone on Cyp2el transcription in the mouse, compared to its
seemingly repressive action on the CYP2E1 gene in the rat, either highlights species
specific differences in the mechanisms of the control of the genes or that growth
hormone level changes in the rat are coincidental to concommitant changes in another
effector in both species.
Section 4.7: The molecular nature of the CYP2E subfamily substrate induced protein
stabilisation
Substrate induced protein stabilisation appears to be a common theme in the regulation
of CYP2E subfamily members. In chemical induction, as well as in starvation and
diabetes where the CYP2E subfamily proteins are elevated, a role for substrate induced
stabilisation has been suggested. Behind this observation is the suggestion that the
rationale for the CYP2E subfamily induction pattern relates to the endogenous role of
the protein in a gluconeogenic pathway. All situations where the CYP2E subfamily
members become elevated can thus be seen to relate to either an elevation in the level of
acetone, the proposed endogenous substrate, or the mimicking of acetone's actions by
other chemicals. It is suggested by both in vivo (Song et al., 1989) and in vitro
approaches (Elliasson et al., 1988) that the presence of the endogenous substrate, or a
mimic, reduces the effect of a fast acting component of the degradative pathway
normally responsible in part for the CYP2E subfamily protein turnover.
As a result of protein turnover, degradation cannot be regarded as less significant than
synthesis in the control of the steady state and inducible levels of a protein. This aspect
of control has attracted less investigation however, due to the technical difficulties
associated with it by comparison to the more readily studied de novo synthesis of
inducible proteins.
In order to gain an insight into the possible common molecular mechanism by which
the CYP2E subfamily proteins become stabilised it is necessary to look at both the
normal degradative systems operating on these types of protein and the possible
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molecular basis by which these normal processes could be perturbed by the presence of
a substrate.
Section 4.7.1: The mechanism of Cytochrome P-450 protein turnover
The technical problems which apply to the study of the degradation of any protein apply
equally to the study of P-450 turnover. The general approach to these studies is to
radioactively pulse label total cellular protein synthesis and then follow the loss of the
radioactive fraction of the particular protein of interest. Problems associated with such
analysis in vivo include the possible re-use and re-incorporation of radioactive
components used in the pulse distorting the apparent turnover of the protein. Attempts
to block de novo synthesis of P-450 proteins after the pulse to reduce this possibility
were hampered by the possibility that they were also blocking the production of labile
proteases necessary for P-450 degradation (Ballard, 1977).
Early studies on the turnover of the whole P-450 population using pulse labelling
studies suggested that there were two components in the degradation of P-450
generating a biphasic degradative profile. Firstly a fast degradative component,
generating a P-450 subpopulation with a short half-life of around 7 to 8 hours, and
secondly a slower degradative component generating a P-450 sub-population with a
half-life of 46 to 48 hours were seen to be present (Levin & Kuntzman, 1969). It was
seen that several inducing agents were capable of reducing the amount of P-450
removed by the rapid component of the degradative pathway, leaving however the
contribution made by the slower component unchanged (Levin & Kuntzman, 1969;
Denk & Eckestorfer, 1977; Achary etal., 1980). Similar biphasic degradative pathways
were noted for other endoplasmic reticulum components, for example the NADPH-
cytochrome c reductase (Negishi & Omura, 1972).
Through the use of radiolabeled 8-amino levulinic acid (8ALA) as a radioactive haem
precursor, it was seen that haem loss from the P-450 was more rapid than turnover of
the apoprotein component itself. This corroborated previous experiments which
suggested that the haem component of the P-450 could be lost and exchanged between
P-450 apoproteins (Farrell & Correcia, 1980. Parkinson etal., 1983).
As antibodies to specific P-450 isoforms were generated it became possible to study the
turnover of single P-450 isoform. Studies employing these antibodies demonstrated
that different P-450 isoforms were differentially degraded and that the turnover of the
total P-450 population could not be used to predict the behaviour of a particular
isoform. Thus in the rat CYP1A1, CYP2B1 and CYP2B2 were seen not to possess a
biphasic degradation profile and were seen only to be turned over by the slower
degradative system. In contrast, CYP2A1 was seen to be degraded biphasically
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generating a short half life (around 12 hours), and a long half life (around 50 hours)
component to the isoforms population (Parkinson et al., 1983). These observations led
to the suggestion of heterogeneity in the distribution of P-450 isoforms within the
endoplasmic reticulum. It was suggested that the more rapidly degraded P-450 species
may be localised to portions of the endoplasmic reticulum associated with secretion and
so were lost more rapidly in a more plastic environment (Chiu & Phillips, 1971). What
was not clear however is how such a heterogeneity would initially be engendered to
specific molecules within the same isoform population. Similar observations of a
biphasic degradation were made in in vivo pulse labelling studies ofCYP2E1 in the rat
where the protein was suggested to possess both a rapid (7 hour half-life) and slow
component (37 hour half-life) to its turnover pattern; addition of acetone reduced the
faster turnover component contribution to CYP2E1 protein removal but left the
underlying slower rate unaffected. This effect was not the result of a general reduction
in the turnover of P-450 as other P-450 proteins, such as CYP2C6, showed unchanged
degradation profiles in both the control and acetone treated animals (Song et al., 1989).
In general terms, degradation of protein components of the endoplasmic reticulum are
thought to occur via an autophagic and microautophagic lysosomal associated process
and this process has been suggested to act upon the P-450 population (Ahlberg et al.,
1985. Masaki et al., 1987). This lysosomal associated pathway is essentially viewed as
a bulk flow system with the limiting factor in the rate of degradation of a particular
protein being exerted by the rate of its entry into the lysosome. Once within the
lysosome the protein is destroyed and no further degradative controls can operate. The
microautophagic pathway is regulated by protein motifs that may be preferentially
recognised by this system leading to an acceleration of degradation of specific proteins,
for example pyruvate kinase and aspartate amino transferase, in certain situations such
as extended starvation (Dice et al., 1986; Dice etal., 1987; Section 3.1).
As well as the lysosomal associated degradative system, the cell also possesses extra-
lysosomal protease systems in the cytosol, mitochondria, nucleus and associated with
the endoplasmic reticulum itself. In general terms these proteases tend to be larger
(Mr approximately 80,000 to 500,000) than those contained within the lysosome
(predominantly members of the cathepsin family, Mr approximately 20,000 to 40,000).
The size disparity in these two protease classes led to the suggestion that the non-
lysosomal proteases may posses regulatory domains not present in their lysosomal
counterparts whose activity is regulated solely by their lysosomal containment. Some of
the extra-lysosomal protease systems become activated when they recognise a protein
that has been modified in some manner. An example of this is seen in ubiquitination,
illustrating clearly how the cell has the capacity to regulate the amount of specific
protein by employing regulatable degradative-proteolytic systems (Hershko &
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Ciechanover, 1982). The extra-lysosomal proteases associated with the endoplasmic
reticulum would be expected to be relevant in terms of P-450 degradation. Some of
these proteases have been characterised for example Tyrase which is a small
(Mr approximately 32 KDa) serine protease attached to the endoplasmic reticulum in rat
hepatocytes (Saklatvala et al., 1981) although it is possible that many such enzymes
exist.
It was thought that haemoxygenase was responsible for endoplasmically associated
P-450 degradation. Haemoxygenase is a membrane associated enzyme which catalyses
the oxidative scission of haem tetrapyrole rings generating carbon monoxide, iron, and
biliverdin. It was seen that induction of haemoxygenase by treatment of animals with
transition metals or endotoxin also led to a decrease in the levels of P-450 (Ishizama
et al., 1983; Bissell & Hammaker, 1976; Maines & Kappas, 1977). It now appears
however that the haem contained within the P-450 holoenzyme does not form a
substrate for the haemoxygenase and so the haem must first be released from the P-450
apoprotein before it can be degraded. Inhibitors of haemoxygenase, such as selenium-
protopophyrin, were also shown not to generate an induction of P-450 levels
confirming this suggestion (Kappas et al., 1985).
The use of primary hepatocytes was employed as a model system to study the
degradation of liver proteins in general and this system has also been used to study the
degradation of P-450 specifically (Sommercon et al., 1981). In both primary
hepatocyte cultures, and stable tissue culture lines in general, P-450 protein is lost
through a process termed "gene extinction" (Steward et al., 1985). This process is
thought to relate to the loss of the differentiated state in the cells leading to cessation of
transcription of the P-450 and a variety of other genes (Section 4.13.2). Using a rat
primary hepatocyte cultures, the degradation and stabilisation against degradation, by
inducing agents of a variety of P-450 species was studied; the effect of inducers on
increasing the time over which a primary culture retained detectable levels of certain
P-450 protein was used as an assay of these effects. CYP3A1 protein was seen to be
stabilised against degradation and loss from the culture system by inclusion of tri-acetyl
andomycin (TAO) in the culture medium (Watkins et al., 1986), and the CYP1A
subfamily were seen to be similarly stabilised in this system by the actions of
polychloro-biphenyl isomers (Steward et al., 1985; Pasco et al., 1987; Voorman &
Aust, 1988). This model system was used to show that the presence of acetone in the
tissue culture medium inhibited the loss of CYP2E1 protein; the CYP2E1 protein levels
were maintained at 75% of the original level of protein detected three days after the
culture was established, whilst control cells grown without CYP2E1 substrates in the
media lost 85% of the original CYP2E1 protein (Elliasson et al., 1988).
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One interpretation of these observations is that the presence of the substrate may in
some manner modify the ability of the rapid degradative system to recognise the
CYP2E1 protein leading to the elevation of CYP2E1 protein levels seen. It seems
unlikely that a specific degradation system exists solely to remove CYP2E1 protein and
so the point of regulation would be expected to reside in the CYP2E1 molecule itself
rather than the protease system, which presumably also operates on other P-450
isoforms.
Section 4.7.2: Potential phosphorylational changes in CYP2E subfamily proteins as
a mechanism for regulating the speed of degradation
Steric changes induced by phosphorylation are one mechanism by which a cell can
modify and regulate protein components post-translationally; such modifications in a
protein tertiary structure can be used to change both stability and activity. It has been a
matter of speculation for many years that phosphorylational mechanisms play a part in
the regulation of P-450 levels. It was seen that agents such as catecholamines, which
increase the intracellular concentrations of 3', 5' adenosine mono-phosphate (cAMP)
depressed the level of hepatic drug metabolism (Fouts, 1962) and membrane permeable
forms of cAMP, such as N6, 02-dibutyrl cAMP (dbcAMP), were similarly seen to
decrease the levels of P-450 in the liver (Ross, 1973). The actions of cAMP and its
analogues lead to the release of the catalytically active components of the cAMP-
dependent protein kinase (PK-A) from the inactive holoenzyme and these observations
suggest that an increase in the activity of PK-A within a cell reduces P-450 levels.
In vitro studies investigated the phosphorylation of specific P-450 isoforms in both
solublised and membrane bound preparations by monitoring the transfer of radioactive
phosphate groups to the P-450 protein in the presence of purified kinase enzymes. It
was seen that the rabbit CYP2B4 protein became phosphorylated at a specific site by
PK-A and that this phosphorylation led to a decrease in it enzymatic activity (Pyerin
et al., 1983; Pyerin et al., 1984; Muller et al., 1985; Janzen et al., 1987). Following
phosphorylation, the CO-reduced spectra produced by the enzyme shifted from 450 nm
towards 420nm suggesting that phosphorylation led to a change in the tertiary structure
of the enzyme effecting the haem and generating an associated fall in enzymatic activity
(Taniguchi et al., 1982; Pyerin & Taniguchi, 1989). The specific site of
phosphorylation in the rabbit CYP2B4 was analysed by peptide mapping and was seen
to be present at serine 128. This serine was seen to be contained within a canonical
basic kinase serine/ threonine recognition site, or "signature", arg. arg. X. X. ser. X
where X represents any hydrophobic amino acid (Krebs & Beavo, 1979; Pyerin &
Taniguchi, 1989). Amino-acid alignment of all the Family 2 P-450 members revealed
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the presence of this kinase signature in most of the proteins; in some members of the
CYP2C subfamily, it is seen that the serine has become replaced by a threonine and in
one chicken Family 2 sequence by an arginine. This signature is lost in other P-450
families although the arg. arg. portion of the signature is retained; in Family 1, although
the signature is present it has become interrupted by an additional 8 amino acids
(Nelson & Strobel, 1988).
In vitro studies on a variety of different P-450 using both "basic" (i.e. those which
recognise sites flanked by groups of basic amino acids, such as PK-A, and the
calcium/phospholipid dependent kinase PK-C) and "acidic" (recognising sites flanked
by acidic amino acid residues, such as Casein kinase II) kinases supported the
observation that the main site of phosphorylation in the Family 2 P-450 was serine
128/129 and was mediated by basic kinases; no phosphorylation resulted from the
action of acidic kinases. Certain members of the CYP2C family were not
phosphorylated by PK-A, although it is not possible, for nomenclature reasons, to
assign which specific CYP2C isoforms these proteins represent. This observation may
relate to the replacement of serine 128 by threonine as seen in some CYP2C subfamily
isoforms for example. Members of Families other than Family 2 were also seen to be
phosphorylated by PK-C suggesting that sites other than the serine 128/129 may be
phosphorylated; other phosphorylation sites have been observed in some classes of
P-450 involved in steroid biosynthesis, for example serine 267 in the human CYP19
aromatase family was shown to be a target for phosphorylation by PK-A (Pyerin &
Taniguchi, 1992). PK-C was seen to phosphorylate some P-450 isoforms but this was
form-specific, for example rat CYP2B1 and CYP2B2 were both phosphorylated by
PK-A whereas only CYP2B1 was phosphorylated by PK-C ( Pyerin et al., 1987).
Treatment of primary rat hepatocytes with the calcium ionophore A23187, however,
did not lead to any phosphorylation of either CYP2B1 or CYP2B2 suggesting that PK-
C, and thus calcium signalling pathways, may not produce any effect on these isoforms
(Koch and Waxman, 1989).
Experiments performed on a series of P-450 isoforms in rats suggest that the changes
seen to occur in vitro may also control P-450 in vivo. Members of the CYP2B
subfamily were induced by phenobarbital and the effects of treatments known to
modify intracellular cAMP levels on CYP2B isoforms was studied in vivo. Treatment
of the animals with dbcAMP (a cAMP anologue) and glucagon (which increases
intracellular cAMP levels) elevated CYP2B1 and CYP2B2 phosphorylation suggesting
that PK-A plays an in vivo role in this process (Koch and Waxman, 1989).
From these studies it is possible that phosphorylational changes at the kinase signature
around serine 128/129 in Family 2 P-450 can form part of the post-translational control
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mechanism by which a cell can change the structure, activity and possibly stability of a
P-450 protein.
Section 4.7,3: The nature of the Family 2 serine 128/129 phosphorylation site
From amino acid alignment it was seen that most family 2 P-450s contained a
canonical basic kinase signature around a phosphorylatable serine 128/129 residue.
This area of the P-450 protein sequences is highly conserved suggesting that it may be
part of a common structural element (Figure 4.7). The conserved features in this region
include the retention of basic amino-acids (either arginine or lysine) in the arg. arg
region of the Family 2 kinase signature in all P-450 sequences, both mammalian and
bacterial as well as a tryptophan residue a few residues towards the N-terminus from
this basic region (Nelson & Strobel, 1988).
Using the computer generated alignment made between the available CYP2E subfamily
predicted amino-acid sequences and the crystallographically solved bacterial P-450cam
(CYP101) it can be seen that all the conserved elements in the kinase signature would
be predicted to reside within the C-helix by analogy to the P-450cam structure (Figure
5.5). In P-450cam arg 112 and the nearby glu 108, both residues of the C-helix, are
seen to form hydrogen bonds with the haem proprionate group (Poulos et al., 1987 );
on alignment it can be seen that these amino-acids are represented by the arginine
residue of the kinase signature and the conserved tryptophan (Figure 4.7). Thus the
phosphorylatable serine of Family 2 appears to be located within a highly conserved
region of the P-450 structure which may contribute to the C-helix and is therefore likely
to be involved in the interaction between the apoprotein and the haem group. The
introduction to this evolutionarily conserved basic region of the P-450 protein of two
negative charges as the result of phosphorylation may be expected to interfere with the
charge of the protein and potentially the interaction between the C-helix and the haem.
It is of interest that, although no comparable phosphorylation site is present within the
C-helix region of P450cam, a search of the P450cam protein sequence for the basic
kinase signature, using the GCG package Best program, revealed a site (arg. arg. phe.
ser 293. leu ) just N-terminal to the helix-K (Figure 5.5). The K-helix region is another
area of the P-450cam protein seen to interact with the haem group, particularly val 295
and arg 299 (Poulos et al., 1987; Section 5.3.2). If a phosphorylation event is possible
at this site in the bacteria, a perturbation of the haem environment may result.
In this manner, phosphorylation may be a mechanism by which the cell could exert
post-translational control over P-450 enzymes. Phosphorylation may lead to a change
in structure in the apoprotein and potentially change the apoprotein:haem interactions,
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phosphorylation (Taniguchi, et al., 1982; Pyerin & Taniguchi, 1989). Phosphorylation
may also form a signal for degradation of the CYP2E subfamily by a rapid proteolytic
system as a result of structural modifications.
Section 4.8: A potential role of serine 129 phosphorylation in the post-translational
control of CYP2E subfamily protein
Purified rat CYP2E1 protein was phosphorylated by PK-A and this event produced a
shift in the carbon monoxide-reduced spectra from 450nm towards 420nm. In common
with similar studies on other Family 2 isoforms, tryptic analysis of the CYP2E1 protein
showed that phosphorylation occurred at serine 129 (Eliasson etal., 1990).
The level of serine 129 phosphorylation was seen to be elevated in rat primary
hepatocyte cultures by the presence of 8-bromoadenosine (similar in action to the
membrane permeable cAMP anologue dbcAMP), glucagon and adrenalin, both of
which elevate the level of intracellular cAMP, for example the presence of glucagon
increased the control CYP2E1 phosphorylation level of 27 arbitrary units to 100
(Eliasson et al., 1990). The loss of CYP2E1 protein from the primary hepatocyte
cultures was seen to be elevated by the inclusion of the agents capable of increasing
CYP2E1 phosphorylation; the loss of CYP2E1 from 2 day old cultures was increased
by 40 to 50% by dbcAMP addition for example (Eliasson et al., 1990). It was seen that
inhibitors of the autophagasomal/lysosomal degradative pathway, such as NH4CI,
leupeptin, chloroquine and 3-methyladenine, did not inhibit the increased degradation
of CYP2E1 on addition of glucagon and it was suggested that the accelerated
degradation resulted instead from a Mg2+-ATP activated proteolytic system associated
with the endoplasmic reticulum (Ingelman-Sundberg et al., 1992). The rate of loss of
CYP2E1 protein from the primary hepatocytes was seen to be decreased by the addition
of cycloheximide suggesting that components of the degradation system were labile and
needed continual synthesis (Eliasson et al., 1988; Ingelman-Sundberg et al., 1992).
As was noted in previous experiments (Eliasson et al., 1988) the inclusion of CYP2E1
substrates in the culture media reduced both the level of phosphorylation and the
increased loss of the CYP2E1 protein produced on addition of the cAMP elevating
agents. The level of phosphorylation, presented as a percentage of the control value
without the substrate, was seen to be 53%, 61% and 39% in the presence of
isopropanol, ethanol, and acetone respectively. The presence of the substrate also
blocked the carbon monoxide-reduced spectral shift towards 420nm in studies on
purified proteins in association with PK-A (Eliasson et al., 1990). Treatment of the
primary hepatocyte cells with insulin which, amongst other things, decreases the
intracellular levels of cAMP, led to stabilisation of the CYP2E1 protein; in the absence
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of any substrate in the media a doubling in the amount of retained CYP2E1 protein was
seen on addition of insulin (Johansson et al., 1989). All these effects were suggested to
be specific to the regulation of CYP2E1 phosphorylation and degradation alone as no
change in the rate CYP2B1 phosphorylation was seen (Eliasson et al., 1990;
Johansson etal., 1989).
In an in vivo study of CYP2E1 degradation pathways in intact rat livers, it was seen
that feeding the animals with CYP2E1 substrates led to, as well as the increase in
CYP2E1 protein levels, an increase in the presence of CYP2E1 degradation products
within lysosomes suggesting a shift in the pathway by which the CYP2E1 protein
becomes degraded following substrate stabilisation (Ronis etal., 1991).
Taken together, and in connection with the observed biphasic pattern of CYP2E1
degradation (Song et al., 1989), these pieces of information suggest that there are
potentially two degradative systems operating on CYP2E1. The rapid component,
generating a CYP2E1 half- life of 7 hours, may be associated with the endoplasmic
reticulum and the slower component, generating a CYP2E1 half-life of 37 hours, may
be associated with the lysosomal degradative processes. These results also suggest that
the rapid proteolytic pathway acts upon CYP2E1 protein after serine 129 becomes
phosphorylated and that agents, such as dbcAMP, adrenalin and glucagon accelerate
both the phosphorylation and the degradation of CYP2E1 proteins through this
pathway; inhibitors of the slower autophagasomal pathway do not affect the
acceleration of CYP2E1 degradation by these agents. Phosphorylation may potentially
lead to a conformational change within the CYP2E1 protein and modification of the
haem interactions, either or both of which events may enable the rapid proteolytic
system to degrade the protein. The presence of CYP2E1 substrates, or the blocking of
the phosphorylation pathway through the action of cAMP agonists such as insulin, may
reduce phosphorylation, blocking the structural change and the CYP2E1 recognition by
the rapid proteolytic system. This phosphorylation block may then switch the method
of CYP2E1 removal instead predominantly to the slower, bulk-flow, lysosomal system
as suggested by the increased levels of CYP2E1 degradation products in the lysosomes
following chemical induction (Ronis et al., 1991).
In vitro studies suggest that cellular signalling systems associated with glucagon lead
to an acceleration of CYP2E subfamily protein phosphorylation and degradation,
whereas in contrast, insulin appears to stabilise the protein. This does not fit with the
apparent control mechanisms seen to operate on the protein in vivo. In the diabetic
state, insulin levels fall as the [3-cells become destroyed, and glucagon levels rise as the
body switches from the use of glucose to fatty-acids as a fuel source (Johnston et al.,
1984. Pilkis et al., 1988). In the diabetic state the level of both CYP2E1 protein and
mRNA are seen to be elevated and this elevation is seen to be reversed by the
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administration of insulin (Section 3.4.1). It may be expected from this in vivo
observation that lowered insulin levels, and presumed glucagon raised levels, would
increase the levels of CYP2E1 protein; this is in stark contrast to the observed effects of
these hormones on CYP2E1 protein in tissue culture systems where glucagon is
associated with accelerated CYP2E1 degradation. By producing the effects suggested
by the in vitro experiments, hormonal signalling may generate a more responsive
CYP2E1 protein induction system given the proposed endogenous role of the CYP2E
subfamily proteins as gluconeogenic enzymes. Thus in a starved or diabetic state where
glucagon levels are high it would be expected that the rate of CYP2E1 phosphorylation
and so degradation would be accelerated, but increased acetone levels in this situation
prevents phosphorylation from occurring and so the CYP2E1 protein is stabilised. In
the non-starved state the levels of acetone fall and the CYP2E1 protein becomes
available to phosphorylation potentially leading to accelerated degradation but the fall in
glucagon and rise in insulin levels reduce the activity of the phosphorylating system and
the CYP2E1 loss. In this manner antagonistic actions mediated by the biochemical and
hormonal changes associated with the normal, starved and diabetic states may allow a
more rapidly controlled regulation of CYP2E subfamily protein levels to be mediated
and acetone-derived inductions of CYP2E protein can be both rapidly generated and
quickly disapated. These ideas are represented in Figure 4.8.
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Figure 4.8: The proposed role of serine 129 phosphorylation in the control of the
CYP2E subfamily protein stability. A: In the absence of a substrate serine 129 is
available for phosphorylation, the level of phosphorylation is accelerated by an
elevation in cAMP levels resulting from the actions of hormones such as glucagon. The
CYP2E subfamily protein is available, as a result of structural changes induced by
serine 129 phosphorylation, to both a rapid endoplasmic reticulum-associated, and
lysosomal degradation systems. B: In the presence of a substrate, or if cAMP levels are
decreased by the actions of hormones such as insulin, the level of serine 129
phosphorylation falls. The CYP2E subfamily protein is stabilised in these instances as
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Section 4.9: The potential role of serine 129 in the control of mouse Cyp2el protein
degradation
By analogy to the studies on the rat CYP2E1 in primary hepatocytes (Eliasson et al.,
1990; Johansson et al., 1989; Ingelman-Sundberg et al., 1992) serine 129 in the mouse
Cyp2el would be expected to be phosphorylated by PK-A and may influence the rate
of removal of the protein by a putative endoplasmic reticulum-associated proteolytic
degradation system. By employing Cyp2el cDNA clones in which the serine 129 had
been mutated, the effect of the change at this site on the accumulation of heterologously







Section 4.9.1: Generation of Cyp2el serine 129 mutations
The serine 129 within a mouse Cyp2el cDNA was modified by site-directed
mutagenesis to alanine 129 and glycine 129 in two separate constructs. Alanine and
glycine were selected to replace serine as they most closely resemble serine in size,
structure and charge and so would not be expected to peturb greatly the folding of the
mutant Cyp2el protein; these three amino acids are all classified together based on a
previously established mutational matrix (Taylor, 1986). The area of the P-450
sequence containing serine 129 is highly conserved and expected to form the C-helix by
analogy to P-450cam (Figure 4.7 and Figure 5.5). It is of note, however, that the
serine at this site is replaced by an arginine, with its much larger R-group, and
threonine in a chicken and rabbit CYP2C protein (Nelson & Strobel, 1988) suggesting
that any slight steric perturbations introduced by these mutagenic changes may be
accommodated by this region of the P-450 structure.
The mouse full-length mouse Cyp2el cDNA was subcloned into the Xba I and Sal I
restriction endonuclease sites of the bacteriophage M13mpl8. Single-stranded
M13mpl8 DNA generated from Cyp2el cDNA recombinant plaques was prepared
from the E. coli JM109 host cells and this DNA was used both to transform BW313, a
dutr ung~ strain of E. coli, and as a template in sequencing reaction to check that the
mutagenic oligonucleotides annealed in the expected position within the Cyp2el cDNA.
Single-stranded M13 DNA was prepared from the BW313 E. coli and this DNA was
used in the mutagenic reactions. The dut~ ung~ E. coli strain contains elevated
intracellular levels of dUTP (dut) and uracil glcosylase (ung ) which increases the
incorporation of uracil into DNA templates in a few instances following replication in
place of a thymidine residue in the original template. Using single-stranded templates
containing several uracil residues however generates a second strand with thymidines in
the place of the randomly added uracils.The products of this reaction are then used to
transform non-durung' E. Coli strain which inactivates the original uracil containing
strand and so only the second thymidine containing and potentially mutated strand is
replicated (Kunkel et al., 1985). Mutated single-stranded M13 DNA prepared in this
manner from several plaques was sequenced and the introduction of the desired
mutations confirmed; replicative form double stranded DNA was prepared from
successfully mutated M13 plaques. The two mutant Cyp2el cDNA clones were then
subcloned into the Kpn I and Hind III restriction endonuclease sites of the transient
eucaryotic expression vector pCMV4. Both mutant clones were then resequenced in the
pCMV4 vector by double-stranded sequencing to confirm the presence of the mutations
in the final constructs. The introduction into the pCMV4 vector of the various portions
of poly-linkers from the pBS SK II (-) and M13mpl8 vectors in the preparation of
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these mutated cDNA constructs allowed the use of the Not I restriction endonuclease
site to clone in the unmodified Cyp2el cDNA directly. The orientation of the Cyp2el
cDNA cloned into the Not I site was assayed by the use of diagnostic Sea I restriction
endonuclease sites and these constructs were sequenced from the pCMV4 double-
stranded template to confirm the presence of the serine 129 codon. The oligo¬
nucleotides employed, the determination of the mutations and the strategy used in the
preparation of these normal and mutant Cyp2el constructs is shown in Figures 4.9 and
4.10.
Section 4.9.2: The pCMV4 vector expression system and the proposed model for
P-450 degradation generated through the use of the mutated Cyp2el proteins in COS 7
cells
The pCMV expression system vectors contain the powerful (-730 to +3) promoter
region of the human cytomegalovirus (CMV, Towne strain) major intermediate early
gene as well as the SV40 and fl bacteriophage origins of replication to allow replication
in both mammalian and bacterial cells. A synthetic fragment of DNA corresponding to
the 5' UTR of the Alfalfa-mosaic virus 4 RNA is also placed downstream of the CMV
promoter which acts as a translational enhancer by decreasing the translational initiation
requirements of the generated message.The transcripts generated from the CMV
promoter are terminated by a poly-A addition signal present in a human growth
hormone 3' UTR region present downstream. The combined vector has proved a
powerful tool in the generation of heterologous protein expression in Simian COS cell
tissue culture systems (Anderson et al., 1989).
The PCMV4 constructs, although they contain an SV40 origin of replication, are only
present transiently within mammalian cells following transfection and do not integrate
into the genome of the recipient cells. Thus the heterologous protein encoded by the
construct is expressed only during the time in which the CMV construct is present
within the cell, and as the plasmid is lost then both the heterologous transcript and
protein cease to be produced and are degraded. The Simian COS 7 stable cell line is
derived from the kidney and in common with most other stable mammalian cell lines
does not retain expression of several P-450 genes; as a result the cell line would not be
expected to contain a complicating endogenous CYP2E1 protein. By using transiently
generated expression of parental and mutant Cyp2el protein forms in the COS 7 cells it
was intended to generate a system mimicking the event of CYP2E1 gene extinction and
protein loss studied previously in primary hepatocytes (Eliasson et al., 1990; Johanson
et al., 1989). Using this system the role of serine 129 as a phosphorylation site in the
regulation of Cyp2el protein degradation could then be investigated.
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Figure 4.9: The generation of Cyp2el cDNA sequences with directed mutations in
serine 129. Serine 129 in the parental Cyp2el cDNA was mutated to encode alanine
and glycine through the use of oligonucleotide-directed mutagenesis. The mutations
were confirmed by sequencing of M13 single-stranded DNA templates and the cDNA
sequences subcloned into the pCMV4 mammalian transient expression vector. The
figure shows the confirmation of the presence, and absence, of the serine 129 codon in
the native and 2 mutant pCMV4 constructs respectively through the use of the final
pCMV4 constructs as double-stranded DNA templates for sequencing. The mutated
serine codon is shown in hollow type. SER 129: The parental Cyp2el cDNA
containing the serine 129 codon. SER TO ALA: The mutated Cyp2el cDNA
encoding alanine at posistion 129. SER TO GLY: The mutated Cyp2el cDNA
encoding glycine at posistion 129. The tracks are loaded, left to right, A, G, C, T.
The 2 mutagenic oligonucleotides employed:
1. Alanine 129: GGATACTTAGGGCAAACCTCCGC
2. Glycine 129: GGATACTTAGGCCAAACCTCCGC
(Parental 129: GGATACTTAGGGAAAACCTCCGC)
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replaced by parental
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Figure 4.10: The cloning strategy employed to generate the 3 Cyp2el cDNA
constructs in the pCMV4 mammalian transient expression vector. Through the use of
the available restriction endonuclease sites in the pBS SK II (-) and M13mpl8 vectors
(1 & 2) the oligonucleotide-directed Cyp2el cDNA mutants were directionally cloned
into the Kpn I and Hind III restriction sites in the pCMV4 mammalian transient
expression vector (3). The parental Cyp2el cDNA was inserted into the Not I
restriction endonuclease sites introduced into the pCMV4 vector as a result of these
manipulations and the orientation of the clones determined through the use of a
diagnostic Sea I digestion (4). CMV Promoter: The human cytomegalovirus (Towne
strain) major intermediate early gene promoter region. hGH poIy-A: The poly-(A)
addition site of the human growth hormone gene.
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The same predicted processes leading to substrate-induced stabilisation of the CYP2E1
protein in the primary hepatocytes would be expected to occur in kidney cells; the
Cyp2el protein, for example, was seen to be elevated on acetone treatment in the
mouse kidney (Figure 4.2).
By replacing the serine 129 in the Cyp2el mutants with similar but non-
phosphorylatable amino acid residues it would be expected that the mutant Cyp2el
proteins should behave as if they were constantly in the presence of a substrate. As the
mutant forms of the Cyp2el protein cannot be phosphorylated at position 129 they
would not be expected to be degraded by the postulated, rapid, endoplasmic reticulum-
associated proteolytic system but instead being removed only by the slower, potentially
bulk-flow, lysosome-associated degradation mechanism. By contrast the normal form
of the Cyp2el protein, with a serine 129 phosphorylation site still present, would be
expected to be removed by both the rapid and slow degradative pathways. After the
CMV vector has been lost from the transfected cells the differences in the pathways
available to the cell to remove the normal and mutant heterologous Cyp2el proteins
should manifest themselves. The normal Cyp2el protein, degraded by both the rapid
and slow removal pathways, should be observed to be lost from the system more
rapidly than the mutant forms acted upon theoretically only by the slower degradative
pathway. By contrast the mutant proteins may be expected to accumulate in the cell as
they are only removed by the slower lysosomal degradative pathway. It should
therefore be possible to determine the differences in the rates of degradation of the
different proteins, by a combination of the length of time which they are retained in the
cell line after loss of the CMV construct and an increase in mutant protein levels relative
to those of the native protein due to an accumulation of the mutant forms. The transient
expression of Cyp2el protein itself acts as an easily assayed protein pulse without
requiring the need to use any other labelling approaches as the recipient COS 7 cell line
would not be expected to contain any complicating endogenous CYP2E1 protein.
Section 4.9.3: Transfection of Cyp2el pCMV4 constructs and the time course for
Cyp2el protein loss from COS 7 cells
The ability of the pCMV4 construct to produce immunologically detectable levels of
Cyp2el protein in COS 7 cells was established; COS 7 cells were transfected with the
normal Cyp2el cDNA pCMV4 construct contained in both the correct and reverse
orientation for expression of the Cyp2el transcript from the CMV promoter (Figure
4.11). The cells were harvested two days after transfection, disrupted by sonication and
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Figure 4.11: The expression of Cyp2el protein in COS 7 cells directed by the
pCMV4 transient espression construct containing the parental Cyp2el cDNA. COS 7
cells were transfected with the pCMV4/parental Cyp2el cDNA construct in the correct
orientation for protein generation (pCMV4 Cyp2el FOR.), the pCMV4/parental
Cyp2el cDNA construct in the reverse orientation for protein generation (pCMV4
Cyp2el REV., see Figure 4.10), and mock transfected without any DNA (COS7
cells only). Total COS 7 protein was isolated and 50ug of each sample separated by
SDS/PAGE on a 12% gel together with 20ug of DBA2/N male mouse kidney
microsomes (KIDNEY). The protein was transferred to a nitrocellulose filter and
probed with polyclonal antisera raised to purified rat CYP2E1 protein; the immune-
complex was visualised using the enhanced chemiluminescence technique (Section
2.21,3).The Cyp2el protein migrated with a Mr of approximately 53,000 and no bands
other than those shown were detected.
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Cyp2el protein was seen to be produced from the correctly orientated Cyp2el construct
but no bands were present in protein prepared from cells either transfected with reverse
orientated Cyp2el cDNA, or mock transfected without DNA. These results
demonstrate that the pCMV4 vector produces immunodetectable levels of Cyp2el
protein and that there is no complicating endogenous CYP2E1 protein in the COS 7 cell
line (Figure 4.11).
The Cyp2el pCMV4 construct was transfected into a series of COS 7 cultures; a
transfected culture was harvested, sonicated to disrupt the cells and total cellular protein
prepared at daily intervals over an eight day period. The transfected cells were washed
and re-fed with fresh media every two days following the transfection but were not
split; total cellular protein from each time point was probed using antisera raised to
purified CYP2E1 protein. It was seen that Cyp2el protein was expressed at detectable
levels up until day six of culturing but was then lost. The viability of the COS 7 cells
was seen to be little changed between day six and seven of culturing through the use of
a Nigrosin dye exclusion assay; the cells were 90% and 85% viable at day six and day
seven respectively.
Section 4.9.4: The effect of the alanine and glycine 129 mutant Cyp2el proteins on
the level of accumulation and rate of loss of the Cyp2el protein
Separate COS 7 cultures were transfected with equal amounts of the two mutant
Cyp2el and normal Cyp2el PCMV4 constructs. Total cellular protein was harvested
from the cultures daily over an eight day period, the time period during and beyond
which normal Cyp2el protein expression had been detected in this system. Despite the
lack of serine 129 in the two mutant Cyp2el protein forms all the Cyp2el proteins,
both mutant and normal, were seen to be lost from the COS 7 cellular protein at day six;
these observation were repeated in three separate experiments. The cellular proteins
obtained from the staged cell extracts were probed using both 125I-protein-A and
Enhanced Chemi-luminescence (ECL, Amersham) detection systems but neither
technique detected the presence of Cyp2el protein beyond day six of culturing after
transfection. The extracts also demonstrated that the relative levels ofmutant and native
Cyp2el protein present at each sample point in the expression study were not markedly










Figure 4.12: The effect of the removal of serine 129 on the accumulation and
retention of the Cyp2el protein in COS7 cells using the pCMV4 transient expression
vector. COS 7 cells were transfected with the parental, serine 129 containing,
Cyp2el/pCMV4 construct (SER 129), and the two mutant Cyp2el cDNA pCMV4
constructs containing alanine at posistion 129 (ALA 129), and glycine at posistion
129 (GLY 129). Total COS 7 protein was isolated from cultures maintained for 1 to 7
days following transfection (1 to 7) and lOOpg of each sample was separated by
SDS/PAGE on 12% gels together with lOpg of DBA2/N male mouse kidney
microsomes (KIDNEY). The protein was transferred to nitrocellulose filters and
probed with polyclonal antisera raised to purified rat CYP2E1 protein; the immune-
complex was visualised using '-^I-Iabelled protein A. The Cyp2el protein migrated
with a Mr of approximately 53,000 and no bands other than those shown were
detected.
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Section 4.9.5: The effect of insulin on the Cyp2el protein levels
In the primary hepatocyte experiments the addition of insulin to the cells was reported
to increase the amount of protein retained in the cells and this may result from the
lowering of intracellular cAMP levels as a result the actions of insulin (Johansson
et al., 1989). The effect of insulin on the protein levels of both the native and mutant
Cyp2el at day four after transfection was studied; the cells were treated identically
except one group had insulin present in the media (1 X 10"7M). It would be expected
that the presence of insulin would lead to a blocking of the degradation of the native
Cyp2el protein and so an elevation, due to an accumulation, of protein levels in this
cell population, relative to the control cells, would be seen. By contrast he relative
protein levels of the mutant Cyp2el proteins would be expected to be unaffected by the
presence or absence of insulin.
COS 7 cells were transfected with the contracts in the presence, or absence of insulin
and were harvested 2 days after transfection. The COS 7 cells responded to the
presence of insulin in the media by an increased protein concentration present in the cell
extracts relative to the control cells suggesting an increase in protein synthesis and
potentially proliferation as noted previously (Section 3.3.4). Following normalisation
of the protein concentrations in the samples it was seen that the presence of insulin in
the media appeared to lead to a slight elevation in the levels of all the Cyp2el protein
generated by both the native and mutant constructs alike (Figure 4.13).
This observation does not support a role for a serine 129 phosphorylation blocking
affect of insulin in its presumed role as a stabilising agent of the CYP2E subfamily
proteins. This suggests either that insulin may be stabilising the CYP2E subfamily
proteins by a post-translational change elsewhere in the protein, and present in both
native and mutant Cyp2el proteins, or as a result of non-specific global changes in the
rate of translation of a whole series of transcripts due to changes produced in the
translational machinery (Section 3.3.4).Similar observations have been made in studies
on the effect of insulin on steroid hormone metabolising P-450 in primary culture; here
it was noted that insulin generated an overall increase in the metabolic activity of these
P-450 (Gulati & Skett, 1989). The cellular response to insulin also leads to a slowing
of membrane bulk-flow. Insulin treatment, in certain cell types, leads to the appearance
of elevated levels of glucose transporter proteins and these actions may be mediated
through either a slowing of endocytosis or an acceleration of exocytosis; increases in
the levels of other receptors, such as the transferrin receptor, have also been noted
(James et al., 1988; Tarner & Lienhard, 1987). It is another possibility therefore, that
the increased levels of Cyp2el protein following addition of insulin, may relate to a
decrease activity in the presumed bulk-flow lysosomal degradative pathway.
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Figure 4.13: The effect of the presence of insulin in the culture medium on the level
of mutant and parental Cyp2el protein generated in COS 7 cells by the pCMV4
transient expression constructs. COS 7 cells were transfected with the parental
Cyp2el/pCMV4 construct in the correct orientation (SER 129), the 2 mutant Cyp2el
pCMV4 constructs with alanine (ALA 129) and glycine (GLY 129) at amino acid
posistion 129 respectively, the parental Cyp2el cDNA in the reverse orientation
(Cyp2el REV.) and without DNA (COS 7 only), in the presence (+), or absence
(-) of 1 X 10 7 M insulin in the medium. Total cell protein was isolated 2 days after
tranfection, and lOOpg of each sample was separated by SDS/PAGE on a 12% gel
together with 20pg of acetone-treated female DBA2/N mouse kidney microsomes
(KIDNEY). The protein was transferred to a nitrocellulose filter and probed with
polyclonal antisera raised to purified rat CYP2E1 protein; the immune-complex was
visualised using 1 -5I-labelled protein A. The Cyp2el protein migrated with a Mr of
approximately 53,000 and no bands other than those shown were detected.
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Section 4.9.6: Possible explanations for the lack of an observed difference between
the behaviour of the mutant Cyp2el proteins and the native Cyp2el in the COS 7
system
According to the postulated mechanism by which the relative contribution made by the
two degradative mechanisms proposed to operate on CYP2E subfamily protein are
controlled, the removal of the serine 129 in the Cyp2el mutants should present the cell
with a much more stable Cyp2el protein. From the experimental system employed in
these experiments it does not appear that this is the case. Both mutant and normal
Cyp2el protein is lost from the cells by the same time point, accumulates to comparable
levels over the period of expression and are equally affected by the presence of insulin
in the medium.
This observation could be explained by a variety of possibilities. It is possible that the
postulated labile endoplasmic reticulum-associated protease system suggested to
mediate the rapid and regulatable degradation of the CYP2E subfamily protein
(Ingelman-Sundberg et al., 1992) may be subject to gene extinction and loss from the
stable tissue culture line in a manner similar to that observed for P-450 proteins
themselves. However the levels of Cyp2el protein were not seen to accumulate over
the period of expression suggesting that the lysosomal/ autophagasomal degradative
pathways were still operational.
Alternatively is possible that the phosphorylation site at serine 129 does not play a role
in the regulation of stability of the CYP2E subfamily proteins mediated by the presence
of substrates. The observed elevation of phosphorylation at this site may therefore
represent a marker of a change produced by the absence of the substrate and be
associated with, rather than the cause of, an accelerated degradation. The cause for the
slowing of degradation by the presence of the substrate may therefore relate to a change
within another potential structural signal, allowing degradation by a rapid proteolytic
system to occur. It has been noted in the purification of several P-450s, other than
those from Family 2, that addition of an appropriate substrate to the purification
procedure increases the yield of the resultant active P-450 protein. This observation
suggests that substrate stabilisation may be a common theme for the stabilisation of
several P-450s regardless of whether or not they can be phosphorylated in the C-helix
(Yu & Gunsalus, 1974; Takemani et al., 1975; Kellis & Vichery, 1987). It was also
seen from studies on the phosphorylation of several P-450 isoforms that nearly all the
Family 2 members could be phosphorylated by PK-A; by contrast in studies of the
degradation patterns of P-450 proteins it was seen that only a few possessed a biphasic
degradation pattern as seen to be the case in CYP2E1 and CYP2A1 (Song et al., 1989;
Parkinson et al., 1983). Although both rat CYP2B1 and CYP2B2 proteins were
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phosphorylated both in vivo and in vitro (Koch and Waxman, 1989) these proteins did
not not possess a biphasic degradation profile and were seen only to be turned over by
the system acting to generate a long half life P-450 population (Parkinson et al., 1983).
What is not clear is how a similar phosphorylation event upon arguably similar protein
structures can produce accelerated degradation of one P-450 isoform by a rapid
proteolytic route, but leave another isoform still resistant to such an attack.
Section 4.9.7: Other systems to assess a role for serine 129
The results obtained from this experimental system demonstrated clearly that the
presence or absence of serine 129 produced no effect on the accumulation or time of
retention of the Cyp2el protein. Although not affecting the lack of mutant Cyp2el
accumulation in the culture system, the precipitous loss of the Cyp2el protein at day
six, rather than a steady decay of protein levels as might be expected following loss of
the vector, suggests that events in the cells associated with continuous culturing
following transfection may effect the Cyp2el protein degradation. Although the COS 7
cells were seen to be approximately as viable at day six as at day seven it is possible
that, on having reached confluency around this time, the cells may activate new
degradative systems potentially associated with ageing; age-related down-regulation of
P-450 has been noted in vivo in rats for example (Marie et al., 1990). Alterations in the
levels of activity of the autophagasomal pathways have been associated with starvation
for example (Dice et al., 1986; Dice et al., 1987; Mortimore et al., 1988) and are also
seen to occur in similar circumstances in other eucaryotic systems such as in
S. cerevisiae (Hirsch et al., 1989). To assess this possibility and so obtain clearer data
concerning the time span of the mutant and native Cyp2el proteins, it would be
necessary to generate a system which removed the requirement for long-term cell
culture. One possibility would be to use inducible expression vectors to generate the
Cyp2el expression; in this manner a pulse of Cyp2el protein could be produced over a
much shorter period and its loss examined without the need to wait initially for the loss
of the transiently expressing plasmid construct with a constitutive promoter activity.
Further refinements to this system may be to generate a more unstable heterologous
message, for example by introducing destabilising UAAAU elements into the 3' UTR
(Section 4.5.1) and so reduce further the time period over which a pulse of Cyp2el
protein would be produced.
The results from this experiment suggest that serine 129 plays no role in the stability of
the Cyp2el protein in the study system employed; it is not clear however whether this
is also the case for the substrate-induced stabilisation of the protein observed in vivo, as
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the results obtained could be argued to reflect the extinction of the rapid proteolytic
degradative system in the tissue culture cell line.
Section 4.10: The induction of CYP2E1 by hyperbaric oxygen: generation of
CYP2E subfamily protein stabilisation without a substrate
As well as acting as monoxygenases, P-450s can also act as oxidases through the
reduction of oxygen to hydrogen peroxide or water; this observation suggested a role
for P-450 in the generation of oxidative stress by the production of hydrogen peroxide
and the generation of free-radical damage to membranes and other cellular components
(Gorsky et al., 1984). It was noted that exposure of rats to 95% oxygen led to an
increase in the concentration of P-450 in both the lung and liver by around 50%.
Further analysis of the specific isoforms of P-450 associated with this phenomenon
illustrated that 60% of the total induction could be attributed spectrally to an induction
of CYP2E1 protein. This observation was confirmed by Western blotting; it was seen
that the CYP2E1 mRNA levels were however unchanged (Tindberg & Ingelman-
Sundberg, 1989).
Thus both the presence of the substrate and oxygen alone has been associated with an
increase in the stability of CYP2E1 protein. It is possible that in both cases a common
structural modification of the CYP2E1 protein occurs as a result of the presence of
oxygen or a substrate leading to its stabilisation. In both instances the structural
modification may be producing the same external signal, or lack of it, to a rapid
proteolytic system.
Other observations however may cloud this hypothesis of a common inductive pathway
for oxygen and CYP2E subfamily substrates by means of altered CYP2E protein
stability. It was seen in the case of super-oxide dismutase induction by hyperbaric
oxygen that the elevations in protein which were seen resulted from an increase in
message translatability (Hass et al., 1987). In this context, the possible control of
CYP2E translatability, as suggested to occur on exposure to solvents (Kim et al., 1990;
Kim & Novak, 1990), may have a role in the elevation of CYP2E1 protein seen. It is
an intriguing possibility that factors may interact with the conserved structure and
potential NFKp recognition site within the 5' UTR of the CYP2E subfamily in these
conditions (Section 5.4.4, Figures 5.7a and 5.7b). It has been shown that the activity
of the NFKp transcription factor itself is tightly controlled by levels of oxidative stress
and a similar activity may be displayed by other factors capable of binding NFKp
recognition sites (Meyer et al., 1993).
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Section 4.11: Transcriptional control of the CYP2E subfamily genes
In both the starved mouse (Section 4.5) and diabetic rat ( Section 3.4.1) the levels of
CYP2E subfamily transcripts have been seen to be elevated; in the chemically-induced
diabetic rat the transcript elevation has been suggested to relate to a stabilisational event
(Song et al., 1989). Arguments have been presented against this suggestion based on
the nature of the control transcript used in these experiments (Section 3.7.3) and on the
observed retention of mRNA induction in the starved mouse even though the Cyp2el
3' UTR is interrupted by a p2 SINE (Section 5.4.1) suggesting that stabilisation
would not proceed by previously identified mechanisms. It remains a possibility
therefore that the increases in CYP2E subfamily mRNA levels seen in these situations
is mediated by transcriptional activation of the gene. Physiological signalling pathways
may therefore be responsible for the activation of the CYP2E subfamily genes in
response to biochemical changes detected in these physiological and pathological states.
Precedents for the transcriptional regulation of the CYP2E subfamily have been seen
both during early development and in the adult. Through the use of methylation
sensitive Hha I and Hpa II restriction endonucleases, it has been shown in both
human (Jones et al., 1992) and rat development (Umeno et al., 1987) that CYP2E1
gene becomes demethylated and transcriptionally activated after birth; although the
demethylation of genes is often associated with transcriptional activation it is likely that
it occurs as the result, rather than the cause, of transcriptional activity in the gene
generated by another effector (Bird, 1984). Studies in the rabbit suggested that the two
CYP2E genes were developmentally regulated in a differential manner, with CYP2E2
levels rising immediately after birth but CYP2E1 levels only appearing at week four
postpartum (Bonfils et al., 1990). This is consistent with the observation of two peaks
of aniline hydroxylase activity, associated with CYP2E, being seen in the rabbit, with
one peak occurring immediately after birth and the second some four weeks later
(Tredger et al., 1976). Using the 800 base-pair partial Cyp2el cDNA, no Cyp2el
transcripts could be detected in total RNA prepared from mouse embryos (Kind gift
Dr R. Hill, MRC Human Genetics Unit, Edinburgh) suggesting that in a similar
manner the mouse Cyp2el gene is transcriptionally inactive prior to birth.
It has been noted that both the mouse Cyp2el gene, through the indirect action of
androgens in the female kidney (Hong et al., 1989), and rat CYP2E1 gene, through the
removal of growth hormone (Williams & Simonet, 1988; Yamazoe et al., 1989a), were
seen to be transcriptionally activated in the adult animal in certain circumstances.
These observations imply a clear role for transcriptional regulation in the developmental
activation of CYP2E subfamily and also in adult animals in certain circumstances and
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set a precedent for the possible involvement of control of the CYP2E subfamily genes
in situations in which their transcript levels are seen to be elevated.
In general terms transcriptional activation mechanisms operate via either the binding
de novo of transcription factors to controlling portions of the gene, or the modification
of prebound transcription factors, leading to initiation, or acceleration, of transcription
from the promoter. The controlling regions of a gene are generally seen to be located 5'
of the transcriptional initiation site but this is not necessarily always the case. Although
earlier studies suggested the existence of tissue specific DNA elements within a gene
that were active only in the presence of tissue specific transcription factors (Maniatis
et al„ 1987), it is now a general observation that a single DNA element within a gene
can be bound by a variety of transcription factors. The factors which are able to bind
this site are dependent on the tissue type, and it is the interaction between these protein
elements, rather than an exclusive nature of the DNA element itself, that allows a high
degree of complexity in the tissue specific expression of a gene to be established
(Lenardo & Baltimore, 1989).
The possible transcriptional regulation of the Cyp2el gene was investigated; such a
study may possibly give an insight into the similar situations in which other CYP2E
subfamily genes may also be activated, and could relate to the observed developmental
regulation of the gene and the processes surrounding the extinction of the CYP2E
subfamily genes in tissue culture systems.
Section 4.12: Levels of homology in the 5' region of the CYP2E subfamily genes
and regions important in their control
The 5' region of the mouse Cyp2el gene was cloned and sequenced and its level of
homology to the rat CYP2E1 gene analysed (Section 5.8.5). The levels of homology
were seen to be very high, sround 80%, suggesting that any controlling mechanisms
operating on the genes would be conserved between species.
A study of the 5' region of the rat CYP2E1 gene has delineated potential areas of
importance in the control of transcription of the CYP2E gene subfamily (Umeno &
Gonzalez, 1990); the results from this study are summarised in Figure 4.14. Deletion
analysis of the 5' portion of the rat CYP2E1 gene in association with an in vitro
transcription assay demonstrated the existence of several regions important in the
transcriptional activity of the gene. The in vitro transcription assay system involved the
use of liver nuclear extracts to produce transcripts from constructs containing portions
of the CYP2E1 5' region, and the transcript levels produced were quantified through
the use of a primer extension assay using radioactively labelled oligonucleotide probes
to the CYP2E1 mRNA generated. Using an initial construct of -4,600 to +190 base-
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pairs of the rat CYP2E1 gene the basal activity, termed therefore 100%, of the gene
was assessed. Deletions were then performed from the 5' most end of the CYP2E1
gene; by deleting 2 kilobase-pairs ofDNA the transcriptional activity of the gene was
seen to rise to 130% of the basal value suggesting the presence of a negative element
between -4,600 and -2,600 base-pairs of the CYP2E1 gene. Deletion of the portion of
the gene between -2,600 to -190 however had little effect on the transcriptional activity
suggesting this region played little role in the control of transcription. Further deletions
however revealed the presence of 2 regions which had a positive action on CYP2E1
transcription and loss of which led to a fall in transcriptional activity. These regions
were -274 to -170, leading to a fall in activity from 128% to 77%, and -113 to -87,
which led to a fall in activity from 81% to 14%. DNAse I protection assays of these
two regions showed that no protein in the extract appeared to bind between -274 to
-170, but footprints were seen in the -113 to -87 area suggesting that this region was
bound by protective protein factors. The -113 to -87 portion of the promoter was seen
to possess three protected areas and these were further analysed by the use of bandshift
assays on oligonucleotides made to these three regions. All three areas (-120 to -93,
denoted area A, -89 to -81, denoted area B, and -71 to -55, denoted area C) were seen
to specifically interact with, and be band-shifted by, protein components in the nuclear
extracts employed. The bandshifts generated by area A could be competed through the
addition of an oligonucleotide previously known to interact with the transcription factor
HNF-1 (also termed HP-1, LF-B1, and APF. Baumheuter et al., 1988; Frain et al.,
1989 ). In a similar manner the band shift produced by area C could be competed
through the addition of an oligonucleotide containing the site recognised by the NF-Y
factor (Raymondjean et al., 1988). The B region oligonucleotide however was not
competed by addition of any of the oligonucleotides used in this study and was
therefore suggested to represent a region bound by a factor more specific to CYP2E1.
Through the use of these oligonucleotides in conjunction with the CYP2E1
transcriptional assay system it was seen that only region A led to a decrease in activity
of the CYP2E1 promoter suggesting either that the factors binding regions B and C are
in vast excess or are not important in the control of CYP2E1 transcription (Umeno &
Gonzalez, 1990). The results from these studies are represented in Figure 4.14.
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Figure 4.14: The regions of the rat CYP2E1 gene seen to be important in the control
of transcriptional activity; the diagram is not to scale. Start: the transcript start site.
-274 to-170:





Activity drops from 81%-14%;
contains areas
A, B, & C and generates
footprints
The rat CYP2E1 gene is seen to become demethylated and transcriptionally active one
day after birth (Umeno et al., 1987); however by using nuclear extracts from fetal, day
3 and adult rat livers it was seen that the bandshifts produced by the adult and foetal
extracts were identical. When region A, the HNF-1 site, was used in the foetal and
adult bandshifts it was seen however that a higher mobility band was produced by the
fetal extracts than the adult. These results were taken to suggested that HNF-1 may
become post-translationally modified, possibly by glycosylation, at birth and activated
(Umeno & Gonzalez, 1990).
Section 4.13: Transcription factors possibly interacting with the 5' region of the
mouse Cyp2el gene
The transcription factors which may potentially interact with the 5' region of the mouse
Cyp2el gene were analysed. The 5' sequence of the mouse Cyp2el gene was analysed
to see if it contained known transcription factor recognition sequences using the
homology consensus searching computer program MacPattern and by using
permutational changes of published transcription factor recognition sequences (Locker
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& Buzard, 1990; Faist & Mayer, 1992) with the Best and Gap programs of the GCG
package (Devereux et al., 1984 ) (Figure 4.15).
These searches identified the HNF-1 (around -130) and NF-Y (around -100) sites
suggested to exist by bandshifting studies of the rat CYP2E1 gene (Umeno &
Gonzalez, 1990), as well as the presence of several other sites within the Cyp2el gene
potentially capable of affecting transcriptional activity (Figure 4.15). The Cyp2el gene
is predicted to possess a TATA box (around -60) suggested by the presence of several
TATA box and viral proteins recognition sites around this area; the TATA box binds the
TF13D protein and directs the positioning of the RNA polymerase II (Nickolov et al.,
1992; Greenblat, 1992). Upstream from this region, the Cyp2el gene is C-rich
suggesting that factors like Spl, which are often associated with the TATA box, may
also bind this region (Briggs et al., 1986). Upstream (around -100) from the potential
TATA box the Cyp2el gene is suggested to bind CCAAT motif recognising proteins
such as NF-1A and NF1-B as well as the NF-Y factor. Upstream of the proposed
HNF-1 site (around -140) is a predicted GATA recognition site (around -160); these
elements are often associated with the development of tissue-specific gene expression
(Ho et al., 1991; Ito et al., 1993).
Alignment of the rat CYP2E1 and mouse Cyp2el promoter sequences shows that the
region termed B, suggested to interact with a more specific CYP2E1 transcription factor
in the transcription assay study of the rat gene (Umeno & Gonzalez, 1990), is lost in
the mouse gene; this region forms the only gapped site in this portion of the otherwise
highly conserved sequences (Figure 4.15). This suggests that either this factor does not
play a significant role in the regulation of rat CYP2E1, as indicated by oligonucleotide
competition studies (Umeno & Gonzalez, 1990), or that this portion of the rat gene
generates a possible divergence in the control of the gene in the two species. It has
previously been noted that such differences may occur, for example the rat gene is
apparently transcriptionally activated by a fall in the level of growth hormone (Yamazoe
et al., 1989a) whereas transcription from the mouse gene is unaffected (Hong et al.,
1990).
Although in the rat CYP2E1 gene, removal of the -2,600 to -190 portion of the 5'
region was not seen to affect the basal promoter activity (Umeno & Gonzalez, 1990)
there are potential recognition sites within the portion of the gene highlighted by the
homology-based computer analysis. A putative AP2 site, flanked by cAMP responsive
element binding sites, was seen around -320 in the Cyp2el promoter; AP2 binding
factors have previously been shown to interact with cAMP responsive elements
(Imagawa et al., 1987).This portion of the gene is highly conserved between the rat and
the mouse with only one base change within the AP2 site binding consensus at this site.
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All the CYP2E subfamily genes contain a near consensus NFKp recognition sequence
just upstream of the initiation codon. This recognition sequence provides a good
example of the observation that a single site may be bound by a variety of protein
factors dependent on those present in a specific tissue. The NFk(3 recognition sequence
has previously been shown to be bound by a series of factors including the rel family
(Levin et al., 1991) of proteins (NFk(3, c-rel, v-rel, and dorsal ), as well as a series
of unrelated factors such as C/EBP (Clark et al., 1988), MBP-1 (Baldwin et al., 1990),
KBF-1 (Israel et al., 1987), and H2TF1 (Baldwin etal., 1987) and has been discussed
previously (Section 5.4.4). The predicted transcriptional recognition sites are illustrated
in connection with the aligned mouse Cyp2el and rat CYP2E1 5' region sequences in
Figure 4.15.
Section 4.13.1: The nature of the transcription factors suggested to interact with the
5' region of the Cyp2el gene
The nature of the putative transcription factors suggested to interact with the mouse
Cyp2el gene by computer analysis and the common factors suggested to interact with
the rat CYP2E1 gene by transcriptional assay (Umeno & Gonzalez. 1990) may give an
insight into the potential physiological, developmental and extinction-related controls
operating on this subfamily. Several of the recognition sites and the variety of proposed
factors which may bind to them are reviewed and the relevance of the sites and possible
binding factors to these aspects of the CYP2E gene subfamily are discussed.
HNF-1 recognition site (consensus: GTTAATNATTAAC): The HNF-1 transcription
factor has been shown to interact with a variety of liver specific genes including
albumen, C-reactive protein, aldolase B, pyruvate kinase, a-fetoprotein, a- and (3-
fibrinogen, and ai-antitrypsin (Cereghini et al., 1990). HNF-1 is a member of the
homeobox family of proteins and as such contains the helix-turn-helix homeobox motif
commonly seen in proteins associated with developmental regulation (Dressier &
Gruss, 1988). Its role has been characterised in connection with the control of the
albumin gene in the liver; the albumin gene, in common with CYP2E subfamily genes,
contains predicted binding sites for NF-Y and HNF-1, as well as C/EBP (Cereghini
et al., 1990). In a manner similar to that observed for CYP2E subfamily and in
common with a variety of P-450 genes the albumin gene is seen to become "extinct",
i.e. it is no longer transcriptionally active, in certain stable liver cell lines and notably in
poorly differentiated or de-differentiated liver cell lines. In de-differentiated liver cells,
although the albumen gene was transcriptionally inactive, a factor was still seen to bind
to the HNF-1 recognition site; this factor, termed vHNF-1 (variant), was shown to
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Figure 4.15: A comparison of the 5 ' region of the mouse Cyp2el (upper) and rat
CYP2E1 (lower) promoter regions. The sequences were aligned using the GCG Gap
alignment program and the gapped similarity between the two sequences is 85.53%.
The areas of the mouse sequence, and the corresponding rat sequence, predicted to
potentially encode transcription factor binding sites are boxed. The translation initiating
methionine codon of the two CYP2E subfamily transcripts is boxed and the
transcriptional initiation site of the rat CYP2E1 gene is arrowed. The three areas of the
rat gene, A, B, and C investigated by bandshift assays (Ueno & Gonzalez, 1990) are
underlined.The nature of the transcription factors potentially relevant to the control of
the CYP2E subfamily genes, their consensus binding sites, and the nature of the A, B
and C sequences are detailed in the text.
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bind the same site as HNF-1 but generate a higher mobility band in a bandshift assay.
cDNA clones for both HNF-1 and vHNF-1 have been obtained showing them to be
two distinct proteins, which nonetheless possess identical DNA recognition sites, and
both proteins were shown to be present in the adult liver (Bach et al., 1991). This
observation suggests that the higher mobility band produced on the HNF-1 recognition
site in the rat CYP2E1 gene by foetal rat liver extracts (Umeno & Gonzalez, 1990) may
relate to a developmental switch between vHNF-1 and HNF-1 in the initiation of
transcription from the CYP2E1 gene post-partum and not, as suggested, to a post-
translational modification of HNF-1 itself. Examples of pairs of transcription factors
with antagonistic actions similar to that observed for HNF-l/vHNF-1, are seen in the
development of tissue-specific gene expression. The transcription factors Oct-1, the
effective equivalent of the inactivating vHNF-1, and Oct-2, the effective equivalent of
the activating HNF-1, have been seen to control the development of certain
B-lymphocyte specific genes (Muller et al., 1988; Scholer et al., 1989).
It was seen that the more differentiated a cell line was, the higher the HNF-1: vHNF-1
ratio present; well differentiated rat liver cell lines cells such as HepG2 expressed both
proteins whereas poorly differentiated cells, such as the H5 line, expressed only
vHNF-1 (Cerighini et al., 1990). This observation emphasises the fact that the same
DNA site can be bound by different transcription factors producing entirely different
transcriptional results. This observation also suggests that the possible reason for the
extinction of P-450 and other genes may due to transcription factor de-differentiation
and loss in the cell lines; other transcription factors have be seen to be lost in cell lines,
such as C/EBP (Friedman etal., 1989).
AP-2 recognition site (Consensus: CCCA/CNG/cG/cG/c)- An AP-2 recognition site
was observed in a variety of genes including metallothionein IIA, collagenase, c-myc ,
growth hormone and pro-enkephalin and these recognition sites have been implicated
both in the developmental and adult control of gene expression (Winning et al., 1991).
The recognition site is bound by the AP-2 factor itself, as well as a variety of other
factors such as NF-1 (Cantois et al., 1990). An AP-2 recognition site has been seen to
be present in the cAMP responsive regions of many genes and all the genes it has been
noted in previously have been responsive to either phorbol ester or cAMP modifications
(Imagawa et al., 1987). In the human pro-enkephalin gene for example an AP-2 site
was seen 10 base-pairs downstream of two cAMP responsive elements and around 100
base-pairs upstream from the transcription start site; removal of the AP-2 site reduced
the cAMP inducibility of the gene suggesting that the factor binding the AP-2 site
interacts with the cAMP responsive factors to generate the response but may not itself
be directly responsible for the induction (Hyman et al., 1989). The cAMP responsive
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element motifs associated with the AP-2 site in the pro-encaphalin gene (CGTCA) were
used in a search of the Cyp2el gene; this revealed the possibility of two such elements
just proximal and distal to the potential AP-2 site and conserved in both the Cyp2el and
the rat CYP2E1 5' regions and annotated as ENK. in Figure 4.15.
The ability of AP-2 factor to interact with DNA has seen to be reduced by CpG
methylation (Coub & Goodman, 1990); both the rat (Umeno etal., 1988b) and human
(Jones et al., 1992) CYP2E1 genes have been shown to be methylated before birth and
this methylation may therefore be interfering with the ability of factors, potentially like
the AP-2 factor, to bind the promoter. The AP-2 factor is seen to interact with other
nuclear proteins such as the SV40 large T antigen,which prevent its interaction with
DNA (Mitchel etal., 1987); this binding of factors important in the generation of P-450
transcription by other transcription factors, either endogenously expressed as a result of
de-differentiation or related to the method of establishing the cell line, may play a part in
their extinction in tissue culture systems.
GATA recognition site (consensus: t/aGATAa/q): The GATA recognition sites are
bound by a family of transcription factors important in the development of cell specific
gene expression, and have been associated with the generation of tissue specific gene
transcription in lymphocytes (Ho et al., 1991), endothelial cells (Wilson et al., 1990),
testes (Ito et al., 1993) and the brain (Yammamoto et al., 1990). The potential presence
of such a site in the Cyp2el gene may relate to the widespread expression pattern of the
Cyp2el protein (Figure 4.3); expression of CYP2E1 protein in other species has also
be seen in diverse tissues such as the rabbit bone marrow (Schnier et al., 1989) and the
rat brain (Hansson et al., 1990).
NF-Y recognition site (consensus CTN6A/ga/gCCAATCANc/tg/t): NF-Y, or CP-2,
recognition sites are seen as a common component of both generally and tissue
specifically expressed genes. A variety of transcription factors recognise this site and
many factors, such as TF-1 or C/EBP, have been shown to bind it although only the
NF-Y protein itself to date was shown to have an absolute requirement for the NF-Y
site. An NF-Y factor cDNA has been isolated showing it to be highly homologous to
the yeast HAP transcription factor suggesting that these proteins play a highly
conserved general role in eucaryotic transcription (Hooft van Huijsduijen et al., 1990).
Factors binding to the TF-Y recognition site are unlikely to be the actual point at which
a gene may be regulated, but factors important in transcriptional regulation may exert
their action via NF-Y site factors. An example of this is seen in the human heat shock
gene hsc70 promoter which is regulated by the Ela transcription factor mediating its
actions through the CCAAT binding factor (Agoff etal., 1993).
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NFKp recognition site (consensus GGGAa/cTNt/cCC): The NFKp recognition site
provides one of the clearest examples of a single DNA region being bound by a series
of different transcription factors. The site is bound by members of the rel gene family,
which includes NFKp, v- and c- rel , and dorsal , as well as a variety of factors
unrelated to the rel family. NFKp itself is the best understood factor which binds this
element and is associated with the control of several classes of genes in the immune
system, acute phase and inflammatory processes although it has also been detected in a
wide series of non-immune related cells. The NFKp factor is composed of a
heterotetramer comprised of two DNA binding and two non-DNA binding proteins;
prior to activation this heterotetramer is held in an inactive complex in the cytoplasm by
a group of binding proteins. A variety of signals, including mitogens, cytokines,
oxidative stress and interleukins in the immune system and tumour necrosis factor and
phorbol esters in non-immune system cells, produce phosphorylation changes in this
latent complex leading to release of NFKp, nuclear localisation and DNA binding
(Meyer et al., 1993). The Drosophila development controlling factor dorsal is
controlled in a similar manner by its retaining factor termed cactus ; similar mechanisms
of control have been seen for the c- and v-rel proteins (Lewin et al., 1991).
Non-re/ related factors which will bind to NFKp sites include H2TF-1 (Baldwin
et al., 1987) and EBP-1 (Clark et al., 1991), both associated with the MHC enhancer
in the HeLa cell line, and KBF-1 (Israel et al., 1987), found in thyroid cell extracts.
MBP-1 a large protein recognising the NFKp was seen in HeLa, fibroblast, retinal and
the HepG2 liver cell lines. A partial cDNA clone showed that MBP-1 contained a
consensus Cys2- X12. His2 zinc finger motif; MBP-1 protein levels were seen to be
transcriptionally controlled and the message level was seen to be inducible by
phosphorylation (Baldwin et al., 1990). Zinc finger binding proteins are thought to be
very ancient and have been shown to be capable of binding both RNA and DNA
recognition sites (Dressier & Gruss, 1988).
NFKp recognition sites can effect transcription even if present downstream of the
transcript initiation site as has been seen in the case of the mouse c-myc gene where the
site is present within exon 1, 440 base-pairs downstream of the start site (Kessler,
etal., 1992).
The potential NFKp site in the CYP2E gene subfamily is both highly conserved and
close to consensus and, if bound by a zinc finger recognition protein, could either be
recognised within the mRNA or the DNA. The structure which contains the putative
NFKp site is has been discussed previously and is shown in Figure 5.7. The putative
NFKp site may function either in the control of the CYP2E subfamily gene transcription
or possibly effect the translatability of the CYP2E subfamily mRNA.
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Section 4.13.2: Implications of the factors which may interact with the Cyp2el gene
5' region
The computer-generated prediction of potential control elements in the Cyp2el
promoter suggests the presence of basic control elements such as a TATA and CCAAT
boxes, tissue specific regulatory sites such as the GATA and HNF-1 recognition sites,
and regulatable elements such as the AP-2, its associated cAMP elements, and the
NFKp recognition site. The substantial overall homology between the rat and the mouse
CYP2E subfamily 5' regions and the high level of conservation seen in the predicted
basal, inducible and tissue specific recognition sites suggests that both the basal and
regulatable control of the genes would be similar (figure 4.15). The only divergence in
the promoter region between the two genes is the presence of an element, termed region
B, at around -120 base-pairs in the rat gene absent in the mouse. This region was
however suggested to be unimportant in a transcription assay system (Umeno &
Gonzalez, 1990).
The basal elements of the Cyp2el gene are not unusual and may form the targets for the
mediation of the control effects of other proteins. The close proximity of the tissue
specific GATA and HNF-1 predicted sites suggests that possibly these elements may
play an overlapping or functionally redundant role in allowing the expression of the
gene in the variety of tissue types noted (Section 4.4). The predicted presence of
regulatable elements suggests that signalling systems may exert an effect on the
transcriptional activity of the Cyp2el gene. These sites may be responsive in the
pathological and physiological situations where the CYP2E subfamily transcript levels
are elevated and may potentially mediate their actions at both transcriptional and post-
transcriptional levels.
Clearly, with the exception of the HNF-1 and TF-Y sites which have been examined
experimentally (Umeno & Gonzalez, 1990), the predicted recognition sites in the
Cypel promoter are speculative and such sequence elements may have arisen by chance
(Mikkelsen, 1993) or may play no function in the regulation of the gene. However the
fact that these sites are conserved accross species may strengthen the argument for their
possible relevance but this can only be substantiated by further experimental analysis.
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Section 4.14: Cyp2el 5' promoter assays; an investigation into a role for insulin in
transcriptional control of the the CYP2E subfamily genes
Cyp2el mRNA levels rise in starvation (Section 4.5.2); rat CYP2E1 mRNA levels rise
in diabetes which could be regarded as an extreme form of starvation (Section 3.4.1).
Although initial suggestions related the elevation of the rat CYP2E1 mRNA in diabetes
suggested a role for a stabilisation event (Song etal., 1987) arguments presented here
suggest that both this event, and so by analogy the Cyp2el transcript level, could be
mediated transcriptionally (Section 3.7.3; Section 5.4.3).
The rat CYP2E1 gene was suggested to be transcriptionally repressed by the action of
growth hormone (Yamazoe et al., 1989a) and the fall in growth hormone levels was
suggested to be one reason to explain the CYP2E1 mRNA increase in diabetes. Cyp2el
transcription however appears unaffected by the levels of growth hormone (Hong
et al., 1990; Henderson et al., 1990); given the observed high level of homology
between the mouse and rat genes and the conserved response of the genes to starvation,
it seems unlikely that the actions of growth hormone alone would account for the
elevation of rat CYP2E1 mRNA but that a common inducing factor may be shared
between the CYP2E subfamily genes to produce the increases in mRNA levels. One
factor which may be the common effector in the CYP2E subfamily control is insulin;
insulin has been seen previously to affect the transcriptional activity of a variety of
genes involved in glycolysis and gluconeogenesis whose mRNA levels have been seen
to change in diabetes and starvation. Insulin was also suggested to be involved in the
stabilisation of rat CYP2E1 protein in transient tissue culture systems (Elliason et al.,
1990; Ingelman-Sundberg et al., 1991) and a possible rationale involving an
antagonism between the biochemical and hormonal regulation of CYP2E subfamily has
been suggested (Section 4.8). The possibility that insulin may be involved in the
stabilisation of the CYP2E subfamily protein per se also suggests that the hormone
may play a role in the control of transcription of the genes.
The demethylation and transcriptional activation of the CYP2E genes in the rat (Umeno
et al., 1987), human (Jones et al., 1992), rabbit (Bonftls et al., 1990), and potentially
mouse, may also relate to hormonal changes associated with the biochemical
modifications resulting in a mammal at birth. Prior to birth, mammals receive a high
carbohydrate and low fat diet from their mother via the placenta. At birth, however,
there is a dramatic switch to a high fat milk diet. Gluconeogenic processes are absent in
foetal rat livers with well-fed mothers but these processes can be induced by starvation
of the pregnant animal (Girard, 1986; Girard et al., 1987). However, gluconeogenesis
is only normally detected after birth and is associated with a rise in glucagon and a fall
in insulin resulting from the switch post partum leading to a transcriptional activation
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of gluconeogenesis (Lyonnet et al., 1988). Bearing in mind the proposed
gluconeogenic role of the CYP2E subfamily (Koop & Cassaza, 1986) it is possible that
the post partum switch in the diet, and its associated activation of gluconeogenesis,
initiates transcription from the CYP2E gene subfamily. What is not clear from this
suggestion is why the rabbit CYP2E1 gene, unlike the CYP2E2 gene, is only
maximally transcriptionally active 4 weeks after birth (Bonfils et al., 1990) but this may
reflect a redundancy of function of the CYP2E subfamily in this species following the
gene duplication event.
The nature of the actions of insulin, and some of the genes which it has been seen to
transcriptionally control, are discussed in relation to the assaying of potential control
mechanisms of insulin on CYP2E subfamily.
Section 4.14.1: The cellular response to insulin
In common with a variety of peptide hormones the first step in the action of insulin
involves an interaction with a specific receptor on the cell surface which triggers a
series of changes in the activities of the cellular signalling systems; these post-receptor
events are not yet fully understood. Insulin alters the phosphorylational state of many
intracellular proteins however the exact identity of the second messenger(s) which
mediate these changes is unknown. Insulin is seen to reduce the intracellular levels of
cAMP, and so cAMP-dependent protein kinase (PK-C) activity, through the activation
of membrane-associated phosphodiesterases and this event is thought to underlie a
number of its actions (Degerman et al., 1987). Insulin is seen to control metabolic
processes associated with the use and storage of glucose and the cessation of the release
and use of fatty acids as a fuel source; its actions for example lead to the
dephosphorylation of glycogen synthase leading to the activation of glycogen synthesis
and the dephosphorylation and activation of the mitochondrial pyruvate dehydrogenase
complex in adipocytes leading to increased Acetyl Co-A production and fatty-acid
storage (Thomas & Denton, 1986). The insulin response also leads to the appearance of
elevated levels of glucose transporter proteins on the surface of several responsive cell
types such as muscle and adipocytes, allowing an increased uptake and use of glucose;
these actions may be mediated through either a slowing of endocytosis or an
acceleration of exocytosis and increases in the levels of other receptors, such as
transferrin, have also been noted (James et al., 1988; Tarner & Lienhard, 1987). The
action of insulin also stimulates protein and DNA synthesis as well as cellular division.
The actions of insulin on genes controlling cellular division, such as c-fos , are thought
to relate to the increase in cell proliferation (Thomas et al., 1982; Stumpo et al., 1988).
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The actions of insulin are, however, not solely confined to the generation of
dephosphorylation on effector proteins. Through the intricate interactions of
phosphatases and kinases contributing to the insulin signalling pathway examples of
proteins becoming phosphorylated are also seen. An example of this is seen in the
activation of the membrane associated phosphodiesterases and the activation of
glycogen synthase phosphatase, in both these cases insulin mediates its actions by
decreasing levels of phosphorylation of these proteins (Czech et al., 1988; Lavionne
et al., 1991; Dent et al, 1990). The insulin receptor itself possesses an intracellular
tyrosine kinase subunit which is activated on insulin binding. The potential roles of
this kinase, other than mediating an autophosphorylational event, are unclear.
Autophosphorylation of the insulin receptor has been suggested to lead to the
generation of an active receptor which may then go on to generate another secondary
signal. One suggestion for the insulin second messenger is a membrane associated
glycosylated inositol phospholipid moiety which is released into the cell on activation of
an insulin responsive phospholipase-C and acts, in conjunction with the associated
diacylglycerol, in a similar manner to the release of phosphatidyl-inositol groups into
the cell in response to a variety of other signals (Saltiel & Cuatrecasas, 1986 Suzuki
et al., 1991).
By whatever secondary signalling mechanisms, insulin mediates both positive and
negative actions on the transcriptional activities of a variety of genes associated with
glycolysis and gluconeogenesis (Pilkis et al., 1988). Given the proposed endogenous
gluconeogenic role for the CYP2E subfamily it is this aspect of its actions that are
potentially of relevance in the transcriptional control of these genes.
Section 4.14.2: The transcriptional effects of insulin on gluconeogenic and
glycolytic gene transcripts
Insulin has been shown to play a key role in the reciprocal control of glycolysis and
gluconeogenesis, which it accelerates and represses respectively, and exerts some of its
actions on the associated genes transcriptionally. If the CYP2E subfamily has an
endogenous role in the gluconeogenic conversion of acetone (Koop & Cassaza, 1986;
Section 3.10.1) it may be expected that the gene may be regulated in a similar manner to
several other gluconeogenic enzymes and so potentially be repressed by the actions of
insulin. Studying the mechanism by which insulin exerts this effect on these
gluconeogenic genes may give an insight into a possible role for the hormone in the
changes seen to occur in the levels of the CYP2E subfamily in starvation and diabetes.
The transcription rates of the three key mammalian glycolytic enzymes, glucose kinase
(Sibrowski & Seitz, 1984), 6-fructose, 1 kinase (Gehnrich et al., 1984), and pyruvate
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kinase (Decaux et al., 1989) are seen to be elevated by the actions of insulin and
repressed by elevations in cAMP levels as a result of glucagon or adrenalin/epinephrine
actions. By contrast the transcript levels of the gluconeogenic enzymes phoshoenol-
pyruvate carboxykinase (PEPCK) (Sasaki et al., 1984) and fructose 1, 6
bisphosphatase (El-Maghrabi et al., 1988) are elevated in starvation and diabetes and
decreased by the addition of insulin. A message for the microsomal glucose 6
phosphatase, the third key gluconeogenic enzyme, has not yet been isolated and so the
effect of insulin on the transcript levels of this enzyme are unknown. The enzymatic
activity of glucose 6 phosphatase is seen to increase in starvation and diabetes (Nordlie
et al., 1968). The enzymatic activity of the bifunctional enzyme of the fructose 6
phosphate/ fructose 1, 6 bisphosphate cycle are seen to be increased by insulin and
decrease in diabetes and starvation although the message levels are unchanged
suggesting a role for regulated degradation or mRNA translatability (Colosia et al.,
1988; Crepin et al., 1988).
Higher levels of complexity involving other hormones and metabolites are seen in the
control of certain glycolytic/gluconeogenic enzymes. Pyruvate kinase, PEPCK and the
bifunctional enzyme are effected by glucocorticoids, so called for their ability to
promote gluconeogenesis; the levels of other components are however unchanged by
their actions (Sasaki et al., 1984; Decaux et al., 1989; Marker et al., 1989). As a
general theme in the control of gluconeogenic/glycolytic enzymes it is seen that the
negative actions of a signalling system are dominant over any opposing activational
signals (Granner & Pilkis, 1990) for example the repressive actions of insulin are
dominant over glucocorticoid positive actions in the control of PEPCK transcription
(Sasaki et al., 1984). The ambient levels of glucose present also appear to have a
permissive effect on changes in the level of the glycolytic enzymes produced by insulin
although gluconeogenic enzymes do not appear to be changed by this parameter
(Granner & Pilkis, 1990).
One of the enzymes studied in most detail is the gluconeogenic enzyme PEPCK and the
control of this enzyme, mediated via the antagonistic effects of cAMP and insulin, is
highly complex and executed on many levels. Only in the case of PEPCK has any
success been obtained in the analysis of promoter elements involved in the response of
gluconeogenic genes to insulin. The difficulty in analysis of the molecular basis for
transcriptional control of these processes by insulin relates to the difficulty in generating
repressive insulin responses, seen to occur in vivo , in tissue culture study systems
(Granner & Pilkis, 1990). The system used, and results obtained, in the study of the
gluconeogenic PEPCK enzyme are discussed; the observed changes in the levels of
PEPCK mRNA in starvation and diabetes are very similar to those seen in the CYP2E
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subfamily transcripts making the possibility of a similarity in control mechanisms a
possibility.
Figure 4.16: The key sites for the regulation of glycolysis and gluconeogenesis
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Section 4.14.3: Phosphoenolpyruvate carboxykinase (PEPCK): the transcriptional
repression by insulin of a gluconeogenic enzyme
Phosphoenolpyruvate carboxykinase (PEPCK) catalyses the conversion of oxaloacetic
acid to phosphoenolpyruvate, the flux generating step of gluconeogenesis (Figure
4.16). In tissue culture systems cAMP elevations and glucocorticoid actions were seen
to increase the levels of rat PEPCK transcripts, through the elevation of initiation,
elongation and stabilisation of pre-existing messages; glucocorticoids also increase the
translation rate of PEPCK mRNA and the culmination of these changes leads to an
elevation in gluconeogenesis. Insulin by contrast represses basal transcription of the
PEPCK gene and dominantly reverses the inductive effects of glucocorticoids and
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cAMP; the repressive actions of insulin are mimicked by phorbol esters and
diacylglycerol (Kahn etal., 1989).
The promoter of the rat PEPCK gene was analysed in promoter assay constructs in rat
H4IIE liver cell lines leading to the mapping of regions responsive to glucocorticoids
and cAMP. Insulin reproduced its dominant repressive effect on the glucocorticoid
induced PEPCK transcriptional elevation and a half-maximal value of 1 X 10"11 M for
insulin action was obtained in these studies which is similar to that observed in vivo
(Magnusson et al., 1987; Sasaki et al., 1986). Insulin decreased basal levels of PEPCK
transcription to between 14 and 22 % of control levels and produced a similar level of
repression on PEPCK transcription after it had been induced, around 2.5 fold, by the
synthetic glucocorticoid, dexamethasone. The prior induction of the PEPCK gene in
this manner enabled the repressive action of insulin to be more easily assessed
(Magnusson et al., 1987; Kahn etal., 1989).
The actual location of an insulin responsive element was difficult to determine using
promoter assays although it appeared to be present in the first 600 base-pairs of the
PEPCK gene. Attempts to further delineate the insulin responsive element by deletional
analysis of the promoter were not successful and it was concluded that the repressive
action of insulin may be mediated through chromatin structural modifications and so
could not be reproduced in the transient promoter assay systems. To investigate this
possibility -600 to +69 base-pairs of the PEPCK gene, and deletions of this construct,
were fused to a thymidine kinase gene and used to produce stable cell-lines. In this
manner it was hoped that the resulting chromatin arrangement around the promoter may
reflect more the in vivo structure. These studies highlighted two insulin response
elements (IREs) at -468 to -271 and -271 to +69 of the PEPCK gene. Maximal insulin
repression of PEPCK promoter activity was only seen if both elements were present
but the more distal element appeared to be the most powerful in isolation and was
further dissected in connection with transient promoter assays (O'Brien et al., 1990).
These studies delineated an insulin response region (IRE) between around -411 (TGG
TGT TTT GAC AAC) -396 which repressed transcription in transient assay systems
and this activity could be removed by site directed changes within this element. Gel
retardation analysis of this site generated a band shift using liver extracts from both
control and diabetic animals suggesting that insulin may mediate its actions via post-
translational modifications of a pre-bound factor (O'Brien et al., 1990). The IRE area
overlaps a site seen to be bound by accessory factors to the two glucocorticoid elements
suggesting that post-translational changes of the putative pre-bound IRE factor may
change its interaction with these elements (Imai et al., 1990). The more proximal IRE
area did not possess any sequence elements similar to its distal neighbour suggesting
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that the actions of insulin on transcription may be mediated by changes in a variety of
protein factors (O'Brien et al., 1990).
The transient assay approaches used to study the effect of insulin on the PEPCK
promoter activity were used in connection with the promoter analysis of the putatively
gluconeogenic Cyp2el gene promoter.
Section 4.14.4: Investigating the effect of insulin on the promoter activity of
the Cyp2el promoter; Cyp2el promoter-chloramphenicol acetyl-transferase (CAT)
constructs and the HepG2 cell line
Transient promoter assay experiments were performed using the Cyp2el promoter
fused to the Chloramphenicol acetyl-transferase (CAT) reporter gene. By analogy to the
PEPCK promoter analysis it would be expected that insulin might produce a repressive
effect on the level of the Cyp2el promoter activity if it too represented a gluconeogenic
enzyme controlled in a similar fashion. In whole animal studies Cyp2el protein was not
induced by the action of the synthetic glucocorticoid dexamethasone, or by many of the
other chemicals that have previously been seen to induce other P-450 levels and so the
potential repressive effect of insulin could not be more easily assessed by prior
induction of the promoter by another chemical (Section 4.3). The use of prior
transcriptional induction, which had greatly eased the study of the PEPCK promoter
(Magnusson et al., 1987), was therefore not available to the study of the Cyp2el gene.
The promoter region of the Cyp2el gene from -525 to -1 base-pairs was amplified
using the polymerase chain reaction (PCR) employing oligonucleotides which also
contained Xba I and Sal I restriction endonuclease sites. This portion of the Cyp2el
gene contains the predicted basal transcriptional regions of the promoter (TATA and
CCAAT boxes), the potential tissue specific regions (GATA and HNF-1 site), and the
potentially regulatable elements (AP2 site and flanking regions and the NFkP
recognition site). The PCR product generated was subcloned into the plasmid pBS,
sequenced confirming it to represent the expected area of the Cyp2el gene and then
directionally subcloned into the Xba I and Sal I restriction endonuclease sites of the
transient reporter plasmid pCAT-Basic (Promega). The oligonucleotides used to
generate this construct are shown in Figure 4.17.
The CAT reporter system allows the analysis of DNA fragments with promoter and
enhancer activity in transient transfection assays in mammalian tissue culture. The
transcriptional activity of the region of the gene being assessed is reflected by the level
ofCAT transcripts and protein produced in the assay system. CAT is a bacterial protein
which confers resistance to chloramphenicol by modifying it to mono- or di- acetylated
forms, an enzymatic activity not endogenously present in the mammalian tissue culture
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systems employed in the assay; the acetylated forms of chloramphenicol possess
differing solubilities and so can be separated and quantified. The level of CAT
enzymatic activity produced as a result of heterologous expression driven by the test
DNA fragment in mammalian cells is then assayed by the level of chloramphenicol
modification produced; the level of activity obtained indirectly reflects the level of the
transcriptional activity of the test DNA fragment (Gorman et al., 1982).
Initial transient transfections of the Cyp2el promoter CAT construct were carried out
in both the Hepa I liver (Bernhard et al., 1973) and C3HIOTI/2 embryo (Rezinikoff
et al., 1973) mouse cell lines; also included in these transfections was a control
plasmid, pCAT-Control, containing an SV40 promoter region upstream of the CAT
gene, and a construct containing a portion of the human CYP2D6 gene promoter
(encoding bases -297 to +69, kind gift of Dr C. A. D. Smith, ICRF MPG, Edinburgh).
No CAT activity was detected as a result of transient transfection of any of these
constructs in either of these mouse cell lines. Transfections were then carried out in the
human liver HepG2 cell line; given the high level of homology between the rat, human
and mouse promoters potentially important control factors, both basal and regulatory,
would be expected to be conserved between these two species and so would be
expected to be operational in the mouse promoter.
The HepG2 liver cell line was derived from a hepatocarcinoma, is parenchymal in
morphology and was seen to be highly differentiated expressing all but one of twenty
liver antigens screened for many of which, such as albumen, insulin-like growth factor
receptor and the 0C2-plasmin inhibitor, were seen to be extinct in less well differentiated
lines (Aden et al., 1979; Zannis et al., 1981; Knowles et al., 1980). Studies revealed
that the HepG2 cell line contained a high ratio ofHNF-l:vHNF-l transcription factors,
again suggesting that it retained a differentiated state (Cerighini et al., 1990). The
HepG2 cell line was also been shown to retain some residual P-450 enzymatic activity
which was seen to be modified by phenobarbital and 3-methyl-cholanthrene suggesting
that the HepG2 cell line retains components required for P-450 enzyme induction
(Dawson et al., 1985). However no aniline hydroxylase, an enzymatic activity
associated with the CYP2E subfamily, was seen in this cell line (Grant et al., 1988;
Sassa et al., 1987). The Hep G2 cells have previously been seen to be responsive to
insulin, for example, on treatment with insulin they were seen to demonstrate an
increase in insulin receptor proteins and transcripts (Hutad et al., 1989).
These observations, particularly the retention of HNF-1 with its proposed interaction
with the CYP2E subfamily promoter and their ability to respond to insulin, made the
HepG2 a good candidate cell line in which to study the potential control of Cyp2el
transcription by insulin. The Cyp2el-CAT construct, control CAT construct and
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CYP2D6-CAT constructs all produced CAT responses on transfection into the HepG2
cell line.
Section 4.14.5: Insulin responsiveness of the HepG2 cell line and the effect of
insulin on Cyp2el promoter activity
The HepG2 cell line is routinely cultured in 15% (volume: volume) foetal calf serum
(FCS); in an attempt to reduce the possible effects of other serum factors present in the
HepG2 culture medium other groups of HepG2 cells were permanently grown in 10%
and 5% FCS. In previous experiments analysing the PEPCK promoter the rat H4IIE
cells were maintained in 2.5% each of new born and fetal calf serum (Magnusson et al.,
1987). In other experiments using the Hep3B human line, which were generated
concomitantly with HepG2 line (Aden et al., 1979), the cell lines were serum-starved
for 6 days prior to transfection in 10% FCS (Chou et al., 1989). Attempts to transform
the Cyp2el-CAT and other constructs into similarly starved HepG2 cells were not
successful and so this approach was not pursued. The insulin responsiveness of the
HepG2 cells was assayed haemocytometrically via the increase in cell proliferation on
two equally seeded culture plates in the presence of insulin compared to control cells,
and as a function of protein synthesis/proliferation, through the assaying of the protein
amounts present in two equal volumes of cells grown in the presence or absence of
insulin. Insulin addition had previously been seen to elevate both these parameters in
the related Hep3B cell line (Chou et al., 1989; Thomas et al., 1982) and both of these
parameters were seen to be elevated as a result of insulin addition to the HepG2 culture
medium indicating that an insulin response was occurring.
The maximal concentration employed in the study of insulin suppression of the basal
and dexamethasone-induced PEPCK transcription was 1 X 10"7 M insulin (Magnusson
et al., 1987) and this insulin concentration was used to study the potential repressive
effect of insulin on the Cyp2el-CAT construct. HepG2 cells were transfected with
Cyp2el-CAT, pCAT-Basic (the parental vector of Cyp2el-CAT without the Cyp2el 5'
region), pCAT control, and CYP2D6-CAT constructs in 5% or 10% FCS in the
presence or absence of 1 X 10"7M insulin. The medium containing the transfected DNA
was left on the cells overnight and then replaced with medium containing the
appropriate FCS and insulin concentration and the cells were left for another day to
allow CAT expression before harvesting. The protein concentrations of the various
samples were normalised, as the cultures containing insulin had increased cell and
protein concentrations as a result of insulin's actions, and the level of CAT activity
present in an equal protein aliquot of each transfection experiment was assessed (Figure
4.17).
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Figure 4.17: Investigating the effect of insulin addition on the transcriptional activity
of the Cyp2el 5 ' region using a chloramphenicol acetyl transferase (CAT) assay
system. Hep G2 cells were transfected with: pCATc: control CAT vector. pCAT2e:
pCAT basic (b) vector containing the -525 to -1 region of the Cyp2el gene. 2D6:
pCAtb containing the the -297 to +69 region of the human CYP2D6 gene. B: pCATb
alone. Cells were transfected in the annotated conditions: 10% /5%: the amount (v/v)
of fetal calf serum present. + /- : in the presence or absence of 1 X 10~7 M insulin.
Samples in the upper box were normalised for protein content befor assaying; samples
in the lower box were assayed as equal volumes of cell lysate indicating the inductive
effect which the presence of insulin has on the level of CAT protein present in the
samples.
Oligonucleotide sequences used to generate the 5 1 region of the Cyp2el gene:
Xba I
-1 to -16 of the Cyp2e 1 gene: TCGTAGA AGTGCCGATGGGGCTCC
Sal I
-532 to -516 of the Cyp2el gene: GGTCGAC AAGTGAGATTCCTGTTC
1 90
Although an insulin response was recorded in all the cultures to which insulin had been
added by virtue of an increase in total cellular protein there was no unequivocal
difference in the levels of transcriptional activity of the Cyp2el promoter in the
presence or absence of insulin; these experiments were repeated in duplicate three
times. The level of CAT activity produced by transient transfection, both with
normalised and non-normalised protein levels to illustrate the inductive effect of insulin
on both the level of cell proliferation and protein synthesis, are shown in Figure 4.17.
Section 4.14.6: The Cyp2el gene, a putative gluconeogenic enzyme displaying no
detectable repression of basal transcription by insulin
The observed in vivo control operating on the Cyp2el transcript levels in starvation
(Section 4.5) and the proposed endogenous gluconeogenic role for the CYP2E
subfamily (Koop & Cassaza, 1986) had led to the suggestion that, by analogy to other
gluconeogenic enzymes, insulin may repress basal transcriptional activity in this
subfamily. However such an effect was not seen in the reporter system employed in
conjunction with 525 base-pairs of the Cyp2el gene; this observation may be accounted
for in part by a variety of reasons.
One possibility is that the CYP2E subfamily genes are not insulin responsive; in this
instance then other common factor(s) must be responsible for the inductive patterns
seen in this group of genes in starvation and diabetes. A variety of technical reasons in
the assaying of insulin responsiveness in a gene means that this is by no means the only
explanation.
In assaying the suppressive action of insulin on the PEPCK gene the effect was more
easily seen only following prior induction of transcription with dexamethasone; this
prior induction allowed an easier interpretation of the fall in transcriptional activity
induced by insulin (Magnusson et al., 1987). This initial augmentation of the
transcription rate is not available in the study of the Cyp2el gene as neither
dexamethasone nor a variety of other P-450 inducing chemicals produced any effect on
Cyp2el levels (Section 4.4). As can be seen by the comparison of Cyp2el-CAT
constructs activity relative to that of the pCAT-Control a decrease in activity by the
action of insulin was being sought on the background of an already fairly low
transcriptional rate (Figure 4.17). The human CYP2E1 gene promoter (-539 to +8
base-pairs) was analysed in a luciferase reporter system where similarly its activity was
seen to be very low with the control vector, a Rous Sarcoma virus long terminal repeat,
being 100-fold more powerful in a rat hepatoma cell line (Umeno et al., 1988). It is
difficult to conceive of a way of augmenting the Cyp2el basal transcription rate given
the lack of responsiveness of the gene to chemical inducers. The Cyp2el gene was seen
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to be transcriptionally activated by the indirect action of androgens in the female mouse
kidney but this effect took 8 days to occur making it an unlikely candidate for study in
primary renal lines and this control is potentially unique to the kidney (Henderson
et al., 1990; Hong et al., 1990). However attempts to mimic the effects of glucagon or
adrenalin/epinephrine via the elevation of intra-cellular cAMP levels and studying their
effects on the basal activity of the Cyp2el gene would be of interest; by continuing the
gluconeogenic analogy for CYP2E subfamily, such an elevation of cAMP might be
expected to induce the transcriptional activity of the gene. It is clear that this is not seen
in dexamethasone administration however (Section 4.4.1)
It is possible that the HepG2 cell line retains enough of a differentiated phenotype to
allow basal transcription of the Cyp2el-CAT construct by CCAAT, TATA and HNF-1
binding factor activity but other proposed inducible factors, such as the AP2 and NFKp
recognition site binding factors may be lost. It may be the factors which bind these sites
which are important for the mediation of the repressive actions of insulin. The lack of
aniline hydroxylase activity in the HepG2 cell line (Sassa et al., 1987) suggests that the
endogenous CYP2E1 gene may have become extinct; such an extinction may have
occurred as a result of the loss of certain protein factors needed to keep the gene active
(Section 4.13.2). Studies on the PEPCK promoter in tissue culture demonstrated that
the co-expression of nuclear factors associated with the regulation of the promoter
increased the levels of activity obtained suggesting that the presence of key response
factors may be necessary to allow an insulin response to be generated (Roesler et al.,
1989).
The lack of response may relate to the loss involved in the generation of the insulin
signal rather than the transcription factors themselves. Cell lines such as HeLa, which
were seen to contain the cAMP response factors CREB and ATF-1, still did not
generate a PEPCK response on glucocorticoid stimulation and this observation was
suggested to relate to a breakdown in certain signalling components normally
responsible for the transduction of the insulin response (Roesler et al., 1993).
Several other studies of the effect of insulin on PEPCK transcription could not
reproduce its suppressive effect even in cell lines closely related to H4IIE. These
observations suggest that loss of a specific factor in dedifferentiation may produce
profound effects on the results obtained between cell lines (Wynshaw-Boris et al.,
1986). Attempts to study the inductive of insulin on transcription from the glucose-
kinase promoter, which is elevated by insulin in vivo , proved unsuccessful in vitro
due to the lack of a cell line that would reproduce this effect (Garner & Pilkis, 1990).
These observations, in conjunction with the observed heterogeniety of the factors
binding to IREs in the PEPCK gene (O'Brien et al., 1990), suggest that an insulin
response can be lost in a tissue culture system as a result of the loss, through
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extinction, of one or more of a variety of cellular signalling components. It is only
through the use of a wide range of cell lines that the lack of a Cyp2el-CAT insulin
response reflected the lack of a factor in the tissue culture system could be addressed.
Alternatively the HepG2 cell line could be transfected with constructs containing the
characterised PEPCK IRE to establish the intactness of an insulin to transcription factor
signalling link (O'Brien et al., 1990); this would however presume that the same
signalling pathways would be operative on the Cyp2el promoter which clearly may not
be the case.
The lack ofCyp2el-CAT response to insulin may also be due to a lack of inclusion of
an IRE(s) in the promoter construct and may require sequences more distal to the
initiation site than those included. However to date the observed IREs have been shown
to be within the size constraints of the promoter used in these studies with the
repressive elements for PEPCK being seen around -411 and -278 and the inductive
elements of fructose 1, 6 bisphosphatase around -169 (El-Maghrabi et al., 1988). The
inclusion of a larger Cyp2el promoter fragment may address this possibility.
The exploitation of the observation that the CYP2E genes in rabbit (Bonfils et al.,
1990), rat (Umeno et al., 1987), human (Jones, et al., 1992) and potentially mouse are
not transcriptionally active prior to birth may allow the possibility in vivo of
successfully assaying the proposed repressive action of insulin on these genes.
Gluconeogenic processes are not present in normal rat liver prior to birth but are
activated postpartum , possibly as a result of a switch in diet from carbohydrates to fats
(milk) and the associated fall and rise in insulin and glucagon levels respectively
(Lyonett et al., 1988). It was seen however that gluconeogenesis could be induced
in utero by starving the pregnant mother (Girard, 1977; Girard et al., 1986). If the
CYP2E subfamily genes are controlled by similar processes that are seen to affect
gluconeogenic enzymes it would be expected that starvation of the pregnant female
would lead to induction of the CYP2E subfamily genes prior to birth. Such
observations have been made for the embryonic chemical induction of a variety of
P-450 genes including rat CYP1A1 by 3-methyl cholanthrene (Young et al., 1989), and
this approach may provide firmer evidence to substantiate a role for insulin in the
transcriptional regulation of CYP2E subfamily although it would not directly prove it in
a manner that a promoter assay system could.
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Section 4.15: Summary
The observation that the mouse Cyp2el subfamily is seen to be regulated in a similar
manner to the CYP2E subfamily in a variety of other species has several implications.
The fact that acetone leads to an elevation ofCyp2el protein levels, in the absence of a
concomitant increase in Cyp2el mRNA levels, suggests that a protein stabilisation
event is a common theme in the regulation of this subfamily. This regulation may be
mediated through the ability of certain solvents to mimic the actions of acetone, which
is the proposed endogenous substrate of the CYP2E subfamily. The observation that
Cyp2el mRNA levels are elevated in starvation questions further the proposed role of a
message stabilisation event in the induction of the CYP2E subfamily in diabetes and
starvation (Song et al., 1987). The fact that the 3' UTR of the Cyp2el mRNA is seen
to be ablated by insertion of a (32 element, necessitates that a stabilisation event, if it
were to occur at all, were to mediated either by the residual UTR features of the Cyp2el
mRNA or by the coding region of the transcript itself.
The molecular mechanism for the induction of the CYP2E subfamily by substrates is
unclear. One proposal suggested a role for phosphorylation of serine 129 in controlling
the rate of degradation of of the CYP2E subfamily proteins. Protein stabilisation was
suggested to be mediated by events leading to a reduction of this serine 129
phosphorylation; events generating reduced levels of phosphorylation were suggested
to include the presence of a substrate or insulin, with its associated decrease in cAMP
levels. By contrast the rate of the CYP2E subfamily protein degradation was suggested
to accelerated by the elevation of intracellular cAMP by agents such as glucagon and
epinephrine (Ingelman-Sundberg et al., 1992). This proposed control mechanism was
investigated through the generation ofCyp2el mutants lacking the proposed controlling
serine 129 site. The results obtained from the analysis of the accumulation and point of
loss of Cyp2el proteins with or without the proposed degradation controlling serine
129 did not substantiate these suggestions. Mutant Cyp2el proteins, lacking a
phosphorylatable residue at position 129, were not seen to accumulate, or be retained
for a longer period, when expressed in mammalian tissue culture. Treating the cells
expressing the Cyp2el proteins with insulin generated an elevation in both mutant and
native protein levels suggesting that the proposed effect of insulin either relates to its
global effect on the level of protein translation in general, or is mediated at a site other
than serine 129. Collectively these observations suggest either that the actions of the
substrate in stabilising the CYP2E subfamily are not mediated by changes in
phosphorylation at serine 129, or that the components necessary to allow this control
processes to operates in vivo are not present in the tissue culture system used.
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Analysis of the promoter of the Cyp2el gene, in conjunction with the rat CYP2E1
gene, highlighted the possible presence of a variety of basal, tissue specific and
regulatable elements which may possibly contribute to the transcriptional regulation of
the CYP2E subfamily. One interesting observation was the possible presence of an
NFKp recognition site present in both the promoter and the transcript. This site could
affect both transcription and translation of the CYP2E genes and this observation may
explain some of the anomalies attached to the regulation of the CYP2E subfamily. For
example, CYP2E1 protein levels are elevated in rats following exposure to hyperbaric
oxygen (Tindberg & Ingelman-Sundberg, 1989) and the translation of CYP2E1 mRNA
in rats increases following solvent exposure (Kim & Novak, 1990; Kim et al., 1990).
Factors binding to NF,^ recognition sites have been seen to be responsive to oxidative
stress and elevate transcription from responsive genes in these situations (Meyer et al.,
1993); the possible interaction of a protein factor with the CYP2E subfamily transcripts
may allow a control step in the regulation of the subfamily to be placed at translation.
The observed similarity of the regulation of the CYP2E subfamily and several
gluconeogenic enzymes, in conjunction with the proposed gluconeogenic role for this
subfamily (Koop & Cassaza, 1986), prompted an analysis of the potential repressive
action of insulin on the transcriptional activity of the Cyp2el promoter. The presence of
insulin however did not modify the basal level of Cyp2el transcription; the limitations
present in this assay system, particularly relating to the inability to generate a prior
induction of Cyp2el transcriptional activity, mean that a role for insulin in the control
of transcription in the CYP2E subfamily can not however be firmly ruled out.
Collectively these observations suggest that the regulation of the CYP2E subfamily is
conserved between species suggesting that situations in which the levels of the CYP2E
subfamily are elevated in experimental animals, resulting in a concomitant increase in
the potentially damaging metabolic activities associated this subfamily, could relate
directly to the control of the subfamily in man. The details of the molecular mechanisms
by which the controls of the CYP2E subfamily are executed however remain occult.
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Chapter 5: Molecular Characterisation and Analysis of the mouse Cyp2el subfamily
Section 5.1: Introduction and Aims
To enable a study of the regulation of mouse the Cyp2e subfamily and to ascertain the
level of homology, and so potentially the level of functional conservation, a mouse
Cyp2el cDNA was cloned. cDNA sequences had previously been obtained of CYP2E1
from human, rat (Song et al., 1986) and rabbit (Khani et al., 1986) and CYP2E2 from
rabbit (Khani et al., 1987). The Cyp2el cDNA was used to generate heterologous
expression of Cyp2el protein in E. coli, S. typhimurium and S. cerevisiae in an
attempt to enable the characterisation of the potential role of the CYP2E subfamily in the
generation of mutagenicity following exposure of the organism to chemicals such as
nitrosamines. The Cyp2el cDNA was also used to clone and characterise the Cyp2el
gene, portions of which were sequenced. The 3' portion of the Cyp2el gene was used
in the generation of a construct to allow targeting and deletion of the Cyp2el gene from
the genome of the mouse. Using the combination of these approaches both the level of
homology in the CYP2E family and its potential role in carcinogenesis could be
studied.
Section 5.2: Cloning a mouse Cyp2el cDNA
A full-length human CYP2E1 cDNA (Song etal., 1986; Kind gift Dr F. J. Gonzalez,
NCI, Bethesda) was radiolabeled and used as a probe to screen an adult male C57BL/6
mouse liver cDNA library contained within a bacteriophage Xgtl 1 vector (Clontech,
Palo Alto, CA.).The library and host cells were titrated to enable the use of a host cell:
phage ratio allowing single plaques to be isolated from the library plates. Phage
obtained from two plaques cross-reacting to the human CYP2E1 cDNA probe on
duplicate lifts of the plated library were purified by further rounds of screening until
they contained single pure clonal phage (i.e. they were made "plaque pure"). Fourteen
other plaques, isolated through their cross-reactivity to the human CYP2E1 probe, were
also obtained but were not processed through these further rounds of screening. Phage
DNA was prepared from the two plaque pure clones and the recombinant cDNA insert
released on restriction endonuclease digestion with EcoR I. The clones contained
independent inserts of around 600 and 800 base pairs respectively. These fragments
were isolated and subcloned into the EcoR I restriction endonuclease site of the plasmid
vector pUC18 and then the replicative form of the filamentous bacteriophage-based
vector M13mpl8 and 19. Single-stranded DNA was prepared from the recombinant
insert containing M13mpl8 and 19 and sequenced. The clones did not encode a
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full-length Cyp2el cDNA. The 600 base pair insert spanned from within exon 6 to
exon 9 (base-pairs 922 to 1545 on the full-length mouse cDNA clone) and the 800 base
pair insert spanned from within exon 5 to within exon 9 (base-pairs 720 to 1458 on the
full-length mouse cDNA clone) by comparison with the rat CYP2E1 sequence (Song
et al., 1986). In an attempt to obtain a full-length Cyp2el cDNA clone the insert sizes
in the remaining fourteen primary positives were further analysed. These clones were
screened until plaque pure and then their insert sizes assessed. Using oligonucleotides
which hybridise to sequences within the left and right arms of Agtll in conjunction
with the polymerase chain reaction (PCR) with an aliquot taken from the plaque pure
Agtl 1 clone-stock as a template, the insert sizes could be quickly assessed. The results
from this analysis indicated that all the inserts appear to be further copies of either the
600 or 800 base pair fragments originally isolated (Figure 5). This observation
suggests that the commercially produced cDNA library has been heavily amplified and
is unlikely to contain a full-length mouse Cyp2el cDNA.
Section 5.2.1: Generation of a BALB/c liver cDNA library in AZAPII
In order to obtain a full-length Cyp2el cDNA clone a cDNA library was constructed
from purified poly-(A)+ RNA isolated from total RNA prepared from an adult male
BALB/c mouse liver. The cDNA prepared from the poly-(A)+ RNA was passed
through a size selecting spun-column to allow the removal of cDNA fragments of less
than 400 base-pairs, thus reducing the potential background level of partial Cyp2el
cDNA inserts. The size selected cDNA was then ligated into EcoR I/Not I adaptors: this
allows the cDNA inserts to be removed from the vector using Notl restriction
endonuclease which has a rare recognition site unlikely to occur in the cDNA itself. The
size selected and Not U EcoR I adapted cDNAs were then cloned into pre-digested
AZAPII arms and packaged. The library and host cells were titrated to enable the use of
a host celkphage ratio allowing single plaques to be isolated and the library was
screened using the 800 base-pair partial Cyp2el cDNA as a radiolabelled probe. Two
plaques which cross-reacted with the probe in a duplicate lift of the plated library were
passed through further rounds of screening until plaque pure. Unlike the Cyp2el
clones obtained in Agtll the AZAP II clones did not require preparation of
bacteriophage DNA, restriction endonuclease digestion and subsequent subcloning into
a plasmid or phagemid vector. AZAP II enables the recombinant insert to be excised
in vivo from the bacteriophage arms. The phage arms of this vector contain a divided
filamentous bacteriophage fl origin of replication with the initiation and termination
functions of the origin dissected and subcloned facing each other with one functional
half in each bacteriophage arm. By super-infecting the host cells containing the AZAP II
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Figure 5: PCR analysis of the recombinant inserts contained within the 14 mouse
cDNA Xgtl 1 clones which hybridised with a probe generated from the human CYP2E1
cDNA. The 14 (1 to 14) mouse cDNA clones which hybridised with a probe generated
from the human CYP2E1 cDNA were analysed for the possibility that they contained
larger, or independent, inserts than those already obtained (Section 5.2).
Oligonucleotides annealing to sequences within the A,gtl 1 arms were used to amplify
the recombinant insert present within the clones and the products of this reaction were





clones with filamentous fl bacteriophage, or "helper phage", proteins are produced,
termed "helper proteins", which recognise the fl sequences within the A.ZAP II arms
and nick the DNA at the initiation sequence. DNA synthesis then begins at the nicked
initiation site; as this site has been placed upstream of the recombinant insert then both
the insert and another sequence, the pBS SK(-) phagemid vector, also placed down¬
stream of the fl initiation site are replicated before the downstream termination site is
reached. The single-stranded DNA produced in this manner is circularised, leading to
the regeneration of a function fl replication origin, and packaged into phagemid
particles by other proteins encoded by the super-infecting fl phage DNA. By isolating
and reinfecting other host cells with these phage particles, double-stranded pBS SK(-)
plasmid containing the recombinant insert can be obtained. Preparation and Notl
restriction endonuclease digestion of the two recombinant double-stranded Cyp2el
clones following in vivo excision generated two inserts of around 1,800 base-pairs.
Single-stranded DNA was prepared from one of these clones and sequenced. The
Cyp2el cDNA insert was subcloned into the Xbal and Hindlll restriction
endonuclease sites of the plagemid vector pTZ18R and 19R, which have reversed
polylinker sites, and single-stranded phagemid DNA prepared and sequenced. The
DNA sequence, predicted amino acid sequence, sequencing strategy, and restriction
endonuclease sites relevant to further experiments involving the Cyp2el cDNA are
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jvTO** eProPhePheGlyAsnlXe heGlnLeu spLeuL-ysA Ile roLysSerLe ThrLy Wo190210230̂81qgttggcaaagcgcttcgggccagtgttcacactgcacctgggtcagaggcgcatcgtggt2QsLeuA1aysArgPheGlyProVa1PheThrLeuHisLeuGlyGInAr Arg11eVa1Va 3Ẑ>25070290 ZJ-cctgcatggctacaaggctgtcaaggaggcgctactgaaccacaagaatgagttctctggTOGlLeuHisGlyTyrLysAlaValLysGluValLeuLeuAsnHisLysAsnGluPheSerGl G. 3103303506J 3 Cl.-iccgaggggacattcctgtgttccaggagtacaagaacaaggggattattttcaataatgg <-t-yArgGlyAspIleProValPheGlnGluTyrLysAsnLysGlylleXlePheAsnAsnGl 3to' Sft37939943" —q_acccacatggaaggacgtgcggaggttttccctaagtatcctccgtgactggggaatggg
tOMyProThrTrpLysAspValArgArgPheSerLeuSerlleLeuArgAspTrpGlyMecGlOQ.3 o =3'4304504705>,§gaaacagggtaatgaggcccgcatccaaagagaggcacaccccccg tgg ag tcaa5 «,yLysGlnGlyAsnGluAlaArglleGlnArgGluAlaHisPheLeuValGluGluLeuLyTO 5:qJ490510530 ftaaagaccaaaggccagccttttgaccctacctttctgattggccgtgcaccctgcaatgt q0sLysThrLysGlyGlnProPheAspProThrPheLeuIleGlyCysAlaProCysAsnVa o"S on55057090̂ 3cattgcggatattctcttcaacaaacgtttcgattacgatgacaagaagtgtctggagctTO1IleAlaAspIleLeuPheAsnLysArgPheAspTyrAspAspLysLysCysLeuGluLe TO gfS,610630650 gt3̂catgagttt ttcaatgaaaacttctacctgctgagtactccctggatccaggcttacaaTO87" uMetSerLeuPheAsnGluAsnPheTyrLeuLeuSerThrProTrpIleGlnAlaTyrAs 2o67069010 ttacttttcggattatctacaatatctacctggaagccacagaaaagtcatgaaaaatgt t/)73nTyrPheSerAspTyrLeuGlnTyrLeuProGlySerHisArgLysValMetLysAsnVa3*TO "O730750770 OiSgtctgaaataagacagtacacacttggaaaagccaaggaacaccttaagtcactggacatlSerGluIleArgGlnTyrThrLeuGlyLysAlaLysGluHisLeuLysSerLeuAspIl 83TO3r-790810830 caactgcccccgggatgtgactgactgtctcctcatagagatggagaaggaaaaacacag eAsnCysProArgAspValThrAspCysLeuLeuIleGluMetGluLysGluLysHisSe






Figure 5.1b: The sequencing strategy and oligonucleotides employed to characterise
the 600bp (A), 800bp (B) and full-length (C) Cyp2el cDNA clones, and the relative
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Figure 5.2: The restriction endonuclease sites present in the Cyp2el cDNA and the
polylinker region of the pBS SK II (-) phagemid. A: The restriction endonuclease
sites present in the polylinker region of the pBS SK II (-) phagemid and the presence of
those sites in the Cyp2el cDNA indicating the sites available for cloning strategies.
Also present are the restriction endonuclease sites used to orientate the Cyp2el cDNA
when non-directionally cloned. B: The restriction endonuclease sites used to orientate
the Cyp2el cDNA when non-directionally cloned displayed in isolation of the
polylinker sites.
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Section 5.2.2: The mouse Cyp2el cDNA
On sequencing a Cyp2el cDNA insert obtained from the A.ZAP II library, it was
confirmed that the clone contained the complete coding sequence (Figure 5.1a). The
Cyp2el cDNA encoded a protein with 493 amino-acid residues and a Mrof 56,781.
The mouse cDNA displayed a very high level of homology to the CYP2E cDNA
sequences obtained from other species suggesting that the function and reactions
catalysed by this group of proteins may be highly conserved (Table 5.1).
Table 5.1: The level of sequence homology between the mouse Cyp2el cDNA and
predicted amino acid sequence and the CYP2E subfamily members characterised in
other species. The sequences were aligned using the GCG package Best program
(Devereux et al., 1984).
Percentage identity
Species Coding region Total sequence Predicted Amino-acid Reference
Human 79% 75% 77% Song et al., 1986
Rabbit 1 80% 75% 79% Khanieta/., 1988
Rabbit 2 79% 74% 79% Khani et al., 1988
Rat 92% 88% 92% Song et al., 1986
Section 5.2.3: Analysis of the distribution of amino-acid changes between the mouse
Cyp2el predicted amino acid sequence and those of other members of the CYP2E
subfamily
The level of amino-acid homology, or orthology (implying that the similarity seen is
evolutionarily related), can be displayed using dot-matrices using generated by a
computer program (Genejockey, Biosoft). The amino-acid residues of the two
sequences to be compared are written as rows on two axes and a dot is generated on the
matrix where the residues are coincident as well as randomly present throughout the
other sequence. Using this approach to compare the two rabbit, human and rat CYP2E
predicted amino-acid sequences with the mouse Cyp2el sequence it can be seen that not
only are the sequences highly related, generating a near perfect diagonal amino-acid
coincidence, but that the differences that occur between the sequences are scattered
throughout the length of the protein. This suggests that the CYP2E subfamily will
probably possess highly conserved behaviour as no significant coincidental areas of
sequence dissimilarity are present between them (Figure 5.3).
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Figure 5.3: The distribution of amino acid changes across the length of the mouse,
rat and human CYP2E subfamily protein sequences. In each instance the protein
sequences are aligned using the GeneJockey (Biosoft) package and the coincidence of
an amino acid residue marked as a point on the matrix. A: A comparison of the mouse
and rat CYP2E subfamily sequences. B: A comparison of the mouse and human
CYP2E subfamily sequences. C: A comparison of the mouse Cyp2el and rabbit
CYP2C5 aminio acid sequences (See Figure 5.5).
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Section 5.3: Predicting structural and substrate binding features of Cyp2el and the
CYP2E subfamily
Cytochrome P-450 are ubiquitous in nature and catalyse reactions with the common
theme of the insertion of molecular oxygen into a hydrophobic substrate; they possess
however a massive variety of substrates which they can metabolise dependent on the
particular isoform of the P-450 concerned. Arguably therefore the evolution of P-450
will maintain a tertiary structure which contains the components and features which
allow the common-theme reaction to proceed but may modify those residues involved
in the substrate interactions of a particular isoform to facilitate the metabolism of the
wide variety of chemicals metabolised. If this is the case, the comparison of the
predicted amino-acid sequence of Cyp2el, in conjunction with the highly conserved
predicted amino-acid sequences of CYP2E subfamily from other species, to a P-450
with a known tertiary structure, may allow the prediction of regions within the CYP2E
subfamily proteins which may play a role both in the generation of tertiary structure and
substrate interaction.
The tertiary structure for the bacterial P-450 CYP101 (P-450 CAM) has been resolved
and this could form the basis for this analysis. Bacterial P-450 are soluble, unlike the
corresponding proteins in eucaryotic cells which are membrane bound; the premise that
the overall structure however will be similar in order to maintain the general function
may apply and it has been suggested that both soluble and membrane bound P-450
possess overall similar tertiary folding patterns (Zvelebil et al., 1991; Laughton et al.,
1990). The N-terminal hydrophobic region found in eucaryotic P-450 may solely
account for the differences in the solubility of eucaryotic and procaryotic P-450
proteins; heterologous expression studies have shown that removal of this N-terminal
hydrophobic region from eucaryotic proteins has no effect on their activity suggesting
that this portion of the protein plays no function role in the reactions of the eucaryotic
protein (Cullin & Pompon, 1988; Larson et al., 1991). Most studies now postulate that
the N-terminal region of approximately the first forty-five residues acts as a membrane
anchor and targets the proteins to the endoplasmic-reticulum. Various models have
been suggested for the structure of the N-terminal region with either a single membrane
spanning or a hairpin double spanning motif holding the protein in place. Using these
models it would be predicted that the rest of the eucaryotic P-450 molecule within the
cytoplasm would potentially be folded in a similar manner to its soluble procaryotic
counterpart (Nelson & Strobel, 1988; Brown & Black, 1989; Edwards et al., 1989;
Kemper & Szczesna-Skorupa, 1989.). Other models however have been proposed for
the structure of eucaryotic P-450 suggesting the existence ofmany membrane spanning
regions which would not be consistent with the postulate of a conserved structure
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between the procaryotic and eucaryotic P-450 proteins (Mornier et al., 1988; Ozols et
al, 1985).
The postulate that procaryotic and eucaryotic proteins with conserved functions will
also possess conserved structural features has been successfully demonstrated in
connection with several other enzymes. For example, both glyceraldehyde phosphate
dehydrogenase (Blesecker et al., 1977) and dihydrofolate reductase (Voltz et al.,
1982) on crystallisation have been seen to possess common tertiary structures for
example. The comparison of the Cyp2el predicted amino acid sequence and P-450cam
was therefore undertaken to attempt to assign possible structural and functional regions
to the protein.
Section 5.3.1: The structure of P-450cam (CYP101)
P-450cam (CYP101) is a camphor hydroxylase enzyme isolated from Pseudomonas
putida and its structure has been solved crystallographically both in the presence and
absence of its substrate camphor (Poulos et al., 1985; Poulos et al., 1987). A
representation of the results gained from this analysis is shown in Figure 5.4. In
general terms the P-450 structure broadly divides into a helix-turn-helix rich side and a
helix poor side containing the majority of the anti-parallel (3-pairs (right and left hand
side of figure 5.4 respectively).
Section 5.3.2: The nature of the P-450cam substrate binding site and haem
environment
The haem prosthetic group in P-450cam is held between the helices designated L and I
in Figure 5.4; the haem proprionate groups are surrounded by hydrogen bond donor
residues derived mainly from amino-acids associated with the C-(gln 108, arg 112),
K-(asp 297, arg 299) and L-(his 355) helices. An anti-parallel region between phe 350
and gin 360 forms a pocket at the end of the L-helix which houses the cysteine residue,
cys 357, which forms the thiolate ligand with the haem. The haem itself provides the
largest hydrophobic surface within the molecule for interactions with the substrate,
however amino-acids associated with the F-helix (thr 185), I-helix (leu 244, val 247),
the K-helix (val 295, asp 297) and the (3' anti-parallel region (phe 87, tyr 96) are also
seen to interact with the camphor molecule (Poulos et al., 1987). How camphor enters
the molecule is unclear and unlike the structures of many other enzymes, P-450cam
does not possess an active site defined as an open cleft but, due to the hydrophobic
nature of its substrate has an active site sequestered within the interstices of the
molecule.
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Figure 5.4: A representation of the high resolution structure of the soluble bacterial
CYP101 (P450cam) protein structure and the protohaem group. The nomenclature for
a-helices and (3-sheets in this diagram are those used in the text. Figure modified from
Poulos, et al. (1987).
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It is possible that the camphor molecule enters the P-450 through an access channel
bounded by hydrophobic residues which opens and shuts with the "breathing" of the
structure. The (33 region of the P-450 molecule, just outside the K-helix and adjacent to
the P' region containing the haem interacting residues is suggested to play an important
role in determining the ability of the P-450 molecule to accommodate its substrate
(Figure 5.4). Oxygen co-ordinates with the iron atom and so the portions of the I-helix
which have been seen to interact with the haem may interact with the oxygen molecule
also. The conservation of primary amino-acid sequence around this area between a
wide variety of functionally diverse P-450 is striking and strengthens the suggestion
that the proteins may all possess a similar structure based around the need to perform a
common enzymatic step (Nelson & Strobel, 1988). In this context most P-450 possess
either a glycine or an alanine at the residue equivalent to gly 248 in the P-450cam
I-helix as well as a highly conserved threonine, thr 252 in P-450cam, residue close by.
The P-450cam I-helix containing these features is, at thirty-four residues, relatively
long and all the residues it contains possess normal helical hydrogen bonding with the
exception of thr 252. Thr 252 generates a kink within the I-helix in the crystal structure;
the generation of the I-helix kink is thought to allow the formation of a pocket which
may accommodate the oxygen molecule and this pocket is further stabilised by a
complex series of hydrogen bonds which form around the kink. It is thought that this
potentially conserved pocket is capable of restricting the relative positioning of the
oxygen and camphor adjacent to the haem moiety within the P-450cam molecule and so
the nature of the products generated (Poulos et al., 1987).
Section 5.3.3: The P-450 superfamily: a group of enzymes with structures capable
of evolving rapid changes in substrate specificity
If all P-450 adhere to a similar helically determined tertiary skeleton as seen in
P-450cam, it is possible that the delineation of the P-450 enzyme into a structurally
rigid helix-rich moiety and a less well defined globular moiety has not occurred by
chance. The rigid portion of the structure appears to make the principal interactions with
the haem and generates a pocket within the I-helix for oxygen binding and orientation
that will be required by all P-450 isoforms as they all catalyse the same common theme
reaction. As a result of the structural restraints generated by the common reaction
requirements it would be expected that these regions of the P-450 molecule would be
most highly conserved. Around these conserved structurally restrained regions
however, it would be possible to generate evolutionary modifications in the less
structured moiety of the molecule and the intervening loops between structural
elements. The P-450 molecule may therefore represent a molecule in two structural
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parts, one part the haem and oxygen binding portion providing the engine to drive the
common reaction and thus possessing a highly conserved structure, the other part
determining what substrates the molecule is capable of accommodating and
metabolising which is consequently less structurally restrained.
The specificity of the accommodation could be determined at two levels. Firstly
modification of residues at the substrate entrance site could determine the chemicals
which can gain access to the haem and oxygen associated reaction centre, and secondly,
having once entered the molecule, the location of other critical residues would
determine those molecules capable of being held in a productive orientation relative to
the active site. The nature of the residues contributing to the generation of these two
theoretical levels of substrate specificity could be changed not only by direct
modification of the key interacting residues themselves, but also more subtly through
the modification of other more distal residues leading to perturbation of the enzyme
structure as a whole. As a result of this, although it may theoretically be possible to
predict those portions of a P-450 sequence that contribute to the conserved structural
part of the molecule, the prediction of residues that may be responsible for the
generation of substrate specificity would be expected to be much more difficult.
Section 5.3.4: Comparing the CYP2E subfamily to P-450cam (CYP101)
By aligning the predicted amino-acid sequences of the known CYP2E subfamily
members and generating a consensus which is then aligned to that of CYP101
(P-450cam), an idea of those portions contributing to the structural and functional
regions of the CYP2E subfamily can potentially be obtained. Refinements to this
general procedure have been obtained in the modelling of other P-450 sequences to
CYP101 by shifting the alignment generated to take into account conserved structural
requirements of the molecules, such as haem contacts, as well as the insertion of
secondary structures predicted to be generated by certain amino-acid groups by analogy
to other known structures outside expected structural domains of the P-450 molecule.
In this manner, 3-D models of eucaryotic P-450 structures have been generated
(Zvelebil, et al., 1991; Laughton et al., 1990). A linear comparison of the known
CYP2E subfamily sequences and P-450cam is shown in Figure 5.5; predicted
structural regions of the CYP2E subfamily as a consequence of this alignment are
marked. The incorporation of the rabbit CYP2C5 amino-acid sequence into the CYP2E
subfamily alignment exploits the energetic predictions previously modelled into a
structural prediction ofmammalian P-450 (Zvelebil et al., 1991).
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Figure 5.5: An alignment of the CYP2E subfamily, rabbit CYP2C5, and CYP101
(P450cam) amino acid sequences. The predicted amino acid sequences for all the
CYP2E subfamily members isolated to date were aligned with the mouse Cyp2el
predicted amino acid sequences using the GCG package Best and Lineup programs.
Only at points where amino acid residues differ from the Cyp2el sequence are they
displayed; a consensus for the CYP2E subfamily protein sequence was determined
from this information as is displayed below the aligned CYP2E subfamily sequences.
The CYP2E consensus sequence was aligned with the rabbit CYP2C5 protein sequence
which had previously been compared to CYP101 (P450cam) (Zvelebil, et al. , 1991)
allowing a comparison of the CYP2E subfamily sequences and the crystallographically
solved CYP101 protein to be undertaken. The structural features of CYP101 are boxed
and annotated according to the nomenclature of Poulos, et al. (1987) (See Figure 5.4).
Boxed areas of the CYP2E subfamily correspond to those areas predicted to interact
with the haem group (H) and substrates (S) and are discussed in the text. The
following features of the alignment, also discussed in the text, are also marked:
1) The exon arrangement of the CYP2E subfamily, lined below the consensus
sequence.
2) The potentially phosphorylated serine group in the C-helix (*).
3) The kinked region of the I-helix suggested to hold the substrate and oxygen in
apposistion (S & Ox.).
4) The potential phosphorylation site in CYP101 (CYP101 Phos. site).
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Figure 5.5 (continued) 212
Section 5.3.5: Predicted features of the Cyp2el protein
The haem of P-450cam is held between the L- and I-helices (Figure 5.4); equivalently
placed amino-acids in the Cyp2el protein and the CYP2E subfamily in general are
shown in Table 5.2 and Figure 5.5 respectively.
Table 5.2: The amino acids seen to interact with the haem group in P-450cam and the
predicted cognate residues in Cyp2el
Nearest structural P-450cam residue Predicted Cyp2el equivalent
region residue
C-Helix Gin 108 Trp122
Argll2 Arg 126
K-helix Asp 297 Leu 367
Arg 299 His 369
L-helix His 355 Arg 434
Three of these five predicted Cyp2el haem contacts could theoretically form hydrogen
bonds analogous to those present in P-450cam: arg 112/ arg 126, arg 299/his 369, and
his 355/ arg 434. These three amino-acid residues are invariant in the aligned CYP2E
subfamily sequences (Figure 5.5) and are also seen to be highly conserved in multiple
alignments carried out on a large number of mammalian P-450 (Nelson & Strobel,
1988; Nelson & Strobel, 1989). Equivalent hydrogen bonds could not however be
provided by the Cyp2el leu 364 or trp 122 residues.
The I-helix of P-450cam, with the thr 252 generated kinked oxygen pocket, is
potentially seen to be preserved in the thr 252 of Cyp2el which is also surrounded by
several other proportionately spaced similar amino acid residues. This portion of the
P-450 structure has been seen to be highly conserved in multiple alignments of several
P-450 isoforms, suggesting the potential validity both of the suggested functional role
of this feature of the molecule and also that it forms a highly conserved structural motif
in all P-450 molecules (Poulos et al., 1987). The presence of several other threonine
residues around this proposed oxygen pocket in Cyp2el may potentially increase the
size of the kink in the I-helix and affect the substrates which it is capable of
metabolising.
The predicted C-region of the Cyp2el protein, in common with many other family 2
P-450, is seen to contain a potentially phosphorylatable serine 129 residue within a
canonical basic kinase recognition site. The potential relevance of this and the effect of
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introducing such a post-translational change in a region of the protein structure
predicted to form contacts with the haem are discussed in more detail in Section 4.7.3.
As in all P-450 studied to date, a cysteine forming the thiolate axial ligand between the
P-450 protein and the haem group is seen; in P-450cam this is cys 357 whose
equivalent residue is predicted to be cys 435 in CYP2E subfamily. The thiolate binding
cys 357 in P-450cam is held within a P-bulge pocket bounded by phe 350 and gly 359
whose equivalent residues in CYP2E may be phe 428 and gly 437 respectively.
All these features and their relative positioning to predicted structural elements of
P450cam are illustrated in Figure 5.5.
Section 5.3.6: Amino-acids potentially contributing to the substrate binding site of
CYP2E subfamily
From the co-crystal derived from P-450cam and its substrate camphor the principal
amino-acids making contacts with the substrate were ascertained (Poulos et al., 1985).
Using the structural alignment it may be possible to predict the equivalent residues
which may interact with the CYP2E subfamily substrates. Those residues seen to be
making both major and minor contacts with camphor in P-450cam and their equivalent
residues in CYP2E subfamily are shown in Tables 5.3a and 5.3b.
Table 5.3a: Amino acids seen to make major contacts in P-450cam with its substrate
camphor and their equivalent residues on alignment with the CYP2E subfamily.
Camphor/P-450cam Closest structural element Equivalent residue in
interacting residue the CYP2E subfamily








Table 5.3b: Amino acids seen to make minor contacts in P-450cam with its substrate
camphor and their equivalent residues on alignment with CYP2E subfamily.
Camphor/P-450cam
interacting residue














The putative CYP2E subfamily substrate interacting residues are highly conserved
between species suggesting that the proteins may be expected to display a high degree
of similarity in the substrates which they metabolise. The one exception to this is the
replacement of the consensus phe 108 by leu 108 in the rabbit CYP2E2 protein. The
change of this residue would be predicted to occur within the P'-helix/p3-antiparallel
region adjacent to both the axial haem cysteine ligand and the oxygen encompassing
kink in the I-helix in the rabbit CYP2E 2. Such a change could potentially be expected
to affect the substrates metabolised by this isoform or its general kinetic parameters;
enzymatic analysis of both of the purified rabbit isoforms demonstrated that CYP2E2
was less active in the metabolism of nitrosamines, ethanol, aniline and chloroxazone
(Pernecky et al., 1991). It is clear however that, with reference to the proposal of the
P-450 structure as being composed of both a rigid and more plastic moiety, other
regions and residues of the protein may play an important role in the generation of
substrate specificity of a specific isoform.
Section 5.3.7: The validity of structure and function predictions of membrane bound
P-450 based on structural evidence from the soluble P-450cam
The validity of this kind of structural and functional prediction of membrane bound
mammalian P-450 based on information gained from P-450cam can not be truly
assessed until the crystal structures of other P-450 have been obtained. In the past the
alignment of families of sequences and the application of algorithms predicting
structures on the basis of known structural motifs have proven to be successful as seen,
for example, in the case of tryptophan synthase (Crawford et al., 1987).
Site directed mutagenic studies conducted on those regions of the P-450 protein
predicted, as a result of similar alignment studies, to be involved in substrate
metabolism have proved successful, suggesting that the hypothesis that the P-450
/
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retains an overall conserved structural topology is valid. For example, mutant P-450
proteins generated with modifications in the size of the predicted I-helix oxygen kink
can modify the kinetics of the resultant enzyme; the replacement of the proline, that
generates the kink, by valine in the rat CYP1A2 protein greatly reduced the enzymic
activity towards benzephetamine and 7-ethoxycoumarin (Furuya et al., 1989), and
similar results were seen on the removal of the equivalent kink inducing residue in the
human aromatase CYP19A1 in its subsequent activity towards androgens (Graham-
Lorence etal., 1991).
Mutagenesis of residues in the P'-helix/p3-antiparallel region, predicted to be important
in the determination of enzyme specificity and adjacent to both the axial haem cysteine
ligand and the oxygen encompassing kink in the I-helix, have been seen to affect the
substrates metabolised and the kinetics of the reactions, adding validity to an argument
for a conserved structural/functional role for this portion of the molecule (Kronbach
etal., 1989; Uno & Imai, 1987; Aoyama et al., 1989).
The concept that the substrate specificity of a P-450 enzyme can be dramatically
modified by changing a single amino-acid is well illustrated by experiments on the
mouse Cyp2a4 and Cyp2a5 proteins. Although these proteins differ only in eleven
amino-acid residues dispersed throughout the enzyme they have greatly divergent
substrate profiles; Cyp2a4 metabolises, amongst other things, testosterone, and
Cyp2a5, coumarin. By changing the eleven differing amino-acids in these two proteins
it was seen that some were critical in determining the specificity of each isoform for
either coumarin or testosterone. If phe 209 was modified in Cyp2a5 to a leu, as present
in Cyp2a4, the specificity of the enzyme was changed from coumarin to testosterone.
This mutation would be predicted to modify the structure of the P-450 between the
F- and G-helices near to the regions seen to interact with the substrate in P-450cam and
suggested to be important in the determination of those molecules which the P-450
structure can accommodate. Other residues which were seen to be important in the
determination of Cyp2a4/5 specificity, map to the P3 region of the molecule adjacent to
both the haem and I-helix oxygen pocket (Lindberg & Negishi, 1989; Gotoh, 1992).
The results from these studies go some way to validate the suggestion that all P-450
may have a conserved structure evolving through the modification of residues at key
sites. The true validity of this suggestion however can only be gauged when further
P-450 crystals are available allowing structural comparisons to be drawn and potential
regions of conservation to be reinforced. There are reports of two new crystal
structures which are being prepared which may enable such a comparison to be
established. The two structures are those of the bacterial P-450terp, and the P-450
portion of the catalytically self-sufficient bacterial P-450BM-3 (CYP102) enzymes;
results obtained from these crystals may allow the reappraisal of the value of structural
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and functional predictions made for mammalian P-450 on the basis of the extrapolation
of data gathered from P-450cam (Petersen et al., 1992).
Section 5.4: Features of the untranslated regions (UTRs) of the Cyp2el message
Section 5.4.1: Disruption of the Cyp2el 3' UTR by a (32 repeat element
The 3' untranslated region (3' UTR) of the Cyp2el message has become disrupted
sometime after the speciation of mice by a (32 repetitive element; as a result of this
disruption the poly-(A) addition site used by the Cyp2el mRNA is that of the (32
repetitive element itself. The (32 element present in the 3' UTR of the Cyp2el message
was completely sequenced from the Cyp2el gene as the cDNA clones terminated before
the end of the repeat element. The 02 element is highly similar to those observed
previously in other messages and genes and possesses the characteristic repeat motifs
at the 3' and 5' boundaries of its insertion site (Figure 5.6).
The origin, function and mechanism of insertion of such elements are still unclear but it
appears that they form a family of such motifs present in many organisms. The best
studied of this family of repeating elements is the human "Alu " element to which the
mouse 0 elements may be related. The biology and function of these elements, as well
as the implication of the presence of such a feature in the Cyp2el mRNA, are
discussed.
Section 5.4.2: Repetitive transposable elements
S1 nuclease digestion of rapidly denatured and reannealed genomic DNA revealed the
presence of rapidly annealing repeating elements resistant to nuclease attack in the
genomes of many organisms; in mammalian genomes these segments of DNA represent
a series of retro-transposable repetitive elements. This group of repetitive sequences
divides into two subpopulations based on size; firstly smaller elements, termed short
interspersed repeat elements (SINEs) and secondly larger elements, Large interspersed
repeat elements (LINEs); LINES they are suggested to be of a different evolutionary
origin from SINES and are not further discussed here (Jelinek & Schmid, 1982; Jelinek
et al., 1980; Deninger et al., 1992).
On sequencing, both rodent and human SINEs were seen to fall into two main groups
by homology; firstly the primate Alu and the homologous rodent 01 family and
secondly the rodent 02 family. SINEs from both families are seen to be present in both
orientations throughout the rodent genome and are seen to be transcribed either due to
their insertion into DNA dependent RNA polymerase I or II (pol I and II)
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Figure 5.6: Alignment of the 3 ' UTR of the Cyp2el transcript and the rodent (32-
repeat element. The mouse Cyp2el sequence (upper) and the rodent [32-repeat element
(lower) (Krayev, et al. , 1982). The stop codon of the Cyp2el mRNA is boxed as are
the repeat sequence boundary motiffs which probably represent the site of insertion of
the (32-repeat element. The poly-A tail addition site in the (32-repeat element is
underlined. The arrow marks the end of the sequence present in the cDNA clone and
data beyond this is compiled from genomic sequence (See Section 5.8.3)
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transcriptional units, or as the result of transcriptional initiation from the internal DNA
dependent RNA polymerase III (pol III) promoters present within some of the SINEs
themselves; however, no open reading frame is found in the SINEs (Rogers, 1985;
Krayevefa/., 1982; Kramerov etal., 1979).
The best studied of these elements is the human Alu family, so termed because the
repeating element contains an Alu I restriction endonuclease recognition site. The
primate SINE Alu is repeated at between three and five million copies in the genome
and is around three hundred base-pairs in length with around a ten percent sequence
variation amongst primates, suggesting a neutral drift of sequence retention between
species in these non-coding elements (Houck et al., 1979; Deinger et al., 1981). The
rodent pi family is around one hundred and thirty base-pairs in length, is thought to
exist at between ten and fifty thousand copies in the rodent genome and is related to the
primate Alu SINE. The Alu and pi SINEs appear to have been generated as the result
of retrotransposition of a previously functional structural RNA molecule. Both Alu
and pi SINEs show a high degree of sequence similarity to the 7SL RNA molecule
which is a structural component in the signal recognition particle (SRP) involved in the
translocation of proteins across the lumen of the endoplasmic reticulum. As such both
Alu and pi SINES are regarded as processed retro-pseudo genes (Elder et al., 1981;
Walter & Blobel, 1982). The primate Alu SINE is generated essentially from a dimer
of two such 7SL elements which is suggested to have been the result of recombination
of one 7SL retrotransposon into the A-rich 3' end of another such element already in
place in the genome; the rodent pi element however is a monomeric 7SL-like sequence.
In both Alu and P1 SINEs there is an internal deletion of around one hundred and fifty
nucleotides from the 7SL molecule and it is suggested that this may be the result of
reverse transcription activity missing out a highly structured region of the 7SL
molecule; it is possible that the loss of this portion of the 7SL has resulted in the release
of the element from functional restraints, leading to sequence drift from its 7SL
progenitor (Walter & Blobel, 1982; Weiner et al., 1986). The right hand element in the
Alu dimer has independent transcriptional activity but the left hand end of the dimer no
longer possesses a functional pol III promoter and is therefore transcribed only in
association with the left hand component. The rodent pi SINE family is more like the
right hand component of the primate Alu dimer as only one functional pol III promoter
has been reported in this family (Haynes et al., 1981; Weiner et al., 1986).
The P2 family of SINEs is thought to have arisen through retrotransposistion of a
previously functional RNA element by a similar mechanism to that proposed for the
generation of the Alu and pi SINEs. The progenitor molecule for the
retrotransposistional event is thought to be a tRNA molecule (Laurence et al., 1985).
The homology between the active P2 SINE pol III promoter and that present in tRNAs
219
is high but the sequence drift in the (32 SINE as a result of loss of structural constraints
has resulted in too great a divergence to allow a precise determination of the parental
tRNA molecule (Laurence et al., 1985). Unlike the (31 and Alu SINE families the (32
SINE family contains a functional poly-(A) addition signal (Krayev et al., 1982).
The exact series of events which lead to retrotransposistion and proliferation of these
elements is obscure. It is suggested that structural RNA derived SINEs may be
particularly prone to self-priming; thus the element, generated either as a discreet RNA
pol III transcriptional unit or in conjunction with another message, by some mechanism
generates a reverse transcribed copy, second strand synthesis and then recombines back
into the genome (Jagardeeswaran et al., 1981; Flavell, 1981; Baltimore, 1985).
Retrotransposition of such elements has been seen to lead to the disruption of
functional genes, as in the case of the loss of a functional neurofibromatosis type I
associated gene following Alu SINE insertion (Wallace et al., 1991). A (32 element has
been seen to have inserted into one of the 18S rRNA genes in a mouse cell line leading
to the loss of the functional transcript; this insertion is not present in the parental mouse
cell line, suggesting that the insertional event has occurred within the past decade
(Oberbaumer, 1992). Tissue culture systems selecting for the loss of a negative
selection marker by Alu SINE disruption have been developed to illustrate
retrotranspositional events occurring; in this instance retrotransposition was accelerated
by ultra-violet radiation potentially increasing genome damage and recombination (Linn
et al., 1988; Linn etal., 1989).
The insertion of a SINE element also increases the recombinational activity around the
region of the genome associated with its insertion site; thus SINE elements have been
seen to cluster, with one element inserting into another making this region of the
genome unstable as seen in the case ofAlu driven recombinational events in the human
genome (Lehrman et al., 1987; Rouger et al., 1987) and the clustering of (32 elements
within the rat growth hormone gene (Barta etal., 1981; Page etal., 1981).
SINE insertion can result in the loss of a transcriptionally functional unit either through
the subsequent generation of an incorrect message, inhibition of correct splicing, or the
generation of a recombinational hotspot and the loss of that portion of the genome
through recombination between sequences containing SINE elements (Lehrman et al.,
1987; Rouger et al., 1987).
The biological function, if any, of these families of sequences is unclear. The level of
retrotransposistional activity is suggested to become elevated in embryonic and
cancerous cells as well as in situations which result in genomic damage leading to the
suggestion that these elements may play a role in the repair and rescue of damaged
chromosomes (Linn et al., 1988). The fact that these elements may have their origin in
otherwise functional structural RNA molecules however suggests that they may
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represent artefacts resulting from a coincidence of aberrant reverse transcriptase and the
self-priming activities of the elements and that they may not therefore be performing
any directed function within the cell. What is clear however, even if a true role for these
elements can not be arrived at, is that the disruption of functional transcriptional
elements within the genome, either by direct retrotransposition or subsequent
homologous recombinational events, has the potential to generate significant genomic
disruption (Wallace et al., 1991; Grossbauer, 1984; Rouger et al., 1987; Lehrman et
al., 1987).
Section 5.4.3: The significance of the 02 element in the Cyp2el 3' UTR
The insertion of the 02 SINE into the 3' UTR of the Cyp2el gene means that the
mRNA generated no longer contains the endogenous 3' sequence and the message now
terminates at a poly-(A) addition site within the 02 SINE. As discussed (Section 5.4)
the Cyp2el message level becomes elevated in starvation in common with results
obtained from studies on the CYP2E subfamily messages of other species; the
mechanism suggested to account for this event in the rat has been suggested to be
through the stabilisation of pre-existing CYP2E1 message (Song et al., 1987).
Previous messages controlled as a result of regulated message stability have been seen
to contain features within the non-coding portions of the message, and principally
within the 3' UTR generating a structural motif interacting with a regulatable RNA
binding protein (Section 3.7.6). Loss of the Cyp2el 3' UTR as a result of the 02
SINE insertion would therefore theoretically lead to the loss of this form of regulation if
it were executed via a conventional 3' UTR-related mechanism. The fact that the
elevation of the Cyp2el mRNA still occurs in starvation suggests that, unless a protein
recognises a motif in the remainder of the 3' UTR, there is no role for this portion of
the 3' UTR in this event and either that stabilisation occurs by a previously unknown
mechanism, potentially involving sequences within the 5' UTR or motifs within the
coding region, or that stabilisation does not actually occur and the elevations observed
may be transcriptional (Section 3.7.7). The 02 element insertion into the Cyp2el
3' UTR in this manner provides a genetic argument against a role for conventional
message stabilisational control of the CYP2E mRNA levels.
Another implication of the presence of the 02 SINE within the Cyp2el gene is the
possibility that the gene may be open to recombinational modification as the result of
further retrotransposistional and crossing-over events as seen to occur in Alu driven
recombination (Lehrman et al., 1987; Rouger et al., 1987). Such an event may already
have occurred in an as yet undefined mouse strain potentially leading to the functional
disruption of the Cyp2el gene.
221
Section 5.4.4: The nature of the 5' UTR of the CYP2E subfamily messages
The sequences of the known rat and human CYP2E1 5' UTRs and the predicted mouse
Cyp2el 5' UTR are highly conserved. These 5' UTR sequences were analysed to
generate the most energetically stable RNA folded structure using the GCG package
Stemloop and Fold programs (Devereux et al., 1984; Zucker et al., 1989) and it was
seen that a similar folding pattern was generated by all these CYP2E subfamily
messages. To establish the accuracy of the predicted 5' UTR folding patterns obtained
from these programs the iron responsive element (IRE) of the human ferritin H mRNA
(-186 to -143) was also folded using the same parameters and the result compared to
the previously characterised and experimentally established structure of this sequence
(Rouault et al., 1988). The structure generated by the CYP2E subfamily 5' UTR forms
a strong stem-loop structure similar in size to the IRE previously shown to be involved
in the regulatable translatability and stability of the ferritin and transferrin receptor
messages (Section 3.7.6). The 5' UTR of the CYP2E1 subfamily sequence was seen
to contain a consensus NFKp recognition site and could potentially be bound by a series
of protein factors (Section 4.13). The results of this analysis are shown in Figure 5.7a
and Figure 5.7b.
NFKp sites are bound by a series of transcription factors including the rel-family
which includes NFKp itself, the development controlling " dorsal " factor of Drosophila
as well as the oncogene product v-rel and its cellular counterpart c-rel (Lewin et al.,
1991) and a rapidly expanding series of unrelated factors such as C/EBP (Clark et al.,
1988), MBP-1 (Baldwin et al, 1990), KBF-1 (Israel et al., 1987), and H2TF1
(Baldwin et al., 1987). It appears that as a general rule eucaryotic transcription factor
recognition sites can be bound by more than one protein factor in a competitive manner.
These protein elements, their nature and possible regulation are discussed in more detail
in Section 4.13.1.
The consensus sequence for NFKp type sites is formed by a dimeric pentamer of
GGGa/cTNt/cCC; within this site the completely conserved residues are
GGG(NNNNNN) C where N is a defined series of nucleotides around a limited
number of variable residues which may confer specificity to one or more of the variety
of factors capable of binding these sites (Figure 5.7b). Purified NFKp was seen to be
capable of binding single-stranded DNA containing this motif and this was capable of
competing with double-stranded DNA for the protein (Zabel et al., 1991). The putative
NFKp site within the folded 5' UTR of the CYP2E subfamily messages retains a
correctly orientated site containing all the completely conserved residues and all but two
of the less conserved consensus residues present in the site bound by NFKp itself are
retained. No thiamine residues are conserved in any of the NFKp type recognition sites
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suggesting that the replacement of these nucleotides by uracil in the potential RNA
derived recognition site may not affect the binding ability of a protein (Figure 5.7b).
Although studies on NFKp protein itself have shown that the protein is capable of
binding a single stranded recognition site, the folding of this portion of the CYP2E
subfamily 5' UTR renders the majority of the potential recognition site double stranded.
Interactions between transcription factors and RNA molecules have been previously
noted specifically for those proteins which possess zinc-finger binding motifs; zinc-
finger proteins are thought to be very ancient and in their ability to bind RNA as well as
DNA potentially pre-date a DNA derived genome (Dressier & Gruss, 1988). NFKp
protein itself requires zinc for binding to its recognition sequence although the factor
does not appear to contain any of the previously recognised zinc-finger motifs (Zabel et
al., 1991); in the case of other factors capable of binding the NFKp site, such as MBP-
1 there is sequence evidence for the presence of a consensus cys2- Xi2- his2 zinc-
finger motif (Baldwin et al., 1991).
Although clearly speculative the suggestion that the 5' UTR of the CYP2E subfamily
messages may contain an NFKp recognition sequence within a secondary structural
feature generated by a conserved sequence is of interest. Such a feature of the message
may allow, in a manner akin to the regulation of translatability of ferretin mRNA
(Section 3.7.6 ), control to be exerted, potentially through a factor like MBP-1, at the
translational level on these messages. Such an event could go some way to explaining
some of the anomalies which have arisen concerning the regulation of these messages.
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Figure 5.7a: The predicted folding pattern adopted by the 5' untranslated regions
(UTR) of the mouse, rat and human CYP2E subfamily transcripts. The suboptimal
folding patterns of the 5' IJTRs of the 3 sequences, from +3 to - 39, were generated
using the GCG package Stemloop and Fold programs A: Mouse Cyp2el 5' UTR. B:
Rat CYP2E1 5' UTR. C: Human CYP2E1 5' UTR. D: The 5' UTR IRE (iron
response element) of the human ferritin H mRNA, from 186 to -143, was also folded
using the same parameters as those employed to generate the predicted structures of the
CYP2E subfamily and this analysis is shown. E: The published suboptimal folding
pattern generated for the -186 to 143 region of the ferritin mRNA (taken from Rouault
et al. , 1988). This region has been shown experimentally to be involved in the
regulation of the ferritn mRNA function. The inclusion of D and E indicates that the
folding programs used to generate the CYP2E subfamily predicted structures produce
similar results to those used previously in the ferritin 5' UTR and that the stem-loop
predicted to be present within the 5' UTR of the CYP2E subfamily is of a similar size
to those shown previously to be capable of interacting with mRNA binding proteins.
In each instance the sequences run from 5' (top) to 3' (bottom); in the CYP2E
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Figure 5.7a (continued).
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Figure 5.7b: The nature of the putative NFk(3 recognition sequence within the
promoter region / 5' UTR of the CYP2E subfamily genes and transcripts. A: The
NFk|3 recognition site general consensus sequence; the totally conserved residues in the
sequence are in bold. B: Some NFk|3 elements located in a variety of genes showing
the variation possible within the recognition sites. The totally conserved residues are in
bold (Modified from Zabel, et al. , 1991). C: The region of the mouse, rat and human
CYP2E subfamily genes upstream from the translational initiation codon but
downstream from the transcriptional start site, predicted to contain the NFicf)
recognition region which is boxed in the figure; all the variations in this element in the
CYP2E subfamily have been seen to be present before (C.). D: The position of the
putative NFk(3 element within the suboptimally folded 5 ' UTR of the mouse Cyp2el
cDNA (See Figure 5.7a). Differences within the region containing the putative
recognition sequence are shown (Hu. human , Ra. rat) and the initiation AUG is in
hollow type.
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Section 5.5: The heterologous expression of the Cyp2el eDNA
In an attempt to enable the study of some of the chemicals metabolised by Cyp2el and
its gain an insight into its role in the initiation of carcinogenesis, the Cyp2el cDNA was
employed in heterologous expression studies. Due to the observed high conservation
between the CYP2E genes from several species it would be expected that the
biochemical activity of the Cyp2el protein would be representative of the actions of
CYP2E sufamily proteins in general.
Section 5.5.1: The use of heterologous expression systems in establishing roles for
P-450 enzymes in carcinogenesis
The overlapping nature of the substrate profiles metabolised by mammalian P-450,
coupled with the differences in the tissue distribution of specific isoforms and the
contribution of other xenobiotic metabolising systems, means that an attempt to study
the role of a P-450 isoform in the context of the whole organism is complicated. Such
a study can be made in situations where sex-differences in P-450 levels occur in a
particular organ; in these cases a subtractive approach to the role of a particular P-450 in
the metabolism of a certain chemical could be assessed by the ability of a chemical to
generate damage in that particular organ in the different sexes. An example of this
approach could be argued to have applied in the case of the observed sexual
dimorphism of Cyp2el in the mouse kidney where the male has higher levels than the
female (Chapter 4, Section 4.4). In the mouse kidney, the toxicity of several
nitrosamines (Noronha, 1977; Hong et al., 1980; Mohla, 1981; Hawke & Welch,
1985; Ampy & Williams, 1988; Hong et al., 1989) and chloroform (Pohl et al.,
1984) produces a much higher injurious effect on the male than the female kidney
which may be argued to reflect the sexual dimorphism of Cyp2el protein.
One method of determining the potential role of a specific P-450 isoform in the
metabolism of a chemical is to employ a reductionist system providing an assay end-
point based on genome damage. Applying the knowledge gained from these studies
then gives some insight into the possible roles of particular isoforms in the nature of the
metabolism and the kinetic parameters of a certain chemical and these observations can
then be applied to the observed metabolism of the chemical in the whole animal.
Reductionist test-systems have been established employing the genomes of yeast,
bacterial and mammalian tissue culture cells as the targets for the activated chemicals
(Simula et al., 1993). An example of a widely employed approach to study the
mutagenicity of a chemical is the Ame's test where the mutagenic ability of a test
chemical is assessed through its ability to generate wild type reversion of a his' strain
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of Salmonella typhimurium (S. typhimurium ) (Ames, 1979). Other systems assay
other bacterial damage responses such as the expression of components of the SOS
operon (Shimada et al., 1989) or the release of bacterial prophages (Elespuru &
Yarmdinsy, 1979) both of which activities are elevated in response to DNA damage.
The specific roles of particular P-450 isoforms in the activation of the chemical can be
assessed by the addition to the assay system of either normal microsome (endoplasmic
reticulum enriched fractions) or preparations of microsomes where the activities of
certain P-450 isoforms have been induced. More specific roles for certain P-450
isoforms could be determined by using purified P-450 enzymes or inhibitory antibodies
to certain P-450 isoforms. These system however have several limitations not least of
which is the extracellular nature of the chemical's activation by the activating
microsomal or purified enzyme preparations. This short-fall of the test systems was
seen to be particularly prevalent in the use of the Ame's test to study the mutagenicity of
nitrosamines, the chemicals in carcinogenic terms which would be potentially most
relevant to study in connection with the CYP2E subfamily. For example it was seen
that neither A-nitroso diethylmethylamine (NDMA), or A-nitroso diethylethylamine
(NDEA), were mutagenic to the S. typhimurium test strains, even if activated by the
presence of microsomal fractions (McCann et al., 1975; Guttenplan et al., 1976; Yoo
et al., 1990; Guengerich et al., 1991). These observation led some researchers to the
conclusion that NDMA for example was not mediating its carcinogenic actions directly
on the genome (Massour et al., 1983). It is thought that the metabolic activation of
nitrosamines involves the initial oxidation of allyl-groups by the action of P-450
yielding alkyldiazohydroxides followed by the generation of diazonium ions which lead
to DNA and other macromolecular alkylation (Lai & Arcos, 1981; Shimada et al., 1989;
Guengerich & Shimada, 1991, Section 1.7.1) The lack of mutagenic action of
nitrosamines, which clearly are carcinogenic in vivo, may therefore relate to the
extracellular nature of the alkyl-diazonium species generation and their inability to make
contact with the bacterial genome.
Attempts have been made to tailor these mutagenicity assays to the testing of
nitrosamines. The mutagenic properties of NDMA and NDEA are thought to be
enhanced on acetylation of the allyldiazohydroxide species generated from the parent
compound. By using S. typhimurium tester strains expressing high levels of
o -acetyltransferase, the enzyme which catalyses this reaction, the mutagenicity of these
chemicals have been shown to be elevated (Yamazaki et al., 1992 ). The mutagenicity
ofNDMA and NDEA was elevated by the inclusion ofmicrosomes in which the levels
of CYP2E1 had been induced, by starvation and acetone treatment, and the
mutagenicity was decreased by the inclusion of CYP2E1 inhibitory antibodies; these
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observations supported the suggested role for the CYP2E family in the generation of
reactive nitrosamine metabolites (Yamazaki etal., 1992 ).
One clear refinement to allow a better mutagenicity system to be developed for the
testing and analysis of the chemicals which CYP2E subfamily proteins could activate to
genotoxic metabolites would be the expression of the CYP2E isoform inside the
bacterial test strain. Using this approach the problems associated with the extracellular
nature of the reactive metabolite generation, the need to generate purified P-450
fractions, or the possibility of cross-reactivity of inhibitory isoform specific antibodies
could be overcome as the potential mutagens would be activated within the
S.typhimurium tester strain itself.
Section 5.5.2: The heterologous expression of proteins in bacterial systems
To express a eucaryotic protein in a bacterial system modifications need to be made to
the eucaryotic transcript before it will be translated by a procaryote. Bacterial transcripts
contain a conserved sequence just 5' of the initiation methionine codon termed the
Shine-Dalgarno (SD), or ribosomal binding (RBS), sequence (Shine & Dalgarno,
1974). This sequence shows a variable degree of complementarity to a region of the
ribosomal 16S rRNA and differing rates of translation have been correlated with the
degree of complementarity between these two sequences (Atkins, 1979). In general, the
SD sequence contains at least four nucleotides from the partial consensus AGGAGG
placed between 5 and 9 residues from the initiation codon with the average distance
being 7 nucleotides. Eucaryotic messages need to be modified by the addition of an
appropriately spaced SD sequence upstream of their initiating codon.
Various other differences between the translation systems employed by pro- and eu¬
caryotic systems have also been noted. For example, differences in codon usage and
bias in the messages of these two systems are thought to reduce the translatability of
eucaryotic messages in a procaryote. This is seen in the usage of the codon AGA/AGG
to encode arginine incorporation in eucaryotic messages. In procaryotic systems the
cognate tRNAarg to these codons is not abundant and the ambient levels appear to be
associated with the replication rate in E. coli.. Thus, eucaryotic messages containing
high levels of this codon, taken to be levels above 35% of the arginine codons present
in the message, are not expressed well in E. coli and interfere with its replication
(Garcia et al., 1986; Ayares et al., 1986; Brinkman et al., 1989).
A problem more specific to the expression of eucaryotic P-450 in procaryotic systems
is the presence of the N-terminal hydrophobic membrane anchor sequence in the
eucaryotic protein absent in their soluble procaryotic counterparts (Section 5.3). Other
membrane attached eucaryotic proteins have however been successfully expressed in
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procaryotic systems and appear to be incorporated into the bacterial inner membrane
(Sarkar et al., 1988; Strittmatter et al., 1988). The soluble Bacillus megaterium
CYP102, BM-3, protein has been expressed in E. coli (Unger et al., 1986; Huiying et
al., 1991), and both the bovine 17a-hydroxylase P-450, CYP17, (Barnes et al.,
1991) and a fusion between a partial rabbit CYP2E1 cDNA and exon 1 of the rabbit
CYP2E1 gene (Larson et al., 1991) have been reported.
Section 5.6: The procaryotic expression systems used to generate Cyp2el protein
Two systems were used to generate the heterologous expression of Cyp2el in
procaryotic cells; the method of operation and use of these two systems is described.
Expression using a modified version of the pKK223-3 (Pharmacia) vector: the parent
pKK223-3 vector contains a promoter derived from the fusion of the bacterial trp gene
promoter and a synthetic DNA fragment containing a consensus -35 region, a partial
Pribnow box and a SD (Shine Dalgarno) and lac I operator sequence from the bacterial
lac UV5 gene ; collectively this promoter is termed the tacll promoter. If the host strain
harbouring this plasmid produces the repressor protein encoded by the lac I gene the
promoter is transcriptionally inactive but can be derepressed by the addition of
isopropylthio-P-D-galactosidase (IPTG) which leads to the release of the lac I encoded
repressor protein from the operator sequence (deBoer et al., 1983). The vector also
contains a procaryotic ribosomal terminator sequence (Brosius et al., 1981) and the
polycloning site of the pUC8 plasmid.
As a result of the intention to generate expression of the Cyp2el protein in
S. typhimurium, in order to potentially exploit the well characterised mutagenicity tests
available in this bacterium, a modified form of the vector was used. The vector requires
that the host strain contains an active lac I gene and it is recommended that a lac IQ
strain, that is a host with a mutation in the lac I gene leading to over-production of the
lac I encoded repressor, is used in conjunction with this vector. Through the
introduction of the lac 11 gene into the vector itself this requirement is circumvented
allowing it to be employed in any host strain. This modification has been performed
and the resultant plasmid is termed pKK223-3(mod) (kind gift, Dr I. Hunter,
Department of Genetics, Glasgow University).
Expression using the pET system, pET15b: The pET series of vectors place the
heterologous transcript under the control of the bacteriophage T7 transcription and
translational signals, as well as inserting an appropriately spaced SD sequence upstream
of the heterologous message; the T7 DNA dependent RNA polymerase
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(T7 "polymerase") is five times as efficient as its cognate E. coli protein, allowing the
generation of a high level of heterologous transcripts from genes recognised by the T7
polymerase (Studier et al., 1990). The gene encoding the T7 polymerase is placed
under the control of an derepressible promoter in the host cell, allowing the expression
of the T7 polymerase and so the heterologous transcript to be regulated. In this study
the host cell employed was the E. coli strain BL21(DE3)pLysE; DE3 encodes a
lysogen containing the T7 polymerase under the control of the lac UV5 promoter and
the lac I gene whose presence leads to the suppression of the T7 polymerase
transcripts by the lac operator until it is derepressed by the addition of IPTG. The
pET15b vector used in this study has been further refined by the additional inclusion of
a lac operator sequence downstream of the T7 promoter itself leading to further
repression of any heterologous transcripts in the repressed state. The pLysE plasmid
harboured by the BL21 strain confers chloramphenicol resistance and encodes the T7
lysozyme gene; T7 lysozyme is a bifunctional enzyme which firstly inhibits the small
amount of T7 polymerase enzymes which may escape lac repression and secondly cuts
specific cross-links in the host cell wall allowing easy lysis of the bacteria. The BL21
strain is also mutant in the Ion and Omp T protease genes and so has a reduced ability
to degrade both the heterologously expressed protein and the T7 polymerase (Grodberg
& Dun, 1988; Studier et al., 1990).
The use of helper phage systems generating integration of the DE3 lysogen allows the
potential use of other host strains, and so S. typhimurium (Studier et al., 1990).
In the pET15b vector a synthetic oligonucleotide within the polycloning site leads to the
addition of six histidine residues fused to the N-terminus of the heterologous protein.
The addition of this histidine "tag" facilitates subsequent purification of the
heterologously expressed protein through the use of nickel containing resins which
selectively bind these histidine residues; the presence of a thrombin recognition site
C-terminal to this histidine-tag allows the subsequent release of the native protein
(Hochuli etal., 1988; Keyse & Emslie, 1992).
Section 5.6.1: Cyp2el expression from the pKK223-3(mod) vector
The full-length Cyp2el cDNA was ligated into the EcoR I restriction endonuclease sites
of pKK223-3(mod); recombinant clones were determined by colony hybridisation
using the partial Cyp2el cDNA as a probe and the orientation of the clones determined
using diagnostic BamH I restriction endonuclease sites. On derepression of the host
cells, E. coli JM109, this construct was not seen to generate any Cyp2el protein as
assayed using polyclonal antibodies raised to purified rat CYP2E1 protein. The distance
between the vector SD sequence and the Cyp2el initiation codon is 22 base-pairs; the
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lack of Cyp2el protein generation potentially related to the presence of too large a
distance between these two elements to allow successful translation of the heterologous
transcript.
To generate constructs with a shorter intervening sequences between the SD sequence
and the initiation codon, oligonucleotides were generated to the N-, and C-terminals of
the Cyp2el cDNA. Both the N-, and C-terminal oligonucleotides were designed to
contain a Hind III restriction endonuclease site and in addition the N-terminal
oligonucleotide contained the SD and intervening sequence present in the E. coli lac Z
gene with the Cyp2el initiation codon consequently 7 base-pairs downstream. In
addition to the generation of the full-length Cyp2el protein two other constructs were
engineered in an attempt to make the encoded Cyp2el protein more like the procaryotic
P-450 proteins. Analysis of the N-terminus of the Cyp2el predicted amino acid
sequence using a Kyte and Doolittle Hydrophobicity plot programme (Genejockey,
Biosoft) shows the presence of an initial stretch of 23 hydrophobic amino acids
terminated by three charged residues and then a second stretch of 18 mainly
hydorophobic amino acids terminated by a charged residue (Figure 5.8). Alignment
comparisons of the N-terminal sequences of all the other CYP2E predicted amino acid
sequences shows that these motifs are conserved. In the human CYP2E1 however the
lysine and glutamic acid present in the other species as the first and second charged
residues are replaced by arginine and lysine, and in the rat and mouse proteins the third
positively charged residue (arginine and aspartic acid respectively) is displaced by one
amino acid more C-terminal from the analogous histidine residue in the rabbit and
human proteins. All these modifications however preserve the overall charge
conservation of the N-terminal region of the CYP2E subfamily proteins. The second
hydrophobic stretch is terminated by glutamic acid in all the predicted CYP2E
subfamily amino acid sequences (Figure 5.5). These observations are in keeping with
the proposed insertion of the N-terminus of the P-450 protein, either as a single anchor
or a hairpin-like loop, into the endoplasmic reticulum membrane. To generate a Cyp2el
protein potentially more like the cognate procaryotic soluble P-450 proteins, N-
terminus Cyp2el deletion mutants, lacking these proposed membrane attachment
regions, were generated. Cyp2el N-terminal coding region annealing oligonucleotides,
still containing the HindiII restriction endonuclease site and the lac Z SD sequence with
an appropriately spaced initiating methionine were generated which would produce N-
terminal truncated forms of the Cyp2el protein beginning at, after the initiating
methionine, trp 30 and leu 48 residues respectively.
These oligonucleotides were used in the polymerase chain reaction (PCR) with the
Cyp2el cDNA as a template. The PCR products generated were cloned into the
Hind III restriction endonuclease site of the phagemid vector pTZ18R (Pharmacia) to
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allow a-complementation selection of recombinants and generate clonal single-stranded
DNA PCR derived cDNA products for sequencing to confirm that the expected regions
of the Cyp2el cDNA had been amplified. The Cyp2el coding sequences and correctly
spaced SD sequence were then subcloned into the HindHI restriction endonuclease site
of pKK223-3(mod), recombinants were screened by colony hybridisation, and the
orientation of the cDNA determined by the use of the diagnostic Bam H I restriction
endonuclease sites.
The pKK223-3(mod) Cyp2el truncations, strategy and oligonucleotides employed in
the generation of these four pKK223-3(mod) vectors is shown in Figures 5.9 and 5.10
respectively. On IPTG induced derepression of the three constructs with reduced
intervening sequences in the E. coli JM109 host cell at 28°C, Cyp2el, and N-
terminally derived truncations ofCyp2el were detected after immunoblotting with the





Figure 5.8: Kyte and Doolittle protein hydrophobicity plots of: A: Cyp2el predicted
amino acid sequence. B: the first 45 amino acids of the Cyp2el sequence representing
the portion of the protein predicted to generate the N-terminal membrane anchor. The
Lys./Arg. and Asp. stops annotated and the 2 proposed transmembrane segments
underlined. The portion of the Cyp2el sequence illustrated in B is underlined in A. C:
CYP101(P450cam) amino acid sequence illustrating the lack of N-terminal
hydrophobicity in the soluble procaryotic P-450.
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Full-length Cyp2el:
Hind III Shine-Dalgarno MA V L G I
A ATC TCC CAA GCT TGG GAG GAA ACA GCT ATG GCG GTT CTT GGC ATC
T V A L A
ACC GTT GCC TTG CTT
Start at Trp 30:
Hind III Shine-Dalgarno ■ M W N L P P
A ATC TCC CAA GCT TGG GAG GAA ACA GCT ATG TGG AAC CTG CCC CCA
G P F P
GGA CCT TTC CCA
Start at Leu 48:
Hind III Shine-Dalgarno M L K D I P




Hind III Stop SRPI VCLVF
AA TCT CCC AAG CTT GGG TCA TGA ACG AGG AAT GAC ACA GAT TAC GAA
E R
TTC GCG
Figure 5.9: The oligonucleotides used to generate the full-length and 2, N-terminal
truncations of the Cyp2el cDNA for expression in E. coli by the pKK223-3(mod)
vector. The restriction endonuclease sites are annotated; the Shine-Dalgarno sites,




START AT Trp 30:





Figure 5.10: The cloning strategies employed to generate the 4 Cyp2el pKK223-
3(mod) constructs. The initiation (ATG) codon and restriction endonuclease sites in the
vector and insert fragments used for cloning are illustrated as are the Bam H I sites
which allowed the orientation of the insert within the vector. SD: Shine-Dalgarno
sequence, Rrn. term: ribosomal terminator sequence. The diagram is not to scale and
the pKK223-3(mod) vector is circular.
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Section 5.6.2: Cyp2el expression using the pET15b vector
To allow the generation of a Cyp2el protein direct from the Cyp2el cDNA the full-
length cDNA was also expressed in the pET15b vector. The full-length Cyp2el cDNA
was first cloned into the EcoR I restriction endonuclease site of the plasmid vector
pCITE-2a (Novogen); the recombinant clones were determined by colony hybridisation
using the partial Cyp2el cDNA as a probe and the orientation of the recombinant clones
determined using diagnostic BamH I restriction endonuclease sites. The pCITE-2a
plasmid vector has a large polycloning site allowing the subsequent excision of the
Cyp2el cDNA as an Nde 1/ Xho I restriction endonuclease fragment; this fragment
was then directionally subcloned into the appropriate restriction endonuclease sites of
the pET15b expression vector. This strategy allows the Cyp2el coding sequence, its 5'
untranslated region and associated restriction endonuclease cloning sites, to remain in
frame with the coding sequence of the histidine-tag and thrombin site present in the
pET15b vector. The protein generated will therefore contain an additional 32 amino acid
residues (Mr 3432). Another Cyp2el/pET15b construct was generated in which the
histidine-tag and thrombin site were removed.The portion of the construct encoding the
extra 32 amino acids and the 5' UTR of the Cyp2el cDNA was released as an Ncol
restriction endonuclease fragment and the construct religated, the loss of the Ncol
restriction endonuclease fragment was confirmed by the loss of a unique Nde I
restriction endonuclease site contained within the Ncol restriction endonuclease
fragment.
These manipulations were performed using E. coli JM109 as the host strain, the final
two constructs were then used to transform the expression E. coli host strain BL21
(DE3)pLysE. The BL21(DE3)pLysE host strain is rec +, unlike the JM109 strain, and
so has a much lower transformation efficiency and hence was not used during the
cloning stages of the pET15b/Cyp2el constructs. The strategies for construction of
these pET15b vectors are shown in Figure 5.11 and the nature of the coding sequences
resulting from this strategy are detailed in Figure 5.12.
On derepression of the T7 polymerase by IPTG addition, and subsequent generation of
Cyp2el transcripts, both these constructs generated immunodetectible Cyp2el protein.
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1: Cyp 2e1 from pBS SK II (-)
2: Cyp 2e1 cloned into pCITE-2a
3: Cyp 2e1 cloned into pET15b
His. Tag etc. removed from Cyp 2e1
Figure 5.11: The cloning strategy for the generation of the 2, Cyp2el constructs in
pET15b. Restriction endonuclease sites in the vector and insert fragments used for
cloning are illustrated as are the Bam H I sites which allowed the orientation of the
insert within the pCITE-2a vector. The Nco I site corresponds to the initiation
methionine of Cyp2el; the diagram is not to scale and the pET 15b vector is circular.
A: The construct which generated His. Tagged Cyp2el protein. B: The construct
which, following removal of the Nco I fragment and religation, removed all non-
Cyp2el coding regions.
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1; Cyp2el cDNA in pBS SK II (-):
tlcO Rl Not I 5' UTR
M A V
QAA TTC cgg gcg gcc gcc acc atg gcg gtt
Library Linker cDNA
Cyp2el cDNA cloned into the Eco R I site of pCITE-2a:
ttde I Bam HI Eco RI Not I 5'UTR
M A V
Cat atg gat atc gga tcc gaa TTC cgg gcg gcc gcc acc atg gcg gtt
pCITE 2a Library Linker cDNA
3; Cyp2el cloned into the Nde I / Xho I sites of pET15b:
Nqo I His. Tag Thrombin
M G S SHHHHHHS S GLVP
atg ggc agc agc cat cat cat cat cat cat agc agc ggc ctg gtg ccg
pET 15b
Site Nde I Bam HI Eco RI Not I 5' UTR
RGSHMDIGS ELRAAA T
CGC GGC AGC CAT ATG GAT ATC GGA TCC GAA TTC CGG GCG GCC GCC ACC
pCITE 2a Library Linker
Nco I
M A V
ATG GCG GTT ....
cDNA
Figure 5.12: The nature of the coding sequences generated as a result of the cloning
strategy employed to generate the Cyp2el/ pET15b constructs; the strategy progressed
chronologically from 1 to 3 (See Ligure 5.1 1). The Nco I fragment with an internal
diagnostic Nde I site which allowed the removal of all non-Cyp2el coding sequence
from the N-terminal of the protein are illustrated in stage 3.
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Section 5.6.3: Subcellular localisation of the Cyp2el proteins and N-terminal
truncations and relative levels of protein production in the two expression systems
Subcellular fractions from the three pKK223-3/Cyp2el and histidine-tagged pET15b
constructs were prepared to analyse the localisation of the Cyp2el protein. The
derepressed cells expressing the various Cyp2el constructs were harvested by
centrifugation, resuspended in a sucrose buffer and then disrupted by passage through
a French Press; enriched membrane fractions were prepared using a modification of the
method of Yoshida and Aoyoma (1984). The cell debris, consisting of whole cells and
large cellular components such as the cell walls, were removed by a 5,000g
centrifugation and a membrane enriched fraction was then sedimented from the resultant
supernatant by two periods of ultracentrifugation at 100,000g and resuspension in
sucrose buffer to remove associated cytosolic proteins. The two crude fractions were
then assessed for the presence of the Cyp2el protein by immunoblotting using the
polyclonal antibody raised against purified rat CYP2E1 protein. The results from these
studies are shown in Figure 5.13.
The full-length protein generated in pKK223-3(mod) appeared to be directed
predominantly to the membrane enriched fraction with a relatively small amount being
present in the cellular debris. In contrast, the two truncated Cyp2el forms generated
from this vector locate proportionately more in the cell debris with a smaller proportion
being associated with the membrane enriched fraction. The truncated Cyp2el protein
forms appear to have been attacked by host cell proteolytic degradation systems,
products of which are seen in the cell debris fraction. The observation that the truncated
forms of the Cyp2el protein still associate with the membrane enriched fraction, and
may therefore still be attached to the membrane, is intriguing. The currently accepted
model for eucaryotic P-450 membrane insertion suggests that a helical-hairpin,
generated by the two hydrophobic stretches removed in the Cyp2el truncations, pass
through the membrane holding the rest of the enzyme within the cytosol; this membrane
attachment region is postulated to represent the only divergence between a common
protein structure adopted by the eucaryotic P-450 and their soluble procaryotic
counterparts (Nelson & Strobel, 1988). A similar result was seen in the expression of
a rabbit CYP2E1 partial cDNA and exon 1 gene fusion; an N-terminal truncation
initiating at amino acid 29, the equivalent of the removal of the first predicted membrane
span in the pKK223-3(mod) trp 30 Cyp2el construct, resulted in a protein which was
still membrane associated (Larson et al., 1991). Membrane attachment may still be
mediated by the second hydrophobic amino acid stretch in these constructs, this
however is not a possibility in the pKK223-3(mod) leu 48 Cyp2el truncation construct
in which both the predicted membrane spanning regions have been removed. Other
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models for P-450 membrane association have postulated the existence of up to 10 trans¬
membrane helices (Hudecek & Anzenbacher, 1988); the observed membrane
association of the Cyp2el truncation without either of the proposed membrane
spanning regions may however not be the result of membrane spanning regions per se
but the effect of strong membrane associations with some of the regions of
hydrophobicity spread along the length of the protein (Figure 5.8). It would be
predicted that, for energetic reasons, these hydrophobic regions of the protein would be
held within the interstices of the P-450 molecule but some may be present on the
surface of the structures and so interact with the membrane.
One problem commonly encountered in the heterologous expression of proteins in
procaryotic systems is that of "inclusion body" formation. Inclusion bodies are formed
from aggregates of insoluble heterologous protein, and several host proteins such as
ribosomal and RNA polymerase subunits, which become sequestered in the bacterial
cytoplasm. The processes leading to the formation of inclusion bodies are unclear and
may not solely relate to the level of heterologous protein produced although this factor
does play a clear role; the proteins within the inclusion body are effectively extracellular
and as such are not acted upon by the degradational systems within the cell (Schein,
1989; Shoemacker et al., 1989). When the morphology of the host cells expressing
Cyp2el protein was viewed using light microscopy, it appeared the same as that
observed in cells not containing the pKK223-3(mod) constructs. The lack of a
filamentous appearance or the presence of refractile granules in the E. coli cells
expressing Cyp2el protein suggests that the constructs have not generated inclusion
bodies. The fact that the truncated Cyp2el forms are being degraded by the host
proteolytic systems also suggests that they have not become precipitated into inclusion
bodies as this event would have made them resistant to proteolytic attack.
The different pKK223-3 Cyp2el constructs generated different levels of Cyp2el
protein; the progressive N-terminal truncation of the Cyp2el cDNA leads to an increase
in the levels of Cyp2el protein produced even though identical promoter and associated
sequences are present in each instance. This observation may be accounted for by the
context of the codon encoding the first methionine; sequences which generate an
unstructured environment surrounding the initiation codon, such as a poly-adenosine
region, lead to higher levels of heterologous protein translation (Balbas & Boliva,
1990). The codons adjacent to the initiating methionine have also been seen to affect the
levels of resulting protein translation; it was seen that the presence of adenosine and
uridine residues at positions 4 and 5 (Stormo et al., 1982), and similarly GCT
(alanine) as the second codon (Looman et al., 1987) increased the level of protein
expression . The first six codons of the three Cyp2el pKK223-3 constructs are shown
in Figure 5.9; the most truncated -49 amino acid construct generates a message
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containing the highest uridine and adenosine content, and with 50% adenosine in
codons 4 and 5 suggesting that these features may relate to the higher protein levels
produced. No protein expression was produced from the native bovine CYP17 cDNA
until such modifications were introduced to these regions of the transcript (Barnes
et al., 1991). In contrast to the suggested effect of alanine as the second codon
increasing the level of expression of a protein, the full-length construct is the only
Cyp2el message, with the lowest level of expression, which contains alanine in codon
two (Figure 5.9). These two observations highlight the problems associated in
attempting to make generalisations in the factors in a transcript which affect the level of
protein that will be expressed.
The majority of the Cyp2el protein generated from the pET15b vector was seen to be
present in the cell debris and relatively little associated with the membrane enriched
fraction (Figure 5.13). The level of full-length protein generated from the T7 promoter
is higher than that from the pKK223-3(mod) construct due to the higher efficiency of
the T7 polymerase. Removal of the 32 amino acid leader in the second Nco I cut
pET15b construct did not affect either the level, or cellular localisation of the Cyp2el
protein produced. The cellular localisation and observed lack of degradation, in
association with a differing morphology in the pET15b Cyp2el expressing host cells
when viewed under light-microscopy, suggests that the majority of Cyp2el protein
produced by this vector is present in inclusion bodies. The use of the pET15b Cyp2el
expression vector constructs in the study of the mutagenicity of Cyp2el would
therefore be negligible. The histidine-tagged construct could allow however the rapid
single step purification of the Cyp2el protein through the use of a nickel agarose
affinity column (Keyse & Emslie, 1992); this may allow the production of an antibody
specific to the mouse Cyp2el protein removing the problem of cross-reactivity present
when the rat CYP2E1 polyclonal antibody is used in some tissues in the mouse (Figure
4.3 and 4.4 ).
The pKK223-3(mod)Cyp2el constructs could potentially be used therefore in
mutagenicity testing to be carried out in S. typhimurium. Although some success has
been obtained in regenerating active proteins from inclusion bodies (Marston, 1986;
Sammuelsson et al., 1991) this approach would not be relevant in the case of the pET
constructs, with their production of Cyp2el inclusion bodies, as this would not allow
the direct use active intracellular Cyp2el protein in mutagenicity testing.
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A pKK223-3(mod) pKK223-3(mod) phi 15bA. Cyp2el Cyp2el
' HI II-
HP MEF HP MEF HP MEF
46.(KK)
START TRP 30 START LEU 4H
Figure 5.13:The subcellular localisation of the Cyp2el protein expressed in E. coli
determined using the polyclonal antibody raised to purified rat CYP2E1 protein.
HP: "Heavy pellet", the protein fraction containing cell walls, whole cells and
insoluble material isolated following low speed centrifugation of French pressed
samples. MEF: Membrane enriched fraction, isolated after two ultracentrifugation
steps of the supernatant resulting from the initial low spped centrifugation. lOpg of
protein was loaded in each track. A: From left to right: Full-length Cyp2el generated
from pKK223-3(mod), control E. coli protein from cells transformed with pKK223-
3(mod) alone and pET15b/Cyp2el+ His.Tag transformed cells. B: The 2 N-terminal
truncations of Cyp2el in pKK223-3(mod).
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Section 5.6.4: Transformation of S. typhimurium strains with the pKK223-3(mod)
Cyp2el constructs
The pKK223-3(mod) Cyp2el constructs were used to transform the S. typhimurium
strains TA1538 and LR5000 by electroporation. The constructs were also used to
transform the BL21(DE3)pLysE E. coli strain to investigate if higher levels of
expression could be produced in E. coli strains other than JM109. The host cells were
lysed by sonication and the level of Cyp2el protein generated assayed by
immunoblotting of equal protein concentrations of total host cell protein (Figure 5.14).
It is clear that the pKK223-3(mod) constructs will generate Cyp2el protein in S.
typhimurium with the highest levels being produced by the LR5000 strain; the
BL21(DE3)pLysE E.coli strain produced relatively less Cyp2el protein than the
JM109 strain. These observations also applied to the truncated versions of the
pKK223-3(mod) Cyp2el constructs.
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Figure 5.14: The detection of full-length Cyp2el protein produced from the
pKK223-3(mod) Cyp2el construct in S. typhimurium and E. coli determined using
polyclonal antibodies raised to purified rat CYP2E1 protein. The bacteria, as stated,
were transformed with either the pKK223-3(mod) Cyp2el construct in the correct,
FOR., or reverse, REV. , orientation for expression of the Cyp2el protein. The cells
were disrupted by sonication and lOjig of total cellular protein was loaded per track.
HEAT SHOCK LOW TEMPERATURE
, II 1
KIDNEY REV. REV. FOR. FOR. CON. CON. REV. REV. FOR. FOR. KIDNEY
Figure 5.17: The detection of N-terminally truncated Cyp2el protein produced from
the pKK223-3(mod) Trp 30 Cyp2el construct in E. coli. using polyclonal antibodies
raised to purified rat CYP2E1 protein. Heat shock: The cells were heated at 42°C
prior to derepression of the tac 11 promoter. Low temperature: The cells were
incubated at 20°C following derepression of the tac II promoter. The bacteria, were
transformed with either the construct in the correct, FOR., or reverse, REV. ,
orientation for expression of the Cyp2el protein. The cells were disrupted by
sonication and lOpg of total cellular protein was loaded per track.
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Section 5.6.5: Spectral and metabolic activity of the heterologously expressed
Cyp2el proteins
The presence of a haem group within a P-450 holoenzyme can be detected on analysis
of the "reduced-difference" spectra. The reduction of the haem group and the analysis
of the absorbence spectra produced on binding of carbon monoxide to the haem relative
to non-carbon monoxide bound haem leads to an absorbence peak at 450 nm if haem
is present (Omura & Sato, 1962).
In the heterologous expression of bovine CYP17 in E. coli it was demonstrated that a
reduced difference spectra could be produced from whole host cells expressing
mammalian P-450 protein (Barnes et al., 1991). This approach was repeated using
whole cell expressing Cyp2el from the pKK223-3(mod) Cyp2el constructs in both
E. coli and S. typhimurium strains and the pET15b Cyp2el expressing E. coli strain
constructs, but no peak could be detected at 450 nm. A large absorbence trough was
detected proceeding from 460 nm and extending to around 430 nm where a peak rose at
approximately 415 nm. These spectral features were observed in S. typhimurium and
E. coli cells whether they were expressing Cyp2el protein or not (Figure 5.15).
Analysis of the cell debris and membrane enriched fractions of all the cells expressing
constructs did not reveal a 450 nm peak and no difference in the spectra produced by
the expressing and non-expressing hosts was obtained. This spectral pattern detected in
the cells expressing Cyp2el was observed in the examination of the cell membranes of
E. coli expressing a rabbit CYP2E1 cDNA and gene fusion (Larson et al., 1991); it is
not clear why it was not recorded in the spectra obtained from whole E. coli cells
expressing bovine CYP17 protein (Barnes etal., 1991).
The spectral patterns seen in the cell preparations are diagnostic of host endogenous
cytochromes; the patterns produced suggest the presence of a membrane bound
cytochrome oxidase, or cytochrome-o, which generates a peak between 410-419 nm
and a trough between 560-547 nm in variety of bacteria studied (Chance, 1961; Revsin
& Brodie, 1969; Miller & Gennis, 1983). In common with the P-450 cytochromes,
cytochrome oxidase contains a protohaem prosthetic group; both cytochrome groups
are therefore classed as b-type cytochromes (Lemberg & Barret, 1973). The study
expressing rabbit CYP2E1 protein also noted an absorbence minium at 444 nm within
the area of the cytochrome oxidase trough indicative of bacterial cytochrome-d; this
cytochrome contains a dihydroporphyrin prosthetic group and is expressed when
oxygen becomes limiting during log or stationary phases of growth (Kita et al.,
1984a, Kita et al., 1984b ), the cultures used for the Cyp2el expression were well


















Figure 5.15: Analysis of the heterologously expressed Cyp2el protein for haem
content by reduced difference spectroscopy. A: The reduced difference spectra
produced by whole E. coli expressing Cyp2el. B: The reduced difference spectra
produced by the membrane enriched fraction of E. coli expressing Cyp2el (2mg/ml).
The trough proceeding from 460nm and terminating in a peak at 415nm is characteristic
of cytochrome-o (Cyt.-o). C: The reduced difference spectra produced by rat liver
microsomes (2mg/ml) demonstrating the characteristic 450nm and 420nm peaks of
haem containing P-450 holoenzyme.
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The fractions prepared from the expressing strains were tested for their ability to
hydroxylate p-nitrophenol, a substrate for the CYP2E subfamily (Reinke & Moyer,
1985; Koop et al., 1989). The supernatant obtained from the initial 5,000g
centrifugation step in fraction preparation was seen to provide reducing equivalents to
the bovine CYP17 protein expressed in E. coli when added at a ratio of 1:1 by protein
concentration to the assay mixture (Barnes et al, 1991) and this fraction was added to
the p-nitrophenol assay mixture. None of the fractions produced any detectable
p-nitrophenol hydroxylation, suggesting that the Cyp2el protein produced is not
metabolically active.
The spectral characteristics of the heterologous Cyp2el protein generated suggest that,
although the apoprotein can be detected immunologically, the protein produced is not
incorporating a protohaem iron prosthetic group. Poor haem incorporation into P-450
apoprotein has been a common phenomenon in yeast (Oeda et al., 1985; Murakami
et al., 1986; Murakami et al., 1987; Fujita et al., 1990) and bacculoviral (Asseffa
etal., 1989) expression systems.
Section 5.6.6: Increasing the protohaem incorporation in the Cyp2el protein
It is thought that the incorporation of the protohaem moiety into the apoprotein is not
enzymatically catalysed (Tokunga & Sano, 1966). The protohaem prosthetic group
appears to be lost and regained by the P-450 apoprotein as demonstrated by the relative
half lifes of the protohaem (short) and apoprotein (long) moieties in pulse-chase studies
(Section 4.7.1). This suggests that the loss of the protohaem does not lead to the
complete deformation of the apoprotein structure allowing its reincorporation. It may
however be the case that the initial generation of the P-450 structure needs the presence
of the protohaem, with its contribution of a large hydrophobic surface within the
molecule, in order to fold correctly. If this is the case initial protohaem incorporation in
the P-450 apoprotein molecule may be the key to generating a correctly folded molecule
capable of protohaem incorporation and exchange.
In an attempt to increase initial haem incorporation into the Cyp2el apoprotein the
levels of protohaem within the host cells were elevated. Protohaem is generated through
a series of steps in bacteria from glycine and succinyl-CoA precursors and the basic
pathway for its generation is thought to be the same in all organisms (Barret, 1969). In
a bacculoviral expression system the level of protohaem incorporation into heterologous
P-450 apoprotein could be increased by the addition of hemin although this
predominantly produced an absorbence spectra at 420 nm suggested to be indicative of
a loss of P-450 structure (Asseffa et al., 1990). This could not be used in the case of
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bacterial expression however as both S. typhimurium and E. coli are not capable of
taking up extracellular hemin (Sarsaman et al., 1970).
Studies on S. typhimurium (Sarsaman etal., 1970) and E.coli (Wulf, 1964) mutants
deficient in the generation of haem prosthetic groups showed that cytochromes could be
produced following addition of the porphobilogen precursor 8-aminolaevulinic acid
(8ALA). The production of 8ALA is suggested to be the key regulatory step in the
production of protohaem and may be controlled by the ambient protohaem levels in a
cell (Burnham & Lascelles, 1963).
8ALA was added to the bacterial cultures at a concentration of 6 x 10"6 M, the
concentration previously used by Wulf (1964), prior to the derepression of the Cyp2el
constructs and membrane enriched fractions were prepared. Addition of 8ALA to the
cultures produced a profound effect on the levels of the endogenous bacterial
cytochromes; the membrane enriched fractions were a deep red compared to the control
cultures paler appearance and an increased absorbence trough and peak were detected.
However, a peak at 450 nm could still not be detected in the difference spectra
produced (Figure 5.16). The bacterial cytochrome-o , in common with P-450, contains
a protohaem prosthetic group. This demonstrated that addition of 8ALA to the bacterial
culture medium leads to increased protohaem incorporation into the endogenous
cytochrome-o, but not the heterologously expressed Cyp2el protein. This suggests
that the lack of protohaem incorporation into the Cyp2el protein relates to an inability
of the hosts to correctly insert the protohaem group rather than to a lack of protohaem
groups available per se . If this is the case then the lack of protohaem in the Cyp2el
apoprotein may relate to the nature of the heterologous protein folding in the host cell
and this possibility was investigated.
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Figure 5.16: Analysis of the effect on the reduced difference spectra of the addition
of S-aminolaevulinic acid (6ALA) to the grown media of E. coli expressing Cyp2el
protein. A: The reduced difference spectra produced by the membrane enriched fraction
(lmg/ml) of E. coli expressing Cyp2el in the absence of 6ALA in the media. B: The
reduced difference spectra produced by the membrane enriched fraction (lmg/ml) of E.
coli expressing Cyp2el with 6ALA in the media; the massive increase in the peak at
415nm may be indicative of an elevation of cytochrome-o content in the samples.
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Section 5.6.7: Cyp2el folding and protohaem incorporation
The lack of protohaem incorporation into the Cyp2el protein may reflect the lack of
presentation of a structure into which the prosthetic group can become correctly
inserted; the completion of the P-450 folding may then follow the prosthetic group
insertion.
The processes leading to the folding of a protein are not clearly understood and are
thought to be mainly driven by the energetic driving force of hydrophobic portions of
the protein coalescing to escape the ionic cytoplasmic environment with the secondary
structural motifs then formed by a shuffling of possible structural permutations within
this complex until the most stable form is generated. This process is complicated by
prosthetic group addition which may sterically limit the degree of such structural
permutations and this may be the case in the generation of the P-450 protein structure
(Gething & Sambrook, 1992).
Although many denatured proteins can be successfully refolded in vitro, suggesting that
the information for correct folding is present within the primary sequence of the
polypeptide itself, other controls impinge upon and further complicate folding; an
example of the factors associated with protein folding within a cell are the molecular
"chaperone" proteins (Georgolopoulos, 1992; Gething & Sambrook, 1992). Within
E. coli the chaperone proteins DnaK and GroEL, which are thought to be the equivalent
of the mammalian heat-shock proteins hsp70 and hsp60, interact with the nascent
protein as it is generated by the ribosome and promote its correct folding. These
proteins are thought to exert their action possibly by holding the nascent protein within
a hydrophobic environment and preventing the aggregation and precipitation of
unfolded proteins (Beckmann et al., 1990). Chaperones are also thought to recognise
particularly hydrophobic portions of a protein, such as membrane insertion or secretion
signals, and bind them to prevent their incorporation into the rest of the protein
structure (Randall & Hardy, 1986; Chiroco et al., 1986). Chaperone levels are seen to
be induced in cells with an increased amount of incorrectly folded protein for example
following a heat-shock, potentially to facilitate the correct refolding of the proteins
(Parsell & Sauer, 1989).
If the Cyp2el apoprotein is being incorrectly folded some diagnostic features may be
expected in the resultant protein generated. In procaryotic systems it is suggested that
proteolytic attack is initiated principally on proteins present in an unfolded, or
incorrectly folded, state and studies have shown that the introduction of amino acid
mutations within a protein which inhibit its correct folding lead to increased proteolysis
(Parsell & Sauer, 1989; Parsell & Sauer 1990; Parsell et al., 1989). Other features of a
protein, such the nature of the N-, and C-termini, have also been associated with
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stability in bacteria (Bachmair et al., 1986). Previously it had been suggested that E.coli
mutants lacking DnaK were deficient in proteolysis (Strauss et al., 1988) but now it is
apparent that the lack of chaperone molecules leads to the generation of insoluble
protein aggregates, as they are unable to fold correctly, leading to inclusion body
formation and resistance to proteolysis (Parsell & Sauer, 1989). Particularly in the case
of the truncated forms of the pKK223-3(mod) generated Cyp2el proteins it is clear that
the expressed protein is subject to proteolytic attack and so possibly incorrectly folded.
The relative resistance of the full-length construct to proteolysis, in the absence of
morphological changes associated with inclusion body formation, suggests that the
presence of the membrane insertion signal may encourage binding by chaperones
facilitating its correct folding. This suggestion does not apply to the pET15b Cyp2el
constructs where the protein formed inclusion bodies and so is resistant to proteolytic
attack (Figure 5.13).
In an attempt to increase the level of correctly folded Cyp2el molecules and so the
possibility of protohaem incorporation, chaperone proteins were induced within the
host cells by a period of heat-shock at 42 °C (Parsell & Sauer, 1990a) prior to
derepression of the Cyp2el expression constructs. In an additional experiment by
culturing the expressing cells at 20 °C it was hoped that by slowing the folding of the
heterologous Cyp2el protein the generation of correct folding and protohaem
incorporation may be encouraged. Neither of these approaches however generated any
increase in the level of protohaem incorporation measured by difference spectra, or
appeared to generate a more correctly folded apoprotein structure as assayed by the
level of proteolysis acting upon the truncated Cyp2el constructs (Figure 5.17).
Section 5.6.8: Why does the rabbit CYP2E1 apoprotein, unlike the mouse Cyp2el
protein, incorporate protohaem upon heterologous expression ?
It is not clear why rabbit CYP2E1 and mouse Cyp2el, two highly similar P-450
proteins possessing 79% amino acid identity (Table 5.1), should behave so differently
in virtually identical heterologous expression systems (Table 5.4). One possibility is
that a very fine balance exists as a result of the levels of protein produced by the
expression vector between a swamping of the ability of the host cell to fold the protein
correctly and allowing enough protein to be produced to enable detectable levels of P-
450 holoenzyme to be generated. The extremes of this scale may be predicted to be
inclusion body formation as the result of excess heterologous protein generation (as
noted in the use of the pET15b Cyp2el constructs) and undetectable haem levels as the
result of insufficient heterologous protein levels (as seen in the case of the pKK223-
3(mod) Cyp2el constructs. It may be the case therefore that the rabbit CYP2E1 cDNA,
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in common with the bovine CYP17 expression system, as a result potentially of
structural differences spread across the protein, has satisfied the requirements of this
fine balance and is producing protein at a rate and level to allow correct folding and
protohaem incorporation to be detected.
Table 5.4: The vectors employed and conditions which have generated the successful
expression of mammalian P-450 proteins in procaryotic systems to-date compared with
the conditions used with the pKK233-3(mod) constructs in this study:
P-450 produced Vector Promoter E.coli Growth Derepression Ref.
Rabbit CYP2E1 pKK3a (pKK223-3
derived by addition
of pUC origin of
replication to increase
copy number).
Bovine CYP17 pCWOri+ (contains













ImM IPTG Barnes, et al.
1991.
tac II JM109 28°C ImM IPTG
The lack of protohaem incorporation into heterologously produced P-450 proteins has
hindered both yeast (Oeda et al., 1985; Murakami et al., 1986; Murakami et al., 1987;
Fujita et al., 1990) and bacculoviral (Asseffa et al., 1989) heterologous expression
systems. Low levels of protohaem incorporation clearly also occur in the use of
procaryotic expression systems to study P-450 activity and this phenomena has been
observed in connection with other P-450 isoforms expressed in similar procaryotic
systems in this laboratory. Some workers have stated that mammalian P-450 can not be
functionally expressed in procaryotic systems (Cullin & Pompon, 1988) although the
possibility of generating functional mammalian P-450 in procaryotic systems has now
been demonstrated (Barnes et al., 1991; Larson et al., 1991). The paucity of data
relating to the use of procaryotic expression systems to study mammalian P-450
activities, given its extremely tantalising potential in relation to mutagenicity testing,
suggests that the production of inactive apoprotein P-450 unable to incorporate
protohaem may not be an uncommon phenomenon. The production of functional P-450
protein may require that a unique set of experimental conditions may need to be
correctly generated.
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Section 5.7: The expression of Cyp2el in Saccharomyces cerevisiae
Although it is feasible to produce active mammalian P-450 in procaryotic heterologous
expression systems (Barnes et al., 1991; Larson et al., 1991), it is possible that a fine
balance between the protein levels produced, correct folding and haem incorporation
may have to be met before sufficient levels of active P-450 are generated. The
difficulties associated with heterologous expression of a mammalian membrane bound
P-450 protein in bacteria may relate to the differences in the structure and
compartmentalisation encountered in the procaryotic system whose own endogenous
P-450 enzymes are soluble. By employing the yeast S.cerevisiae as a host in which to
heterologously express mammalian P-450 some of the problems associated with these
procaryotic differences may be surmounted.
The aims of expressing Cyp2el protein in yeast would be the same as those discussed
in connection with procaryotic expression, that is to allow the study of the potential
role the CYP2E subfamily plays in the activation and metabolism of a series of common
chemicals and carcinogens through the use of mutational assays.
Section 5.7.1: The use of S. cerevisiae in mammalian P-450 heterologous
expression and mutagenicity testing
S. cerevisiae contain the endogenous endoplasmic attached P-450 molecule P450i4DM
(CYP51), a lanosterol 14 a-demethylase involved in the synthesis of membrane
sterols. This enzyme forms the target for the antifungal properties of ketoconazole and
itrakonazole (Yoshida & Aoyama, 1987). S. cerevisiae has also been shown to
possess a membrane bound NADPH P-450 reductase and cytochrome b 5 protein both
of which donate reducing equivalents to P-450 (Hata et al., 1983; Kapelli, 1986). The
levels of endogenous P-450 present is dependent on the fermentative state of the yeast;
low levels of P-450 are seen when the cells are grown in low concentrations of glucose
(below 2.5% w/v) but rise as glucose levels are elevated (Wiseman et al., 1985).
Unlike the procaryotic heterologous expression systems S. cerevisiae is capable of
recognising and translating mammalian messages usually without the initial need for
any modification of a mammalian cDNA sequence. Using this system a variety of
mammalian P-450 enzymes have been expressed and these studies have shown that the
S. cerevisiae recognise the mammalian membrane insertion signal and that the
endogenous P-450 support proteins are capable of reducing the heterologous P-450
enzymes (Guengerich et al., 1991).
Mutation assay systems have been established using S. cerevisiae as a target for
genotoxic damage assessment and a number of chemicals have been studied in this
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manner. These systems operate on similar principals to those described in connection
with bacterial mutagenicity testing and rely on the chemical damage to produce an
assayable mutation within the S. cerevisiae and other fungal genomes. An example of a
mutation assay system in S. cerevisiae is the generation of mutations in the arginine
permease gene (CAN 1 ) which leads to resistance to the arginine analogue
L-canavanine (Whelan et al., 1979). Mutagenicity assays in S. cerevisiae also suffers
from the shortfalls associated with the procaryotic mutation systems principal amongst
these being that many chemicals tested require extracellular activation and cellular
penetration before a mutagenic response is initiated. Extracellular activation systems
employing mammalian microsomal fractions have been used in an attempt to overcome
this failing. Yeast mutagenicity assay systems were seen to be less sensitive than those
employing procaryotes and required much higher minimal concentrations of test
chemicals before a mutagenic response was elicited. The reduced sensitivity of yeast to
mutagenicity was suggested to relate to the presence of complex endogenous
detoxification systems (Cullen & Philpot, 1977; Zimmerman et al., 1984). In a similar
manner to that seen using procaryotic systems, many of the nitrosamines tested in
S. cerevisiae did not generate significant mutagenicity in these systems in spite of their
clear carcinogenic actions in vivo in mammalian studies ( Larimer et al., 1978; Mehta
& VanBorstel, 1984).
The intracellular heterologous expression of enzymes which may be responsible for the
activation of chemicals in S. cerevisiae may circumvent the problems associated with
the extracellular generation of the reactive metabolites in a similar manner to that
proposed in the procaryotic system(Section 5.5.1). By combining the heterologous
expression of rat CYP2B1 and a mutagenicity assay in S. cerevisiae, it was shown that
the mutagenicity of cyclophosphamide, a chemotherapeutic agent, and sterigmatocystin,
a carcinogenic mycotoxin, are elevated in the CYP2B1 expressing cells demonstrating
the efficacy of such an approach (Black et al., 1989).
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Section 5.7.2: Expression of Cyp2el protein in S. cerevisiae
The vectors employed to express the Cyp2el cDNA in S. cerevisiae were episomal and
based on the 2(1 plasmid, an endogenous plasmid present in most strains at around 100
copies per haploid genome. The 2|i plasmid is modified in the expression vectors by
the inclusion of a S. cerevisiae gene promoter region, a selectable marker for cells
carrying the plasmid and in some cases a terminator region of a yeast gene to allow
efficient termination and poly-(A) addition of the heterologous message to occur. The
selectable markers employed in the expression vectors often take the form of genes
which allow complementation of auxotrophic mutations present in the host cells. Most
of the promoters employed in S. cerevisiae vectors are derived from highly expressed
glycolytic enzymes and can either be constitutively or inducibly transcriptionally
activated (Romanos etal., 1992).
Four vectors were used to generate expression of Cyp2el in S. cerevisiae :
The pMA56 plasmid: This vector contains an alcohol dehydrogenase I (ADC1 or
ADH1) promoter which has constitutive transcriptional activity when the host is grown
in the presence of glucose. The Cyp2el cDNA was cloned into an EcoR I restriction
endonuclease site downstream of the ADC1 promoter and the orientation of the insert
was established using diagnostic BamH I restriction endonuclease sites. No specific
terminator regions were engineered into the vector but transcripts produced from the
ADC1 promoter have been shown to terminate as a result of signals contained within
an adjacent interrupted 2|i FLP gene which previously encoded a site-specific
recombinase. The vector carries the TRP1 gene and is selected in the absence
tryptophan (Ammerer, 1983).
The pVTlOOU phagemid: This vector contains a slightly smaller fragment of the same
alcohol dehydrogenase I gene as used in the pMA56 vector. The Cyp2el cDNA was
directionally cloned into Xba I and Hind III restriction endonuclease sites downstream
of the promoter. The heterologous transcript is terminated and poly-(A) added as a
result of the termination sequence of the ADH 1 gene placed downstream from the
cloning site. The plasmid carries a IJRA 3 gene and is selected in the absence of uracil
(Vernet etal., 1987).
The pYeDPl/10-1 plasmid: This vector contains a phosphoglycerate kinase promoter
(PGK) which has constitutive transcriptional activity in the presence of glucose. The
vector was digested with Bgl II restriction endonuclease and the resultant 3' recessed
DNA termini were then end-filled to generate flush, "blunt", 3' and 5' termini using
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the Klenow fragment. The Cyp2el cDNA contains an internal Bglll restriction
endonuclease site and also cannot be excised from the pBS SKII(-) plasmid to yield
blunt-ends with the restriction sites available. The Cyp2el cDNA was released as an
EcoR I restriction endonuclease fragment which was treated with the Klenow fragment
to end-fill the recessed 3' DNA termini generated. The end-filled vector and cDNA
were ligated and the orientation of the Cyp2el cDNA was determined using a
diagnostic BamH I restriction endonuclease site. The transcript is terminated by the
inclusion of signals from the downstream region of the PGK gene (Cullin & Pompon,
1988). This vector was derived from the pMA91 vector and contains the same promoter
and terminator sequences present in the pMA91 plasmid (Mellor et al., 1983; Cullin &
Pompon, 1988); the pMA91 vector has been successfully employed to generate the
heterologous expression of a variety of mammalian P-450 proteins (Guengerich et al.,
1991)
The YepGAL plasmid: This vector contains a hybrid promoter constructed from the
GAL1 and GAL10 genes which are involved in the metabolism of galactose. This
promoter is transcriptionally active only in the presence of galactose; in the absence of
galactose the transactivator of the GAL genes, GAL4, is bound by the repressor
GAL80; in the presence of galactose this interaction is lost and the transactivator binds
the promoter and generates transcription. Transcription is initiated from the promoter by
growing the host cells in the presence of galactose (Geitz & Sugino, 1988). The
Cyp2el cDNA was directionally cloned into the Xbal and Hindlll restriction
endonuclease sites of the YepGAL vector. The plasmid does not carry a formal
transcript terminator region and contains the tryptophan selectable TRP1 gene. The
plasmid was the kind gift of Dr A. Boyd, Department of Biochemistry, University of
Edinburgh.
The vectors, relevant restriction endonuclease sites and cloning strategy employed in
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Figure 5.18: The cloning strategies employed to generate the 4 Cyp2el constructs for
the expression of Cyp2el protein in S. cerevisiae.. The restriction endonuclease sites
in the vector and inserts used for cloning are illustrated as are the Bam H I sites which
allowed the orientation of the insert within the vector. PROM: Promoter TERM:
Terminator. The diagram is not to scale and the vectors are circular.
A: pMA56. B: pVTlOOU. C: pYeDPl/10. D: YepGal.
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The constructs were used to transform S. cerevisiae strains and the relevant
auxotrophic selection applied. Cells were also transformed with the parental vector
alone and if available the construct containing the Cyp2el cDNA in the reverse
orientation. The pMA56, pVTlOOU, and YepGAL constructs were used to transform
the S. cerevisiae KYI 18 strain which has been employed previously in mutagenicity
assays. This strain has been shown to possess very low levels of endogenous P-450
which may otherwise potentially interfere with the activation of mutagenic chemicals
(Black et al., 1989). The pYeDPl/10-1 construct was used to transform the
S. cerevisiae W3031B strain which has previously been seen to generate P-450
protein expression in combination with this vector (Cullin & Pompon, 1988). As all the
constructs were selectable either in the absence of tryptophan or uracil the growth
medium could be supplemented by the addition of the acid protein hydrolysates
casamino acids (CAA); CAA lack these nutrients and their inclusion in the culture
medium increases the growth rate and protein synthesis of S. cerevisiae. Cells were
harvested from these cultures when they obtained an optical density at 600 nm (ODgoo)
of 0.4, 0.6, 0.8 and 1.0 which were taken to represent early, mid and late logarithmic,
and stationary growth phases respectively. Total cellular protein was prepared after the
cells were disrupted using glass-beads and samples containing equal protein
concentrations were subjected to Western blotting and the potential heterologous
expression of Cyp2el protein assessed using the polyclonal antibody raised against
purified rat CYP2E1 protein. Cyp2el protein could only be detected in the cells
transformed with the pMA56 construct and the highest concentration was observed at
an OD600 of 0.8 (Figure 5.19).
These results emphasise the stochastic nature associated with the expression of a novel
cDNA under the control of various promoter constructs. In each instance the
information contained within the heterologous transcript encoding the Cyp2el protein
itself is virtually identical. However, differences in the nature of the recombinant insert
arise however outside the coding region as a result of the cloning strategy employed
and these changes generate messages with different leader sequences which have been
suggested to be important determinants in the efficiency of translation (Cullin &
Pompon, 1988). The observed differences in Cyp2el protein levels also could relate to
the differences in the transcription levels produced by the various promoters and the
nature of the terminator of the heterologous transcript and resultant message stability.
The observation that the pMA56 ADC1 promoter (Ammerer, 1983), which produced
detectable levels of Cyp2el protein, was just a slightly larger version of the promoter
present on the pVTlOOU (Vernet et al., 1987), which did not produce detectable
Cyp2el protein levels, underlines not only how great a role these variables must play in
the generation of successful heterologous expression but also how the expression of a
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novel cDNA to a large extent must still be viewed as an empirical exercise. Subsequent
analysis was performed only on the pMA56/Cyp2el construct.
Section 5.7.3: Subcellular localisation, spectral and activity analysis of the
pMA56/Cyp2el generated Cyp2el protein in S. cerevisiae
Cellular fractions of the S. cerevisiae KYI 18 strain transformed with pMA56/Cyp2el
and expressing Cyp2el protein were prepared to establish the subcellular localisation of
the Cyp2el protein. Cells were harvested at an OD600 of 0.8, disrupted by passage
through a French press, and then separated into crude fractions by density
centrifugation according to a modification of the method of Yoshida and Aoyama
(1984). An initial centrifugation step at ll,000g removed the cellular debris, unbroken
cells, cell walls and larger organelles such as mitochondria. The supernatant was then
centrifuged at 100,000g to pellet a membrane enriched fraction, the resultant
supernatant was taken as a cytosolic enriched fraction. The distribution of the Cyp2el
protein in these fractions was assayed by Western blotting using the polyclonal
antibody raised to purified rat CYP2E1 protein. The Cyp2el protein was localised in
the membrane enriched and debris fraction with no detectable protein present in the
cytosolic fraction (Figure 5.20).
Reduced carbon monoxide difference spectra were performed on the membrane
enriched fraction from the S. cerevisiae KYI 18 strain transformed with
pMA56/Cyp2el in both the correct and reverse orientation. A small amount of haem
incorporation was detected producing an absorbence peak at 450 nm present in cells
expressing Cyp2el protein which was absent in the membrane fractions of the cells
which did not (Figure 5.21). The KYI 18 S. cerevisiae , a strain which has a virtually
undetectable endogenous P-450 population, would not be expected to contain high
levels of endogenous P-450 at the glucose concentrations in which the cells were
grown and most other endogenous cytochrome components would be expected to be
localised in the mitochondrial containing fraction (Black et al., 1989). A peak at 420 nm
was also produced in the membrane fraction expressing Cyp2el; in general, in P-450
studies, it is not clear what the peak at 420 nm represents but it is thought to indicate
the disturbance of the haem:apoprotein interaction as the P-450 begins to lose the haem
moiety (Eliasson et al., 1990), suggesting that problems with haem insertion or
maintenance may still be present. A low level of haem incorporation compared to the
level of apoprotein generated is a common problem in the heterologous expression of
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Figure 5.19: The expression of Cyp2el protein in S. cerevisiae KYI 18 from the
pMA56 vector detected using polyclonal antisera raised against purified rat CYP2E1.
Cells were harvested on obtaining an OD600 (A600) as indicated, and disrupted using
glass beads. 50pg of total cellular protein was loaded per track as well as lOpg of male
mouse kidney microsomal fraction.
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Figure 5.20: The subcellular localisation of Cyp2el protein in S. cerevisiae KYI 18
produced from the pMA56 vector detected using polyclonal antisera raised against
purified rat CYP2E1. The cells were harvested at an OD^x) of 0.8, disrupted by French
pressing, and separated by centifugation into fractions enriched in unlysed cells, large
organelles, etc. (HP), membrane enriched (MEF), and cytosolic protein (CYTO.);
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Figure 5.21: Analysis of the Cyp2el protein heterologously expressed in S.
cerevisiae KYI 18 for haem content by reduced difference spectroscopy. A: The
reduced difference spectra produced in the membrane enriched fractions (2mg/ml) of S.
cerevisiae KYI 18 transformed with the pMA56 plasmid alone. B: The reduced
difference spectra produced in the membrane enriched fractions (2mg/ml) of S.
cerevisiae KY118 transformed with the pMA56/Cyp2el construct. C: A stored trace
of B. with a reduced scale; in both A. and B. peaks at 450nm and 420nm are
produced indicative of haem content within the Cyp2el protein.
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The levels of Cyp2el protein present in the membrane enriched fraction by
S. cerevisiae were low compared to those present in a much smaller total protein
amount from male mouse kidney. This was illustrated by the comparison of the level of
rat CYP2B1 protein generated using the pMA56 vector and which was shown to
produce detectable enzymatic activity. The pMA56/rat CYP2B1 construct (kind gift, Dr
S. M. Black, Department of Paediatric Medicine, UCSF, CA.) was used to transform
the S. cerevisiae KYI 18 strain and total cellular protein prepared; by loading equal
amounts of protein from S. cerevisiae expressing CYP2B1 and Cyp2el and equal
amounts of rat and mouse total microsomal liver fractions the levels of P-450 protein
produced relative to the levels present in the liver were analysed (Figure 5.22). It can be
seen that, given the limitations of the comparison, proportionately a much higher level
of CYP2B1 protein was produced.
The catalytic activity of the membrane enriched fraction was assayed using
p-nitrophenol as a substrate (Reinke & Moyer, 1985; Koop et al., 1989); the membrane
enriched fraction containing Cyp2el did not generate a significant increase in
/7-nitrophenol hydroxylation above the control membrane enriched fraction or the
background activity rate, both of which were around 100 fold less than that produced
by an equal amount ofmouse liver microsomal material.
Section 5.7.4: Possible methods of increasing the expression levels of Cyp2el
protein in S. cerevisiae
Cyp2el protein is expressed in S. cerevisiae using this system and detectable levels of
haem incorporation occur; the lack of detectable Cyp2el activity in the membrane
enriched fraction containing Cyp2el probably relates to the low absolute levels of active
protein present compared to the sensitivity of the assay. It is likely therefore that if the
absolute levels of Cyp2el protein could be elevated, and assuming that a concomitant
increase in the proportion of Cyp2el enzyme with correctly incorporated haem resulted,
activity could be detected and the system could be employed in mutagenicity testing.
Several approaches may enable an elevation in the level of Cyp2el produced to be
achieved. As was illustrated by the initial empirical approach using four vectors to
establish detectable levels of Cyp2el the generation of increased Cyp2el protein levels
is arguably first to get a system that operates and then to modify that system until higher
levels of expression are achieved.
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Figure 5.22: A comparison of the levels of expression of mouse Cyp2el and rat
CYP2B1 protein in S. cerevisiae KY118 from the pMA56 vector. In the left-hand box
the level of Cyp2el present in 5pg of male mouse liver microsomal fraction (LIVER)
is compared to 5pg of S. cerevisiae KY 118 total cellular protein (Cyp2el) using the
polyclonal antibody raised against purified rat CYP2E1. In the right-hand box the level
of CYP2B1 present in 5pg of rat liver microsomal fraction (LIVER) is compared to
5pg of S. cerevisiae KYI 18 total cellular protein (CYP2B1) using the polyclonal
antibody raised against purified rat CYP2B1. In this sample, as discussed in Black, et
al. , (1989), it is seen that degradation of the CYP2B1 protein in S. cerevisiae is
occurring.
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S. cerevisiae possess a codon bias in its transcripts which has been shown to lead to
not only low levels of heterologous protein translation, but also low levels of
heterologous transcript production. The level of translation of a protein directly relates
to the level of codon bias present in its transcript, thus proteins present in the cell at a
high concentration such as alcohol dehydrogenase I has a message which uses 90%
preferential codons, whereas a low concentration protein such as iso-2-cytochrome c
possesses a preferential codon usage of 20% (Bennetzen & Hall, 1981). This control
mechanism has been demonstrated using mutations of the phosphoglycerate kinase
(PGK) protein; normally PGK is present at between 20% and 30% of the total cellular
protein but this level was reduced to just detectable levels as modifications in the codon
bias present in the message were introduced. These mutations were seen to be
particularly effective in the portion of the transcript encoding the N-terminal region of
the protein (Hoekema et al., 1987). The codon usage in the coding regions of a
message also affects the transcriptional activity of the promoter, and downstream
activating sequences (DAS) have been discovered in a variety of transcripts including
those of PGK (Mellor et al., 1987), lipoamide dehydrogenase and pyruvate kinase
(Zamanera/., 1992).
Although ostensively the S. cerevisiae translational machinery can recognise the
translational initiation sequences of mammalian transcripts, the consensus surrounding
the initiation codon differs which affects translational efficiency and leads to a reduction
in the amount of heterologous protein produced (Hamilton etal., 1987. Table 5.5).
Table 5.5: The consensus sequences surrounding the initiation codon in yeast and
higher eucaryotes where 5 indicates the initiation codon.
1 2 3 4 5 6
YEAST A/C/U A A/u A AUG UCU
HIGHER EUCARYOTES C A C C AUG G
The sequence surrounding the initiation codon in S. cerevisiae was seen to be high in
adenosine and uracil residues and is not predicted to be capable of generating any
strong secondary structures. The introduction of such structural elements, as present in
many mammalian transcripts and potentially the CYP2E subfamily (Figure 5.7a), into
the PGK transcript dramatically reduced the translational level and this factor may lead
to low levels of translation of mammalian transcripts in S. cerevisiae (van den Heuvel
etal., 1990).
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Modifying the codon bias of the Cyp2el cDNA and tailoring the context of the initiation
codon to be more easily translated by the S. cerevisiae in order to generate higher
levels of translation, and introducing other changes to the cDNA such as DAS regions
to increase the levels of transcripts produced, would require either a significant amount
of site directed mutagenesis or the generation and ligation of several mutated Cyp2el
cDNA fragments. One approach which may however allow the exploitation of the
potential benefits of these modifications in transcriptional and translational terms
without the need for such a considerable investment of time, would be to fuse
the N-terminal transmembrane spanning region of the S. cerevisiae endogenous
P-450i4DM (CYP51) to the Cyp2el cDNA. This would change both the initiation
codon context and potentially generate a more favourable codon bias in the N-terminal
region of the protein. The N-terminal membrane spanning region has previously been
shown not to participate in the generation of the specific metabolic activity of the
particular isoform (Cullin & Pompon, 1988; Larson et al., 1991) and so would not be
expected to lead to changes in either the nature or metabolic parameters of the reactions
catalysed by Cyp2el protein. This approach leading to the generation of a fusion
between a mammalian protein and its yeast counterpart was undertaken in the
heterologous expression of the mammalian P-450 reductase in S. cerevisiae ; the
replacement of the mammalian membrane spanning region with the S. cerevisiae
endogenous P-450 reductase N-terminal region led to an increase in expression and
stability of the heterologously produced protein (Murakami et al., 1986; Murakhami et
al., 1987; Bligh et al., 1991). By engineering a fusion between the CYP51 and Cyp2el
cDNA sequences in the pMA56 expression system developed it is possible that high
enough levels of active Cyp2el protein could be produced to allow the testing of
CYP2E subfamily substrates in a S. cerevisiae mutagenicity assay system.
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Section 5.8: The Cyp2el gene
Cloning the Cyp2el gene would allow analysis of the potential control regions both
within the regions 5' of the transcriptional start site as well as further analysis of the
nature of the (32 SINE insertion within the 3' UTR. It would allow a comparison of the
gene structures of the Cyp2el gene and other characterised CYP2E subfamily genes
and establish the levels of intervening sequence homology; a knowledge of the Cyp2el
gene may also allow the potential manipulation of the mouse genome through the use of
gene targeting strategies. It was decided that the Cyp2el gene would be characterised
pragmatically and that only those portions required to enable further studies to be
carried out would be completely analysed; no attempt was made to completely sequence
all of the intervening sequences of the Cyp2el gene.
Section 5.8.1: Cyp2el gene copy number
The CYP2E1 gene was seen to be single copy in the rat and human genomes (Song et
al., 1986); in the rabbit however there were two genes, CYP2E1 and CYP2E2 (Khani
et al., 1987a; Khani et al., 1987b). The two rabbit genes were 97% identical over their
coding regions suggesting that, on the basis that a 1% amino-acid sequence divergence
occurs every 3.4 to 3.8 million years, that a gene duplication event in the rabbit
occurred around ten million years ago. The speciation of the rabbit was thought to have
occurred around 60 million years ago (Fitch & Langley, 1976) suggesting that the
rabbit CYP2E1 gene probably duplicated long after the speciation of the rabbit and so
may not be expected to be seen in other species (Khani et al., 1987a).
In order to evaluate the gene copy number of the Cyp2el gene in the mouse, genomic
DNA was isolated from DBA/2N and C57BL/6 livers, subjected to restriction
endonuclease digestion, electrophoresed on an horizontal agarose gel and analysed by
Southern blotting. The resultant filter was hybridised with a radiolabeled probe
constructed from the 800 base-pair partial Cyp2el cDNA cloned from the Xgtl 1 library
(Section 5.2). A simple banding pattern was observed suggesting the presence of only
one Cyp2el gene in the mouse (Figure 5.23).
The Cyp2el gene had been chromosomally localised to chromosome 7 using the a rat
CYP2E1 cDNA as a probe in mouse-hamster somatic cell hybrids (Umeno et al.,
1987b). The mouse Cyp2a (Kimura et al., 1989) and Cyp2b subfamily (Simmons
et al., 1985) clusters have previously been located in this manner to chromosome 7.
Not all the mouse family 2 members are located on chromosome 7 however, for
example the Cyp2c (Meehan etal., 1988) and Cyp2d (Gonzalez et al., 1987) subfamies
have been shown to be present on chromosomes 19 and 15 respectively suggesting that





















Figure 5.23: Southern analysis of the Cyp2el gene. Genomic DNA isolated from
C57BL/6 (C) and DBA2/N (D) mice was subjected to restriction endonuclease
digestion using the enzymes indicated, separated on an agarose gel, and transferred to a
nylon membrane. The membrane was then hybridised with the 800bp partial Cyp2el
cDNA probe; DNA marker sizes are indicated.
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Section 5.8.2: Cloning and characterising the mouse Cyp2el gene
Using the 800 base-pair Cyp2el partial cDNA fragment (Section 5.2) as a probe
several clones were isolated from a BALB/c mouse liver genomic library constructed in
the bacteriophage lamda vector XEMBL3, a replacement vector capable of containing a
recombinant fragment of up to twenty kilobases of genomic DNA (Frischauf et al.,
1983). Three clones were subjected to further rounds of screening until plaque pure
genomic phage clones hybridising to the Cyp2el cDNA were obtained. Phage DNA
from one of the recombinant mouse genomic clones was prepared and subjected to
restriction endonuclease digestion with Sal I, BamH I, Xbal and Hpal and analysed by
Southern blotting. The filter was hybridised with the 800 base-pair Cyp2el partial
cDNA clone used initially to clone the X.EMBL3 recombinant phage. Four reactions
were set up with increasing amounts of restriction endonuclease for each digestion to
ensure that a complete digestion pattern was obtained. The results from this analysis are
shown in Figure 5.24. The recombinant phage clone was seen to contain an
approximately five kilobase-pair Sal I endonuclease fragment hybridising to the
800 base-pair fragment probe which was isolated from an agarose gel and subcloned
into the plasmid vector pUC19. The Sal I fragment was selected for subcloning as the
restriction endonuclease is resistant to the high salt concentrations present in the phage
DNA preparations making it unlikely that the SailI fragment is the result of a partial
digestion of the phage DNA which clearly is a problem with some of the restriction
endonucleases used in the analysis of the phage DNA (Figure 5.24).
Section 5.8.3: Restriction analysis of the five kilobase-pair recombinant Sail
fragment hybridising to the 800 base-pair Cyp2el probe
Restriction endonuclease digestion analysis of the 5 kilobase-pair Sail fragment was
undertaken in order to generate smaller portions of the whole fragment for sequencing.
By using restriction endonucleases with a known cutting frequency within the plasmid
vector pUC 19 the cutting frequencies within the recombinant fragment could be
assessed (Figure 5.25). It was seen that the fragment contained two of the Hpal sites
(a restriction endonuclease generating a blunt ended DNA product) suggested from the
initial Southern analysis of the clone. pUC 19 has no Hpal sites, and so the whole
fragment could be divided into three smaller pieces (approximately 2.8, 1.8 and 0.7
kilobase-pair fragments) by using both Hpal and Sail (Figure 5.25).
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Figure 5.24: Southern analysis a XEMBL3 recombinant clone containing an insert
hybridising to the 800bp partial Cyp2el cDNA probe. The XEMBL3 DNA was
subjected to restriction endonuclease digestion as indicated with (from right to left) 1,
2, 5, and 10 units of the respective restriction endonuclease to ensure that complete
digestion was obtained. The DNA was separated on an agarose gel, transferred to a
nylon membrane and hybridised with the 800bp partial Cyp2el cDNA probe. DNA
marker sizes are indicated.
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Figure 5.25: Restriction endonuclease analysis of the 5 Kbp Sal I Cyp2el fragment
subcloned into pUC 19. In the upper half of the Figure restriction endonucleases, as
indicated, with a single site in pUC 19 were used; in the lower half of the figure
restriction endonucleases with no sites in pUC 19 were used (A: Eco RV B: Apa I C:
Stu I D: Nco I E: Hpa I F: Cla I G: Nco I H: Xho I). The DNA was separated on an
agarose gel, transferred to a nylon membrane and hybridised with the 800bp partial
Cyp2el cDNA probe; DNA marker sizes are indicated. From this analysis it was seen
that the 5Kbp fragment could be restricted to produce 3 smaller fragments following
digestion with Sal I (the original cloning restriction endonuclease) and Hpa I.
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The two smaller Hpal and Sail 0.7 and HpaUHpal 1.8 kilobase-pair fragments were
prepared and subcloned into Smal (another restriction endonuclease generating a blunt
ended DNA product so complementary to the Hpal generated DNA ends) and Sail
respectively digested M13mpl8 and the complementary M13mpl9 replicative form
DNA. The filamentous bacteriophage M13 vectors operate most efficiently with insert
sizes of a maximum of around two kilobase-pairs; DNA fragments larger than this are
both difficult to subclone, affect the bacteriophage replication, and can be subject to
recombinational deletion (Messing et al., 1983). The larger Hpal and Sail 2.8 kilobase-
pair fragment, too big to be successfully analysed in Ml3,was subcloned into the
phagemid vector pTZ18 R and pTZ19 R (Pharmacia) which have inverted polycloning
sites and allows single-stranded DNA to be produced as described in the rescue of
single-stranded DNA from the pBS II (-) phagemid (Section 5.2.1). Single -stranded
DNA was prepared from all of the subcloned fragments and partially sequenced to
allow the assessment of the position of the five kilobase-pair fragment as a whole as
well as the relative positioning of the three smaller sub-fragments in the Cyp2el gene
by comparison to the known human and rat CYP2E1 gene sequences. The five
kilobase-pair fragment was seen to encode the three prime portion of the mouse Cyp2el
gene with the smaller Hpa I and Sal I 0.7 and Hpa llHpa I 1.8 kilobase-pair
fragments containing intron six and intron six/exon seven/intron seven respectively and
the larger Hpa I and Sal I 2.8 kilobase-pair fragment intron seven, exons eight and
nine and downstream beyond the insertion site of the (32 repetitive element. Using this
information, exon primers relevant to the gene area were used to enable double-
stranded sequencing. The results from these studies, the sequences and the sequencing
strategies used are shown in Figures 5.26, 5.27a and 5.27b. The area of the gene
surrounding the (32 repeat insertion site is discussed in Section 5.4.
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Figure 5.26: The sequencing strategy and oligonucleotides employed to characterise
the 5 Kbp Sal I fragment containing the 3 ' portion of the Cyp2el gene. The Hpa I /
Hpa I and Hpa I / Sal I portions of the whole 5 Kbp fragment are shown as are the
positions and numbers of the exons (Ex).
Oligonucleotide sequences
1: Reverse sequencing primer 8: GAAGATTTCCAAGACCC
2: Exon 7, 5 ' (PCR gene structure) 9: AGAGTTCTGGGTGGATT
3: Exon 8, 5 ' " " 10: Oligo. 10 (cDNA sequencing)
4: Exon 9, 5' " " 11: AGCTACTGCATACAAAG
5: Exon 7, 3 ' " " 12: AGATATGTAGGTGAATG
6: Exon 8,3' " " 13: CTCGAGGTGACGTATTT
7: Exon 9, 3 '
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1 AACTAAATATCAATG 15
I I I I I I I I I I I I I
9200 GTAGCATCCCCCATGTGACTTAGACATTTAATGTTAACTAAATATCAACA 9249
16 CATAACTAATATTTTTATTTTATGCATGCTTTAGTATTATACCATACCAT 65
II I I I II I II I II I I II I I II I I I I I II I I I II I I I I I I I I I I I
9250 TATAAC..ATTATTTTATTTTATTCATGCTTTAGTATTATACCATACCAT 9297
66 ACACAACTTATTGCAACTTGCATTTTTTTTTACTCCACATATTATAAAGT 115
II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III
9298 ACCCAACTTATTGCAACTTGC...TTTTTTCACTCCACGTATTAT.AAGA 9343
116 TCCATAGTAAATCCAAACACAGAAAGACCAAGGAACTTGACAAAGGTTGC 165
I I I I I I I I I I I I I I I II I I I II I I II I II I I I I I I I I I I I
9344 TCCATAGCAAATCCCACAGC . . AACGACCAAGGAACTTGACAATGGTTGG 9391
166 T. . .ATTGCCTGTGTCATGATCATGGGGGCTTTTA 197
I I I I I I I I I I I II I I I I I I I I I I
TTGCTGTACCTCTGACATAGTCATGGTGACTTTTAGATTTCAGAAACTAT 9441
AACTTGTCCTAGAGTTAAACAATGCAAAGGTTTCC.. 232
I I I I I I I I I I I I I I II I I I I
AGTCTAGTCTGCCACCCTCTGCTTATTTTTAACAATAGTAAACTGTCCTA 9491
CTCTAAGAAGATTTCCAAGACCCCTTTTATC 263
I I I I I II I I I I II I I I I I I I I I
GAGTAATAATGCAAAGATTCCCCTTAGAAATTTCCAAGA.CTCTTTTATC 9540
TCTACTGCTG ATTGGAAAAAATATCACAAATCTATGTCA 302
I I I I I I I I I I II I I I I I I I I I I I II I I I II I I
9541 TCTACTCCAGCTATAAAGAGAATTGGAAAAACGATCACCAA.CTATGACA 9589
303 ATAGATTCCCAAATCTTCCTGTCAATCTGTGAATAAGCTCACAGGTCTTA 352
I I I I I I I I I I I II I I I I I I I I I I I I II I I I I II II
9590 ACAGATGCCCAAACTGTC AACTGTGAATAAGCTCATGGGTCTCA 9633
353 GCTTTCACTGGCACTTATAAGGAAATGATTTGGCAATTCAAAGATCTCAG 402
I I I I I I I I I I II I I I II I II I I I I I I I II I I I I I I II I II I
9634 GCTTTCACTGACATTTATAAGGAAATGATTTAACAATTGAAAGTACTTGG 9683
403 GCGTATAATATAACTCAGGGGTTAAGTGCTCCATAAACATCTACTGGGTG 452
I I II I I I I I I I I I I I I I I II I I II I I II I I
9684 GGAT TACAAACGCAGTTAAGTGCTCCATAAACATACAATGGG. . 9725
453 GCTTGGCAGACACACGGAAGAAGAGTTAGACAGATATGTAGGTGAATGGA 502
III III III I I II I I II I I I I I I I I I I I I I I I I
9726 . . . TGGTAGATACATGAAGAAAAACT AGGTATGTAGGTGAATGGA 9767
Figure 5.27a: The DNA sequence for the 3 ' portion of the Cyp2el gene present in
the 1.8 Kbp Hpa I / Hpa I and part of the 2.8 Kbp Hpa I / Sal I pieces of the 5 Kbp
Sal I fragment. The mouse sequence (upper) was compared to the rat CYP2E1 gene
sequence (lower) using the GCG Gap alignment program and the gapped similarity
between the two sequences is 81.53%. The exons are boxed and the (32 element in the









503 ACTATTGCAGGATCGTGGGATAGATGGATG AGAGGATAATGAGTA 547
I II I I I I I I I I I I I I I I I I I II II I I I I I I I
9768 GCTACTGGAGGATAGTTGGATGGATGAGTGGATGAGTGGGTGAATGAGGA 9817
548 GGTAAGAATGTGGAGGGTGCTATCTGGTGGGTAAATGAATATGTAAGTGT 597
I I I I I III I I I I I I I I I I I I I I I I I I I I I I I I I I I I
9818 TGTAAGGATGGAGAGGTACTATTCTGGCGGGTAAATGAATAGGTAAGTAG 9867
598 ATGGAAAAACCGGGTGGCTTAACAGGGGTATATAGGTGAGCCAGGCAGAT 647















I I II III I I I I I II I I I I I I I I I I I I I I II I I I I II I I I
GGAA. . ATGTATGGGTAGATGGTACGTAGACATCAATTCTGGAATTAACC
CTTGAGACTGACTTTATCCCTATCTTGGC.





I I I I I I I I I I I I I I I I
GAAACTTCATGAAGAAAT
TGACAGGGTTATTGGGCCAAGCCGTGCCCCTGCAGTCCGAGACAGGATGA




I II I I I I I II I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I
ATATGCCCTACATGGATGCTGTGGTGCATGAGATCCAGAGATTCATCAAT
CTCGTCCCTTCCAACCTGCCCCACGAAGCAACCCGAGACACCGTGTTCCG
II I I I I I I I I I I I I I I I I I I I I I I I I II II I I I I II I I I I I I I
CTTGTCCCTTCCAACCTACCCCATGAAGCAACCAGAGATACTGTGTTCCA
AGGATATGTCATCCCCAAl
















I II I I I II II II I I I I I I I
TCAGGC...AAGAGTTGGAAAGTACTCCAT 10209
948 GGGCATGTGTACTGTTAGCTTATCGCCGAGGTCGCCCTTCAGGAGACTCA 997
I I I I I I I I I II I I I I I I I I I II I I I I I I I I II I I I
10210 TGGCA.CTGTTCTATTGGTTTATCACCTTGGTTGCCCTTCAGGATAGAGA 10258
998 CCCATAGTCACTG 1010
III I I I I I I
10259 CTCAAGGGCACTGTTGACCAGCATATATTGTTAGATGTGGGAATCAAGCC 10308
1011 CCAATAA 1017
I I I I I I I
10309 AGCATTCATTCTTGCCCTGCAGAATGTTTCACCCAAAGTCACCCCAATAA 10358
1018 CCTCATGACCAAAGAAATCAAAGAAATGGAAAATATCACCTCAACTGGTC 1067
I I I II I I II I I I I I I I I I I I I I I I I II I I II I II I I II I I I I I I I I I
10359 CCTCATGACCAAAGAAATGAAAGAAATGGAAAGTGTCACCTCAACTGGTC 10408
1068 CAGAGGACTTGTGAACCACTCTTAAAACTGAGATCCCATGGCAGCA. CAA 1116
I I II I II I I I II I I III I I I I I I I I I II I I I I I I I I I I I III
10409 CAGAGGACTTGTAGAACTCTC . TAAAACTGAGATCCCATGAAAGCAGCAA 10457
1117 CCGAGCCTGGGACCCATCCTCTGAAAGATATCGGGCCTTCCTTTTCATTT 1166





I I I I I II I I II I II I I I II I I II I II I II I I I I I I I I I I I Mil
10508 AGACCTGATCTGATCCCTGTCTCTTTTTCTAAGTCATCCTGAAAT.AAAC 10556
1217 AACACTGAAAATTTAAAATATGCTAGCCTACATATGTAAAATTCCAACAG 1266
I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I
10557 AACACTACAAATTAAAAATATGCTAGCCTACATATGTAGAATTCCAACAG 10606
1267 CCCTCTTCACTAGGGTCTTCCAGATGAAAGAAAGCCTATGTTTTGTTAAC 1316
I I I I I I I I III I I II I I I I I I II I I I I I
10607 CCCTGTCCGCTGAGATCCCCCAGATAAAAG CCTGTGTTTAAC 10648
1317 TTGACTAATAGA.ACTTCTAATTCTTCCAG










I I I I I I I I I II I II I I I
GpGTACAGTTGTGATTCCAAC
TCTGGACTCCCTTTTATTTGACAACTATGAGTTTCCAGATCCAGAGACAT




I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I
TTAAACCTGAGCATTTCCTGAATGAAAATGGGAAGTTCAAGTACAGTGAC
TATTTCAAGGCGTTTTCTGCAG









I I I I I I I I I I II I I I I I I I
1TAAGCAGAGTCTGGGAGTCACACCTTC 10848
1565CCTGGGAAACTGTCTTGTTCAGCCCTAAACTTCCTCCCATGTGCTCTTCC
I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I II
10849 CCTGGGAAAGTGTC...TTCAGTCCTAAACTTACTTCCCACGTGCTCTTC 10895
1566 CCCATCCTAGATGAGGACTACCATCTCGACTCCATTATGCCCCTGTAATA 1615
I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I II I I I I I I
10896 CCCATCCTAGATGAGGTCTACCATCCCAACTCCATCA. CTCCTTGTAATG 10944
1616 TACAACCCAAGTACATTCGTCCCTGTTCAGAGAAGTCAATCG.ACAGATT 1664
II I I I I II I II II I I I I I I I I I I II III I III I III II
10945 TATAACCCAAGTACATTCCTCCCTGTTTAGAAAGTCAAATGGCACACATC 10994
1665 TCACAAGGAGCCCAGGGAATCAGAGTTCTGGGTGGATTATCACAGAATGG 1714
I I I I I I I I I I III III I I I I I I I I I I II I II II I I I I I I I I I I I
10995 TCACAAGGAATCTAGGAAATGAGAGTTCTGGGTAGATTATCACAGAATGG 11044
1715 ACATGGTTTTCTAATTAATTGTTGA. CTACTTCTACTCTACCAGGCTCCA 1763
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
11045 ATGTGGTTTCCTAATTAATTTTTCAGCTATTTCTACTCTAACCAGATGCA 11094
1764 TAAAAGGTCT. . . GAGACTGTATACC....TAATCTTAAACGTTCCGCCA 1806
III II I II I I I I I I I I II III II
11095 GTAAAAAGCTCTCAAAACTGTATTACCTAATTCTTCATAAGTTTCAACAA 11144
1807 AAATACTTAAGCTCTAATC . ATAAGTACCTGGCCTCCTCTTAGG. AGCAA 1854
I I I I I II I I I I I I I II I I I I I I I I II I I I I I I I I I
11145 AAATTGCTAAACTCTATTCTTTATCTACCTAGATTCTTCTTAGGAAGCAT 11194
1855 CCAAACCT. CGGAGATGGTCCCATGGCAGGCCCTCACCTAGGGTTCCTGT 1903
Ml II II I I II II II I II II II II I II II II II I II II II II I I
11195 CCAGACCTCCTCAGATGGTCCCATCGCAGGGCCTCACCTAGGGTTCCTGT 11244
1904 AAAGGGAGA. CCCACAGCCAGTTCAATCATCTTAACAGTCCATGTTTTGC 1952
II I I II II I II I II II I II I III II II II II I I




I II I I I I I I I I II I I I I I I I II I I
11292 ATAGGCTTCACCTGTACCATCT GGATGTTTTGG 11324
2003 GTCCATTTCCCTAAACTACTACTTGTTTATGCAGTGGAGCTCTCAACGAG 2052
II I I I I II I II I I I I II I I I II I I I I I II I I I I I I I I I I I I I III
11325 GTCTATTTCCCTAAACTACCACTTATTTATGCAGTGGAGTTCTCAATGAG 11374
2053 TGGGGTCAGTTGCTGGTTC..AAGTCAGTGTCACTGACATTCATGAGCTC 2100
III II I I I I II I I I I I I I I I I I I I I I I I I I II II I II III
11375 TGGTGTCAGTAGCTGGTCCCTAAGTCAGTGCCACTGCCATTCTTGTTCTC 11424
2101 TGACATATGGGCATTGGTGTTCTGGGACTAA. GGGCAAGGATGGAGAATC 2149
I I I I I I I I I II I II I I I I I I II II II I I I II I I I I I I I I II
11425 TGACATATGATCACTGGTGTTCAGGGACCAATGGGCAGGGATGATGAATC 11474
2150 CTGGTTTCA.GTGGTGTGCCTGAAGCCTCCTCOCACACCTCCAAGCCCTC 2198
II III I I I II I I I I II I I I I I I I I I I I I I I I I I I I I I II
11475 CTACTTTAAGGTGGTGTGCCTGAAGCCTCCTCCCACAC. .TCCAACACTT 11522
2199 AATGTTATGCGAGTTAGCTCTGCTCTGCTCCCTCAGCACCTCATCAGCAC 2248
II I II II I I I I I I I III I I I I I I I I I I I I I I I I I I I I I I
11523 GATGTTATCAGTGCTAGCTTTGCAAGGGTCCCTCAGTACCTCATCAGCAC 11572
2249 TGTTGTCTCATGi











I I I I I I I I I I I I I I I I I I I II I I I I I I II I I II I
AAAGCGTGTGTGTGTTGGAGAAGGCCTGGCCCGC
ATGGAACTGTTTCTGCTTTTGTCTGCTATTCTGCAGCATTTTAATCTGAA




I I II I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I III I I I I II
GTCTCTGGTTGACCCTAAGGATATCGACCTCAGTCCTGTCACAGTTGGCT
TTGGCAGTATCCCACGCGAATTCGTAATCTGTGTCATTCCTCGTTCATGA










2449 GACCTGA TGCCCATCATTATCCCTTACAAAATGA 2482
I I I I I I I I I I I I I II I I I II I I I I I I
11773 GACCTGAAAACTTCCTGATATCCCTTCCATTGTTATCCCTTAAACTATGA 11822
2483 CTGTTTAAAAAAATGCCAAGC 2503
M I II I II I I I II I II I p2 REPEAT ELEMENT
11823 CTGTTTTTAAAAAACCCAAGCATATAGAGTTCCTATCATAAAATGAAACC 11872
2504 GGGCTGGTGAGATGGCTCAGTGGGTAAGAGCACCC 2538
I I I I I II I III I I
11873 GAAA|AAATAA£frAAAACCTTGATGAATTGTATTGGTTGTGGATTTAATGA 11922
2539 GACTGCTCTTCCGAAGTCCGGAGTTCAAT.CCCAGCAACCACATGGTGGG 2587





I I I I I I I I I II I II I I I I I I I III I
11973 TCACAGCCAGTAGTATAATCTTCCAATCTATCTGTCCCTGACTTCTCATA 12022
2637 GACAGCTACAGTATCGAGATCTGACTCTGTCTTCTGGAGTGTCTGAAGAC 2686
II III II I I II I I I I I I II I I I I I
12023 ATTTGTTTGCATATGCACAGATGACCCTGGCTATCTGCCCATCACAAGAC 12072
2687 AGCTACAGAGTACT. TACATATAATAAATAAATAAGTCTTTAAAAAATGC 2735
I I I I I I I III I I I I I I I I I I
12073 ACTGAATTAACAATATATTCAAAGTTCTTTTACCATACAGTATCATATTC 12122
2736 CAAGCATATGGAGTTCCTA. . . TCATAAAATGAAACAGAAAAGTATTAGA 2782
I I I I I I I I I I I I I I I III
12123 ATAGGCTCTTGGGATTATAATGTGAGCAGTTTTATGCTGACCCTACTTTC 12172
2783 TATTGATGAACTATGTTAGTTGTAGATTTAATGAGAGCTTGTCCCCTTGA 2832
I I II I I I I I I II II
12173 CAGCTCATCTACCTTGGGGTACTACTGAAACCCAAAGCTAACAGACACCA 12222
2833 CCATGTGAAAGTTCCCCAGTGAGTGAATAGCATTTCACAGCCAGGAGGAT 2882
II I I I I I I I I II I I II I I
12223 CAACAGTGGCCTCACTGAAGGCGTTTGGATCATCATAGCTCCACAATGGC 12272
2883 AACACCTTCTAATCTATCAGGCCCGGACTTCTCAAAATAATTTGGTTGAA 2932
III I I I I I I I I I I I I
12273 AAGATTGCTTCCAGGGGAAAAAAATGTAATTTTAAAATTTGCTTTGGGGC 12322
2933 TATGCATGGATGATCTGGTTATCTGCCCCTCACAAGATACTGAACTAACA 2982
I I I I III I I I I I I II I I I I I I
12323 AGAGATGTTTCAACTTCATAGATTACCATTAGCAAAATTCTCAAGTGACA 12372
2983 ATATACTCAAAGTTCTATTACCACATAGGTATCAAATTCTCGGGTT. . . . 3028





III III II III II
8550 CAAGACTTTGAAACCAAAATCTGGGCAGGAAGAATTCTGTGCCTGAAGCA 8599
32 GTATGCAGAGGGTCATACATACATTTACCAGATAGAGG.AGTGTGAGGAT 80
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
8600 GGCATGCAAAAGATCTAAACACATTTACCAGATAGAGGAAGTGTGATCAC 8649
81 CCCTACATGTAAGTATTGGGGCTCACCTTTAGTAAAGAAACTGGGGGGGC 130
III I I II I I I I I I III I I II I I I I I I I I I II I I I I I
8650 CCCCACATGTAAGTCACTGGGGCTCACCTTAGTAGAGAAACTGAGAGGGC 8699
131 TGACAAACTAAGG.GGAGGTGCTCTAAGGCCTGAAA..CTTGCATTCTCT 177
I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I II III I I I I
8700 TGACAGCCTAAGGTGAAGGTGCTCAAAGGCCTGAAACCCTACCATCCTCT 8749
178 GAGCTG...GCATAGATGGCAGCTACTGCATACAAAGCAATGTT..CCAA 222
II I I I I II I I I I I II I I I I II I I I I I I II I I I I I I I II I
8750 GAGCTGAGCTTAGATCTGGCAGCTACTGCATACAAAGTAATGTTTCCCAA 8799
223 GAACATTATTGTGTGTCTGTCTGGTCAGGTCTAAGTGTCTGGTCCAGGTC 272
I I I I I I I I I I I I I I I I I I I I I I I II I I
8800 GAACATGGTTGTGTGTC TATCTAGTCCAGGAC 8831
273 TAAGATCTGAGCTCTGGCCTTCCTGTCAGCAATGCCTTTGACTTTCCACA 322
I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I
8832 CAAGATCTGAGCTCTGGCCTTCCGGTCAGCAATGCCTTTGACTTTCCACA 8881
323 CCAC AGAGAAAAAAAAATGGAATATGACTAAAGTTCCAATGG 364
I I I I I I I I I I I I I I I II I I I I I I I I I I I I III
8882 CCACATAAAAAAAGAAAAAAAAAACCAAAAGGTGACTAAAGTTC . . AAGG 8929
365 AGGGAAATATACAAATTACAGTAGCTAGAACTTTTATTACTGTGCTAGGG 414
III I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
8930 AGGAAAATGTACAAATTACAGTAGTTAGAACTTTTACTACTATGCTAGGG 8979
415 AAACATAAATTTTAAAATGTTTTAAATTAGTAACATAATGGATTTCTAA. 463
I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I
8980 AAACATAAAATTTAAAATGTTTTAAATTATTAGTATAATGAATTTCTAAT 9029
Figure 5.27b: The DNA sequence for the 3 ' portion of the Cyp2el gene present in
the 1.8 Kbp Sal I / Hpa I 0.7 Kbp fragment of the 5 Kbp5G/ I fragment. The mouse
sequence (upper) sequence was compared to the rat CYP2F21 gene sequence (lower)
using the GCG Gap alignment program and the gapped similarity between the two
sequences is 80.36%. The sequence encodes an intronic portion of the upstream from
exon 7.
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5.8.4: Characterisation of the Cyp2el gene structure
Using the GCG package Best program (Devereux et al., 1984), gapped alignments
between the mouse Cyp2el cDNA sequence and the human and rat CYP2E1 genes
were generated, allowing the prediction of the potential intron and exon boundaries
within the Cyp2el gene. Based on this data, oligonucleotide primers were constructed
to the most 5' and the most 3' regions of the intron/exon junctions for the predicted
exons two through to eight and to the most 3' and most 5' region of the junctions for
exons one and nine respectively. Using these primers in conjunction with DNA
prepared from the three plaque pure XEMBL3 clones hybridising to the 800 base-pair
Cyp2el cDNA fragment, the structure of the Cyp2cl gene was assessed using the
polymerase chain reaction (PCR). The sizes of the respective introns were illustrated
therefore by the sizes of the PCR products generated; the results of these reactions, the
predicted intron sizes, the predicted gene structure and the sequences for the
oligonucleotides employed are shown in Figures 5.28a and 5.28b.
The results demonstrated that the mouse Cyp2el gene has the same basic structure as
that seen in the rat and human genes and that the mouse Cyp2el coding region is
approximately eleven kilobase-pairs in length (Figure 5.28b). From these results also it
was possible to quickly assess the portions of the Cyp2el gene contained within the
A.EMBL3 genomic clones. The previously analysed clone and one other clone were
seen to contain at least the 3' portion of exon three to the 5' portion of exon nine, and
the third clone contained at least the 3' portion of exon one to the 5' portion of exon
seven.
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Figure 5.28a: Charaterisation of the Cyp2el gene structure. Oligonucleotides to the
predicted intron/exon boundaries of the Cyp2el gene were used in a PCR mixture to
prime DNA isolated from genomic Cyp2el clones in AJEMBL3. The products of these
reactions are shown in conjunction with DNA size markers. Numbers above the lanes




Exon 1 176 176 176
Intron 1 904 761 800
Exon 2 159 159 159
Intron 2 2938 3404 4100
Exon 3 149 149 149
Intron 3 388 304 250
Exon 4 160 160 160
Intron 4 406 325 300
Exon 5 176 176 1 76
Intron 5 881 788 750
Exon 6 141 141 141
Intron 6 2836 1873 1900
Exon 7 187 187 187
Intron 7 498 496 450
Exon 8 141 141 141
Intron 8 883 766 850
Exon 9 184 184 184


















Figure 5.28b: Comparing the Cyp2el gene structure and those of other CYP2E
subfamily members. A: A comparison of the known gene structures of the rat and
human CYP2E1 genes and the predicted structure of the Cyp2el gene B: The
oligonucleotide sequences to the predicted Cyp2el intron/exon boundaries used to
characterise the gene structure.
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Section 5.8.5: Cloning the 5' portion of the Cyp2el gene
In order to assess the potential control functions mediated by the 5' flanking regions of
the Cyp2el gene, the A.EMBL3 clone which was seen to contain at least the 3' portion
of exon one was further analysed. Phage DNA was prepared from the recombinant
XEMBL clone, subjected to restriction endonuclease digestion with Sal I, EcoR I, and
BamH I, and transferred onto a nylon membrane. The resultant membrane was
hybridised the 3' exon 1 oligonucleotide (Figure 5.29). An approximately 4.8 kilobase-
pair BamH I fragment, hybridising with the Cyp2el 3' exon 1 probe was subcloned
into the phagemid vector pTZ18 R. The 4.8 kilobase-pair BamH I fragment was
characterised for restriction endonuclease sites; using the 3' exon one oligonucleotide as
a probe it was seen that exon 1 hybridising portion of the 4.8 kilobase-pair BamH I
fragment was localised to a 1.4 kilobase-pair BamH 1/ Hindlll and a similarly sized
BamH 1/ Xbal restriction endonuclease fragment (Figure 5.30). The PCR derived
Cyp2el intron one (which contains the exon one 3' oligonucleotide sequence) and
intron two (which does not contain any exon one sequence) were included on the gel to
assist in the washing of the filter. Further restriction endonuclease characterisation of
the 1.4 kilobase-pair BamH \JHindlll fragment revealed the presence of three Hindlll
sites within the 4.8 kilobase-pair BamH I fragment and not, as may be expected from
Figure 5.30, two sites; the BamH I site used in cloning the 4.8 kilobase-pair BamH I
fragment has aHindlll site very close by and the fragment produced is too small to be
seen on an agarose gel or affect the running of the other larger fragments (Figure 5.31).
Digestion by the HindllVBamH I restriction endonucleases of the 4.8 kilobase-pair
BamH I fragment generated three sub-fragments of 1.1, 1.8 (Hindlll), and 1.3
(HincCllUBamH I) kilobase-pairs respectively; these were subcloned into pTZ18R and
pTZ19R phagemid vectors, single-stranded DNA was prepared and portions of the
fragments were sequenced. From this analysis it was seen that, on alignment with the
known human and rat CYP2E1 gene sequences, the 1.3 kilobase-pair HindlllJBamH I
fragment contained the upstream region of Cyp2el, exon one and part of intron one,
the 1.8 kilobase-pairHindlll fragment contained part of intron one, exon two and part
of intron two and the 1.3 kilobase-pair Hindlll fragment contained part of the large
intron two. Double stranded sequencing was also carried out on these fragments using
exon oligonucleotides; the sequencing strategy and information gained from this
analysis are shown in Figures 5.32, 5.33a, 5.33b, 5.33c and 5.33d. Further analysis
of the 5' region of the Cyp2el gene and promoter assay studies are discussed in
Section 4.11.
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Figure 5.29: Restriction endonuclease analysis of the AEMBL3 clone seen, by PCR
analysis, to contain at least the 3 ' region of Cyp2el exon 1. The isolated A.EMBL3
DNA was digested with the restriction endonuclease indicated, separated on an agarose
gel and transferred to a nylon membrane. The membrane was probed using a
radioactively labelled oligonucleotide to the 3 ' portion of exon 1. DNA size markers
are present and marked sizes are in base-pairs.
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Figure 5.30: Restriction endonuclease analysis of the pTZ18R subcloned 4.8 Kbp
Bam H 1 fragment which hybridised to a Cyp2el intron 1 oligonucleotide probe. The
4.8 Kbp fragment was subjected to single, or double, restriction endonuclease
digestion as indicated B: Bam H I. E: Eco R I. H: Hind III. X: Xba 1. The pTZ18R
phagemid vector is seen as a 2.9 Kbp band; the Bam H 1/ Xba 1 double digest generates
a product from the 4.8 Kbp fragment of nearly identical mobility to the vector seen as
an intense band at 2.9 Kbp. PCR generated Cyp2el gene intron 1 (1) and intron 2 (2)
DNA was also included to aid the generation of specificity in subsequent washing
steps. The DNA was transferred to a nylon membrane and hybridised to the
radiolabelled Cyp2el exon 1,3' oligonucleotide the results of which are seen in the
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Figure 5.31: Further restriction endonuclease characterisation of the 4.8 Kbp Bam H
I fragment containing the 5 ' region of Cyp2el. A: The 4.8 Kbp Bam H I fragment
was digested in reactions with either single or double restriction endonuclease additions
as indicated, H: Hind III, B: Bam H I. DNA size markers are in base-pairs and the
DNA samples were overloaded as the gel was preparative. This analysis indicated the
presence of 3 Hind III sites in the Bam H I fragment and not 2 as may be expected from
analysis in Figure 5.30. B: The map of the 4.8 Kbp Bam H 1 fragment indicating the 3
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Figure 5.32: The sequencing strategy and oligonucleotides employed to characterise
the 4.8 Kbp Bam H I fragment containing the 5 ' portion of the Cyp2el gene. The
Bam H 1 / Hind III and 2, Hind III IHind III portions of the whole 4.8 Kbp fragment
are shown as are the positions and numbers of the exons (Ex.); sizes are in Kbp.
Oligonucleotide sequences
1: Reverse sequencing primer
3: TACGGTTCTTGGCGGTA
5: Exon 2, 5 ' (Figure 5.28a)
7: TGATAGCCAACTGCAGC
2: Forward sequencing primer
4: Exon 1,3' (Figure 5.28a)
6: TTAGGAGACCAACGACC
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1 GATCCAGAAGTGAGAT TCCTGTTCTGCCCTCAATTTCC 3 8
I 111 II III I I I I II II I I I I I I I I II I
1001 GCTGATTTGACATGAAATGGGATCCAGATGCTGTTCTGCTCTCATTTTCC 1050
39 . AGGTGGGGATTAGGGTTGTGGTGCCAGGTTCAGAAGTTAGAGGTCTGCA 87
I II II I I I I I I I I I I I I I I I I I II I I I I II I II II
1051 AAACAGGCCATTAGCGCTGTGGTGCCA. GATCAGAAGTTAAGTATTTGCA 1099
88 GCCTAGTGCTGGTCTTTGGCCTGGAATGAGCAGTAAATGGTTGGAA.... 133
II I I II II I I I I I II I I II II I I I I I I I I I II I I I I I I I
1100 GCCTAGTGC . CGTCTTTGGTCTGGAATGAGCGATAAATAGTTGGTAGTGC 1148
134 AAAAAACCTTTCCCAGCAAACAAACACATGCAAACATGATCTGAA 178
I II I I I II III I II I I I I I I I I II I I I I I II I I I I I I I I
1149 TTTGCAAAAACCTTTCCCCTACAAACAAACACGTGCAAACATGATCTGAA 1198
179 TGCATGCCTTCTGTGCTGACCAGTGCCATGGGGAAGACATTCCCCCACCC 228
I I I I I I I I II I II I I II I I I I I I II I I II I I I I I II I II I I
1199 TGCATGCCCACTATGCTGACCAGTGCCAGGGGGAGGACAGCTTCCCACCC 1248
229 CCAGGACTGACCTATGAATTGGTGAGGTATTCCTACATGTACTCACCACA 278
II I II II I I II I I I I I I I II I I II I II I I II I I II II I I I I I I II
1249 CCAGGACTGACCTATGAGTTGGTGAGGTATTCCTGCATGTGCTCAC . . CA 1296
279 GCCCTGACAGGTGCCAGCAACCAGAGGATT. .GCAGGCCCAGCCTCATCC 326
II I I I I I I I I I I I II I I II I I II I III I I I I I I I I I I I I I I I
1297 GCACTGACTGGTGCCAGCAACCAGAGTATTGAGAAAGCCCAGCCTCATTC 1346
327 TTGTCAGATCAGTAGATGCAACTTCTAAGAGGCAATGGCTCCAAGGGTCA 376
I II I I I II I I II I I I II I I II I II I I I I I II I I II I I I I II III
1347 ATGTCAGGTCAGTAGATGCAATTTCTAAGAGGTAAAGGCTCCAAGGTTCA 1396
377 GCCTT. . GAATGATAGCCAACTGCAGCTAATAATAAACCAGCACTT. . . . 420
I I I I I I I II I I I I I II I I I I I II I I I I I I I I I I I I I I I II I
1397 GCCTTTGAAATGATAGCCAACTGCAGCTAATAATAAACCAGTACCTTAGG 1446
421 AGCAAGGAGATGAGTGGTTATTGGCTGATGAGCCACCCTCCTTCTCAACG 470
I I I I I I I I I II I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I
1447 CCAAGGGAGAAGAGTGATTATTGGCTGATGAGCCACCCTCCTTCTCAAGG 1496
Figure 5.33a: The DNA sequence for the 5 ' portion of the Cyp2el gene present in
the 1.3 Kbp Bam H I / Hind III piece of the 4.8 Kbp Bam H 1 fragment. The mouse
sequence (upper) was compared to the rat CYP2E1 gene sequence (lower) using the
GCG Gap alignment program and the gapped similarity between the two sequences is
81.89%. Exon 1 is boxed; see also Figure 4.15 for analysis of the regulatory elements
potentially present within the promoter region of the Cyp2el gene.
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471 ACACGTTATAAAATCCTTGTTTCTCCTCAGGAAATTCCTACAAATTTAGA 520
I II I I I I I I I I I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I
1497 ATACATTATAAAATCTTTGTTTCTCTTCAGCAAATTCCTACAAGTTTACA
521 GTGGAGCCCCATCGGCACC ATGGCGGTTCTTGGCATCACCGTTGCCTTGC








I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
VTGGCGGTTCTTGGCATCACCATTGCCTTGC
TTGTCTGGATCGCCACCCTCCTCCTCGTATCCATCTGGAAACAGATCTAT




I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I II I I I I II
AACAGTTGGAACCTGCCCCCAGGACCTTTCCCTCTTCCCATCCTTGGGAA
CATTTTTCAGCTGGATTTGAAGGATATTCCCAAGTCTTTAACCAAGGTAA 720










I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1747 GGGGAAACATTGTTTCATTAAGAAAGCAAGTTAAAGATTAGATATAATGG 1796
771 GTATATATTAAACTCAGTGCCAGCTGTTATCCAATGACAGATTACCAAGA 820
I I I I I I I I I I I I I I I II II I I I I I I I I I I I I I I I I I I I I I I I
1797 ATATATATTAAACTCATTGTCATTTGTTATCCAATGACAGACTACCATGT 1846
821 TACTGAATTAACAGTTCAGCCCATCTTGCG.ATGGAACACTCACCGTGAG 869
I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I
1847 TACTGAACTAACAGTTCAGTTCATCCTGGGCATGGAACACTCACAGTGAA 1896
870 TAGTGCCATACAGGCTTCAGAGGCCTGTACATTTGAAGTGATTATGAGAT 919
I I I I I I I I I I II I I I III III I II II I I I II I I I I I I I I I
1897 TAGTGCCATGCAGGC. CCGGAGCCCTCTGCAGTTAAAGTGACTATGAGAT 1945
920 ACTGATGTTGTTGTTAACTTCC 941






I I I I I I I I II II I I II I I I I I I I I I I I I I I II I I I I I I
GTCCAAGTTAGCTTGTACTGTCAGATAAGGCAGAG. CTTAACTTTAGAAG 2249
45 CAAACAAGAATGTGGTGAGTGTTGGCATTGATTTGGCCTGTTTAGGCACA 94
I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I
2250 CAAACAAAAGGGTAATGAGTGCTGGCATT GGCTGAATAGGCACA 2293
II .
95 GAGAAGAGAATTGTGTCTAGATAGAAGGAAGGTCCTCCACAAACCCAGAA 144
I I I I I I I I I I I I II I I I I II I I I I I II I I I I I I II I I I I I II I I
2294 GAGAAGAGAATCGTGTCTAGATAGAAGGCAGGTCCCCCGC . AACCCAGCA 2342
145 GCTTGAGGTGGAAAGGGTATCCCCATATCAGACTAGACACAATGCCCTTT 194















I I I I I I I I I I I I I I I I I I II II I I I I I I IMII' II
CCCCCAAGTCCGTCTAACTCCTGTGAAGTACAGTACAGGAGCAATAGCAG
GAGATGTGGTCTG
I I II III
GAGACACGGTCTAf
TCTAAAGCAGGCTAAGTCCTG TTCTGTGCAT
I I I I I I I I I I I I II I I I I I I I I I II I I I
rCTAAAGCAGGCCGAGCCCTGTCTATCTTCTGTGCAT
TGGTCCCTGCAGTTGGCAAAGCGCTTCGGGCCAGTGTTCACACTGCACCT




I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I II I I I II I I I I I I
TGGCTCAAGGCGCATCGTGGTCCTGCATGGCTACAAGGCTGTCAAGGAGG
TGCTACTGAACCACAAGAATGAGTTCTCTGGCCGAGGGGACATTCCTGTG













I I II I I I I I I I I I I I II I I I I I I I I
TTCCAGGAGTACAAGAACAAG GGTAAGTTGGCTTCTTAGGACATTGGGAG 2692
Figure 5.33b: The DNA sequence for the 5 ' portion of the Cyp2el gene present in
the 1.3 Kbp Bam H I / Hind 111 and 1.8 Hind III pieces of the 4.8 KbpBam H I
fragment. The mouse sequence (upper) was compared to the rat CYP2E1 gene
sequence (lower) using the GCG Gap alignment program and the gapped similarity
between the two sequences is 87.5%. Exon 2 is boxed; H: Hind III site.
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1 tcttcccctcggtacctagctt 22
I I I I Ml II II I I I I
3551 TTCAGATCAAAGCATGGCTGGCTCTAGATCTTATTCTCAGTGTCTGGCTT 3600
23 ggtttcccag..actgtttccagaacgattttaccatcaggcatttgant 70
II I I I I I I I I I I I I I I I III I I I I I I I I II II : I
3601 GGCTTCCCAGTTTGTGTTTCCAAAACTATTTTACCTCAAGCATTTGATGT 3650
71 cccctaatcagtactgtgggtttctgttctatctcaggaggaaaaaaaca 120
I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I II I III
3651 CCCCTGATCAATAGTGTGGGTTTCTGTACTATCTCGGGGTGGGGGGAAC. 3699
121 gaagtgactatctcagtccttgtcct ctgattgaag 156
II I I I I I I I I I I I I I II I I I I I I I I I I I I I I
3700 .AAATAACTAGCTCAGTCTTTGTCCTCAATATAGGAGTTACTGATTGAAG 3748
157 agggaccaagcaaggtgacaaggacctgt.ggaagggcacaaa 198
I I I I I I I I I I I II I I II I I II I I I I I I I I I I I I I I I I I
3749 AGGGACCATGCAAGGTGACAAGGACTGCTGGGAAGGGCACAAACCTTTAT 3798
199 ....cctctagcacagctcaggatatagg.cggtgcaattaggg 237
I I I I I I I I I I I I I I I I II II I I I I I I I I I I I I
3799 GTGCCCTCTAGTCCAGCTCAGGCAATGGGCCAGTGCAATCAGGGTCTGCC 3848
Figure 5.33c: The DNA sequence for the 5 ' portion of the Cyp2el gene present in
the 1.1 Kbp Hind 111 piece of the 4.8 Kbp Bam H 1 fragment sequenced from the
Hind III cloning site end. The mouse sequence (upper) was compared to the rat
CYP2E1 gene sequence (lower) using the GCG Gap alignment program and the
gapped similarity between the two sequences is 78.53%. The sequence corresponds to
a portion of the Cyp2el gene within intron 2.
205 TTTAGACACAGTAAATACCAAAACATTATTTATTGAAGAAATGATGGTAG 156








Figure 5.33d: The DNA sequence for the 5 ' portion of the Cyp2el gene present in
the 4.8 KbpBam H I fragment showing the second Hind III (H) site of the 1.1 Kbp
Hind III fragment, close to theBam H I (B) original cloning site. The mouse sequence
(upper) was compared to the rat CYP2E1 gene sequence (lower) using the GCG Gap
alignment program and the gapped similarity between the two sequences is 81.54%.
The sequence corresponds to a portion of the Cyp2el gene within intron 2.
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GAAACGTAAGAGAAGTGGTGGGGAAGAGGATAAAGAAAAAGAAGGACTCC 106
I I I I I II I I I I I I I I I II I II I I I I
AACAAGGAGTAGGGAGGTGTTAAAGAAAGAGAAAGACCCC 4523
H
TGGAGTGTAGAGGGACCAGAGGGCTTTGCTAGGCAAG. CTTGGGTAGGAC 5 7




I II I I II I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TGGGCAGGGCTGTCCCTGGATACCTTGAACTGGTTCCAAGGGGATCCAAA 4623
Section 5.9: Targeting a disruption event in the Cyp2el gene
Understanding both the true contribution Cyp2el makes to processes such as
nitrosamine induced carcinogenesis as well as its possible endogenous gluconeogenic
role in the context of the whole organism is very difficult. In vitro studies employing,
for example, purified Cyp2el protein, or Cyp2el protein heterologously expressed in
bacterial or yeast systems would allow the assay of the mutagenic and metabolic
activities of the enzyme in abstraction and only in respect to the particular chemical
employed in the assay; the relevance of this data to the in vivo role of the enzyme can
always be easily questioned.
One potential approach to overcoming the difficulties associated with these methods of
analysing the role of Cyp2el would be to generate an animal system within which the
Cyp2el gene had been functionally deleted. Such an approach involves the "targeting"
of the Cyp2el gene by a homologous piece of DNA, potentially either disrupted or
rendered nonsensical, and so generating in turn a non-functional Cyp2el gene in the
genome as a result of a homologous recombinational event.
Although theoretically possible in any organism, the frequency at which homologous
recombination occurs in a particular species varies dramatically. Very high rates of
homologous recombination are seen in yeast cells whereas very low rates are
experienced in mammalian cell systems. The technique of gene-targeting to date has
only been applied in mammalian systems in the mouse, because this is the only species
for which pleuripotential cell lines capable of re-integrating into the embryo following
manipulation have been established (Evans et al., 1981; Jasin & Berg, 1988). Using
this approach it is now possible to generate heritable changes within the genome
allowing the potential generation of a mouse with virtually any desired genotype; this
approach has been successfully employed on around thirty genes (Capechi, 1990;
Frohman & Martin, 1991). Using such an approach it would be potentially possible to
study the effect which the loss of the Cyp2el gene and its cognate protein would have,
not only on the carcinogenic properties of certain chemicals such as the nitrosamines,
but also to assess the possible endogenous role of the enzyme through the
gluconeogenic behaviour of the animal not expressing the protein in starvation or
chemically induced diabetes.
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Section 5.9.1: General recombination, the mechanism by which homologous
recombination occurs
Although it is possible to introduce very precise changes into the genome of an
organism by a process of sequence homology driven gene targeting, the mechanisms
by which these processes occur are still not completely understood. General
recombination within eucaryotic cells, that is recombination dependent on the sequence
homology between two sequences and not on specific sequence motifs generating
recombination, occurs at meiosis, mitosis, and during DNA repair. The result of this
general recombination can either be the reciprocal exchange of two double-stranded
molecules,"crossing-over", or a non-reciprocal process of "gene-conversion", in which
information is passed from one duplex to another in one direction only.
Most of the information on these general recombination processes has been gained from
studies in yeast and other fungi and the reactions have a common theme in which a free
end of single-strand of DNA invades a homologous region of double stranded DNA to
produce a joint molecule. This intermediate joint molecule passes through various
intermediates leading to cross-exchanges of DNA which finally resolves, resulting in
various permutations of DNA exchange (Holliday, 1964). Similar processes have now
been shown to occur as the result of double-strand initiated breaks and invasions of
homologous DNA stretches (Orr-Weaver et al., 1981). The enzymology and relative
importance of the two general recombination patterns in vivo in yeast systems are not
well understood.
The enzymology of recombination in bacteria, principally E. coli, has been more fully
elucidated however and parallels have been drawn between these processes and those
observed in yeast and other eucaryotic cells (Smith, 1989).
Studies in mammalian cell culture systems have provided information on the
mechanisms of recombination in higher eucaryotes. Extrachromosomal recombination
has been studied in tissue culture systems by assaying for the regeneration of selectable
markers. For example recombination can be assayed by the generation of a functional
neomycin resistance gene as a result of homologous recombination between two non¬
functional neomycin resistance genes mutated at different sites; subsequent selection of
the cells then shows the numbers in which homologous recombination has occurred
(Bollag et al., 1989). These studies have shown that there is measurable homologous
recombination with as few as twenty-five base-pairs of homology between sequences
and that the frequency of recombination increases as the extent of the homology rises.
The increased frequency of recombination with increased DNA fragment size is
however biphasic suggesting that at least two recombinational mechanisms are
operating in mammalian cells with one operating predominantly on DNA fragments
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below 150-400 base-pairs in length and one above this size transistion (Rubnitz &
Subramani, 1984; Ayares et al., 1986). The introduction of a double-strand DNA break
in the sequences used in these studies leads to an increase in the frequency of
recombination as does the inclusion of a transcriptionally active piece of DNA into the
target fragment. These results suggest that there is a role for the opening of the DNA
duplex, or relaxation of the chromatin environment, in the establishment of the
recombinational processes (Nickoloff & Reynolds, 1990).
Inter-chromasomal recombination in mammalian cells has been studied using a similar
approach to that used to analyse extra-chromosomal recombination. The introduction
of selectable markers containing various complementable mutations into the genome of
tissue culture cell lines allows the selection of cell lines in which a productive
homologous recombinational event has occurred. The frequency of homologous-
recombination observed in these experiments is lower than that obtained in similar
studies on extra-chromosomal recombination. However, as observed in extra-
chromosomal recombination studies there is a increased frequency of recombination as
the fragment size increases with a requirement of between 134 and 232 base-pairs of
homology before any recombinational events are detected (Bollager al., 1989; Liskay et
al., 1987; Waldman & Liskay, 1988). The introduction of non-homologous sequences
into the region of homology reduces the level of homologous recombination suggesting
that above a certain size non-homologous stretches of DNA may effect the stability of
the recombining hetero-duplex (Waldman & Liskay, 1988; Letsou & Liskay, 1987).
As well as homologous recombination, non-homologous recombination also occurs in
mammalian cells and this process is predominant; integration of non-homologous DNA
is thought to occur at the site of a chromosomal break and the levels of this type of
recombination are seen to be elevated on the generation of double-stranded DNA breaks
following treatment of the cells with ionising or DNA damaging chemicals (Perez et al.,
1985). The level of non-homologous recombination is in great excess of the level of
homologous recombination in mammalian systems. Overlaps between homologous and
non-homologous recombination processes have been proposed with common proteins,
such as the homologous pairing protein (HPP-1), for example, being capable of
catalysing either event (Fishel et al., 1991).
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Section 5.9.2: Gene targeting
By fusing the approaches used to study the processes of intra- and extra-chromosomal
recombination, the possibility of gene targeting was first investigated. The first
experiments using this technique studied the possibility of regenerating a selectable
gene marker by homologous recombination between a non-functional genomically
integrated marker and a complementing non-functional, non-replicative homologous
extra-chromosomal marker. These experiments gave ratios of non-homologous
targeting frequencies to homologous targeting frequencies in the range of 10~2 to 10"7
and integration frequencies of any type in the region of 10~3 to 10"7. Differences in both
the frequency of integration per se and the ratio of homologous to non-homologous
recombination were obtained depending on the cell type and the nature of the DNA
target employed. These differences presumably related to variations in the background
levels of general recombination present in the different cell types and the different
chromosomal locations of the various target sequences (Smith & Berg, 1984; Lin et al.,
1985). It was seen that the rates of homologous recombination did not increase, unlike
the frequency of random integration, with an increase in the amount of exogenously
added DNA, suggesting that the location of the homologous stretch of DNA in the
genome was not the rate limiting step (Thomas et al., 1986). Many studies on the
generation of homologous recombinational events within endogenous genes exploited
the use of the selectable hypoxanthine-guanine phosphoribosyl transferase gene
(HPRT) as a target locus. Disruption of the HRPT gene generated resistance to the base
analogue 6-thioguanine and so no other external selection system needed to be applied;
the HPRT gene also had the advantage of being on the X chromosome and so deletion
of one copy was all that was required to completely remove the gene from the male
genome. Deficiency of HPRT in humans is associated with severe mental retardation
which made it a prime candidate for pioneering medical gene replacement studies.
These cell culture studies showed that targeting frequency was accelerated by the
presence of double-stranded DNA breaks in the region of homology but that the
presence of large pieces of non-homologous DNA, up to 2.5 kilobase pairs, did not
substantially reduce the homologous targeting frequency (Valencius & Smithies, 1991).
Other studies targeted endogenous genes without an internal selection by interupting
the gene with a selectable marker. The first endogenous mammalian gene to be
modified by this approach was the fi-globin gene, the targeting vector contained the
neomycin resistance gene to act as a positively selectable marker for recombination. The
ratio of homologous to non-homologous recombination was 1:1000 yet it was also
observed that the same frequency of homologous recombination was observed in cell
lines expressing the gene, as those that were not (Smithies et al., 1985).
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Vectors employed in these experiments could either generate a replacement event
("replacement vectors") with a marker interrupting the homologous piece of DNA, or
they could generate an insertion event ("insertion vectors") where a marker sequence is
placed outside the homology seeking piece of DNA, requiring therefore a double cross¬
over event to occur in order to allow the disruption of the target gene. Both these vector
types were seen to operate with a similar frequency of homologous targeting, leading to
the suggestion that targeting operates not via initiation of a homologous DNA exchange
duplex at one site rather by following two separate cross-over events (Thomas &
Capechi, 1987; Ellis & Bernstein, 1989).
In order to allow an increase in the ease of selection of homologous as opposed non¬
homologous recombination events, a new type of targeting vector and method of
selection, termed "positive-negative" selection (PNS), were developed. These vectors
allowed the use of a positive selection marker, such as neomycin resistance, to
demonstrate that recombination had taken place, and also a negative selection marker to
select against the higher frequency of non-homologous recombination events (Mansour
et al., 1988). The negative selection is obtained by the incorporation of a selectable
marker such as the Herpes-simplex viral thymidine kinase gene (HSVTK) which, if
integrated into the genome of the recipient cell line, will render the cell sensitive to the
base analogue gancyclovir. This gene is placed outside the region of homologous DNA
being used to targeted the construct and so should be lost on resolution of homologous
recombination. In the case of a non-homologous recombination event however, the
HSVTK gene would be retained and integrated into the genome in conjunction with the
rest of the targeting vector and so non-homologous integration can be selected against.
The positively selectable marker is placed within the region of homologous DNA being
targeted and so is not necessarily lost in the event of either a correctly or incorrectly
targeted recombinational event. Thus the correct homologous recombinational event
between the incoming targeting vector and the host genome can be selected for by the
ability of the cell to withstand positive selection of neomycin, or G418, whereas the
non-homologous recombinational event can be selected against by the use of negative
selection by gancyclovir (Mansour et al., 1988). This selection system is summarised
in Figure 5.34.
In order to allow the regeneration of a complete mouse following a correctly targeted
homologous recombination event, the targeting and selection have to be carried out in
specific mouse cell lines capable of subsequently contributing to a chimeric mouse germ
line. Such a cell line, termed the "Embryonic Stem" cell line (ES), has been established
from a mouse embyro-derived teratocarcinoma; the ES cells are pluripotent and capable
therefore of contributing to the germ-line of a mouse if reintroduced, following
targeting manipulations, to the blastocyst (Evans et al., 1980; Bradley et al., 1987).
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Figure 5.34: The positive-negative selection strategy employed to target a disruption
event in the Cyp2el gene. Theoretically if the construct homologously recombines with
the Cyp2el gene in the genome the neomycin (NEO) gene should disrupt the Cyp2el
gene but the thymidine kinase gene (TK) should be lost as illustrated on the left. The
combinaton of these events should generate a cell resistant to neomycin but not
sensitive to gancyclovir. Conversely, as illustrated on the right, if the construct
integrates randomly into the genome although the cell is resistant to neomycin it is
sensitive to gancyclovir selection.
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Section 5.9.3: Constructing a Cyp2el positive-negative insertional gene targeting
vector
In order to attempt to generate a mouse line which did not possess a functional Cyp2el
gene, a positive-negative insertional gene targeting vector containing the 3' portion of
the Cyp2el gene was constructed. Cyp2el is unique in that it is a single copy gene
unlike many of the other subfamilies in the P-450 family 2 which have expanded
presumably as a result of gene duplication events. Cyp2el is therefore a feasible target
for gene deletion with the possibility of removing its enzymatic activity from the mouse
without the complication of closely related gene products phenotypically masking the
consequence of its loss.
The positive-negative (PNS) vector employed contained a positively selectable
neomycin gene (Stratagene), a yeast leu 2 selectable marker, and a negatively selectable
HSVTK gene on a backbone derived from the plasmid pBS and was the kind gift of
Drs D. Porteous and A. Brooks, MRC Human Genetics Unit, Edinburgh; collectively
this plasmid was termed pHRPNSxic- The yeast leu 2 selectable marker gene was
incorporated into the vector to allow the possibility of the use of the vector in the
generation of yeast artificial chromosomes (YACs). A vector was constructed using
sequences from the 3' end of the Cyp2el gene which had previously been cloned
(Section 5.8.3). The 3' region of the Cyp2el gene was chosen as it encodes a region of
the Cyp2el protein that, on alignment with the known structure of the bacterial
P-450cam, contributes to the binding of the haem prosthetic group (Section 5.3.5).
Therefore, disrupting the protein around this area, even if a truncated protein was
generated, would lead to the production of a non-haem containing Cyp2el apoprotein
which would not be capable of catalysing any of the reactions normally undertaken by
Cyp2el. Portions of the Cyp2el gene downstream of exon 9 are not suitable for
incorporation into a PNS vector; inclusion of the [32 SINE present in the 3' UTR of the
Cyp2el gene in the PNS vector would complicate the selection system as it would
potentially lead to the insertion of the targeting sequence at any of the several thousand
(32 SINE sequences scattered throughout the genome (Section 5.4.1). The restriction
endonuclease sites present within the pHRPNSxK vector did not correspond to any that
were naturally available within the 3' fragment of the Cyp2el gene and so the pieces to
be used in the construct were generated by the polymerase chain reaction (PCR). In this
manner, two Cyp2el derived PCR fragments, one containing exon 7, intron 7, and a
5' portion of exon 8 (around 600 base-pairs in length) with Xbal and Sail restriction
endonuclease sites, and the other containing a 3 ' portion of exon 8, intron 8, and exon
9 (around 1000 base-pairs in length) with BamH I restriction endonuclease sites were
generated (Figure 5.35). The regions of the Cyp2el gene spanned by these fragments
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contained a 50 base pairs deletion in exon 8 which effectively truncated the Cyp2el
protein at leu 396 and led to the loss of the highly conserved pocket around the haem
binding cys 435 (Section 5.3.2). The fragments were subcloned into pTZ18 R and
pTZ19 R phagmids and sequenced confirming them to be the expected regions of the
Cyp2el gene. The fragments were initially subcloned into the phagemid vectors in this
manner to ensure that the PNS vector contained clonal fragments and also to exploit the
a-complementation selection system (Section 2.11.7a) available in the phagemids but
not possible in the pHRPNSxK vector.
The exon 7, intron 7 and 5' portion of exon 8, Xbal/Sall fragment was then
directionally subcloned from the phagemid into the Xbal and Sail restriction
endonuclease sites of the pHRPNSxic vector; recombinant colonies were selected by
colony hybridisation using the subcloned exon 7, intron 7 and 5' portion of exon 8 as a
probe. This leads to the 5' portion of exon 8 being interupted by the neomycin
resistance gene. The 3' exon 8 portion, intron 8 and exon 9 BamH I restriction
endonuclease site fragment was then subcloned into the exon 7, intron 7 and 5' portion
of exon 8 containing pHRPNSxK construct and recombinant clones selected by colony
hybridisation using the subcloned 3' exon 8, intron 8 and exon 9 fragment as a probe.
Clones which contained the correctly orientated exon 8, intron 8 and exon 9 BamH I
restriction endonuclease site fragment were then assessed through the use of PCR in
conjunction with the oligonucleotides originally employed to generate the Cyp2el
fragments. If the oligonucleotides to the 5' of exon 8 and the 3' of exon 9 were
employed in the reaction, only those clones which contained the correctly orientated
BamH I fragment, that is with the exon 8 portion adjacent to the neomycin resistance
gene, would generate a product, which now will also contain the neomycin resistance
and leu 2 genes. The completed correctly orientated vector was termed pHRPNSxK
Cyp2el; this was then digested with XbaUSaR, and BamH I restriction endonucleases
separately and as a triple digest to release the various Cyp2el components and analysed
by Southern blotting, and probed with the two Cyp2el fragments used in the










Figure 5.35: The generation of the pHRPNSTKCyp2el construct. A: The portions
of the Cyp2el gene amplified from the 3 ' Bam H I Cyp2el genomic clone, annotated
a's follows: c: Control reaction with no DNA template in the reaction mixture, the 7
other tracks are as indicated and contain the portions of the Cyp2el gene used in the
pHRPNSjKCyp2e 1 construct. The final track represents the complete region of the
Cyp2el region amplified including all of exon 8 and was not employed in the construct.
Oligonucleotides
Restriction site Region annealing to Cyp2el exons
5 ' Exon 7: TCGAATCTAGA GAAACTTCATGAAGAAATTGACAGGGTTATT
5 ' Exon 8: TCGAAGTCGAC GGAGTCCAGAGTTGGAATCACAACTGTACC
3 ' Exon 8: TCGAAGGATCC GCATTTCCTGAATGAAAATGGGAAGTTCAA
3 ' Exon 9: TCGAAGGATCC GGGATACTGCCAAAGCCAACTGTGACAGG
B: A diagram of the final pHRPNSTKCyp2el construct illustrating the restriction sites
relevant to the generation of the pHRPNSfKCyp2el construct and its linearisation prior
to electroporation into ES cells (TK: thymidine kinase gene. NEO: neomycin
resistance gene). The diagram is not to scale and the arrows above the Cyp2el




C I.XON 7 TO r.XON 8 EXON S TO EXON 9 l.XON 9
Figure 5.36: Restriction endonuclease confirmation of the final pHRPNSxKCyp2e 1
construct. The completed pHRPNSTicCyp2el construct was subjected to single,
double or triple restriction endonuclease digestion as indicated (B: Bam H 1. X: Xba I.
S: Sal I ). The construct generated the expected DNA fragment pattern following
separation on an agarose gel (See Figure 5.35) and was transferred to a nylon
membrane.The membrane was probed with radiolabeled DNA fragments
corresponding to exon 7 to 8 (EX 7/8) and exon 8 to 9 (EX 8/9) of the Cyp2el gene
(the fragments of the Cyp2el gene present in the pHRPNSxKCyp2el construct) and
annealed to the expected DNA fragments.
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Section 5.9.4: Transfection and positive negative selection of the pHRPNStk
Cyp2el construct in Embryonic Stem (ES) cells
DNA preparations of the pHRPNStk Cyp2el vector were digested with the restriction
endonucleases Xbal and Sstl to release the neomycin resistance gene interupted Cyp2el
gene fragment and the flanking HSVTK gene (Figure 5.35). The DNA was then
electroporated into ES cells. Positive-negative selection was applied and 16 clones
survived both the positive, neomycin, and negative, gancyclovir, selection; genomic
DNA was isolated from these clones (Section 2.23.8). These manipulations were
performed in colaboration with Dr J. Dorin, MRC Human Genetics Unit, Western
General Hospital, Edinburgh.
Section 5.9.5: Screening for correctly targeted pNSxicCyp2el in the ES cell line
The genomic DNA isolated from the sixteen ES clones which survived both the positive
and negative selection steps were analysed to see if any had arisen from a correctly
targeted homologous recombination event using a PCR assay. A PCR assay was used
for the screening of the clones due to the limited amount of genomic DNA available
after the selection process and the relatively small fragment sizes of the Cyp2el gene
which needed to be amplified; such an approach has led to the successful detection of
gene targeting in several studies (Kim et al., 1988; Zimer & Grus, 1989; Joyner et al.,
1989; Smithies et al., 1989; Sanona et al., 1991). Optimal PCR conditions were
assessed for the spooled DNA samples obtained from the ES cell clones using
oligonucleotide primers which anneal within intron 6 and exon 8 of the Cyp2el gene.
These oligonucleotides generate an approximately 650 base-pair fragment resulting
from the amplification of portions of the Cyp2el gene both inside and outside the areas
used in the generation of the pHRPNStk Cyp2el construct. When the best conditions
for the reaction had been obtained (Section 2.10.2), the exon 8 primer was replaced
with an oligonucleotide primer which annealed to the 3' region of the yeast leu 2 gene.
Only DNA from the clones in which the pHRPNStk Cyp2el construct had correctly
targeted the Cyp2el gene would generate a PCR product from this primer set, as in the
normal mouse genome such a juxtapositioning of sequences does not occur. No
products however were generated from these or several variations of the
oligonucleotide primer sets both to the leu 2 and neomycin resistance genes and other
regions of intron seven. Using oligonucleotide primers to the 5' coding region of the
neomycin gene and the leu 2 gene it was seen that PCR products were generated
suggesting that the pHRPNSxK Cyp2el construct had somehow inserted
non-homologously into the genome of the surviving ES cell clones; these products
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were larger than expected and this observation suggested that modification and
concatermerisation of the construct had occurred, either during or following integration
into the genome. The fact that a product was generated by the intron 7 and exon 8
oligonucleotide pair suggests that the failure of the intron 7 and Leu 2 oligonucleotide
pair to do so was not due to an inability to amplify this portion of the genome and it is
more likely that no correctly targeted recombinational event had occurred (Figure 5.37).
Section 5.9.6: Possible reasons for the non-targeted pHRPNSxK Cyp2el construct
integrations and future improvements to the Cyp2el deletion system
Although employing a PNS system in using the pHRPNStk Cyp2el construct
theoretically should increase the frequency of homologous recombination events,
several observations as to why non-homologous integration of the construct may have
occurred have been noted.
In several studies the HSVTK gene was seen to become mutated before or after random
integration making the cells in which this has occurred resistant to gancyclovir and
appear phenotypically to have undergone a homologously integration event although the
HSVTK portion of the gene is not physically lost. It has been suggested that the
inclusion of two HSVTK genes into the constructs may reduce the problem associated
with the selection of a mutated integrated from of the construct (Mansourer al., 1988).
A marker variation in the frequency of correct targeting events occurred depending on
the nature of the target locus; the correct targeting of the int-2 gene for example was
seen to be around twenty-fold lower than that for the HPRT gene using effectively
similar constructs. It was suggested that this difference in targeting frequency related to
the relative transcriptional levels of the target genes; int-2 is expressed at very low
levels, whereas the HRPT gene expression is relatively high in ES cells which may
produce an effect on the nature of the chromatin surrounding the target locus.
Potentially if the target locus is not expressed the chromatin associated with it may be
highly compacted either lowering the ability of the recombinational machinery to locate
and initiate the exchange between the incoming construct DNA and the genome, or the
ability of the transcriptional machinery to generate transcripts from either the positive or
negative selection markers (Mansour, 1988). Cyp2el message could not be detected in
mouse embryonic RNA (kind gift, Dr. R. Hill, MRC Human Genetics Unit,
Edinburgh) using the 800 base-pair Cyp2el partial cDNA as a probe, and studies on
the CYP2E1 gene in other species suggest that the gene is not transcriptionally active
prior to birth ( Umeno et al., 1988; Bonfils et al., 1990; Jones et al., 1992).
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Figure 5.37: Screening the 16 surviving ES cell clones for a gene targeting event in
the Cyp2el gene. A: The conditions for the PCR were established using
oligonucleotides to intron 6 and exon 8. B: The exon 8 oligonucleotide was replaced
with a Leu 2 3 ' oligonucleotide; the intron 6 oligonucleotide from the previous reaction
(A) was retained. C: The intron 6 oligonucleotide was replaced by an internal
oligonucleotide to the neomycin resistance gene; the Leu 2 oligonucleotide from the
previous reaction (B) was retained. Annotation: The 16 (1-16)ES samples are
indicated V: The pHRPNSTKCyp2el construct was included as a contol for the PCR.
DNA marker sizes are indicated in base-pairs.
Oligonucleotides:
Intron 6*: TTATCCCTATCTTGGCA Exon 8: Exon 8, 5 ' (Figure 5.28b)
Leu 2*: TCTATAAAGAACTTCGT Neo*: GGCAGCACCGGTCGGTG
"^Oligonucleotides were obtained, and assays performed, for both DNA strands.
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These observations suggest that the Cyp2el gene may not be transcriptionally active in
the ES cells and so the surrounding chromatin structure may not be conducive to the
generation of a recombination event. These observations relate directly to results gained
from studies of extra-chromosomal recombination where higher recombination
frequencies were noted if transcriptionally active portions of DNA were included in the
recombining fragments (Nickoloff & Reynolds, 1990). In contrast to these
observations, however, it was noted that the frequency of targeting of the P-globin
locus was independent of whether the cell type expressed the gene or not (Smithies et
al., 1985; Johnson et al., 1989).
Other reasons for the lack of a correctly targeted recombination event may lie in the
construction and nature of pHRPNSxic Cyp2el itself. In a series of experiments
studying the frequency of homologous targeting of the HRPT gene in ES cells several
inportant factors regarding the nature of the targeting construct have been identified.
Studies viewed the effects of the length of the homologous DNA used in the construct
and the level of sequence homology between the incoming extraneous construct DNA
compared with the genomic target DNA (Deng & Capecchi, 1992). The length of the
homologous DNA used in the construct strongly affects the recombination frequency
obtained; it was seen that 2 kilobase pairs of homologous DNA, similar in size to the
amount of homologous Cyp2el sequence used in the pHRPNSxKCyp2el construct,
produced a targeting frequency ratio of non-homologous to homologous recombination
between 10~6 to 10"7 whereas if the length of the targeting sequence is increased, the
efficiency increased up to a ceiling limit of around 14 kilobase-pairs, where the
recombination system appears to saturate at a recombination frequency of around 10~5.
Although in these experiments the smallest homologous fragment size used was around
two kilobase-pairs, other studies have successfully employed fragment sizes of less
than a single kilobase (Hasty et al., 1991). It is also apparent that extremely small
amounts of DNA can be handled by the homologous recombination system leading to
the generation of clusters of SINEs in areas of the genome, for example in the rat
growth hormone gene (Barta et al., 1981) or a human P-tubulin gene (Lee et al., 1984).
Therefore, in the case of the rodent P2 SINE family, the recombination system if the
same mechanism is employed in this instance as in other cases of general
recombination, is capable of homologously recombining DNA fragments as small as
150 base-pairs in length (Section 5.4.2). In intra-chromosomal recombination it was
suggested that two different recombination systems may operate with one recognising
smaller fragments (150 to 400 base-pairs of homology) and a different system
recognising fragments above this size limit ((Rubnitz & Subramani, 1984; Ayares et
al., 1986).
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The source of the DNA used to generate the construct is now seen to play an important
function in the level of homologous recombination achieved. If "isogenic" DNA, that is
genomic DNA from the same mouse line as that from which the ES cells were derived
(C129), as opposed to non-isogenic DNA is used in the construction of the targeting
construct then around a twenty-fold increase in targeting efficiency is observed. The
base differences between the HPRT gene in the CC1.2 genome and the BALB/c and
Swiss-Webster mice lines were only around 1% different yet still this led, at a targeting
fragment size of two kilobase-pairs, to a shift in the efficiency of homologous
recombination frequency from 10~6 (isogenic) to nearer 10~7 (Deng & Capacchi, 1992);
similar levels of increased recombinational efficiency were also reported for the
targeting of the retinoblastoma gene by isogenic as opposed to non-isogcnic DNA
fragments (teReile etal., 1992 ). It is seen in bacterial recombination that the process of
exchange of DNA between two homologous regions is edited by a mismatch repair
enzyme system which leads to the termination of the crossing-over event if too many
mismatches are detected between the two sequence fragments (Rassiguier etal., 1989;
Shen & Huang, 1989); it is possible that a similar system may be operating in
mammalian homologous recombinational processes. The presence of stretches of totally
non-homologous DNA adjacent to the targeting sequence however does not appear to
greatly effect the targeting efficiency, suggesting that a mismatch system may operate
only when the DNA fragments in question show a certain level of homology (Mansour
et al., 1988 ).
It is possible that strain differences between the BALB/c derived Cyp2el fragment
used in the pHRPNSxK Cyp2el construct and that portion of the Cyp2el gene in the
CI29 genome may contain sequence divergence particularly within the intronic regions
not so highly conserved by coding restraints. This may lead to a decrease in homology
levels between the ES Cyp2el gene and those portions present on the targeting
construct.
Studies have shown that the frequency of homologous recombination is not affected by
the presence of as much as 12 kilobase-pairs of adjacent non-homologous DNA
(Mansour et al., 1988 ). These observations suggest that the large pieces of non¬
homologous DNA may become looped out from the homologous hetero-duplex during
recombination; studies in this area in intra-chromosomal recombination however have
suggested that the insertion of large stretches of non-homologous DNA may reduce the
frequency of recombination (Letson & Liskay, 1987). It is not clear therefore whether
the effect of the inclusion of the non-essential leu 2 gene in the pHRPNSjK Cyp2el
construct as well as the neomycin resistance gene would be expected to have any effect
on the potential targeting efficiency of the construct.
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Section 5.9.7: The generation of a more efficient Cyp2el targeting construct
It is clear that the data surrounding the factors affecting the most efficient approach to
generating a successful homologously recombining targeting vector are not clear and
that disparities arise particularly between the data obtained on gene-targeting per se and
data on intra- and extra-chromosomal recombination studies in tissue culture.
The lack of successful targeting of the Cyp2el gene by the pHRPNSxK Cyp2el
construct could be attributed to a variety of potential shortfalls in the original vector's
construction, or problems associated with the Cyp2el gene itself; if the problem lies in
the targeting construct then this can be more easily remedied.
It is clear that the use of isogenic ES genomic DNA has a marked effect on the
frequency of targeting; screening and recloning the Cyp2el from a genomic library
prepared from isogenic DNA would therefore be the first step in preparing a new
Cyp2el targeting construct.
Although the rationale behind the use of the 3' portion of the gene, based on the
presence of the haem binding region of the Cyp2el protein appears logical, it is now
clear that in a new construct the increase in the size of the Cyp2el gene employed in the
targeting construct to around 14 kilobase-pairs, the seeming saturation point of the ES
cells recombination system, may increase the targeting efficiency. It is of note however
that successful targeting has been reported with homologous DNA fragments smaller
than those used in the original pHRPNSxK Cyp2el construct (Hasty et al., 1991).
This size extension however, given that the coding region of the Cyp2el gene is
approximately 11 kilobase-pairs in length, would have to be extended 5' of the gene to
avoid the inclusion of the J32 SINE element in the 3' UTR of the gene. Such an increase
in Cyp2el insert size would also necessitate the characterisation and sequencing of the
entire Cyp2el gene both to identify restriction endonuclease sites, and to ascertain that
no more SINE or other repetitive DNA elements were present.
In order to circumvent the selection of integrated non-functional mutated HSVTK
genes, the inclusion of more than one copy of the gene may be necessary in a
potentially more successful Cyp2el targeting construct. Other methods of selection are
now being developed which may alleviate the problem of the selection procedure also
selecting mutated vectors; one such approach is to use genes within the constructs
which encode markers detectable by fluoresence activated cell sorting (FACS). This
selection approach also removes the need to use markers conferring the ability to grow
on medium which encourages the selection and clonal expansion of inactivating
mutations within negative growth markers. A FACS selection approach also is more
immediate, rather than requiring clonal expansion of surviving cells over a period of
several days and the cells can be sorted as soon as a suitable time period to allow
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marker expression has elapsed; to date however this approach has not yet been
successfully applied in ES cells (Jasin et al., 1990).
As the Cyp2el gene appears not to be expressed in the mouse embryo and the human
and rat CYP2E1 gene is seen to be transcriptionally inactive embryonically, the
chromatin structure around the gene may be highly compacted and structured making it
unavailable to the recombinational machinery of the cell. If the problem in the lack of
successful targeting of the Cyp2el gene does lie in the nature Cyp2el gene itself, no
amount of targeting vector modification may surmount this obstacle.
Section 5.10: Summary
The results from the analysis of the Cyp2el subfamily in mouse illustrate the high level
of conservation between the Cyp2el gene and predicted amino acid sequence and the
orthologous CYP2E subfamily members from a variety of species. This high degree of
conservation suggests that the CYP2E subfamily may perform similar functions and
may potentially be regulated in a similar manner at a molecular level in a variety of
species. These observations could be argued to validate the use of experimental animal
systems to characterise both the potential behaviour, and the regulation, of the human
CYP2E1 gene.
Although clearly unsuccessful in their stated objectives the two approaches adopted to
enable the true role of the CYP2E subfamily in the initiation of carcinogenesis
following exposure to CYP2E subfamily substrates are informative for future studies.
Although it has been suggested that a stochastic balance must be struck to generate
efficient holoenzyme generation of Cyp2el protein in bacterial systems the fact that
Cyp2el holoenzyme is produced in S. cerevisiae can be further exploited. By
increasing the levels of Cyp2el produced in this system a role for the CYP2E
subfamily in the metabolism and activation of a series of environmental carcinogens
could be established.
By improving the targeting system for the Cyp2el gene using some, or all of the
suggestions made, it is possible that the Cyp2el gene could be removed from the
mouse genome. Such an event would allow the establishment of a Cyp2el null-mouse
line and the role of the CYP2E subfamily could be established in abstraction. This
approach to study the role of the xenobiotic metabolising P-450 is potentially extremely
powerful and will almost certainly be exploited successfully in the future.
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Chapter 6: Summary and Future work
Section 6.1: Characterisation of the mouse Cyp2el subfamily and the in vivo
regulation of the CYP2E subfamily, and other components of the xenobiotic
metabolising system.
The molecular characterisation of the mouse Cyp2el cDNA and gene clearly
demonstrated the high level of conservation present in the CYP2E subfamily; the level
of conservation suggests that the Cyp2el enzyme may be expected to catalyse similar
reactions, and be controlled in a similar manner to those CYP2E enzymes characterised
in other species. The fact that the Cyp2el gene, in common with the CYP2E genes in
most other species studied, is present in a single copy is significant. Other subfamilies
of the P-450 family 2 have undergone an expansion in gene numbers suggested to have
been driven by their role in the metabolism of xenobiotics in the diet (Gonzalez &
Nebert, 1990; Matsunaga et al., 1989). The high degree of conservation and the
maintenance of a single gene in the CYP2E subfamily may reflect a more conserved,
possibly endogenous, role for this subfamily.
Studies on the regulation of Cyp2el in the mouse demonstrated clearly that the CYP2E
subfamily is subject to controls distinct from those observed previously to be operating
on other xenobiotic metabolising P-450 families. Cyp2el protein levels were
seen to be unchanged by chemicals such as phenobarbital, dexamethasone and
3-methylcholanthrene, which lead to elevations in the levels of other P-450. Cyp2el
protein, but not mRNA, levels were seen to be elevated by treatment with acetone; the
variety of the tissues in which Cyp2el protein was seen to be present and induced in,
coupled with the potentially damaging nature of the products of CYP2E subfamily-
catalysed reactions, has a clear implication for the ramifications of the role of the
CYP2E subfamily in carcinogenesis. In starvation it was seen that both Cyp2el mRNA
and protein levels were elevated; in both starvation and chemical induction it is thought
that pre-existing CYP2E subfamily proteins are stabilised (Song et al., 1989). The
endogenous agent for this action may be acetone, which is a substrate for the CYP2E
subfamily, and is produced as a result of elevated P-oxidation in starvation.
Future studies on the control of the Cyp2el subfamily in the mouse could analyse the
effect of the diabetic state. Although it is possible to chemically induce diabetes in the
mouse, strains have been identified which, in a similar manner to the BB rat,
spontaneously become diabetic, such as the non-obese diabetic (NOD) mouse (Makino
etal., 1980; Wicker et al. 1987).
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In studies on the effect of diabetes on a variety of xenobiotic metabolising enzymes in
the BB/E rat, it was demonstrated clearly that endogenous signals produce profound
effects on the activity of the xenobiotic metabolising system. The marked changes in the
levels of these enzymes seen in diabetes would not be expected if the induced P-450
are viewed solely in terms of their ability to catalyse the metabolism of xenobiotics.
However, by establishing possible roles for the P-450 enzymes as components of
either intermediary metabolism, or metabolism controlling signalling pathways, the
modifications in their levels observed in these situations can be rationalised.
In the observed elevations of the CYP2E and CYP4A subfamily levels it is possible that
the enzymes perform endogenous roles relating to the elevation of fatty acid
P-oxidation. In both these subfamilies it is possible to appreciate how an elevation in
the enzymatic activity in the starved or diabetic state may allow the more efficient use of
fuels by the body. The elevated CYP2E and CYP4A subfamily activities would allow
increased acetone derived gluconeogenesis, and the generation of gluconeogenic
products from P-oxidation respectively. Elevations in the other P-450 families seen
could also perform a similar, but as yet undefined, role leading to increased efficiency
in fatty acid metabolism. In this context it is of interest that the P-450 enzymes ofmany
present day unicellular organisms are involved in intermediary lipid metabolism, and a
similar role for the ancestral P-450 gene, from which the present day xenobiotic
metabolising P-450 may have evolved, has been proposed (Gonzalez & Nebert, 1990).
An alternative role for the rationale behind the elevations seen may relate to an
involvement of the P-450 enzymes in autocrine signalling. It is possible that the P-450
activities contribute to the generation of a co-ordinated switch in cellular metabolism in
the starved or diabetic state from glucose towards fatty acids as a fuel source. The
established involvement of P-450 in arachidonic acid metabolism (Fitzpatrick &
Murphy, 1989; Nebert, 1990) and the presence of the the CYP4A subfamily in the
pancreas, makes this an intriguing possibility.
Although the mechanisms for the transcriptional induction of the CYP1A genes
(Hoffman et al., 1991) and the CYP4A genes (Muerkoff et al., 1992) are becoming
more clearly understood and appear to involve inducible transcription factors from the
steroid hormone superfamily, the molecular basis for transcriptional activation of, for
example, some members of the CYP2B subfamily is still unclear. In the observed
transcriptional induction of both the CYP4A and CYP2B subfamilies the affinity of the
transcription factors for the inducing agents is very low; the inducing agents have been
suggested to mediate their actions indirectly via other signalling systems (Okey, 1990;
Gottlicher et al., 1992). The observed induction of a variety of P450 families in
diabetes, in which fatty acid levels are elevated, coupled with the very large number of
'orphan' steroid hormone receptors within a cell (O' Malley, 1990), suggest that the
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molecular basis for the changes seen in several of the P-450 subfamilies may be the
result of as yet uncharacterised internal-signalling, "paracrine", systems. The paracrine
systems may use fatty acid molecules themselves, or metabolites, as the biologically
active ligands. In this manner it is possible that the P-450 enzymes induced in diabetes
may be acting as sensors for changes in ambient fatty acid levels within the body.
When such changes are detected, the elevation of these enzymes and the increased
generation of P-450 derived fatty acid metabolites, may act as signals to create a
concerted shift in intermediary metabolism towards the use of fatty acids.
Future studies of the control of the CYP2E subfamily, and other components of the
xenobiotic metabolising system could further expand these observations and
suggestions. The proposed involvement of enzymes, such as the aldehyde and alcohol
dehydrogenases, in the propandiol gluconeogenic pathway (Koop & Cassaza, 1986)
make these components ideal candidates to extend the study of changes produced in
starvation and diabetes on xenobiotic metabolising enzymes. Such analysis may allow
the drawing together of enzymes of the xenobiotic metabolising system into an adaptive
response to endogenously sensed metabolic changes; this response may form the basis
for the induction of the xenobiotic metabolising enzymes resulting from the exposure to
certain lipophillic xenobiotics.
The roles of the P-450 enzymes in paracrine signalling pathways could be investigated
in isolated {3-cell preparations. Using the release of insulin as an assay, the effect which
general P-450 inhibitors, such as metyrapone, or isoform specific inhibitory antibodies
produced on the response of the cells to metabolic stimuli could be monitored.
An appreciation of the endogenous controls operating on the xenobiotic metabolising
system, whether they are vestigial or still metabolically pertinent, will allow a clearer
understanding of situations in which the injurious actions of this enzyme system will
become elevated.
Section 6.2: The molecular basis for the regulation of the CYP2E subfamily
The mechanism of substrate-induced CYP2E subfamily protein stabilisation
Chemicals which stabilise the CYP2E subfamily protein may potentially operate
through their ability to mimic the actions of acetone; acetone, produced as a result of
elevated fatty acid P-oxidation, may represent the endogenous substrate and controller
of the CYP2E subfamily protein stability (Song et al., 1989). Other than the
observation that CYP2E subfamily proteins are seen to be stabilised by a variety of
solvents, the molecular basis for this observation is unclear.
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It was suggested that the CYP2E subfamily proteins were subject to rapid proteolysis
as a result of phosphorylation of a serine residue. The actions of substrates and
hormones, such as insulin, were suggested to reduce the level of phosphorylation at
this site and so increase the stability of the CYP2E subfamily protein (Ingelman-
Sunberg et al., 1992). Experiments on mutant Cyp2el proteins lacking this proposed
controlling phosphorylation site did not however substantiate this postulate. Both
mutant and parental Cyp2el proteins were seen to accumulate to similar levels and to be
lost at the same time-point in the expression system used. These studies also indicated
that the suggested stabilising action of insulin on the CYP2E subfamily proteins may
just reflect an overall increase, or decrease respectively, in the levels of protein
translation and degradation within the cell.
The mutant Cyp2el protein expression system could be further characterised by a
reduction in the time that a "pulse" of Cyp2el protein is produced. This could be
achieved through the use of an inducible transient expression system and engineering
instability motifs into the 3' UTR of the Cyp2el mRNA.
The fact that P-450 proteins can become phosphorylated has been known for many
years; however to date this observation still appears to represent a phenomenon waiting
for a defined functional role, if indeed such a role exists. Although tantalising,
attempting to postulate a role for phosphorylation in the differential control of P-450
proteins suffers from an inherent lack of specificity. Nearly all family 2 P-450 proteins
contain the proposed "controlling" phosphorylation site, and it is difficult to appreciate
situations in which the cell could use such a post-translational change to modulate the
activity of an individual P-450 subfamily.
The potential role of regulated message stability and translation in the CYP2E subfamily
The elevation of CYP2E mRNA levels in starvation and diabetes has been suggested to
be the result of increased stability of the pre-existing CYP2E subfamily message (Song
et al., 1987). Two observations from this study suggest that this may not however
represent the mechanism by which the CYP2E subfamily transcripts are induced in
these situations:
i) studies in the BB/E rat demonstrated clearly that, in diabetes, the level of (3-actin
transcripts were elevated. The (3-actin gene had been used as a presumed invariant
transcription marker in the study to suggest that the CYP2E gene transcription level was
unchanged (Song et al., 1987).
ii) in the mouse it was seen that the Cyp2el transcript 3' UTR was interrupted by the
insertion of a P2 repeat sequence; in all non-oligomeric protein encoding transcripts
with regulated stability previously characterised, the motif controlling this parameter
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was seen to be located within the 3' UTR (Hod & Hansen, 1986; Owen & Kuhn,
1987; Levin et al., 1987; Bridges & Cudowski, 1989; Petersen et al., 1989). The
observation that Cyp2el mRNA levels were elevated in starvation suggests either that a
stabilisation event in the CYP2E subfamily is mediated as a result of a regulatory motif
elsewhere in the message, or that the elevation was the result of a modification in
another control parameter, possibly transcriptional.
To further corroborate these suggestions, future work must include transcription "run-
on" assays from nuclei isolated from starved or chemically induced diabetic animals.
These assays would compare the level of CYP2E subfamily gene transcription to that of
a gene, such as the microsomal GST, which has been demonstrated to be unchanged in
starvation or diabetes. The inclusion in these assays of a gene, such as
phosphoenolpyruvate carboxykinase (PEPCK), whose transcriptional activity is known
to be elevated in these states, would further substantiate the results from such analysis.
The observations that solvent-induction of the CYP2E subfamily led to a decrease in
mRNA but an increase in protein levels in some instances, and that CYP2E transcripts
were seen to shift to a higher Mr polysomal band following chemical treatment, led to
the suggestion that the CYP2E subfamily may be regulated by the translational initiation
rate of its transcript (Kim et al., 1990; Kim & Novak, 1990).
Analysis of the predicted RNA structures present within the 5' UTR of the CYP2E
subfamily transcripts revealed a conserved stem-loop and the presence of a conserved
NFkP recognition site sequence motif. It is possible that the rate of translation initiation
of CYP2E subfamily messages may be regulated by the differential binding of factors
at this site, as previously characterised in the control of ferritin mRNA translation
(Hentz et al., 1987; Rauoult et al., 1989; Brown et al., 1989). If this is the case then
this type of regulatory mechanism has previously been unreported in the P-450
superfamily.
The role of this 5' UTR element could be assessed through the coupling of the CYP2E
subfamily 5' UTR to the 5' region of a reporter gene, such as chloramphenicol acetyl
tranferase or luciferase, and studying the effect which solvent exposure produces on the
level of reporter protein activity. Alternatively the effect of known inducers of NFk(3
binding, such as exposure to oxidative stress, could be investigated (Meyer et al.,
1993). In this context it is of note that CYP2E1 protein levels were elevated on
exposure of rats to hyperbaric oxygen (Tindberg et al., 1989), analysis of the effect
which such treatment produced on the CYP2E1 message levels would also be of
interest.
3 14
Transcriptional regulation of the CYP2E subfamily
The similarity observed between the regulation of the CYP2E subfamily and
gluconeogenic enzymes, such as PEPCK, prompted the analysis of the possible
repressive action of insulin in the control of the transcriptional activity of the Cyp2el
gene. Although the HepG2 cell line supported basal transcription from the Cyp2el
promoter, this activity was unchanged by insulin. It is still not clear, for a variety of
technical reasons relating to the phenotype of the cells in which the assay was
conducted, whether this represents the true situation in the control of the CYP2E
subfamily in vivo.
Future analysis of the Cyp2el promoter could either be conducted in the rat H4IIE cell
line, previously seen to generate a reduction in PEPCK promoter activity following
insulin exposure, or in the the HepG2 line with the inclusion of constructs containing
insulin responsive PEPCK elements to demonstrate transcriptional modifications were
occurring in a control promoter element.
Other approaches could be adopted to demonstrate an involvement of metabolism
controlling hormones in the transcriptional regulation of the CYP2E subfamily. Foetal
starvation in utero has been demonstrated to induce gluconeogenesis which, like the
CYP2E activity, is only normally present post partum (Girard, 1986; Girard et al.,
1987). Using this approach, indirect evidence supporting a role for metabolic hormonal
control of the CYP2E subfamily could be obtained.
The molecular basis for the observed sexual dimorphism in Cyp2el protein levels in the
male and female mouse kidney could be analysed using the promoter obtained.
Through the use of portions of the Cyp2el promoter, in conjunction with nuclear
extracts isolated from male and female mouse kidneys, the elements in the promoter
contributing to the differential sexual control of this gene could be established using
band shifting assays.
Section 6.3: Assessing the role of the CYP2E subfamily in chemical mutagenesis
The attempts to establish bacterial and yeast systems expressing the Cyp2el protein to
allow the analysis of the role of the CYP2E subfamily in chemical mutagenesis were
not successful in their stated objectives. In bacterial expression systems, a balance
between production of excessive and insufficient protein levels was not achieved and
detectable haem incorporation in the apoprotein generated could not be detected. Given
the greater sensitivity of the bacterial system to chemical damage and the well
characterised mutagenicity assays available, the expression of active Cyp2el in this
system is desirable. Future analysis of this system could be undertaken empirically; by
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employing a variety of different Cyp2el constructs eventually active Cyp2el protein
may be generated. Alternatively it may be possible to exploit constructs previously seen
to generate active mammalian P-450 in bacteria. Through the insertion of a portion of
the Cyp2el cDNA into a vector containing the N-terminal region of a P-450 which had
been successfully expressed in bacteria it is possible that an active Cyp2el, retaining
catalytic integrity, may be produced.
Detectable levels of haem were seen to be present in S. cerevisiae expressing Cyp2el
protein. The levels ofCyp2el protein produced by this system could be elevated, either
by the modification of the context of the initiation methionine of the message, or by
inserting a portion of the Cyp2el cDNA into a vector containing the sequence encoding
the N-terminal membrane anchor of the endogenous yeast CYP51 P-450. Following
the generation of a unicellular tester strain with demonstrable Cyp2el activity towards
model substrates, such as /?-nitrophenol, a clear idea of the role of the Cyp2el protein
in the generation of chemical mutagenicity can be established.
By producing a mouse in which the Cyp2el gene had been removed by a homologous
targeting event the role of the CYP2E subfamily in carcinogenesis, by abstraction,
could elegantly be demonstrated. The characterisation of this experimental approach by
this study has highlighted the requirements which, assuming that the Cyp2el gene is
not refractory to a recombination event, future experiments may need to adopt.
The future Cyp2el targeting vector will require the cloning and complete
characterisation of the Cyp2el gene from a genomic library constructed from C129
mice so that the construct contains DNA fragments isogenic to the CI29 derived
embryonic stem cells. Through the inclusion of the whole of the Cyp2el gene, around
11,000 base-pairs, in the construct, the possibility of a successful targeting event will
be maximised as the size requirements of the recombinational machinery would be more
than adequately met. In addition by inserting several copies of the negative selection
gene into the construct, the selection of randomly integrated constructs with mutated
negative selection markers may also be diminished.
The generation of null-phenotype mouse strains in this manner, assuming that
recombination is physically possible, will almost certainly prove successful in the
future. These studies will allow the study of the loss of a particular P-450 isoform on
carcinogenesis, which has been exploited greatly in epidemiological studies in the
human (Wolf, 1989; Smith et al., 1992), to be applied in experimental animals.
Through the use of this approach the role of particular P-450 isoforms in the generation
of chemical carcinogenesis can move from reductionist approaches involving unicellular
organisms, with all the problems inherent in these systems, into the whole mammal.
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Appendix: Amino acid data and abbreviations used in this work
name code side group MW KD
alanine A ala -CH3 71..0 1 .8
cysteine C cys -CH2-SH 103..0 2 .5
aspartic acid D asp —CH2-COOH 115..0 -3 .5
glutamic acid E glu -CH2-CH2-COOH 129..0 -3 .5
phenylalanine F phe -CH2-phi 147.. 1 2 .8
glycine G gly -H 57.,0 -0 .4
histidine H his -CH2-imidazole 137.,1 -3 .2
isoleucine I ile -CH(CH3)-CH2-CH3 113. 1 4 .5
lysine K lys -(CH2)4-NH2 128. 1 -3 .9
leucine L leu -CH2-CH(CH3)2 113. 1 3 .8
methionine M met -CH2-CH2-S-CH3 131. 0 1 .9
asparagine N asn -CH2-CONH2 114. 0 -3 .5
proline P pro [N]-(CH2)3-[CH] 97. 1 -1 .6
glutamine Q gin -CH2-CH2-CONH2 128. 1 -3 .5
axginine R arg -(CH2)3-NH-CNH-NH2 156. 1 -4 .5
serine S ser -CH2-OH 87. 0 -0..8
threonine T thr -CH(CH3)-OH 101. 0 -0..7
valine V val -CH-(CH3)2 99. 1 4,.2
tryptophan W trp -CH2-indole 186. 1 -0..9
unknown X 0. 0 0..0
tyrosine Y tyr -CH2-phi-OH 163. 1 -1.. 3
MW: Molecular weight (Da).
KD: Kyte and Dooiittle assigned hydrophobicity index.
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DEDUCED AMINO-ACID SEQUENCE, PREDICTED STRUCTURAL FEATURES AND
PROPOSED SUBSTRATE BINDING RESIDUES OF MOUSE Cyp2e1
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Summary: The deduced amino sequence of mouse Cyp2e1 was obtained and areas within the
protein which may contribute to the binding of the haem and substrates were determined by
comparison of aligned CYP2E1 sequences with the crystallographically solved P450cam structure.
Introduction: Certain Cytochrome P-450 (P450) appear to be part of an adaptive response to
chemical challenge and exposure to a foreign compound may thus induce P450 species active in its
metabolism. Members of the CYP2E1/Cyp2e1 subfamily were shown to be induced by and metabolise
a variety of organic compounds for example acetone, chloroform and ethanol. This subfamily was also
shown to metabolise and activate several carcinogenic nitrosamines, for example N -
nitrosodimethylamine (NDMA), and hepatotoxins such as acetominophen, carbon tetrachloride and
benzene (Reviewed in [1]). To begin to study the role of this protein in xenobiotic metabolism in the
mouse and relate this to the role played in other species the cDNA encoding the Cyp2e1 protein was
cloned. Alignment of the deduced Cyp2e1 amino acid sequence and the CYP2E1 sequences of
other species in conjunction with the crystallographically solved structure of P450cam, (CYP101, [2]),
allowed the prediction of regions within Cyp2e1/CYP2E1 potentially involved in the haem environment
and the binding of substrates.
Materials and Methods: Partial Cyp2e1 cDNA clones were obtained from a C57BL/6 male liver
library in Agt11 using the full-length human CYP2E1 as a probe [3]. Using the partial clones as probes a
full-length Cyp2e1 clone was obtained from a BALB/c male liver library in AZAP II. Single-stranded DNA
was prepared from the clone and sequenced in both directions using the Sanger dideoxy-termination
method with a series of synthetic oligonucleotide primers. Sequences were compiled and analysed
using the GCG [4] and GeneJockey (Biosoft) software packages.
Results and Discussion: The deduced mouse Cyp2e1 amino acid sequence is illustrated in
Figure 1. The enzyme contains 493 amino-acids with a predicted molecular mass of 56, 781 Daltons.
The mouse sequence displayed 92, 77, 79 and 79% identity to the rat [3], human [3], rabbit gene 1
and gene 2 [5] CYP2E1 protein sequences respectively. The sequences of these CYP2E1 protein
sequences, rabbit CYP2C5 (a Progesterone 21-hydroxylase, [6]), and P450cam were aligned
according to the method discussed in Zvelebil et al. [7], This alignment allowed the prediction of
(x -helical regions of Cyp2e1/CYP2E1 by analogy to the crystallographically determined structure of
P450cam, shown horizontally boxed in Figure 1 using the nomenclature of Poulos et al. [2],
1) The predicted haem environment of Cyp2e1/CYP2E1: In P450cam the haem is sandwiched
between the L and I helices with the GGLDT (sequence around 244c, "c" donating P450cam amino-
acid number, in Figure 1.) forming the principal contacts. The corresponding haem contacts within the
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Figure 1: Mouse Cyp2e1, and rat, human, rabbit gene 1 and gene 2 CYP2E1, rabbit CYP2C5, and
P450cam sequences were aligned. Differences between the mouse Cyp2e1 and the CYP2E1 of
other species are shown and a consensus generated. P450cam structural elements are horizontally
boxed and labelled according to Poulos et at. [2], Predicted haem and substrate binding sites are
vertically boxed. The canonical cAMP dependant kinase phosphorylation site is indicated ***". Family 2
amino-acids are labelled to the left and right; numbered P450cam amino acids contain a "c" post-script.
predicted I helices of the Cyp2e1/CYP2E1 are AGTET. The haem propionate groups in P450cam are
surrounded by 5 hydrogen bond donors: R112c, R299c, H355c, Q108c, and D297c. Three of these
five bacterial residues contain aligned mammalian residues that could perform a similar function in
Cyp2e1/CYP2E1: R112c/R135, R299c/H369, and H355c/R434. Similar bonds could not be provided
by the aligned W131/Q108C and L367/D297c. The residues potentially contributing to the haem
environment are vertically boxed in Figure 1. it is interesting that a canonical cAMP dependent protein
kinase site (Indicated by *** and S129* in Figure 1.) is near to one of the analagous haem propionate
bonding R112c/R135 and the Q108c/W131 site, active as a bond donor in P450cam but not the
mammalian protein. The possibility that a potential phosphorylation event at S129 may affect
haem/P450 reductase interaction is intriguing but remains to be elucidated.
2) Amino-acids contributing to a putative Cyp2e1/CYP2E1 substrate binding site: Residues involved
in binding the P450cam substrate, camphor, were identified crystallographically [2], Residues making
major contacts with the camphor carbonyl oxygen atom and their corresponding mammalian
counterparts are: F87c/F106 in Cyp2e1/CYP2E1 but L106 in rabbit CYP2C5 and CYP2E1 gene 2,
Y96c/I114 and L244c/D295 in all the mammalian P450. Other contacts in the bacterial crystal occurred
at: T185C/R233 in Cyp2e/CYP2E but K233 in rabbit CYP2C5, V295c/S366 in Cyp2e1/CYP2E1 but
T366 in rabbit CYP2C5, V247c/F298 in Cyp2e1/CYP2E1 but G298 in rabbit CYP2C5 and D297/L368
in all the mammalian P450 aligned. In all but one case in the Cyp2e1/CYP2E1 family, F87c/F106 in all
Cyp2e1/CYP2E1 but L106 in rabbit gene 2, the putative substrate binding residues are invariant.
Cyp2e1/CYP2E1 substrates have been shown to vary between species, for example rat CYP2E1
metabolises pyrazole whilst mouse Cyp2e1 does not [8], The fact that different species
CYP2E1/Cyp2e1 metabolise different substrates yet putative substrate binding residues remain
invariant suggests that other as yet unassigned amino-acids may also play a role in determining the
enzyme s substrate specificity.
Acknowledgements: We thank Dr. F. J. Gonzalez for the full-length human CYP2E1 cDNA clone.
References:
[1] Yang, C. S., Yoo, J. S. H., Ishizaki, H. and Hong, J. (1990) Drug Metab. Rev. 22. 147-159.
[2] Poulos, T. L., Finzel, B. C. and Howard, A. J. (1987) J. Mol. Biol. 195. 687-700.
[3] Song, B. J., Gelboin, H. V., Park, S. S., Yang, C. S. and Gonzalez, F. J. (1986) J. Biol. Chem. 261.
16689-16697.
[4] Devereux, J., Haeberli, P. and Smithies, O. (1984) Nucl. Acids Res. 12. 387-395.
[5] Khani, S. C., Zaphiropoulos, P. G., Fujita, V. S., Porter, T. D., Koop, D. R. and Coon, M. J. (1987)
Proc. Natl. Acad. Sci. (USA) 84. 638-642.
[6] Tukey, R. H. and Okino, S. (1985) J. Biol. Chem. 260. 13347-13354.
[7] Zvelebil, M. J. J. M., Wolf, C. R. and Sternberg, M. J. (1991) Prot. Eng. 4. 271-282.
[8] Honkakoshi, P., Autio, S., Juvonen, R., Ruanio, H., Gelboin, H. V., Park, S. S., Pelkonen, O. and
Lang, M. A. (1988) Arch. Biochem. Biophys. 267. 589-598.
